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LAYOUT OZ XUZ THESIS
Volume 1 of the thesis contains the text for the lU 
chapters. All figures, tables , maps, references and 
appendices: are presented in a separate volume so that the
reader can refer to them while reading the text without 
having continually to turn back pages. Each chapter has a 
coloured first page for easy access, with a summary and 
contents. Each chapter from chapter 6 to 13 has a separate 
introduction, results and discussion for easy follow-up, 
and a general discussion of the entire thesis is presented 
in chapter lU. Figures, maps and tables are numbered 
sequentially for each chapter; for example, in chapter 5 
thare are tables 5-1 to 5.13- References are numbered 
sequentially throughout the thesis. The second volume also 
contains appendices of questionnaires used for baseline 
iata collection, a follow-up and coding schedule and a 
list of Midspan publications since 196&. Appendix D of the 
second volume contains a separate paper concerning 
national mortality trends, with emphasis on mortality 
trends from stroke, since 1950.
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ABSTRACT
Cardio-respiratory diseases and cancer are the most 
important causes of mortality and morbidity in west 
central Scotland. From 1972 to 197 6, more than 16,000 men 
and women were recruited to a well-population study 
(Renfrew and Paisley as part of Midspan) of cardio­
respiratory diseases and risk factors including 10,5^1 men 
and women aged &5-6& whose baseline casual blood glucose 
was measured. This population was **flagged” with the 
National Health Service Central Registry (NHSCR) and has 
been followed up for mortality. By 1986, sufficient deaths 
had occurred to allow an opportunity for epidemiological 
research. This study therefore 1) examined the quality of 
data available from the Midspan survey, 2) explored its 
use in answering a number of epidemiological questions, 
and 3) evaluated the potential for further follow-up 
studies.
1.The establishment and performance of the Midspan 
register for a longitudinal study has been evaluated. The 
initial survey had a response rate of about 80% but a 
major limitation of these data is that 30% of blood 
glucose values were not measured and there also appears to 
be a nine percent shortfall in various stages of the 
reporting of mortality events.
2.Variation in mortality risk has been examined while 
adjusting for seven crdiovascular disease (CVD) risk 
factors measured on recruitment (gender, systolic blood 
pressure (SBP), diastolic blood pressure (DBP) serum 
cholesterol, blood glucose, body mass index (BMI), and
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smoking) in „& BGri.es of age-adjusted- 'and multiple logistic . 
regression (MLR) analyses,
•.The sain.. aiE. m s  been to re-l'sst the hypothesis that.,-' 
. h . l & a  . casual bloofi glacose if; •- risk -• ffc’;or' fo?.. CVD..
lev .b«art disease (IHD), ih/oke . and all caiiEss
mott&lity. Ijnivsrxate "analj/sic showed that, 'excluding
known diabetics, individuals with blood glucose above the 
9.5th centile have a higher mortality rate than those in 
the lowest £> percent. Multivariate analysis showed that 
initial casual blood glucose level is a significant risk 
factor for subsequent mortality. Age, blood pressure,
cigarette smoking and gender were also significant 
predictors.
Most previously published studies of asymptomatic 
hyperglycaemia had only included males so it was decided 
that gender differences should be analysed in more detail 
by carrying out MLR analysis for males and females 
separately. High blood glucose level was a risk factor .for 
CVD mortality in both genders. It was also a risk factor 
for all causes, IHD and stroke mortality in women but not 
in men. Asymptomatic hyperglycaemia therefore shows to a 
lesser extent the same gender differentials in risk of 
mortality as have been demonstrated by studies carried out 
elsewhere amongst known diabetics. On the other hand,
repeating the original MLR analysis and allowing for 
interaction between gender and the other cardiovascular 
risk factors showed that the seven cardiovascular risk 
factors considered do not account for the overall gender 
difference in mortality rates.
Some other studies had suggested that blood glucose
22
ABSTRACT
level was associated with other CVD risk factors,
particularly with BMI, so it was decided to investigate
the extent to which the blood glucose level interacts with
BMI in the prediction of all causes and CVD mortality.
Associations between BMI and all causes deaths were U
shaped. There was no relationship between BMI and CVD
deaths, neither for normoglycaemics nor hyperglycaemics. 
The MLR analyses showed that BMI was not a predictor of 
cardiovascular deaths or of IHD deaths independently of 
the other risk factors. BMI was slightly negatively 
associated with overall causes of death and stroke deaths. 
This relationship depended on smoking as an interaction 
term for overall causes, and gender and age for
cerebrovascular disease deaths.
Lastly, as there was conflicting evidence in the
literature, the relative importance of SBP compared to DBP 
and other combinations of SBP and DBP in predicting the
risk of IHD and stroke mortality was re-examined. MLR
analysis was used to assess the comparative strength of 
SBP, DBP, mean arterial pressure (MAP), mean arterial
index (MAI) and pulse pressure (PP), for the prediction of 
IHD and stroke mortality after adjustment for the other 
CVD risk factors for both males and females. While all 
measures of blood pressure were associated with IHD and 
stroke mortality, the risk of IHD deaths was more strongly 
associated with MAI and SBP alone in both males and
females. SBP and DBP together, MAP and PP do not predict 
future IHD mortality better than SBP alone or MAI.
SBP and DBP are strongly correlated in both genders
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(r=0.66, P<0.001) but their relationship with stroke
mortality was different between males and females. In 
females the risk of stroke mortality was more strongly
associated with DBP; in males SBP and DBP have the same 
predictive strength of stroke death. These findings 
suggest that the predictive strength of SBP and DBP for 
stroke mortality may depend on age and gender.
3.The feasibility of following up a cohort through 
record linkage using the Midspan registry, community 
health index (CHI) and general practitioner (GP) records
has been assessed. Identification details of the Midspan
file were used to identify patients on the CHI. 937 (96%) 
out of 981 were identified and were asked to complete a 
questionnaire about their current diabetes status. Follow- 
up response to three sets of mailings totalled 80%. By 
contacting the GPs of non-respondents complete data was 
obtained for 903 (96%) people showing the feasibility of 
such follow-up studies. The cohort consists of 224 people 
in the top 5% of casual blood glucose distribution (>126 
mg/dl), 426 in the lowest 5% (<70 mg/dl), and 253 in the 
middle 5% (=90 mg/dl), all of whom did not have a
diagnosis of diabetes mellitus at the time of the initial 
survey in 1974-76. Life-table analysis was used to 
estimate a 12-14 year incidence of overt diabetes. This 
was 9 times higher in men and 15 times higher in women for 
those in the top 5% compared to the other two groups. The 
risk of diabetes in overweight persons was significantly 
higher when blood sugar was above 126 mg/dl. This study
has shown that despite some limitations in the data, the 
Midspan file has a unique potential to contribute to the
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epidemiology of cardio-respiratory disease with respect to 
both mortality and morbidity.
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PAPERS iN PREPARATION;available in manuscript form.
The work described in this thesis is in a stage of
advanced preparation for publication, as follow;
1.An epidemiological investigation of interaction between 
asymptomatic hyperglycaemia and body mass index in the 
prediction of cardiovascular mortality risk.
2.Fourteen year prospective population based study of
association between asymptomatic hyperglycaemia and risk 
of cardiovascular and all causes mortality in a middle- 
aged population in two Scottish town.
3.A prospective population based study of gender 
differential in mortality from cardiovascular disease and 
all causes in asymptomatic hyperglycaemics.
U . A n epidemiological assessment of the components of blood 
pressure as predictors of ischaemic heart disease
mortality in a middle-aged population in the west of
Scotland.
5.Systolic and diastolic components of blood pressure as 
predictors of stroke mortality in a middle-aged population 
in the west of Scotland.
6.A prospective population based study of gender 
differential in mortality from cardiovascular disease and 
all causes.
7.Trends in mortality from stroke in Scotland, 1950 to 
1986.
8.Community health index and general practitioner record 
linkage for cohort follow-up purposes.
9.Cohort follow-up using record linkage to measure the
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association between high casual blood glucose value and 
later development of overt diabetes in west of Scotland.
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TEE CHAPTERS
Chapter 1 outlines the Midspan Project, the data 
archive, its use and potential for further cardiovascular 
study, and reviews similar cohorts and population studies.
Chapter 2 reviews the literature and discussion of 
problems encountered in (a) determining associations 
between mortality and asymptomatic hyperglycaemia; (b) 
gender differentials in mortality from an epidemiological 
point of view and (c) the comparative importance of SBP 
and DBP in predicting IHD and stroke.
Chapter 3 outlines the study design to be used to 
test the operational hypotheses that;
any positive association between hyperglycaemia and 
cardiovascular disease mortality is independent of other 
cardiovascular risk factors;
there is no interaction between hyperglycaemia and 
BMI in prediction of all causes, CVD, IHD and stroke 
mortality;
SBP is a better predictor of IHD and stroke mortality 
than DBP or different combinations of SBP and DBP.
Chapter U describes the population and methods, 
including sample size, data collection method, definition 
of the study population and statistical procedures used 
during the course of study.
Chapter 5 describes the baseline situation, mortality 
pattern and mortality linkage used in Midspan.
Chapters 6 to 11 present the results and discussion 
of the different studies both descriptive and analytical.
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Chapter 6 contains results and discussion concerning 
the relationship of hyperglycaemia to cardiovascular 
mortality risk and interaction effects of blood glucose 
levels, with other cardiovascular disease risk factors.
Chapter 7 gives the results and discussion regarding 
gender differentials in mortality from cardiovascular and 
all causes in asymptomatic hyperglycaemics.
Chapter 8 contains results and discussion relating to 
the interaction between asymptomatic hyperglycaemia and 
BMI in the prediction of cardiovascular and overall 
mortality.
Chapter 9 presents the results and discussion 
relating to gender differentials in mortality from CVD, 
and all causes, in the cohort population under study.
Chapters 10 and 11 gives the results and discussion 
regarding an epidemiological assessment of SBP and DBP and 
derived combinations of them as predictors of IHD and 
stroke mortality.
Chapter 12 reviews the concept of medical record 
linkage and contains results and discussion regarding the 
feasibility of the follow-up of a cohort, through record 
linkage using the Midspan registry, CHI, and GP records.
Chapter 13 serves as an example of the feasibility of 
the long-term follow-up of a cohort using record linkage 
and contains results and discussion pertaining to the 
predictive value of a casual blood glucose measurement for 
subsequent progress to clinical diabetes. It also 
discusses whether in subjects with high blood glucose 
other characteristics such as BMI, gender, smoking, blood 
pressure and serum cholesterol are associated with the
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risk of deterioration to diabetes.
Chapter 111 includes a final general discussion and 
conclusions regarding the feasibility and practical
difficulties of this study, risk factors, methodology, and 
unanswered questions together with recommendations for 
future studies.
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■LILS.T- QE ABBREVIATIONS
ABI Atherothrombotic Brain Infarction
AMI Acute Myocardial Infarction
BMDP Biomedical Data Processing
BMI Body Mass Index
CHI Community Health Index
GI Confidence Interval
cm Centimeter
CVA Cerebrovascular Accident
CVD Cardiovascular Disease
DBP Diastolic Blood Pressure
EEG Electrocardiography
F Female
GP General Practitioner
GRO General Registrar Office
GTT Glucose Tolerance Test
hr Hour
IHD Ischaemic Heart Disease
ICD International Classifications of Diseases
ICL International Computer Limited
ISD Information Service Division
Kg Kilogram
M Male
m Metre
MAI Mean Arterial Index
MAP Mean Arterial Pressure
mg/dl Milligram Per Deciliter
MLR Multiple Logistic Regression
mm Millimetre
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LIST OF ABREVIATION
mmHg Millimeter of Mercury
mm/sec Millimetre per Second
MMR Mass Miniature Radiography
MRC Medical Research Council
NHS National Health Service
NHSCR National Health Service Central Registry
NS Not Significant
OD Odds Ratio
PLR Programme Stepwise Logistic Regression
PP Pulse Pressure
PYO Person Year of Observation
RR Relative Risk
SBP Systolic Blood Pressure
SD Standard Deviation
SHIPS Scottish Hospital In-Patient Statistics
SND Standard Normal Deviate
SOR Standardized Odds Ratio
SPSS Statistical Package for the Social Scien
USPHS U.S. Public Health Service
WHO World Health Organization
Yr Year
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SENEGAL BACKfiRQUNP QE MIDSPAN PROJECT
SUMMARY:The Midspan Health Project Is an epidemiological 
screening survey of about 30,000 men and women identified 
by occupational group or by census of the general 
population in the west of Scotland and directed toward the 
study of IHD, stroke, bronchitis, cancer and tuberculosis. 
The Renfrew and Paisley study is a part of the Midspan 
project consisting of a well middle-aged population based 
study. Long-term follow-up of the Renfrew and Paisley 
population has been achieved by continuous medical record 
linkage through the NHSCR for mortality and for ad-hoc 
studies with the Scottish Hospital In-patient’s statistics 
(SHIPS) for morbidity. Record linkage with the West of 
Scotland Cancer Registration Bureau and the local chest 
clinic has been set up to produce data related to the 
development of cancer and tuberculosis and other diseases 
of the chest. Although since late 1950 and early 1970, a 
number of large cohort studies of occupational and general 
populations were being recruited in many parts of the 
world, to study the role of risk factors in the aetiology 
of CVD, Midspan is undoubtedly a unique resource 
containing the only well general population survey carried 
out in the United Kingdom.
.Contents
1.1.Introduction
1.2.Review of Similar Cohort Studies 
1.3*History of Midspan Project
1.4.The Renfrew and Paisley Study
1.5•Principles, Aims, Objectives and Organisation of the 
Renfrew and Paisley Project 
1.6.Sampling Plan 
1.7-Sample Response
1.8.Baseline Survey Follow-up
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1.1.INTRODUCTION
Between 1972 and 1976 the Department of Community 
Medicine, University of Glasgow undertook to study the 
factors associated with the development of cardio­
respiratory disease and cancer and to determine the 
incidence and prevalence of tuberculosis by the long-term 
surveillance of a sample of the middle-aged population of 
Renfrew and Paisley, in west central Scotland. The study 
has been reported in various stages by Professor VM 
Hawthorne and others; key findings have been presented in 
various papers which are included in appendix C. However, 
it is useful to reconsider at this time the reasons for 
bringing the study into being and to prepare a systematic 
account of the major findings and to review similar 
studies. This chapter reviews this past experience as a 
prelude to the new programme of evaluation and original 
epidemiological studies.
Credit must be given to those people who have worked 
on the Midspan project over the years. But, of course, 
special credit must go to Professor VM Hawthorne as 
director of the study, and Dr. CR Gillis as co-director of 
the project, and Mr. D Hole and Mr. WH Gilmour as 
statisticians who brought together from the beginning a 
unique combination of medical and statistical competence. 
It is their contributions over many years that make this 
study possible.
1.2.REVIEW O E  SIMILAR COHORT STUDIES
A major goal of epidemiologic research is to identify 
factors involved in the aetiology of diseases to prevent
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or control such diseases. Arteriosclerotic CVD,
particularly IHD and stroke, leads to more deaths, 
disability, and economic loss than any other diseases in 
many industrialized societies since 1950. Recently, a 
tremendous amount of research has been devoted to examine 
the possible causes and pathogenesis of CVD. These 
researches have focused primarily on basic biological 
mechanisms and on improvements in medical care, but 
considerable research also has been done on the 
epidemiology of CVD and it is to that body of evidence 
that this section is directed.
In the late 19&0s, the great public health impact of
CVD was beginning to be appreciated, but little was known
about factors which put one at increased risk of the
disease. However, for a meaningfull policy to be
developed, it was imperative that these factors be
systematically studied and evaluated. For the first time,
the U.S. Public Health Service began to lay plans for a
longitudinal study of CVD to follow a large population of
people for many years. This study, initiated in
Framingham, Massachusetts, was soon followed by several
other large cohort studies of occupational and general
populations in America, Europe and other parts of the
world primarily to investigate the role of risk factors in
the aetiology of CVD. In USA, results from Framingham,
t'Albany, Chicago, Los Angeles, Minesota, and Tecumseh 
studies eventually combined into the so-called Pooling 
Project. In England, the Whitehall study of male civil 
servant started in the late sixties and in Scotland the
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Midspan study, involving both occupational and general 
populations was initiated in the mid sixties. In the U.K., 
Midspan is undoubtedly a unique resource containing the 
only general well-population survey carried out. In this 
section I have attempted to review briefly the important 
epidemiological studies of CVD before describing the 
Midspan study in detail.
The Whitehall Study (1) is a screening survey for 
cardiorespiratory disease and diabetes among 18,k 03 non­
industrial male civil servants aged k0-6tl years in 1968- 
70, representing a 77# response of those eligible. The 
department of medical statistics and epidemiology, London 
School of Hygiene and Tropical Medicine, undertook 
clinical measurements and carried out the trial of smoking 
prevention measures. The department of medicine, Guy’s 
Hospital Medical School, had responsibility for the 
biochemical aspects of screening and for the trial of 
therapy in those with raised blood sugar.
The Busselton Survey (2) is a study of a total rural 
community in Western Australia. In 1966, based on a census 
of residents from recent electoral rolls, invitations were 
sent to 3,719 adults aged 21 and over in the defined 
population asking for their participation in a screening 
survey aimed at a description of disease prevalence and at 
early detection of chronic disease, particularly of 
cardiovascular disease. Screening was conducted in a 
concentrated period of 2 weeks, and 3. &10 adults attended 
(91# response rate), with complete records obtained for 
3.331.
The Glostrup Population Studies (3) are extensive
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health surveys of a total population aged exactly 40, 50,
60, 70, and 80 years old. When the study of 50 year olds
was Initiated In 1964 the main purpose was an 
investigation of risk factors for IHD in men and women. 
The seven municipalities chosen for the investigation are 
in the western suburbs of Copenhagen. The region has 
experienced the change in Danish society from agriculture 
to industry. In 1964 the area was fairly representative of 
the total Danish population at that time in terms of 
occupation and distribution of other major socio-economic 
characteristics. In 1964, the area included 514 men and 
461 women born in 1914. The response rate was 85% of those 
eligible.
The Helsinki Policemen Study (4) is a prospective 
study on IHD and other atherosclerotic vascular disease 
and their risk factors. During the period from March 1966 
to February 1967. a total of 1,326 men aged 30 or over 
participated in the initial examination of the Helsinki 
Policemen Study. The response rate in this study was
98.4#.
A comprehensive community programme for control of 
CVD was carried out from 1972-1977 in the county of North 
Karelia, Eastern Finland, an area with exceptionally high 
CVD rates (5). The project was started in response to a
petition from the local population requesting that
something be done about the cardiovascular problem. The
main objective was to reduce the mortality and morbidity 
of CVD among the population, particularly in middle-aged 
men. The intermediate objectives were a general reduction
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of smoking, serum cholesterol levels and elevated blood 
pressure among the whole population; early detection, 
treatment and rehabilitation of CVD patients were also 
promoted in the area. More than 10,000 subjects were 
studied each time, with a participation rate of around 
90#.
The Social Insurance Institution’s Coronary Heart 
Disease Study (6) is a prospective population study 
designed to investigate the prevalence, risk factors, 
incidence and prognosis of IHD in middle aged Finnish men 
and women. The study population contained 12 population 
groups drawn from four regions of Finland, a total of 
5,738 men and 5*224 women aged 30-59 year. The study 
started in 1966 and the basic examination was completed in 
1972. The overall response rate to the investigation was 
83%* Nine of the groups consisted of all or a random 
sample of the population from a defined geographical area. 
Four of these areas were urban or semiurban and five 
rural. The other three study cohorts consisted of all 
employees of a factory (two paper mills, one steel 
factory).
The Paris Prospective Study (7) was designed in 1965 
in order to give some insight into the frequency of 
clinical complications of atherosclerosis (cardiac and 
non-cardiac) in a total occupational based French 
population and to evaluate their risk factors. Between 
1967 and 1972, 7*990 men aged 42-53 working in the Paris
Civil Service entered the study, they were invited to 
receive an annual cardiovascular screening examination 
(history, ECG, biological tests and clinical examination).
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The Basle Longitudinal Study (8), conducted by the 
Division of Angiology, Department of Internal Medicine, 
University of Basle, was initiated in 1959t when 6, U70 of 
the total of approximately 22,000 persons employed by the 
local pharmaceutical industry were examined. Basle is a 
city of some 250,000 inhabitants and is situated in the 
north-west corner of Switzerland where the frontiers of 
France, Germany and Switzerland meet. The second study 
followed in 1965-6 8 . A third study began in 1971 and was 
conducted in 1973* The Basle Longitudinal Study had a 
variety of aims. The primary objective was to establish 
the prevalence and incidence of peripheral arterial and 
venous disorders and of IHD in a working population.
The Manitoba Study (9) is the follow-up of a cohort 
of 3,983 subjects aged 15 and over, who during World War 
II were either pilots or pilots-in-training in the Royal 
Canadian Air Force or pilots licenced by the Department of 
Transport. During World War II all these subjects had a 
routine electrocardiogram in addition to regular medical 
examination. After release from the service, a few 
continued to fly, but the majority found different 
occupations and are in all strata of society. For each 
subject, measurements of age, blood pressure, body weight 
and height at the examination time, 19^8, were selected as 
the entry examination. Earlier medical examination provide 
evidence that they were without clinical manifestation of 
IHD or cerebrovascular disease when the population was 
defined. Since then they have been followed by annual mail 
contact and periodic examinations at 5 and later 3 yearly
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intervale. Annual contact has been lost with only one 
person.
In 1948 the United States Public Health Service
undertook to study the factors associated with the 
development of atherosclerotic and hypertensive 
cardiovascular disease by the long-term surveillance of a 
sample of the adult population of Framingham,
Massachussetts (10). A probability sample by household of 
two thirds of the adult population, aged 30 to 62 years, 
based on an annual town census for voting purposes 
maintained by the town, was chosen for study. It was 
possible to bring in for examination 68.6% of the 6,510
selected. They received cardiovascular examinations 
biannally where measurements of blood pressure, daily 
tobacco use, weight, ECG findings and a variety of 
biochemical tests, including cholesterol and glucose, were 
obtained.
The Western Collaborative Group Study (11) is a 
prospective epidemiological study of 3.154 initially well 
men, aged 39-59 years at intake in 1960-61, who were 
employed in ten participation companies in California. 
Data collection was terminated with the annual follow-up 
examination in 196 9. resulting in 8.5 years of follow-up.
During the period from 1967 to 1973 the Chicago Heart 
Association Project in Industry (12) was started and 
screened 39*573 individuals employed in 84 companies and 
organisations in Chicago. The volunteer rate was 
approximately 55% of the work force employed by these 
firms. The total number of persons screened for each of 
the four major gender-race groups were 20,233 white males,
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1^.368 white females, 1,**9** black male and 2,330 black 
females. Participants were followed prospectively to 
ascertain vital status.
Between 1972 and 197**. & 2 % of adult residents of an
older, white, upper-middle-class community of Rancho- 
Bernardo, California, were surveyed for heart disease risk 
factors (13)* This cohort has been followed for vital 
status for an average of nine years. At the time of the 
initial visit, participants were interviewed by means of 
standard questionnaire and given a limited physical 
examination.
The Pooling project Research Group (1**) comprised 
eight longitudinal investigations on the incidence of IHD 
in middle aged white men. The major aim of the project was 
to refine predictive indices for various manifestations of 
IHD in terms not only of single risk factors, but also 
risk factors in combination. It was hypothesized that 
pooling data from several studies would yield analytical 
results giving increased assurance concerning the 
relationship of key risk factors to IHD, and more precise 
quantitative estimates of their importance, both on their 
own and in combination, than individual studies permitted.
Six studies were originally involved in 196** in the 
pooling project -The Albany Cardiovascular Health Centre 
Study, Chicago Peoples Gas Co. Study, Chicago Western 
Electric Co. Study, Framingham Heart Disease Epidemiology 
Study, Los Angeles Heart Study, and Minnesota Business and 
Professional Men Study. At that time these seemed to be 
the only major long-term epidemiological investigations of
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IHD in United States with extensive follow-up information 
sufficiently uniform to be pooled. Subsequently the 
University of Minnesota based Railroad workers study and 
Tecumseh Health Study were added.
Each study attempted to secure the participation of 
as large a proportion as possible of its defined 
population. The proportion were: Albany 87%. Chicago Gas
Co. 92%, Chicago Western Electric Co. 67%. Framingham 69%. 
Los Angeles 75%. Minnesota Business and Professional Men 
(not applicable), North-West Railroad Workers 66%, 
Tecumseh almost 90% of the total community population.
Most of these studies were performed in male
occupational groups and none of them had a plan to 
continue follow a cohort of individuals until death.
1.3. HISTORY QE. MI DSP-Aft EftQJJECT.
Tuberculosis has a special and historic place in the 
studies of cardio-respiratory disease that began in the 
west of Scotland in the mid-sixties. It was the success of 
the mass radiography campaign against tuberculosis in 
Scotland between 1957 and 1959 that suggested the use of a 
similar screening technique to detect bronchitis,
hypertension, angina and other symptoms of coronary
ischaemia. Not only did the campaign suggest the method of 
study, but its detection of 8,000 out of the total of 
12,000 new active cases of infectious pulmonary
tuberculosis in Glasgow and the west of Scotland clearly 
indicated the importance of its location. Used ‘as a
general index of morbidity in the country, tuberculosis
made the City of Glasgow the natural venue for research
directed not only toward the eradication of tuberculosis,
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but also towards the development of mass health 
examination for the whole range of chronic cardio­
respiratory disease.
Shortly after the end of the 1959 compaign and a series 
of mopping-up operations which took the Scottish units as 
far south as Liverpool, routine mass radiography of the 
chest was supplemented by multiphasic screening procedures 
in units of the then Western Regional Hospital Board Mass 
Radiography Service.
The multiphasic cardio-respiratory screening 
procedure was administered first to occupational groups 
being visited routinely in the Mass Radiography Service 
Programme for the control of pulmonary tuberculosis. Then 
in 1967 the first of three census-identified surveys of 
the whole general population, was mounted on the Island of 
Tiree. After a further interval, 7.000 individuals in 
various occupational groups were examined throughout the 
west of Scotland. As a result of these studies it was
proposed that a major epidemiological study be carried out 
in the Scottish Burghs of Renfrew and Paisley. The aim of 
this study was to examine the feasibility of accelerating 
the decline of tuberculosis and, at the same time, 
reducing the risk of cardio-respiratory disease and
disability. In the event the request was jointly accepted 
for support by the trustees of the King Edward Memorial 
Trust and their scientific advisors in 196 9. The trust 
agreed to support the tuberculosis research and the
Scottish Home and Health Department the research in
cardio-respiratory disease.
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Since 1965, the Glasgow Mass Health Examination Unit 
of what is now the Greater Glasgow Health Board, in
association with University Department of Community 
Medicine, has examined and then followed-up a cohort of 
approximately 30,000 males and females identified by 
occupational group or by census of the general population 
in the west of Scotland. The response rates among those 
eligible for examination in most of the defined population 
examined, have been in the region of 80%. All data 
recorded have been stored on computer for prospective
study. Baseline data acquired at the initial examination 
of each group, have been supplemented and updated by
physical re-examination, by postal questionnaire and by
medical record linkage for mortality and for migration, 
through the National Health Service Register of the
Registrar General for Scotland and by medical record 
linkage for morbidity through SHIPS.
It was decided to mount the study in two stages 
starting in March 1972, to provide experience, test
feasibility and validate methods. The then Burgh of
Renfrew was selected for the pilot phase for the main
study to be mounted later in the Burgh of Paisley. The 
pilot study in Renfrew was completed successfully in March 
1972, and between 197& and 1976 the Paisley study was 
conducted. Both populations were to be physically re­
examined by 1979* All these events took place as planned 
and on schedule (15)* The middle-age population, which had 
the highest relative risk of cardio-respiratory diseases, 
was the target population.
The major motivation in conducting the study is a
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continuing need to reduce the risk factors, or conditions 
predisposing to premature death or disability, ranging 
from diseases like hypertension which primarily affect the 
heart and blood vessels of the brain, to tuberculosis and 
bronchitis which affect the lungs and air passages, by 
prevention as well as by management of established disease 
and to eradicate tuberculosis. The cardiovascular and 
pulmonary systems are intimately associated one with the 
other; and so the predisposing agents of interest are 
collectively described as cardio-respiratory risk factors 
and their outcome as cardio-respiratory mortality. The
major diseases under study are IHD, stroke and cancer of 
the lung and respiratory passages. Together they still
represent major epidemics causing premature deaths world­
wide in Westernized countries.
1. fr-THE RENFREW AND PAISLEY .STUDY 
1.A-1—Rationale
Diseases of the circulatory system (16) are the 
leading cause of death in Scotland. In 1972 they accounted 
for 5k. 6 % of a total mortality, comprising 17*399 men and 
18,095 women, to which IHD (16) contributed 10,763 male 
and 8,238 female deaths representing 32. k% and 2 k . 9 %
respectively of the national mortality. In the last two 
decades, the annual increase in IHD in the United Kingdom 
has been greater than in the United States, but not as 
marked as in Northern Europe (17.18). A comparison of age- 
specific death rates in 1969 showed these to be about the 
same in men and women as in the United States and Finland, 
but higher than in Czechoslovakia, Singapore, Sweden and
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Japan (19)-
Cardio-respiratory disease, cancer and tuberculosis 
in the west of Scotland were known to have a higher 
prevalence and mortality rate than the rest of Scotland 
which itself had a higher rate than England and Wales and 
Western Europe (20,21). The scarcity of epidemiological 
knowledge of the diseases which did exist was based on the 
study of mortality statistics, often not very revealing in 
the investigation of long-term diseases, or on clinical 
studies. It was felt that the best hope for new insights 
lay in the study of these diseases in populations of 
normal composition, including both the sick and the well.
The Renfrew and Paisley Study, therefore, focused on 
IHD, stroke, bronchitis, cancer and tuberculosis. These 
were and are the most important causes of mortality and 
morbidity in the west central Scotland. As a working 
hypothesis it was assumed that these diseases do not each 
have a single cause, but that they are the result of 
multiple causes with a long latent period within the 
individual.
It was necessary to define the population on which 
the study would be carried out. Ideally, perhaps, 
epidemiological investigations of CVD should be set up in 
a number of widely separated areas simultaneously, so that 
various racial and ethnic groups will be represented, and 
a variety of geographic, socio-economic, and other 
environmental factors can be considered. The results of a 
study of a single area will be generalisable only insofar 
as the population of the area is representative of some 
larger population. Many thousands of persons should be
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included to allow for numerous aspects of analysis, and it 
would be profitable to follow a cohort of individuals from 
birth to death. Because of the expense of examination and 
follow-up it was not considered practical to carry on 
studies simultaneously in several areas, nor to observe 
directly several thousand people for more than a limited 
number of years. But the survey team believed that long­
term follow-up indirectly through medical record linkage 
was possible. It was concluded, therefore, that the 
study should be set up in two areas close to each other 
with the same socio-economic and ethnic status and 
population structure; Renfrew was choosen as a pilot study 
area and Paisley for a definitive study. Coverage was 
limited to approximately 20,000 persons in the age range 
Zj.5-64 years. This group would be observed through medical 
record linkage for morbidity, and with mortality record 
linkage through the Registrar General indirectly for a 
long period. This method of follow-up is particularly 
worthwhile when economy is a prime consideration.
1. 5. PRINCIPLES. AIMS, .OBJECTIVES Aim ORgAtLIS AXIOM OE XHE 
RENFREW AND PAISLEY PROJECT 
1-5-1-General principles
The historical background of the project dictated a 
community approach. It was further felt that, because 
tuberculosis, cardio-respiratory diseases and cancer were 
a wide-spread health problem and the risk factors affected 
a major proportion of the population, the disease should 
be regarded as a community problem. Accordingly the 
fundamental principle was to eradicate tuberculosis and
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to control cardio-respiratory diseases and cancer in the 
whole community, as in the control of any epidemic (15).
Currently since many heart and lung diseases are 
related in both origin and natural course, the measures 
needed for control also overlap. This also applies not 
only to cardio-respiratory disease but also to other 
related chronic disease problems. Thus the programme 
needed to be comprehensive; it needed to include primary 
prevention, to strengthen treatment and secondary 
prevention, and to evaluate the research.
Even though a comprehensive approach was chosen, 
primary prevention of the disease was emphasised. This was 
because treatment of the clinical stages of chronic 
diseases has only limited success. It was considered that 
this mass epidemic could best be controlled through mass 
prevention.
Because of the high prevalence and general level of 
the CVD risk factors, the preventive activity had to be 
directed towards the whole population. Because risk 
factors are closely related to lifestyle and environment, 
the involvement of the whole community was essential. The 
activity had to be aimed at establishing a healthy 
environment, changes in health behaviour and comprehensive 
treatment or avoidance of the risk factors.
Community control of cardio-respiratory disease 
implies that existing scientific knowledge can be applied 
to serve the population. Even if continuous efforts for 
new medical and technological advances are still needed, 
major steps in the control of cardio-respiratory and 
related disease are possible by the application of
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existing knowledge. Although final proof is lacking -as it 
may always be- it is important to intelligently apply 
available knowledge. Carefully evaluated programmes can 
gradually diminish uncertainty, give information about the 
consequence of new programmes, and guide decision-making 
and allocation of resources in this area.
This approach was essential in the Renfrew and Paisley 
health plan. The concept was to implement the intervention 
in the form of a systematic and planned programme. The 
programme content was determined by existing medical, 
behavioural and social knowledge, and by local factors. 
Evaluation was by continuous follow-up to guide the 
programme.
1.5-2-Aims and objectives
The project aim was to carry out a community based 
health programme to ascertain the prevalence and incidence 
of tuberculosis over a period of 5 years in these two 
defined populations characteristic of west central 
Scotland against the possibility that there might be some 
additional mass measure like tuberculin testing or sputum 
examination that could enhance the precision of diagnosing 
asymptomatic disease and thus hastening eradication. This 
aim coincided with the need to identify and measure the 
risks of dying from the chronic epidemic disease, IHD, 
other forms of CVD, lung and other cancers and chronic 
obstructive airways disease. All of these conditions cause 
excess mortality in west central compared with the rest of 
Scotland and in Scotland compared with England and Wales 
(20,21) .
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The main objective was eradication of tuberculosis 
and to decrease the cardiovascular and cancer morbidity 
and mortality among men and women aged years in
Renfrew and Paisley.
To satisfy the main objectives, intermediate 
objectives were outlined (i.e. those factors that were 
likely to affect the main objectives). These were based on 
knowledge about the natural course of CVD and cancer. 
Changing risk factors could change the rate of the 
disease. The prevalence of these factors in the target 
population was considered. Because of the vast task and 
the complex problems of community intervention, the 
preventive programme was restricted to smoking and blood 
pressure factors of strategic importance. The intermediate 
objectives were:
1.To reduce smoking and high blood pressure among the 
study population (primary prevention).
2.To promote early detection, treatment of high blood 
pressure as well as tuberculosis in the community 
(secondary prevention).
The selection of smoking and hypertenion as risk 
factors was based on available knowledge from 
epidemiological studies and recommendations of expert 
groups and agencies because at the planning stage of the 
programme, there were many uncertainties about the 
aetiology of CVD and lung cancer. Changing these factors 
formed the intermediate objectives for the programme’s 
primary preventive work.
1-5-3-Selection of Community
The adjacent boroughs of Renfrew and Paisley were
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selected as the site for this study for several reasons. 
The population is readily accessible by transportation and 
communication. Additionally, Renfrew was smaller and was 
suitable for a pilot study, and for testing and training 
personnel. The most important step in initiating the study 
was to obtain support from all local physicians. Support 
was also obtained from local newspapers and radio and 
television stations, and particularly, financial support 
from the King Edward Memorial Trust.
At that time Paisley was the largest Burgh in 
Scotland. Its population was considered characteristic of 
that section of Scottish.population at highest risk from 
tuberculosis and other cardio-respiratory diseases.
1.5.b.Community Arrangements for Screening
A programme which involves medical examination of 
large number of people requires the acceptance, 
endorsement, and support of the medical profession. The 
plans for the project were given the endorsement of the 
Renfrew and Paisley general practitioners. In the Renfrew 
and Paisley study the general practitioners offered their 
active support to the programme as proposed. The Royal 
Alexandra Hospital in Paisley continues a close 
cooperation with the study.
From an administrative standpoint it was necessary to 
secure clinical facilities and recruit professional and 
technical staff. The temporary screening centres were 
established in a hall or other suitable public meeting 
place in each of ten sectors of Paisley and in Renfrew and 
included space for clinical and physical examination as
51
CHAPTER 1
well as for diagnostic equipment. Staffing was organized 
which comprised about 30-4-0 permanent, part-time and 
voluntary workers from the British Red Cross Society. 
Numbers varied from month to month according to the 
changing of the work programme. Additional numbers 
included an epidemiologist; an examining physician; a 
programmer; a clinic nurse; X-ray, electrocardiography, 
statisticians; a secretary, and administrative clerks 
plus medical, technical and lay trainees.
1-5-5-Geography and Demography
The estimated total population of Scotland in 1972 
was 5*235*300. Of these, 1,698,200 lived in the Central 
Clydeside conurbation (22), in which the city of Glasgow 
with its population of 861,898 (23) is the major centre of 
an area with a soft water supply and an excess mortality 
from CVD and other diseases compared with the rest of 
Scotland, England and Wales (24-).
Renfrew and Paisley are urban communities eight miles 
West of Glasgow in the South West of Scotland (Map 1.1). 
These towns have a soft water supply.
The population of Renfrew Burgh at the time of survey 
was about 19,000; Paisley, the adjacent town, had a 
population of about 9^*800 people. A census of all people 
between the ages 4-5 and 64- on January 1972 and resident in 
the 6,534- households (99-1% response) on the Renfrew Burgh 
assesor’s rating list was completed between November 1971 
and March 1972. Information on all but 59 (0.9%) household 
in Renfrew show that there were 1,788 male and 2,022 
females (a total of 3.810 subjects) in this age group.
The population of all people between the ages U 5 and
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64 in 1973 and resident in the 32,429 households in the 
Paisley Burch were about 21,600. Information on all 
household residents in Paisley showed that there were 
10,100 male and 11,500 female in this ace croup accordinc 
to the Report of the Recistrar General for Scotland 1973. 
Most of the residents were employed locally in well- 
established business and manufacturing activities. 
Medical care was obtained from local GPs, utilizinc one 
NHS hospital near the centre of Paisley.
1.6.SAMPLING PLAN
The choice of sampling plan for this study was 
dictated by a number of considerations, some of which have 
already been referred to.
One important decision which had to be reached 
concerned the ace ranee of the study population. The 
selection of a middle aged population was for two reasons. 
First, the middle-aged population is at greater risk of 
developing cardiovascular disease. Secondly, a very young 
population would have needed many years to show chances in 
disease rates. Conversely, among an elderly population 
with advanced disease the impact of preventive and other 
control measures would probably be limited. But there were 
good indications to believe that in the middle aged, 
preventive intervention could decrease risk within a few 
years (25). Clearly, if only a very youne croup was 
studied, only a very small number would develop cardio- 
repiratory or cancer even in 10 to 20 years* time and 
since this is a mobile ace croup they would be difficult 
to reexamine regularly or follow through medical record
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linkage. On the other hand, in a very old croup there 
would be too large a proportion with pre-existing cardio­
respiratory disease and cancer. To balance these two 
effects, the ace group 45-64 was selected for study. Nine 
hundred and sixty three people beyond this ace ranee 
voluntarily participated but have been excluded from all 
analyses throughout this thesis. These people were 
included in the original sample because it would be 
desirable not to break up families -that is, if one member 
of a family was to be brought into the sample, all other 
family members resident in the same household who wished 
to participate were also brought in.
1».7..,.SAMPLE BSS.RQKSE
In Renfrew a total of 3,000 people -1,407 males and 
1.593 females- attended for examination in 1972. In 1973. 
1,062 (79*6#) males and 1,201 (79.6#) females eligible and
capable of attending for re-examination -about 60# of 
those originally eligible in 1972- returned for 
examination. In Paisley, 12,446 (77.9# -range 58.4# to 
79.4#-) men and women from 15,971 persons eligible and 
capable of attending for examination attended from the 10 
sectors which were examined in that town between February 
1974 and June 1976.
At the outset an invitation was issued to all town 
residents in the age range 45-64 to come to a clinic for 
examination.
Table 1.1 Shows the response rate for the whole of 
Paisley and Renfrew and for each of the 10 sectors 
outlined in the map of the Paisley Burgh. Response varied 
according to the section of town, which probably
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corresponded to differences in socio-economic
characteristics. From one sector to another the response 
ranged from 58.U% to 79*^%. Of the 19*781 persons in the 
sample who were alive and resident in Renfrew and Paisley 
at the start of the study, 78% had been tested at the end 
of the initial examination. In Paisley, a final non­
response survey concluded the first round of examination 
in 1976 and raised the response rate from 7&.5% to the 
more satisfactory level of 77.9%. But still there were 
about 20% non-respondents and this could result in bias. 
Non-respondents could include people who felt fit and 
could not be bothered, people who felt ill, and people who 
were afraid or unable to attend. However, because of the 
high prevalence of risk factors found among participants 
this non-response rate is less likely to be serious.
The reason for non-participation remained unknown in 
most cases. This means that even after the second 
invitation the subject did not participate and did not 
give any reason. A few people were unable to answer. Only 
one person refused to participate. There were no important 
differences in attendance rates for men and women, for 
afternoon or evening sessions, or for different days of 
the week.
No attempt was made to perform a non-responders 
survey among the Renfrew or Paisley sample, but a non­
responders survey was performed in one of the occupational 
groups of the Midspan survey (Caterpillar Company) where 
the response rate was 69.8%. This showed no consistent 
difference between attenders and non-attenders (26). On
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■this basis it was considered that the possibility of bias 
in those coming for the examination was insignificant. 
However, the possibility of self selection bias cannot be
ruled out.
1.8.BASELINE SURVEY FOLLOW-UP
Those people originally examined in Renfrew and 
Paisley in 1972 to 1976 were followed in several ways to 
obtain additional information both on the programme effect 
at the individual level and on the cardio-respiratory and 
lung cancer risk indicators in the population. These data 
can be used to analyse CVD risk factors in the target 
population. The Renfrew cohort were re-examined in 1973 
and 1977 and the Paisley cohort in 1979*
One of the problems of cohort studies is maintenance 
of an adequate response. Although the response rate for 
both Renfrew and Paisley were of the order of about eighty 
percent at the first examination, the rates for various 
reasons, including death and migration out of the study
area, reduced responses to as low as sixty percent in some 
sections of the two cohorts over the five years* interval 
between the first and second examinations. An expedient 
developed to overcome this problem and to ensure as 
complete coverage as possible of the two cohorts for the
protracted period of years needed to observe the 
development of new disease in those originaly healthy, was 
an indirect method of surveillance called record linkage.
In order to study morbidity in the study population, 
medical record linkage was arranged with the Scottish Home 
and Health Department Research and Intelligence Unit, The 
Western Regional Hospital Board Cancer Registration
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Bureau, and the local tuberculosis department. Medical
record linkage was established and has been demonstrated 
between the study cohorts, the SHIPS collected annually by 
the Common Service Agency in Edinburgh. Written permission 
was obtained from all but one person to consult his or her 
health records for this purpose.
In order to study mortality, with the written and
witnessed consent of each individual checked, the 
individual NHS record for that examinee held in the NHSCR 
of the Registrar General for Scotland in Edinburgh was 
’’flagged". When the individual died or migrated the
information was transmitted to the Mass Radiographic
Centre in Glasgow so that new events, particularly 
mortality, could be accumulated at regular yearly 
intervals and up-dated mortality rates determined. The 
project collected these data and used them in the 
evaluation since they were available much earlier than the 
national mortality data. The original diagnosis of the 
physician in charge was used to classify the cause of 
death according to the International Classification of 
Diseases (ICD) 9th revision.
Up to January 1st 1986, 1,530 male and 1,056 female
deaths had been notified by the NHSCR. Fifty four percent 
of male and forty six percent of female deaths were 
attributed to diseases of the circulatory system (ICD/9 
code 390-1159). IHD rates were k O % and 28.6%*in men and 
women respectively. The corresponding figures for stroke 
were 8.7% and 11% of total deaths in men and women 
respectively.
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The advantages of being able to conduct a long-term 
follow-up indirectly in this way with relatively little 
expense and no physical re-examination, recommend 
themselves especially when economy is a prime 
consideration.
Using the information collected at the baseline 
physical examination e.g. level of blood pressure, serum 
cholesterol, blood glucose, smoking habits, weight and 
height, and relating these levels or values to mortality, 
it was possible to calculate risks of different disease 
mortalities. By comparing mortality in a group within a 
cohort exhibiting low or "normal" risk variables with
groups exhibiting high risk values, a series of risk
calculations could be developed, which as the number of 
deaths accumulate, provides successively more precise 
estimates of the predictive significance for dying amongst 
those initially in the "normal" compared with "high" 
categories.
A special blood pressure clinic was established in 
the local health centre in Renfrew and in the main
hospital of Paisley, staffed for 3 evenings each week by a 
team of part-time doctors and nurses to undertake the 
detailed investigation of confirmed cases of hypertension 
and to initiate and supervise treatment (21).
Subjects with blood pressure in the range 100 to Ilk 
mmHg diastolic are recalled for re-examination. If the 
blood pressure remains in this range patients are referred 
to the clinic. At the clinic examinees were re-measured if 
they remained in the range 100 to 1 1 U mmHg. In the absence 
of certain contra-indications, they were admitted with
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their informed consent and that of their family doctors to 
the MRC multi-centre trial of "mild" blood pressure (27). 
At 12 weeks all examinees and their family doctors 
received a final computer printed report signed and 
checked by the screening unit doctor.
All subjects with abnormalities needing immediate 
attention were referred directly to their general 
practitioner. This group included patients with a DBP of 
115 mmHg or more which had been confirmed by two 
observers. Subjects with DBP between 100 and lift mmHg were 
recalled for— a second screening examination 12 weeks
later. All subjects with other abnormalities had these 
rechecked and where necessary were referred to the general 
practitioner or through the general practitioner to 
hospital. Risk scores for each subject were calculated on 
a scale derived from the Framingham study (28) and a high- 
risk group of smokers constituting about 10% of the 
population most likely to develop IHD, lung cancer and 
chronic bronchitis were randomly allocated to a controlled 
trial of the effects of stopping smoking on mortality.
All of the information obtained, except name and
other identifiable data, was stored on the University of 
Glasgow ICL computer. Names and addresses of examinees 
were stored on a separate magnetic computer tape belonging 
to the Argyll and Clyde Health Board to preserve
individual confidentiality. The data collected on the 
subjects at baseline and at each follow-up examination 
were coded on self-coding forms, then transferred directly 
to tapes for computer analysis.
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REVIEW 02. LITERATURE
SUMMARY: The aim of this review is to provide informa­
tion on associations between high blood glucose and 
morbidity and mortality outcome, gender differential in 
mortality and use of different indices of blood pressure 
as predictors of IHD and stroke. The first section of this 
chapter (2 .1 ) reviews the controversial issues of associa­
tion between asymptomatic hyperglycaemia and morbidity and 
mortality and provides some approaches for further inves­
tigation. The results of several studies considered 
together do not indicate an association between 
asymptomatic., hyperglycaemia and IHD that is consistent, 
strong and graded, while some others did. Also some of 
these studies do not consistently show evidence for a 
threshold relationship. Finally, the negative results for 
some of the studies when multivariate analysis were done 
(including serum cholesterol, blood pressure, cigarette 
smoking) raised additional questions about the relation­
ship between asymptomatic hyperglycaemia and IHD.
There have been a few prospective studies of associa­
tion between asymptomatic hyperglycaemia and morbidity and 
mortality in women with controversial results which 
provide hypotheses for further study. There have also been 
a few prospective studies of association between 
asymptomatic hyperglycaemia and stroke, the results of 
which have been controversial. This indicates the need for 
further study.
The second section (2.2) reviews the gender differen­
tial in mortality in general terms with special emphasis 
on the impact of gender differential in CVD mortality 
risk. For most causes of death which affect both genders, 
males register a higher rate than females, a difference 
which is not completely explained by demographic, psycho­
social, behavioural or biochemical differences.
The last section (2.3) reviews the literature regarding 
the use of different indices of blood pressure as a 
predictor of IHD and stroke. The relative importance of 
SBP versus DBP in predicting risk of IHD or stroke is 
controversial. Recently, for IHD many epidemiological 
studies favour SBP, while for stroke a few studies favour 
SBP. This warrants a detailed re-analysis of the various 
components of blood pressure in relation to IHD and stroke 
in the west of Scotland.
CONTENTS
2.1.Asymptomatic hyperglycaemia and CVD.
2.2.Gender Differential In Mortality
2.3*Blood Pressure as a predictor of IHD and Stroke
60
CHAPTER 2
2.1. ASYMPTOMATIC HYPERGLYCAEMIA AND. C.Y.D.
2.1.1.Hyperelycaemia and IHD
The original observations from population studies 
suggesting a relationship between hyperglycaemia or 
impaired glucose tolerance, excluding clinical diabetes 
and coronary heart disease were published in 1965 from two 
cross-sectional studies from Bedford, England (29)♦ and 
Tecumseh U.S.A. (30). In the Bedford study an increased 
prevalence of "arterial" symptoms and ECG abnormalities 
was observed in subjects with impaired glucose tolerance 
("borderline" diabetes) as compared with normoglycaemic 
control subjects. During a 10-year follow-up, coronary 
heart disease mortality was higher both in men and women 
with impaired glucose tolerance than in normoglycaemic 
control subjects, the relative excess of IHD mortality 
associated with impaired glucose tolerance being more 
marked in men than women (31). In the cross-sectional data 
from the Tecumseh study an increased frequency of impaired 
glucose tolerance was found in subjects with evidence of 
vascular disease (IHD, cerebrovascular disease or 
peripheral vascular disease). In the 7-year follow-up data 
from the Tecumseh study (32) there was a suggestion of a 
trend towards an increased incidence of IHD (IHD death or 
myocardial infarction) in subjects whose 1-hour post-load 
blood glucose levels at the initial examination were in 
the upper tertile of the distribution.
In the Framingham study casual blood glucose values 
were measured instead of carrying out glucose tolerance 
tests. In the 16-year follow-up data from the Framingham
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Study Population casual blood glucose levels showed a non­
linear relationship to the incidence of IHD, with a marked 
increase in the incidence rate at casual blood glucose 
levels above 120 mg/dl (33). In multivariate analyses of 
the Framingham 16-year follow-up data, as in other 
Framingham study analyses (3*0. it appeared that "glucose 
intolerance” was related to the incidence of IHD 
independently of other risk factors, such as blood 
pressure and plasma cholesterol and cigarette smoking. 
Previously diagnosed diabetics were included and this 
increased the predictive value of "glucose intolerance", 
as defined in the Framingham study.
Fuller et al. (35) compared the impact and 
interaction of CVD risk factors or indicators in subjects 
with impaired glucose tolerance and in normoglycaemic 
subjects. IHD mortality was approximately doubled for 
subjects with impaired glucose tolerance defined as blood 
sugar above the 95th centile. A high plasma cholesterol 
level, cigarette smoking and a low occupational status 
were not associated with as high a relative risk of IHD
death in the impaired glucose tolerance group as in the
normoglycaemic group, whereas a high blood pressure and a 
high BMI were associated with a greater relative risk in 
the impaired glucose tolerance group. For subjects with 
ECG abnormalities the relative risk of IHD death was
similar in both blood glucose categories, being more than
three times those without ECG abnormalities.
The results of subsequently published prospective 
population studies examining the relationship of glucose 
tolerance to the risk of IHD have been conflicting. The
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best evidence comes from the Joint publication of the 
results from a number of population studies by the 
International Collaborative Group (36). This Joint 
publication is based on 15 studies in different 
populations. Each study had measured circulating glucose, 
obtained an ECG, and assessed a number of variables 
relevant to cardiovascular status, -relative weight, blood 
pressure, smoking history and circulating cholesterol. 
Each had the capacity to follow to death those examined at 
baseline, 11 studies completed four or more years of such 
follow-up. For the other four studies, only cross- 
sectional data are presented. The benefits of such 
collaboration were several. Mortality follow-up requires 
either large numbers or many years of observation if 
meaningful comparisons are to be made. Few individual 
studies are of sufficient size to accomplish this in a few 
years.
In nine of these studies participants were employed 
workers (England, Finnish Policemen, France, Italy, Japan, 
Switzerland, USA (three studies)). In five studies they 
were community populations, total or random samples 
(Australia, Denmark, Finnish Social Insurance and 
Scotland). An Irish study involved volunteers in a 
community screening programme.
These studies had not been planned according to a 
similar protocol and the methods used in the assessment of 
glycaemia were not similar. In. some studies only fasting 
or casual blood or plasma glucose levels were measured, 
whereas in other studies oral glucose tolerance tests were
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carried out, but again there was a large variation between 
studies in the timing of blood sampling and other aspects 
of glucose tolerance tests. The common feature in the 
dointly published series of papers by the International 
Collaborative Group was a similar approach to the analysis 
of data.
Although several studies involved both men and women, 
data are included for males only, since numerator cases 
were few for females.
Nearly all the International Collaborative Group 
studies showed an increased prevalence of ECG 
abnormalities in the highest blood glucose quintile, and
in addition, in those studies with numbers large enough to
analyze the upper 2 .0-2.5 per cent of the glucose
distribution separately, an even more markedly increased
ECG abnormality rate was observed in this highest 
quintile. Blood glucose levels showed statistically 
significant associations with other risk factors (37). In 
the majority of these studies, an independent relationship 
between blood glucose and prevalence of ECG abnormalities 
did not persist in multivariate analyses.
The results concerning the relationship of blood 
glucose level to IHD mortality based on ll to 15 year 
follow-up periods, are the most important among the 
results presented in the papers published by the 
International Collaborative Group. Mortality data were 
published from 11 different studies, but the results of 9 
studies were based on post-load blood glucose values. 
These studies are: Busselton study from Western Australia
(38); Peoples Gas Company study (39) » Western Electric
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Company study (39). and the Chicago Heart Association 
Detection Project in industry (40) from Chicago, U.S.A.; 
Social Insurance Institution’s Study (111), and Helsinki 
Policemen Study (42) from Finland; Whitehall Study (43) 
from London, United Kingdom; Paris Prospective Study (7) 
from France; and Basle Longitudinal Study (8 ) from 
Switzerland. The other two studies are the Renfrew 
community study as a part of the Midspan study (44) from 
Glasgow, Scotland based on casual post-prandial blood 
glucose determination and the Glostrup population study 
(37) from Denmark based on fasting blood glucose levels. 
Comparison of cardiovascular and IHD mortality rates in 
the highest blood glucose quintile to those observed in 
the lowest quintile showed that this risk ratio was, for 
both cardiovascular disease and IHD, greater than 2.0 in 
only 3 of the 9 studies based on the oral glucose 
tolerance test (GTT) (Whitehall study, Helsinki Policemen 
study and Peoples Gas Company study). On the other hand, 
if in the same 9 studies cardiovascular and IHD mortality 
in the uppermost end of the blood glucose distribution 
(highest 2 .0-1 0 .0%) was considered, the mortality ratio 
observed/expected was, for all CVD and IHD, both near to 
2.0 or greater in 5 to 9 studies, although in some of 
these studies this was based on very small numbers of 
deaths. Multivariate analyses of data from different 
studies showed that, with one single exception, blood 
glucose levels did not have a predictive value independent 
of other risk factors.
It is difficult to explain inconsistencies between
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different studies of the International Collaborative Group 
with respect to the relationship between hyperglycaemia 
and IHD mortality. One can not, however, exclude the 
possibility that the failure of some studies to find any 
association between post-load blood glucose level and IHD 
mortality could be related to a lesser degree of 
standardization of the conditions and methods of the oral 
glucose tolerance test leading to incorrect classification 
of individuals with respect to glycaemia.
In the Whitehall Study the 7«5 year follow-up data 
showed that IHD mortality doubled above the 95th centile 
(^96 mg/dl) for 2-hours post-load blood glucose, 
suggesting that there would be a threshold phenomenon in 
the strongly non-linear relationship between blood glucose 
and IHD mortality (35)* In the Paris Prospective Study a 
similar threshold phenomenon was observed in the 
relationship between blood glucose and IHD mortality, but 
at a 2-hours post-load blood glucose of 140 mg/dl (45)* In 
the Paris Prospective Study the incidence of non-fatal 
myocardial infarction was also analyzed, but blood glucose 
levels were not found to have any definite relationship to 
the incidence of this manifestation of IHD (45). In the 
9.5 years follow-up data from the Helsinki Policemen Study 
(4.6) a non-linear relationship was also observed between 
fasting, 1-hour or 2-hour post-load blood glucose levels 
and the incidence of "hard criteria” IHD events (IHD death 
or non-fatal myocardial infarction). The greatest increase 
in the IHD incidence occurring above the 80th centile of 
blood glucose levels. In the Helsinki Policemen Study the 
rates for both IHD death and non-fatal myocardial
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Infarction were increased in the upper quintiles of blood 
glucose levels. In multivariate analyses, however, blood 
glucose variables were not found to be predictors of IHD 
risk independent of other risk factors.
In Busselton, Australia (38), the rate of ECG 
abnormalities in the highest quintile of post-load plasma 
glucose was twice that observed in the lowest glucose 
quintile in univariate analyses. In an 11 year mortality 
follow-up, similar univariate analysis showed no
association of baseline glucose value and subsequent
coronary or cardiovascular death. When other factors such 
as age, blood pressure, serum cholesterol, relative weight 
and cigarette smoking were considered in multivariate 
analysis, no association between initial glucose level and 
mortality was seen. As a result of this study, the data do 
not give evidence that asymptomatic hyperglycaemia was a 
significant risk factor for mortality in this population
aged ll0-59* However the number of coronary events used in
this study was small and caution is required in drawing 
conclusions.
In the Glostrup, Denmark study (37) « based on fasting 
blood glucose levels, no positive association between 
baseline glucose level and ECG abnormalities was found, 
either in univariate analysis or in multiple logistic 
analysis. A significant positive association between blood 
glucose and blood pressure, resting heart rate, serum 
triglycerides and BMI was found in this study. In a 10 
year follow-up, baseline glucose levels were not found to 
be predictive of mortality or of combined fatal and non-
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fatal cardiovascular events. As a result, in this study 
asymptomatic hyperglycaemia based on fasting blood glucose 
was not associated with higher incidence of CVD. Of course 
again the number of cardiovascular deaths is relatively
low to draw any strong conclusions.
In the Social Insurance Institutions’s Study, Finland 
(ill), the 1-hour post-load plasma glucose, in males aged 
il 5 - 5 9 years, showed a linear and partly independent 
relationship to ischaemic ECG abnormalities. During a 4 
year follow-up, the 1-hour post-load plasma glucose level 
had no relationship to total mortality or to mortality 
from CVD or IHD.
In the Renfrew community study (44) blood glucose 
levels were measured in 1,134 men aged 45-64 in 1972, and 
these were followed for 6 years to determine mortality 
rates. A positive association was found in univariate
analysis, between the baseline glucose level and the
prevalence of ECG abnormalities as defined by nearly all 
the International Collaborative Group Studies. In
multivariate analyses of these cross-sectional data, an 
association was seen for Whitehall but not Pooling project 
abnormalities. No association was found between
asymptomatic hyperglycaemia and coronary mortality at 6 
years, either in univariate, bivariate or multivariate 
analyses. Of course, the sample size was small and
mortality data was based on a very small number of deaths.
In the Basle Longitudinal Study (8 ) from Switzerland, 
no consistent association between baseline glucose and 
resting ECG endpoints either in univariate or
multivariate analyses was seen. In this study the
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frequency of peripheral artery disease was also analysed, 
and was negatively associated with glucose elevation. In a 
5-year mortality follow-up too few deaths from coronary 
disease occurred to permit any conclusions on long term 
risk of hyperglycaemia. However, the available data did 
not show a positive association of mortality with glucose 
level.
In the Chicago Western Electric Company study and 
Chicago Peoples Gas Company study (39) from USA, in 
univariate analysis, those at the highest glucose levels 
had a higher rate of ECG evidence of IHD, but this 
association in multivariate analysis, when such factors as 
age, blood pressure, weight, cholesterol and cigarette 
were taken into account, did not remain. These long-term 
follow-up mortality studies (1 0 , 13 and 15 year) showed
inconsistent findings on the association of hyperglycaemia 
and subsequent death. In one cohort (Gas Company men
followed for 10 year after a 1-hour post-load glucose 
determination) a positive glucose-mortality association 
was found in both univariate and multivariate analysis.
But in the two remaining cohorts (Gas Company 13-year 
after casual glucose determination and Western Electric 
15-year after 2 -hour load determination) no such 
association was found. While differences in the method and 
sample size as well as other limitations may have 
contributed to the differences observed, the inconsistency 
of the findings do not permit a conclusion that
asymptomatic hyperglycaemia is a positive coronary risk 
factor.
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In the Chicago Heart Association Detection Project in 
Industry (4.0) from USA, a cross-sectional analysis of the 
frequency of ECG abnormalities showed that those in the 
upper 2 .5% of glucose distribution had higher rates of 
such abnormalities than the rest of the group. Men in the 
highest quintile likewise had higher rates of ECG 
abnormalities than were seen in the lowest quintile. MLR 
analysis showed an inconsistent positive association of 
glucose with prevalence of ECG abnormalities but no 
association with definite MI, on ECG. In the 5 year 
mortality follow-up, while men with overt diabetes
experienced coronary death rates 2-3 times higher than
those without such a diagnosis, similar univariate 
analysis that excluded diagnosed diabetics showed no 
association between initial glucose and subsequent
coronary or CVD mortality, although all cause mortality 
rates were significantly related to glucose levels. The 
inconsistent results between univariate and multivariate
analyses, as well as between cross-sectional and
prospective findings, do not support a conclusion that 
asymptomatic hyperglycaemia is a major coronary risk 
factor.
In four of the Collaborative studies the mortality 
follow-up was not performed (Denmark 4.0-year, Ireland, 
Italy and Japan) but the results of cross-sectional 
studies are as follows: The study of the Republic of
Ireland (47) included volunteers in a community screening 
programme. After a 1-hour 50-g oral glucose load in 
univariate analysis no linear relationship between
hyperglycaemia and ECG abnormalities was observed. In
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multivariate analysis, considering also age, SBP, relative 
weight, serum cholesterol and cigarette smoking, no 
independent association was seen between glucose levels 
and frequency of ECG abnormalities.
In the Olivetti Survey, Italy (&8 ) no association was 
seen between initial fasting blood glucose level and ECG 
abnormalities using the criteria of the Whitehall study. 
However, there was a positive association between baseline 
glucose and ECG abnormalities defined by the US Pooling 
Project. These associations were also evident in 
multivariate analyses.
In Japanese National Railways Workers (U9), in both 
univariate and multivariate analyses, an association between 
ECG abnormalities and IHD was seen.
In the Glostrup population study (3), both fasting
glucose and 1 , 2 and 2.5 hour glucose after an oral load
in forty-year old men showed no consistent relationship 
between glucose variables and resting ECG abnormalities.
For post-exercise ECG abnormalities, all glucose variables 
showed a positive association both in the univariate 
analyses and in the multivariate analyses and the 1-hour 
post-load glucose values were significantly correlated to 
the prevalence of post-exercise ECG abnormalities 
independent of other risk factors for IHD, such as SBP,
cholesterol, BMI, and cigarette smoking. A significant
positive correlation was found between all four serum 
glucose variables and BMI, SBP, DBP and serum uric acid.
2.1.2.Hyperglycaemia and Cerebrovascular Disease
The epidemiological studies of association between
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high blood glucose values and stroke mortality and 
morbidity are scant. Analyses of the Framingham study 
concerning the relationship of casual blood glucose 
levels, including previously diagnosed diabetics, to the 
incidence of atherothrombotic brain infarction (ABI) 
suggest that this relationship is curvilinear, with a more 
marked increase in the incidence at the upper end of the 
blood glucose distribution (50). In the Whitehall study 
population the relationship of stroke mortality and 
impaired glucose tolerance, as defined by 2-hour post-load 
blood glucose levels at the initial examination, was 
analyzed on the basis of 10-year follow-up data (51)* No 
trend of stroke mortality was found below the 90th centile 
for 2-hour blood glucose (<90 mg/dl), but the stroke 
mortality showed an increase in the 90th-95th centile 
range and was doubled above the 95th centile (2-hour blood 
glucose from 97 mg/dl to 200 mg/dl). Multivariate analysis 
showed that a blood glucose level above the 95th centile 
was a risk factor for stroke mortality, independent of 
blood pressure, plasma cholesterol, smoking and obesity.
2^ .2. .gENPSB DIFFERENTIAL IK MORTALITY
The earlier work suggests that cultural, behavioural 
and biological factors contribute to the longer life 
expectancy of women (5 2 ).
Wingard (53) examined the gender differential in 
mortality risk in Alamada County, California after a nine 
year follow-up, while simultaneously controlling for 16 
demographic and behavioural risk factors. Risk factors 
included age, race, socioeconomic status, occupation, 
physical health status, use of health services, smoking,
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alcohol consumption, physical activity, weight, sleeping 
patterns, marital status, social contact, church and group 
membership and life satisfaction. These demographic and 
behavioural risk factors do not account for the overall 
gender differential in mortality rates. In a later study 
Wingard et al. (5^) added biological variables. The
risk factors included age, marital status, education, 
cigarette smoking, cholesterol, SBP, fasting plasma 
glucose, and obesity. These risk factors explain a good 
portion of the gender differential in mortality from all 
causes. However, this study indicates that a substantial 
gender differential remains in heart disease mortality 
after adjustment.
Waldron (55) reported that the largest differences 
between male and female death rate occur for IHD, 
accident, suicide, lung cancer and cirrhosis of the liver. 
She suggests that these causes of death are linked to 
patterns of behaviour which are encouraged or more 
accepted in males (e.g. smoking, drinking alcohol and 
working in hazardous Jobs).
The total pathological effect of smoking, 
particularly the elevation of IHD, lung cancer and 
emphysema, makes a major contribution to the gender 
differential in total death rates. Retherford (56) 
estimates that as much as half of the gender differential 
in life expectancy from the ages of 37 to 87 may be -due to 
the effects of higher rates of cigarette smoking in men.
Burbank (57) reported that changes in the male and 
female lung cancer death rate in the United States
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parallel changes in male and female smoking patterns. 
Burbank was able to adjust only for age, while it is known 
that smoking is also correlated to socioeconomic status 
(5 8 ) and alcohol consumption (5 9 ), factors also related to 
increased mortality risk.
Hammand (60) and Johnson (6 1 ) have also examined the 
gender differential in relation to smoking behaviour. 
Utilizing data from the American Cancer Society, Hammand 
(6 0 ) adjusted only for age, concluding that smoking is a 
risk factor for both genders but more so for men. Using 
Framingham data, Johnson (61) adjusted for age and several 
biological measurements (e.g. blood pressure and 
cholesterol), and similarly concluded that IHD mortality 
for male smokers is considerably higher than for female 
smokers. Adjustments were not made for factors such as 
socioeconomic status and alcohol consumption.
Genetic factors apparently also contribute to higher 
male mortality, although the evidence for this is not as 
strong as commonly has been believed. Relatively few 
studies have explored the possibility that women live 
longer than men because they are biologically more fit 
than men. A few studies have noted that the male death
rate is higher even in prenatal life and infancy (62-64).
Since behavioural factors that increase mortality risk do
not vary by gender of the foetus, gender differences in 
the rate of miscariage, stillbirth and early infant death 
are presumably due to unspecified biologic factors. Males 
have a higher mortality than females in many different
species, and this has been cited as evidence for a genetic 
contribution to the higher mortality of men (65)* However,
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although higher male mortality ie widespread among 
insects, other Arthropods and fishes (65). higher female 
mortality appears to be dust as common as higher male 
mortality among our close relatives, the birds and mammals 
(65-6 7 ). Among humans, higher female mortality is also 
common at certain ages, between one and forty and in some 
cases at older ages in many non-industrial countries (68). 
However, it is striking that, wherever statistics are 
available, males have had higher mortality during the 
first year of life (6 9 ). Males also have been found to 
have higher foetal mortality in most studies (69). 
although foetal mortality during late pregnancy is as high 
for females as for males in twins of opposite gender (70), 
in multiple births of triples or more (.64), and in a few 
geographic areas, for example Scotland (6 3 ). Male 
mortality is higher for many different causes of death. 
Several authors (6 5 . 71) have inferred from these
observations that genetically determined metabolic
differences may contribute to the higher mortality of 
males.
Another study which has been cited widely as evidence 
of the importance of genetic factors is Madigan's (72) 
comparison of life expectancy for Roman Catholic Sisters 
and Brothers in teaching orders. Madigan found that the 
differential in life expectancy between Sisters and
Brothers has been almost as large as the differential 
between women and men in the general population, even 
though the Sisters and Brothers had more similar adult 
roles. However, the higher mortality of Brothers cannot be
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attributed solely to genetic causes, since the Brothers
smoked and drank more than the Sisters and probably were 
socialized differently as children, and each of these 
differences would contribute to higher male mortality.
Most previous discussions of the gender differential 
in IHD have focused primary attention on the hypothesis 
that this gender differential is a result of the
physiological effects of the gender hormones. The evidence 
for this hypothesis is suggestive, but it is ambiguous and 
inconsistent. Castration of men apparently does not reduce 
deaths due to CVD (73). and castration of older men does 
not seem to reduce arteriosclerosis (74). Gerther and 
White (75) suggest that androgen levels of male coronary
patients do not differ from androgen levels in a control 
group. Thus male hormones do not appear to increase the 
risk of IHD. Do female hormones lower the risk of IHD? 
Several studies have found that oopherectomy of young 
women is associated with increased artherosclerosis and
IHD (76-80) but other studies have not found this (81, 
82). One investigation with negative findings is particu­
larly interesting because women with a simple hysterectomy
were used as the control group and the prevalence of
arteriosclerotic heart disease was as high for those women 
with only their uterus removed as it was for women whose 
ovaries had also been removed (81). For both groups the 
prevalence of arteriosclerotic heart disease was higher 
than the prevalence for the general female population.
Since there appears to be no physiological reason why the
simple removal of the uterus should lead to increased IHD 
(8l, 8 3 ). these observations suggests that hysterectomy
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may be associated with behavioural characteristics, such 
as cigarette smoking, or physiological characteristics 
such as anxiety and neuroticism (84), which in turn are 
associated with elevated risk of IHD (8 5 ).
Thus, if we tentatively accept the weight of evidence 
as indicating that oopherectomy of young women is 
associated with increased atherosclerosis and IHD, we
still are left with the question of whether this increase 
is due to the removal of females* hormones or to some
behavioural or psychological characteristic of women who 
undergo these operations. Studies of the effect of 
replacement therapy are the ideal method for resolving 
such questions, but in this case such studies have-yielded 
conflicting results. One study of oestrogen therapy in 
castrated women found a decreased prevalence of
arteriosclerotic CVD (80), and another found trends 
suggesting a reduced prevalence of electrocardiographic 
(ECG) abnormalities (86). However, a third study found no 
effect on death rates or prevalence of IHD (81). 
Furthermore, most studies of oestrogen therapy in men have 
found an increased risk of recurrence of myocardial 
infarction (74, 87-8 9 ). although in two studies, some
treatment groups appeared to have a reduced risk (7 6 , 8 7 ).
In adults, a possible biological basis for the gender 
differential in mortality has been examined through the 
relationship of hormonal status and IHD. These studies 
(90, 91) reported that IHD mortality increases among women
around the age of menopause and varies by pregnancy 
history, suggesting that changes in oestrogen or prolactin
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levels may be the cause. However, increased mortality and 
morbidity among those receiving supplemental oestrogen 
does not support this hypothesis (92, 93). Heller and
Jacobs reported that women do not lose protection from IHD 
after menopause (94). They suggested male gender hormones 
may be risk factor for IHD.
It is possible that behaviour patterns may make a 
larger contribution to the risk of IHD than does gender
per se. Both Haynes et al. (95) and Waldron et al. (96)
reported that Type A behaviour is more prevalent among
men. Using Framingham data, Haynes et al. (95) reported
that 50# of the men in their sample and 38# of women are
Type A. Therefore, adjustment for Type A behaviour would 
probably lower the gender differential. But Haynes et al. 
(95) also reported that the relative risk of IHD (fatal
and non-fatal) associated with Type A behaviour is
actually higher for women than for men. These data suggest 
the hypothesis that men have more IHD than women is in 
part because Type A is more prevalent among men. 
Housewives may be even less likely to be Type A than 
employed women (97). Agressiveness and competitiveness are 
two key components of the Coronary Prone Behaviour 
Pattern. Maccoby and Jacklin (98) concluded that on 
average, males are more aggressive and competitive than
females.
Why do males develop more aggressiveness and 
competitiveness than females? Genetic factors make some 
contribution to the gender differences in aggressiveness 
(98), but the extent of aggressiveness among males varies 
enormously, depending on child-rearing and cultural
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conditions (99)* Gender differences in competitiveness are 
fostered by parents and schools who push boys to achieve 
in the occupation world and girls to seek success in the 
family sphere (98* 100-102). Occupational achievement
apparently requires competitiveness, since in
industrialized societies there are seldom as many dobs as 
there are people who want and can do them. In the family 
sphere, on the other hand, warmth and love are believed to 
be much more appropriate and aggressive competitiveness 
much less appropriate than in the business world (101). 
Evidence that cultural pressures and expectations do have 
a substantial influence on the development of the Coronary 
Prone Behaviour Pattern comes from the observation that 
this Behaviour Pattern rarely develops in the social 
environment of many non-industrial societies (99, 103).
Bengtsson et al. (10 ll) in their study of gender
differential in IHD in 50-5^ year old Swedish women and 
men conclude that men's higher rates of IHD are related to 
their higher rates of smoking and drinking alcohol, higher 
aggressive and achievement scores and greater self- 
reported stress. These authors believe that additional 
factors also contribute to the observed gender differences 
in IHD mortality.
The gender differential in mortality also varies for 
different groups. For example the excess of male mortality 
is lowest among married and highest among divorced -adults 
(105). The excess of mortality for un-married males is 
particularly large for causes like cirrhosis of the liver 
which are strongly influenced by behaviour, and for
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diseases like tuberculosis in which health habits and care 
play an important role. Gove (105) has argued that the
major reasons why the gender mortality differential is 
higher among males who are not married are that men do not 
adjust as well as women do to being unmarried, and that 
men derive greater advantages from being married, both in 
care received and in psychosocial well-being.
The gender differences observed may depend only on 
various distributions of the primary risk factors in the 
female and male populations, which to some extent is 
supported by findings from previous studies (106-108). In 
the Framingham study, at least as large logistic
coefficients were reported for women for blood pressure 
and serum cholesterol, but for cigarette smoking this was 
found only below age 50 (106-108). It has been suggested
that high serum cholesterol might not be as strong a risk
factor in women as in men, while high serum triglycerides 
might be an important risk factor in women contrary to the 
finding in men (106). In the Johansson et al. study the 
frequency of current smokers was the only primary risk 
factor that showed a consistently higher prevalence in 
male compared with female patients (109). This finding
has been supported by the Dick and Stone (110) study and 
may contribute to the male preponderance in the incidence 
of myocardial infarction.
The San Francisco-Oakland Study (111), which combined 
blood pressure, cholesterol and glucose levels, weight and 
ECG measurements into one variable - *IHD Risk Factors*- 
found a higher relative risk associated with these 
biological measurements for men than women.
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2.3. BLQQD PRESSURE A S  A  PREDICTOR OR Hill AND STROKE 
3*3*1*Blood Pressure as a predictor of XHD
The relative Importance of SBP versus DBP in predic­
ting risk of IHD is controversial. This viewpoint has been 
considered and a number of studies have found that SBP is 
a better predictor of IHD than DBP (108, 112-120) although
this is not a universal finding (121, 122, 123).
Roeenman et al. (119), in the Western Collaborative 
Group Study of employed men aged 39-50 years, found the 
risk of IHD was more strongly associated with SBP than 
DBP.
Lichenstein et al. (120) also compared SBP and DBP as 
predictors of death due to IHD in male civil servants, 
aged U 0 - 6 k years in the Whitehall study. They found SBP as 
a better predictor of IHD mortality than DBP.
Kannel et al. (115) compared the contribution of SBP 
versus DBP of risk of IHD and role of MAP, PP and systolic 
lability in Framingham study. Assessment of the net effect 
of each indicates a stronger association of SBP than DBP, 
MAP or PP with risk of IHD.
Aagetverdal (122) compared SBP and DBP as a predictor 
of IHD mortality in Norwegian men aged 35-^9. He found DBP 
as a better predictor and suggested that the relative 
predictive strength of SBP and DBP may depend on age.
The relative importance of SBP versus DBP in 
predicting risk of IHD was also studied by Rabkin et al. 
(12/1), in the Manitoba study. DBP showed a stronger 
association at the earlier examinations, whereas SBP was 
more important when the majority of the cohort was between
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40-50 years of age. They suggested that in middle-aged men 
the risk of IHD was more strongly associated with SBP than 
DBP.
2.3*2.Blood Pressure as a predictor of Stroke
The relative importance of SBP versus DBP in
predicting risk of stroke was compared in Manitoba study 
by Rabkin et al. (124). The,y found a stronger association 
with stroke for SBP compared to DBP.
Kannel et al. in the Framingham study also compared 
various components of blood pressure, including SBP and 
DBP, PP, lability of pressure, MAP and tension-time index 
in relation to ABI (125. 126). They stated, while all
measures were associated with ABI incidence, that the
simple casual SBP emerged as good a predictor of ABI
incidence as any other component of blood pressure.
Evans (127) in his pathologic study of blood pressure 
found a stronger association of SBP than DBP with 
cerebrovascular disease.
In summary, as indicated by the literature review, the 
associations between asymptomatic hyperglycaemia and 
morbidity and mortality, as well as gender differential 
and its relationship with other CVD risk factors, are
controversial. The gender differential in mortality is not 
completely explained by demographic, psychosocial, 
behavioural or biochemical differences between the 
genders. The relative importance of SBP versus DBP in 
predicting risk of IHD or stroke is debatable and provides 
a potential hypothesis for further studies.
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STUDY D££Ii3Ii
SUMMARY: The study can be roughly divided into three
stages:
First, to evaluate the use and performance of a 
register of a well (middle-aged) population (the Midspan 
Study) for longitudinal studies. The aim of this section 
is to give a comprehensive and balanced picture of how the 
project was formulated, implemented and evaluated.
Second, variation in mortality risk is examined among 
men and women while adjusting for seven CVD risk factors 
in a series of age-adjusted and MLR analysis. To test a 
series of specific hypotheses relating to:
1) The measurement of trends in and the determinants 
of all causes mortality, and mortality from CVD, IHD and 
CVA in asymptomatic hyperglycaemia (Chapter 6).
2) The extent to which asymptomatic hyperglycaemia 
interacts with other known cardiovascular risk factors 
(age, gender, SBP, DBP, serum cholesterol, BMI and 
cigarette smoking habit) in the prediction of mortality 
(Chapter 6).
3) Differences in mortality rates for asymptomatic 
hyperglycaemia and associated risk factors by gender 
(Chapter 7).
ll) The interaction between blood sugar value and BMI 
in the prediction of CVD mortality (Chapter 8).
5) Gender differentials in mortality (Chapter 9).
6) The use of different indices of SBP and DBP as 
predictors of IHD and stroke mortality (Chapters 10 and 
11).
7) Trends in overall and stroke mortality in Scotland 
since 1950 (Appendix D).
Third, to determine the feasibility of following up a 
cohort, through record linkage using the Midspan 
registry, CHI and general practice records (Chapter 12), 
and to examine baseline high blood glucose as a possible 
risk factor for the later development of overt diabetes 
(Chapter 13).
CONTENTS
3.1.Overall Design
3.2.Hypothesis Tested in the Study
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3.1.OVERALL DESIGN
This study focused on the use and evaluation of a
well population register- in the study of all causes, CVD, 
IHD and stroke mortality and associated risk factors, and 
the association between asymptomatic hyperglycaemia and
later development of overt diabetes. However, the study 
can be roughly divided into three distinct stages:
First, description of the general aims and objectives 
of the project as well as the background of the study and 
evaluation of the use and performance of a register of a 
well (middle-age) population for longitudinal study.
Second, a series of investigations related to
mortality from all causes, CVD, IHD and stroke. These 
were: how the gender differential in mortality is
influenced by seven cardiovascular risk factors; how 
asymptomatic hyperglycaemia influences all causes, CVD, 
IHD, and stroke mortality and their gender differential; 
what is the relative importance of SBP, DBP and different
indices of them as a predictor of IHD and stroke
mortality.
Third, an evaluation of how a cohort study could be 
followed indirectly through medical record linkage for 
mortality and morbidity without physical re-examination. 
For this purpose individuals with asymptomatic
hyperglycaemia at baseline have been followed through 
record linkage using the Paisley registry and CHI, to 
examine asymtomatic hyperglycaemia as a possible risk 
factor for the later development of overt diabetes.
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3. 2. HYPOTHESES TESTED JUL THE, STUDY
In this thesis a series of hypotheses were developed. 
The task of the present study was to attempt to prove 
these hypotheses. These hypotheses are presented in this 
section, along with some of the detailed considerations to 
be discussed in subsequent chapters. However, The 
following chapters discuss and answer the basic questions: 
Does an initial high casual blood glucose level 
itself constitute a risk factor for all causes, CVD, IHD 
and stroke death? Does it do so independently of other 
well-established major CVD risk factors such as high blood 
pressure, high serum cholesterol level, obesity and
cigarette smoking? Chapter 6 examines whether blood 
glucose is associated with mortality outcome. This
analysis compares the age-adjusted ratio of quintiles and 
percentiles of mortality rates before and after adjustment 
for confounding variables. They involve quintile and
correlation techniques for univariate assessment, 
bivariate, cross-classification analyses and regression 
techniques for multivariate analyses.
Do men with high casual blood glucose value have higher 
mortality rates than women with high blood glucose level? 
Chapter 7 focuses on whether asymptomatic hyperglycaemia 
displays the gender differences as found in diabetes or 
the mortality rates found in general population 
independent of established major CVD risk factors. This 
discussion begins by determining whether asymptomatic 
hyperglycaemia defined by the upper 5% of blood sugar 
distribution is associated with mortality, noting the
differences in the relative mortality risk for men and
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women and ends by comparing the distribution of the high 
blood glucose level among men and women. If asymptomatic 
hyperglycaemia is both associated with mortality and 
distributed unequally among men and women, that factor may 
be masking or enhancing the gender differential in 
mortality rates.
In this study, how does adjustment for CVD risk 
factors influence the gender differential in mortality in 
persons with high casual blood glucose compared to 
individuals with low blood glucose value? This analysis 
compares the age-adjusted ratio of male to female 
mortality rates, before and after adjustment for 
potentially confounding variables. These adjustments are 
accomplished through the MLR analysis. The interaction 
between blood glucose level and SBP, DBP, BMI and 
cigarette smoking, age and gender was examined through 
application of the interaction term between blood glucose 
and other confounding variables in the MLR model.
Chapter 8 covers whether the strength of the 
relationship between the degree of glycaemia and mortality 
is independent of weight. These analyses were completed 
through a set of quintiles analyses, bivariate cross­
tabulations and multivariate analyses.
Might the CVD risk factors be a confounding variable 
for an examination of the gender differential in overall 
and CVD mortality? Chapter 9 covers whether the variable 
is associated with mortality and if so, whether it appears 
to be unequally distributed among males and females and if 
the mortality risk associated with that variable is
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different for men and women. If a variable is both asso­
ciated with mortality and distributed unequally among men 
and women, that factor may be masking or enhancing the 
gender differential in mortality rates.
How does adjustment for these variables influence the 
gender differential in mortality? This analysis compares 
the age-adjusted ratio of male to female mortality rates, 
before and after adjustment for potentially confounding 
variables. These adjustments are accomplished through the 
MLR analysis.
Does SBP predict IHD and stroke mortality better than 
DBP or other indices of SBP and DBP? Chapters 10 and 11 
cover whether the SBP predicts IHD and stroke mortality 
better than DBP alone or other combinations of SBP and 
DBP, and if so, whether they are independent of other CVD 
risk factors. We also wish to assess the strength of SBP 
and DBP as predictors of IHD and stroke mortality to see 
if it is different between males and females. How does 
adjustment for other CVD risk factors influence the 
predictive strength of SBP and DBP and other indices of 
SBP and DBP in mortality from IHD and stroke? These 
adjustments are accomplished through univariate, bivariate 
and multivariate analyses.
In chapter 12 the feasibility of follow-up of a 
cohort, through record linkage using the Paisley registry, 
CHI, patients and GP’s records, was examined. This part of 
the study began by determining the feasibility of record 
linkage between the cohort and CHI to access the last 
known address and GP's name and address of the baseline 
examinees in the Paisley study, and ends by attempting to
87
CHAPTER 3
contact them, as well as their GP, through combinations of 
mailing and telephone enquiries.
Is initial high casual blood glucose level associated 
with later development of overt diabetes? To what extent 
does the presence or absence of an arbitrarily defined 
high single casual post-prandial blood glucose level play 
a role in the prediction of diabetes mellitus? How 
important are BMI, blood pressure, serum cholesterol and 
cigarette smoking in influencing later development of 
frank diabetes? Is there any gender difference between the 
presence of risk factors and later development of 
diabetes? In Chapter 13 attempts are made to clarify these 
questions by means of univariate, bivariate, life-table 
techniques and multivariate analyses.
Finally, have stroke mortality rates, overall and sub­
divided by age and gender, changed in Scotland? If so, are 
they independent of the decline in overall mortality? If 
this is the case, what are the possible explanations? Is 
there any geographical variation in decline of stroke 
mortality in Scotland? Appendix D covers the secular 
trends in all causes and stroke mortality in Scotland 
during the period of 37 years from 1950 through 1986 based 
on age-specific and age-standardized death rates, using 
official data published by the Registrar General in 
Scotland. This secondary data analysis is put in a 
separate appendix rather than kept within the body of the 
study, to preserve consistency throughout the thesis.
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POPULATION ANO. METHODS
SUMMARY: This chapter provides a description of the study
population and general methodology used in the present 
study. In 1972-76, 10,5^1 men and women aged I15- 6 ll were
recruited in a well-population study (MIDSPAN) of cardio­
respiratory disease and risk factors. In this study during 
a mean follow-up of 11.6 year (Renfrew 1972 to 1986 and 
Paisley 197& to 1 98 6), 1,632 deaths occurred among which
794 (^8.6?<0 were of cardiovascular origin, 518 (31.7?0 due 
to IHD and 159 (9-7%) due to stroke. All participants were 
offered an appointment to attend a temporary examination 
centre established in the town. Before attending, each 
patient was asked to complete a standard questionnaire. 
Individual questionnaires were checked , height, weight 
and blood pressure were measured. A 10-ml non-fasting 
blood sample was taken for plasma cholesterol, and blood 
sugar. The baseline examinees were followed through 
flagging with NHSCR for mortality outcomes and through 
record linkage using the CHI and GP records for survivors. 
Univariate, bivariate and multivariate logistic regression 
analysis was performed.
CONTENTS
ll.1.Introduction
ll. 2. Population
ll.3* Examination
ll.ll. Blood Pressure Components
ll. 5 . Mortality Follow-up
ll. 6. Methodological Approach to Follow-up Study of Survivors 
4.7.Definitions and Statistical Analysis
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а.1.INTRODUCTION
Because of different analytical features in various 
sections of this study* this chapter will concern itself 
with the general principles of statistical analysis. 
Further details of the statistical analyses used in each 
individual chapter will be discussed in the chapter 
concerned if required.
The data presented in this report are based on 
information gathered by Professor VM Hawthorne and his 
team in the Renfrew and Paisley study. The population 
sampling frame of Renfrew and Paisley have been described 
in detail in Chapter 1. In this chapter the sampling frame 
used in this thesis is described. 
ft.2.POPULATION
Subjects: In 1972, during 15 days in March and April
a pilot study was completed in Renfrew Burgh. There were a 
total of 1,366 men and 1,5^8 women in the age group a 5 and 
6a years who participated in the pilot study.
In 1973* Paisley was divided into 10 sectors, each of 
which was examined in turn between February 197a and 
January 1976 by the mass health examination unit. There 
were a total of 5,603 men and 6,691 women in the age group 
a5 and 6a years who participated in the study.
Briefly, the population of this cohort study comprised
б,969 men and 8,239 women in Renfrew and Paisley combined, 
aged U 5- 6 U years old when they accepted a general health 
examination between 1972 and 1976; in this thesis they 
have been followed-up to January 1986 for mortality. Table
a . 1 shows the baseline survey, by area, age and gender.
90
CHAPTER 4
Because blood glucose data were not collected in the first 
three sectors of Paisley town and missing values in 
other variables 4,667 men and women were excluded with 
incomplete blood glucose or missing data leaving a group 
of 10,541 men and women for study. Among 10541 men and 
women on the date of screening 126 (1.2%) were known
diabetics (also, 5 cases failed to respond). Since
interest in Chapters 6, 7. and 8 centres on apparently
asymptomatic hyperglycaemia, and also in Chapter 9 because 
of well-established gender differential in mortality in 
diabetics, these men and women were not included in these
chapters (Table 4.2). However, available data on diabetics
are presented separately in Chapter 6, to complete the 
description. Information on diabetes status was obtained 
from the personal history reported by the study
participants. 'Thus, definition of diabetes in this report 
differs from that in some other epidemiological studies
because it is based entirely on a personal history of 
diabetes and was independent of current blood glucose
determinations. Thus, the remaining 10,410 men and women 
provide data for the Chapters 6, 7« 8 and 9*
4.3.EXAMINATION
In each sector being studied a temporary screening 
centre with a layout similar to that in Figure 4.1 was 
established in a hall or other suitable public meeting 
place. Then timed appointments were issued to all
residents between the age of 45 and 64 years identified by 
the census as living in the sector. Before attending, each 
patient was asked to complete a standard questionnaire on
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symptoms of cardiovascular and respiratory disease and 
diabetic status. The Questionnaire contained demographic 
data and previous disease, information on bronchitis, 
smoking habits, drinking habits, amount of physical 
activity undertaken at work and during leisure, 
cardiovascular and respiratory symptoms, behavioural 
characteristics and diabetes mellitus (Appendix A). Ten 
subjects arrived every 10 minutes during each session. 
Individual questionnaires were checked for missing 
information and any doubts expressed by the examinee 
regarding the questions were resolved and standard 
investigations lasting about 20 minutes were undertaken, 
ft. 3.1. Smoking Habits
Smoking was measured by a set of questions 
recommended by the Medical Research Council (MRC) (128)
and shown in appendix A. Those subjects who reported that 
they smoked regularly at the time of examination and 
smoked more than 5 cigarettes a day on average, were 
classified as current cigarette smokers, 
ft. 3.2.Weight and Height and Body Mass Index
Weight was measured in indoor clothing and without 
shoes to the nearest kilogram using a clinical balance 
scale. Height was measured to the nearest centimetre 
without shoes.
Adiposity was expressed as BMI which was calculated 
for each person as weight in kilograms divided by the 
square of height in metres. The ratio is calculated to two 
decimal places, 
ft.3*3-Blood Pressure
Systolic and diastolic readings have been expressed
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in millimetres of mercury on the manometer scale. Blood 
pressure was taken by a trained nurse when the subject was 
seated with his left arm at heart level, and was measured 
using the recommendations of Rose and Blackburn (129)* 
Before carrying out the field work observers were trained, 
the major emphasis being on the theory and practice of 
blood pressure measurement. Blood pressure was measured 
using the London School of Hygiene and Tropical Medicine 
Sphygmomanometer (130), in this apparatus, pressure is 
raised and lowered automatically at a constant rate of 2 
mm/sec when using a standard cuff of 12x22 cm. The machine 
has three mercury columns controlled blindly by the 
observer to prevent confusion between aural and visual 
signals and to reduce bias due to digit preference. The 
mean of two readings was taken. DBP was taken at the 
disappearance of the fifth Korotkoff sound. Observers had 
been trained to measure blood pressure using a special 
tape recording in order to reduce bias and observer 
variation (131). Digit preference in collaborating centres 
was monitored by the MRC computer estimating the rates of 
terminal zeros being reported by observers in different 
centres.
ft.3-4.Blood Sugar and Serum Cholesterol
The amount of glucose present in the subjects* whole 
blood and amount of cholesterol present in the serum of 
the subjects* blood, in milligrams per 100 milliliters, in 
Renfrew and in millimoles per litre in Paisley was 
measured. To ensure compatibility between the two areas, 
the Paisley measurement units were converted to milligrams
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per 100 millilitres using the conversion coefficient of 18 
and 38.6 for blood glucose and serum cholesterol 
respectively.
Conversion Factors 
Blood sugar, 1 mg/dl=0.056 mmol/1 
Serum cholesterol, 1 mg/dl=0.026 mmol/1
A 10 ml. non-fasting blood sample was taken for plasma 
cholesterol, electrolytes, urea and blood sugar. 
Blood samples were collected in the afternoon and 
evenings. Blood samples were collected from the 
antecubital vein without venous stasis and plasma total 
cholesterol measured by an autoanalyser technique (132). 
Glucose was determined (using whole blood) by a measure of 
oxygen consumption (133). 
ft.3.5.Vital Capacity
A nurse or technician measured the subjects vital 
capacity by getting the subjects to take the deepest 
breath possible and exhale to the fullest extent into a 
tube of a water-sealed spirometer in one second (Gathur 
Vitalometre (13ft)) with the subject standing. Two trials 
were made for each subject and the highest reading was 
recorded. This measurement of vital capacity was read to 
the next lower 0.1 litre on the scale of the spirometer. 
No adjustment was made for possible variation in room 
temperature, 
ft.3.6.Electrocardiogram
An electrocardiogram was made at the baseline 
examination with the subject in a sitting position. A six
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lead electrocardiogram (lead I, II, III, aVR, aVL, and 
aVF) on the three channel Minograph 34 was made and 
tracing was subsequently classified according to the 
Minnesota code criteria (129).
4. 3-7-Chest X-Ray
Postero-anterior and left lateral 70 mm. miniature 
chest X-ray were taken in the standing position. A 
tuberculin Tine test (Lederle) was made and sputa 
collected for direct examination and culture as part of 
the study of tuberculosis.
The cost of the health examination was £4.31 per 
person in 1972 and £6.39 in 1976.
4, 41 BLOOD PRESSURE COMPONENTS.
The parameters of blood pressure examined in the 
prediction of IHD and stroke mortality in Chapters 10 and 
11 included: SBP. DBP, PP (SBP - DBP), MAP (DBP + one-
third the PP) and MAI (one-third DBP+ two-thirds SBP).
4. 6. MORTALITY PQLLQW-I?P.
In order to study mortality in the whole population 
individuals were "flagged" with the NHSCR for Scotland in 
Edinburgh.
Following this survey, mortality data were collected 
for the 10-14 (mean 11.6) years from 1972-76 to 1986. In 
this study deaths are reported monthly by the NHSCR in 
Scotland. Cause of death was classified using the Eighth 
Revision (1972 to 1978) and the Ninth Revision (1979 to 
1986) of the International Classification of Disease, 
Injuries and Cause of death (ICD) (135). The comparability 
ratio for the change of classification from the Eighth to 
Ninth Revision used in this analysis, was estimated as
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1.04, 0.93 and 1.04 for CVD. IHD and CVA mortality
respectively by the Registrar General in Scotland (1 3 6). 
Causes of death were ascertained from copies of death 
certificates and grouped into:
1- All mortality
2- CVD mortality (ICD-9 codes 401.0-453*9: heart disease
plus cerebrovascular disease, rubrics 430-438, plus
hypertensive disease rubrics 401-404, plus arterial
disease, rubrics 440-453).
3- IHD mortality (ICD-9 codes 410.0-414.9: acute 
myocardial infarction, angina pectoris, chronic IHD).
4- CVA mortality (ICD-9 codes 430.0-438.9: subarachnoid
haemorrhage, intracerebral haemorrhage, other and
unspecified intracranial haemorrhage, occlusion and
stenosis of precerebral arteries, occlusion of cerebral 
arteries, transient cerebral ischaemia, acute but ill-
defined cerebral disease, other and ill-defined
cerebrovascular disease, late effects of cerebrovascular 
disease).
In this study CVD deaths are analysed globally,
because of the well-known limitations of the accuracy of
death certificate data with regard to the various 
manifestations of CVD (108). IHD deaths and CVA deaths 
have been analysed separately, since considering other 
specific cardiovascular causes of death would have
resulted in too small a number of deaths for the groups to 
warrant a valid statistical analysis.
During a mean follow-up of 11.6 years, 1,632 (968
male and 664 female) deaths occurred among which 794
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(48.6%) (505 male and 289 female) were of cardiovascular
origin among which 518 (31*7%) (350 male and 168 female)
were due to IHD and 159 (9*7%) (79 male and 80 female)
were caused by CVA.
,4.« .6.-METHODOLOGICAL APPROACH Z& FOLLOW-UP STUDY 
SURVIVORS
In order to study the association between
asymptomatic hyperglycaemia and later development of overt 
diabetes a follow-up study of survivors has been arranged. 
A follow-up survey in October 1987 to April 1988 located 
about 15% of alive non-diabetics of the Paisley sample.
The detailed method of this follow-up is described in
section 5 of Chapter 12.
In summary, the CHI holds the patient’s name,
address, date of birth, gender, marital status, G P ’s name 
and address, date of registration with the practice, date 
of removal, NHS number and CHI number. This information 
may be matched with that held on a separate Midspan file 
to determine the last known address of patients as well as 
the identity of the patient’s GP. The practice records
could then be examined to collect the required clinical
information.
4.7.DEFINITIONS AND STATISTICAL ANALYSIS 
4.7 .1•Person-Years of Observation
Person-years of observation (PYO) were calculated in 
order to fully utilize the period of observation for each 
individual and properly weigh their contribution to the 
study. PYO refers to the length of time the subject 
entered the cohort until observation (follow-up) was
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terminated. For mortality, observation was terminated at 
first January 1986 or at death if this occurred 
previously. For analysis of survivors in Chapter 13, 
observation was terminated at first April 1988 or at 
diabetes diagnosis if this had occurred previously. The 
period of observation was calculated by computer to the 
nearest day.
4.7.2.Risk and Mortality
Risk and mortality rate are used interchangeably. Rates 
were calculated for the total and for various subgroups 
classified by age and gender from the formula: number of
mortality events or progressed to diabetes/number of 
person-years at risk. Where data are not presented for 
specific age groups, then use was made of standardization 
to take into account differences in the age composition of 
subgroups and to remove statistically that portion of any 
difference attributable to age differentials. The
mortality rates were adjusted for age in both genders by 
the direct method using the 1981 Scottish population as 
standard. Age adjustment was based on four 5-year age 
categories: 45-49, 50-54, 55-59* 60-64. The age group
45-49 includes subjects who have just passed 45 and just 
reached 50. For simplicity, this terminology is also
employed here for actuarial type analyses where the
equivalent actuarial label would be 45-50 for the same age 
span.
4.7*3-Cut-off Values
There is no natural limit between normal and an 
abnormal risk factor level. The risk of CVD increases as 
the level of any risk factor increases.
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The concept of "normal" and the specification for 
separating "positives" from "negatives" deserves some 
discussion. The term "normal" can refer to the usual or, 
typical, values of a characteristic for a population 
group. It can also be used to describe "functional status" 
either present or future. In this sense any value can be 
considered normal if no increased risk has been found to 
be associated with it. Since the goal of screening is to 
identify persons who have a disease or are at increased 
risk for the future, screening is concerned ultimately 
with a functional definition of normality. However, we 
must also consider how the statistical use of the term 
"normal" relates to the goal of screening.
In the present investigation for compatibility with 
the other studies, the statistical concept of normality 
was considered. Two standard deviations above and below 
the mean correspond to the central 95% area under the 
curve for normally distributed variables. By extension, 
the normal range in laboratory tests or physiological 
measures is defined in terms of the central 95% of values 
derived from a series of presumably healthy individuals. 
However some biochemical measures are not normally 
distributed and ranges corresponding to the mean +. 2SD do 
not then represent the middle 95% of values. But beyond 
this, a dichotomous classification of people as "normal" 
or "abnormal" with respect to a certain value often over­
simplifies a complex situation.
c
In response to problems of this nature Elvebajk (137) 
has suggested that laboratory data on individuals be
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presented in terms of a percentile level, and furthermore, 
that this be specific for age and gender. Such specificity 
is needed because the same level of cholesterol might 
represent one percentile value for a 60-year old female, 
another for a 30-year old male. The use of age-specific 
percentiles rather than the 95% central range would 
emphasize that 1) no assumptions are made that the 
distribution is normal; 2) the same biochemical value e.g. 
300 mg/dl of cholesterol, could represent a common value 
for an older woman, but a distinctly unusual one for a 
young man and 3) health and disease lie along a continuum 
and that separation of the two on the basis of a single 
"cut-off" point may be arbitrary.
In these analyses, comparison of risk by level of the 
various risk factors, where the risk factor was 
continuously distributed (as in the case of blood 
pressure, serum cholesterol, blood sugar and BMI), was
usually done by dividing the groups into quintiles. For 
example, fifths, from the lowest to the highest, and/or 
upper and lower 5% and 2% of distribution or arbitrary 
categories established by prior research. The age-specific 
and age-adjusted mortality rates were computed for the 
quintiles, upper and lower 5% and 2% or arbitrary
categories. Where there were ties at the boundaries of
quintiles, individual values were not assigned to the
higher or lower quintile so the numbers in each quintile 
may not be exactly equal.
Comparison was made of the ratios between rates, e.g. 
for the highest and lowest quintile groups in the term of 
relative risk.
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ft.7-ft.Standardised Normal Deviate
This statistical procedure was applied in Chapters 10
and 11 concerning the assessement of the comparative
strength of various components of blood pressure as 
predictors of IHD and stroke mortality. As SBP and DBP and 
derived combinations of them differ in range and variance
and also depend upon age and gender, they were transformed
to give an age-gender adjusted standardised normal deviate 
(SND) for each individual by subtracting the age-gender 
specific mean and dividing by the age-gender specific 
standard deviation as in the Whitehall Study (120). For 
example, for a male in the ft5-ft9 age group
observed SBP - mean SBP for males in ft5-ft9 age
group
SND for SBP=------------------------------------------------
standard deviation of SBP for males in ft5-ft9 
age group
The SND indicates the degree to which an individual's 
pressure (whether SBP, DBP, MAP, MAI or PP) deviates from 
an age specific mean in standard deviation units. These 
differences provide a direct method for comparing the
power of these five measures of blood pressure to
discriminate IHD or stroke mortality. The sign gives the
direction of the association and the size of the value the 
strength of the association. If the null hypothesis of no 
difference between the relative rises in SBP and DBP and 
derived combinations of them in subjects dying of stroke 
or IHD is true, we would expect the average difference in 
those subjects to be close to zero. Significance was 
assessed by a paired t-test for the difference between
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each component of blood pressure and DBP and a two sample 
t-test for the difference between blood pressure in 
persons who died compared to subjects who were still alive 
at 10-lft years.
ft.7«5-Logistic Regression Analysis
To examine the contributions of each risk factor as 
well as calculating adjusted estimates of relative risk as 
the standardized odds ratio (SOR) to mortality outcome, 
MLR analysis (BMDP program PLR (138)) was used to allow 
for confounding factors (139)*
The logistic in its univariate form,
P=l/[l+exp(- a - bX)] 
was also used to provide estimates of risk of a new 
mortality event over the years of follow-up for men and 
women separately. Logistic analyses were carried out for 
individual risk factors (univariate logistic), and 
adjusted for age (bivariate logistic), and combinations of 
risk factors (multivariate logistic). They permitted a 
test of the relationship between continuous variables and 
all causes, CVD, IHD, and stroke causes of death on a 
continuous scale. In these logistic analyses, both the 
logistic coefficient and standardised logistic coefficient 
were computed. The latter, the product of the logistic 
coefficient times the standard deviation of the risk 
variable, served as a measure of the gradient of risk 
independent of the absolute value of the variable. In 
multivariate logistic analyses, the standard logistic
coefficient permits a comparison of the relative
contribution of each independent variable to risk of
mortality. SBP, DBP, and the derived MAP, MAI and PP,
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age, BMI, serum cholesterol and casual blood glucose were 
entered as continuous independent variables.
Current cigarette smoking habits were entered as a 
dichotomous variable (current cigarette smokers and non- 
smokers ) .
It was assumed that the probability of dying was
l/( 1 + Exp [- ( a £bi Xi)])
where Xi includes SBP and DBP (mmHg), and the derived MAP,
2
MAI and PP, age in year, gender, BMI (Kg/m ), blood 
glucose (mg/dl), serum cholesterol (mg/dl) and cigarette 
smoking at the initial examination. The parameters of the 
model (a and b) were estimated using the maximum 
likelihood method described by Walker and Duncan (139) and 
the coefficients divided by their estimated standard 
errors as a test of significance to indicate whether these 
relationships were significantly different from zero 
(PC0.05 when Z^l.9 6 ). The numbers of deaths or cases 
developing diabetes were used as the dependent variables 
and analysed for males and females separately. To test for 
differences between the effects of the high and low risk 
factors, interaction terms comprising one of the blood 
pressure variables (SBP, DBP, MAP, MAI, PP), blood sugar, 
BMI and each of the risk factors were included in MLR 
models. The regression coefficient, b ,affords a measure 
of the association between increased risk of the event and 
levels of the characteristics.
The measure used for comparison of the predictive 
strength of each controlling measure is the SOR. This 
estimates the (approximate) relative risk (odds ratio) per
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bi
unit change in the level of risk factor, Xi, is e . More 
Dbi
generally, e approximates the relative risk per D units 
of change in the level of risk factor (Xi) and can be used 
to determine the relative risk from the highest to the 
lowest category of a variable. Because of differences in 
the usual range of values for confounding variables and 
since the magnitude of the coefficients is affected by the 
variance of the characteristic, a direct comparison of the 
logistic function coefficients is not appropriate to 
determine the relative predictive strength of each 
variable. In order to put all the coefficients on the same 
scale, the coefficient is multiplied by the standard 
deviation of the variable, and then exponentiated. This 
gives the odds ratio associated with a change of one 
standard deviation in the continuous variables of 
interest. The standard deviations for the distributions 
of risk factor scores have not been given but they can be
computed from information that is provided. The standard
deviation equals the In(SOR) divided by the logistic 
coefficient.
Statistical significance of the findings was assessed 
by a variety of methods. Although the tests varied, all 
were interpreted in a common fashion, i.e. differences,
ratios, and other statistics were termed significant if 
the test indicated that chance alone would account for 
variation from a value suggested by a null hypothesis with 
probability <0.05*
In the Tables in the following chapters, certain 
conventions were used. Where there are no events, the
symbol used is -. Statistical significance is indicated
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conventionally by a single asterisk for P<0.05, a double 
asterisk for P<0.01, a triple asterisk for PCO.OOl. The 
relevant definitions and statistical methods used in each 
table are also given in the table’s footnote.
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BASELINE CARDIOVASCULAR RISK FACTORS AND MORTALITY PATTERN
IN RENFREW AND. PAISLEY.
SUMMARY:This chapter considers the prevalence of baseline 
characteristics and a brief description of baseline 
findings in the target community. The prevalence of 
cardiovascular risk factors at baseline was relatively 
high. This section also considers, by univariate, 
bivariate and multivariate analysis, the relation of 
certain key characteristics to the four causes of death - 
all causes, CVD, IHD and stroke. These key characteristics 
-SBP, DBP, serum cholesterol, casual blood glucose and 
BMI- have been related to at least one of these four 
causes of death. In general, the relationship appears to 
be stronger for women than men.
Contents
5.1.Introduction
5.2.Prevalence of Primary CVD Risk Factors 
5.3-Baseline Survey Mortality Follow-up 
5. il.Gender Differential 
5.5*Missing Values
5.6.Later Mortality
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5.1.INTRODUCTION
This chapter describes the prevalence of baseline 
characteristics and a brief description of the baseline 
findings in the target community. This chapter will also 
consider the evaluation of the role of chosen risk factors 
in mortality among the baseline survey sample who were 
followed-up through record linkage with the Registrar 
General.
The four "causes" of death considered were -all 
causes, CVD, IHD and stroke- in relation to certain 
characteristics measured at baseline. The main
characteristics considered are SBP, DBP, serum
cholesterol, cigarette smoking, casual blood glucose and 
BMI.
5.,.,2. PREVALENCE QZ PRIMARY. CVD RISK FACTORS 
5•2.1.Smoking
The baseline survey participants were divided into 
three cigarette smoking categories: current smokers, who
smoked regularly more than 5 cigarette each day at the 
time of examination; ex-smokers, who had smoked regularly 
more than 5 cigarettes a day, but had stopped; never- 
smokers, who had never smoked regularly more than 5 a day.
Fifty one percent of men and H 2 % of women in the area 
and aged 45- 6li years were current cigarette smokers in 
baseline examination. The proportion of never-smokers 
increased among women towards the older age groups. 
However the proportion of both male and female current 
smokers was lower in older age groups (Table 5.1). This
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decrease was more prominent in women than men.
A few of the men (2%) smoked pipes or cigars. The 
mean daily cigarette consumption among smoking men was 
20.5 (SD=8.4) and 16.2 (SD=6.1) among smoking women. The 
average daily cigarette consumption among the smokers was 
significantly lower in older age groups in both genders 
(F=l4. 2, PC0.001 for male and F=15.7. PC0.001 for
females). Heavy cigarette smoking (25 or more per day) was 
observed in l 8>.6% of men and 5*2% of women cigarette
smokers.
5.2.2.Serum Cholesterol
The serum cholesterol levels among the Renfrew and 
Paisley population (aged 45-64 years) were high; men
generally had lower values than women, the average value 
was 225.6 (SD=40.4) mg/dl for men and 246.7 (SD=47.4)
mg/dl for women. The mean values increased from the 
youngest to the oldest age group among women, but no 
increase was found among men (Figure 5.1). The 
distribution of serum cholesterol values by age and gender 
are presented in Table 5-2. Only 24.4% of men and 12.3% of 
women had a cholesterol value below 200 mg/dl, while 3*2% 
and 10.7% respectively had a value over 300 mg/dl. 
Seventeen percent of men and 20.5% of the women had a 
serum cholesterol value greater than 260 mg/dl. 
5-2.3.Blood Glucose
The average blood glucose value was 93.1 (SD=26.6)
mg/dl for men and 91.6 (SD=25.2) mg/dl for women. The mean 
values increase with advancing age in both genders. In all 
age groups except age 60-64 men had slightly higher mean 
blood glucose value than women (Figure 5.2). The
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distribution of blood sugar values by age and gender are 
presented in Table 5-3. Only 0.7% of men and women have a 
value over 200 mg/dl.
In the estimation of the prevalence of asymptomatic 
hyperglycaemia the arbitrary criterion of ^126 mg/dl
(upper 5% of glucose distribution) was used. The
proportion of asymptomatic hyperglycaemic men and women 
increased towards older age groups. This increase was 
considerable and almost linear among women, while less 
marked and even less consistent among men. The proportion 
of people with asymptomatic hyperglycaemia under 55 years 
was greater among men than women but the situation was
reversed among older age groups (Figure 5*3).
52.ft.Blood Pressure
Average blood pressures were also high: the mean
values in Renfrew and Paisley were 1^8.5/86.0
(SD=23.0/13.2) mmHg among men and 150.1/85.1 
(SD=25•4/13.5) mmHg among women. The SBP level was higher 
in the older than in younger age-groups among both men and 
women. Men under 50 had a mean SBP level higher than
women, but in the older age groups women had higher means
than men. The mean DBP level was higher in men under 60 
years of age but after that women had higher means. 
However, this varied less by age and gender than SBP. The 
patterns are presented in Figure 5.4. The distribution of 
SBP and DBP in Renfrew and Paisley at baseline by age and 
gender are given in Tables 5 .^ and 5.5*
Twenty six percent of men and 30% of women in Renfrew 
and Paisley had a SBP of 160 mmHg or more and 21.6% of men
109
CHAPTER 5
and 20.2% of women had a DBP of 95 mmHg or more.
In estimation of the hypertension prevalence rate the 
arbitrary criteria of ^160 mmHg SBP and/or 95 mmHg DBP 
suggested by World Health Organisation (WHO) were used. 
The proportion of hypertensive men and women increased 
towards older age groups. This increase was considerable 
and almost linear among both men and women. Thus whereas 
the proportions of hypertensives under 50-55 years of age 
were greater among men than among women, the situation was 
reversed among the older age groups (Figure 5.5).
Table 5*6 shows the Pearson correlation coefficients 
between baseline continuous variables.
Pearson correlation coefficients were used to 
describe the relationship between elevated blood pressures 
and age, serum cholesterol, blood glucose and BMI. SBP had 
a positive correlation with age, DBP, BMI, serum 
cholesterol, and blood glucose in both genders. DBP also 
had a positive correlation with BMI, blood glucose and 
serum cholesterol. The correlation between DBP and age was 
not statistically significant in men. SBP and DBP had the 
greatest numerical correlation in both genders as expected 
(0.66). After that, BMI and age had the greatest numerical 
correlation with SBP (0.20 and 0.20 for male and 0.29 and 
0.28 for females respectively) and BMI had greatest 
numerical correlation with DBP (0.30 for men and 0.35 for 
women respectively). When men and women were analysed 
separately, age and BMI explained more of the variation in 
SBP and DBP among women than among men.
5- 2.5.Body Mass Index
The average BMI values in Renfrew and Paisley were
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2 2
25.7 (SD=3.fc) Ke/m for men and 25.6 (SD=4.*l) Kg/m for
women. The mean value slightly increased from youngest to
the oldest age group among women, but no increase was
found among men (Figure 5.6). Men under 55 years had a
slightly higher mean BMI than women, but in older age
groups women had a slightly higher mean than men. The
distribution of BMI by age and gender is presented in
Table 5.7. Twenty percent of men and 28% of women had a
2
BMI value below 23 Kg/m while 35% of men and 33% of women
2
had a BMI of 27 Kg/m or more.
To estimate the prevalence of obesity an arbitrary
2
criterion of ^27 Kg/m was used. The proportion of obese 
women increased in the older age groups but this was not 
true for men (Table 5*7). The Pearson correlation
coefficients (Table 5*6) show a significant positive 
correlation between BMI and SBP and DBP, serum cholesterol
and blood glucose in both genders and a significant
positive correlation between BMI and age in women.
5. 3. BASELINE SURVEY MORTALITY POL LOW-.UP
The 10-1& year risk of death from all causes, CVD,
IHD and stroke was studied in the baseline survey sample
of both Renfrew and Paisley areas. Univariate, bivariate
and multivariate logistic coefficients and SOR are given 
in Tables 5.8-5.10.
5.3.1.Univariate and Bivariate Analysis
The crude and age-adjusted relationship of age, SBP 
and DBP, blood glucose, serum cholesterol, cigarette 
smoking habits and BMI to mortality based on univariate
and bivariate logistic regression analysis is presented in
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Tables 5*8 and 5*9 for men and women respectively. The 
data confirm that the relationship between the major risk 
factors and susceptibility to mortality events is a highly 
significant one.
As expected, age was strongly associated with an 
increased risk of death in both men and women. SBP and DBP 
are consistent and powerful contributors to all causes, 
CVD, IHD and stroke mortality in both genders which SBP is 
a slightly stronger predictor of all four causes of death 
than DBP in both men and women except for females. DBP is 
a more powerful predictor of stroke mortality than SBP. 
Further detail concerning SBP and DBP as predictors of IHD 
and stroke mortality is in Chapters 10 and 11.
Cigarette smoking habit also is confirmed as a 
significant risk factor for all four categories of death 
independently of age in both genders.
For women, casual blood glucose was related to all
causes, CVD, IHD and stroke mortality independent of age.
In men, casual blood glucose had a significant age- 
adjusted relationship with an increasing risk of death 
from all causes and CVD but the association with IHD and 
stroke mortality after age-adjustment was of borderline 
significance (P<0.1) while the crude relationship was 
statistically significant.
Serum cholesterol is revealed to be consistently and 
strongly related to IHD and all causes of death 
independently of age in both genders and to CVD in males.
BMI is less strongly and consistently related to risk
of CVD and IHD in women and the relationship was not 
statistically significant for all causes death in both men
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and women and stroke death in men. BMI is related 
negatively to stroke death in women independently of age. 
Since it has been shown that being overweight and a gain 
in weight are associated with a worsening of atherogenic 
traits (e.g. hypertension), the limited role of obesity as 
a risk factor in middle age remains an enigma needing 
further investigation.
5-3.2.Multivariate Analysis
When tha seven major risk factors 1) age, 2) SBP, 3) 
DBP, ll) serum cholesterol, 5) casual blood glucose, 6) 
cigarette use and 7) BMI are considered simultaneously by 
applying a MLR model, it is further demonstrated that 
there is a consistent relationship between each of these 
traits independently (except BMI) and IHD and CVD in at 
least one gender.
The method of treating the major risk factor as
continuous variables has distinct advantages over
categorical classification i.e. defining a risk factor by
a fixed cut point (e.g. DBP^95; SBP^l60 mmHg; serum
2
cholesterol^250 mg/dl; BMI>27 Kg/m ). In this later method
much information is lost, e.g. a DBP of 7H- mmHg is
indistinguishable from one of 9^* Moreover, when persons
have multiple marginal abnormalities (e.g. DBP 92, SBP 155
mmHg, serum cholesterol 2kii mg/dl) their risk may be 
underestimated and overlooked as ’mild* and without
significance.
Age: In the MLR analysis of death age was entered as a
continuous independent variable for complete age-
ad Justment. Age appears as the most important risk factor
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among men and women for all causes of death and the risk 
of death increases with age in both genders.
Cigarette Smoking: In the MLR analysis, cigarette
smoking was presented in the form of a dichotomous
variable, smokers and non-smokers. In this form of
analysis cigarette smoking appears as a pernicious
powerful risk factor among men and women for all four
death categories.
Blood Pressure: In multivariate analysis, where blood 
pressure was considered as a control variable or as a
contributor to multiple regression, both SBP and DBP were 
used together. However, when blood pressure is considered 
by itself it is awkward to use the Joint multivariate 
regression coefficients for SBP and DBP. Hence in Tables 
5.8 and 5.9 attention is restricted to the SBP and DBP 
coefficients which are based on univariate and bivariate
analysis but in Table 5-10 the SBP and DBP coefficients 
which are based on multivariate analysis that include both 
SBP and DBP components. The effects of single and combined 
SBP and DBP on multiple regression coefficients will be 
discussed in detail in Chapters 10 and 11.
In the balance, after age and smoking, SBP appears to 
be the strongest of the factors considered for all causes 
and IHD in both genders, while DBP appears to be strongest 
of the considered factors for stroke and CVD in both 
genders. The relationship between DBP and stroke mortality 
is particularly strong. SBP was a significant predictor in 
both men and women who died from all causes, CVD, IHD and 
males who died from stroke. DBP was a significant 
predictor in both men and women who died from CVD and
11U
CHAPTER 5
stroke and in males who died from all causes and IHD.
Serum Cholesterol: Serum cholesterol was another
significant predictor only in men and women who died from 
IHD and men who died from CVD.
Blood Sugar: A standardized glucose tolerance test was 
not administered in this study, so assessment of 
"asymptomatic hyperglycaemia ft is less than optimal; but 
as may be Judged from data in univariate, bivariate and 
multivariate analyses, casual blood glucose bears a 
distinct relationship to mortality from all causes and CVD 
for both men and women and IHD and stroke mortality in 
females. However, the relationship of casual blood glucose 
to IHD and stroke mortality events appears to vary with 
gender. Further detail regarding gender differential in 
the relationship between high casual blood glucose and 
mortality will be discussed in Chapter 7*
Body Mass Index: BMI had a negative association with 
female overall causes of deaths and females who died from 
stroke.
5.a.GENDER DIFFERENTIAL
In terms of SORs each of these risk factors, except 
DBP, appears to be more strongly related to IHD in women 
than in men. In multivariate analysis there is a 
suggestion that casual blood glucose may not make a 
contribution independent of age to IHD in men. In fact the 
relationship between casual blood glucose and IHD is 
stronger for women than men. In multivariate analysis DBP 
was not a significant independent predictor of IHD in 
females. This is due to the inter-relationship between SBP
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and DBP. In univariate and age-adjusted logistic 
regression it was a statistically significant predictor of 
IHD in both genders.
For stroke mortality the association of cigarette 
smoking and DBP is stronger in females. SBP, on the other 
hand, had a stronger relationship in men. There is a 
suggestion in MLR analysis that casual blood sugar 
positively and BMI negatively are related to stroke in 
women but not in men.
The relationship of CVD to blood pressure is stronger 
in men, while cigarette smoking, casual blood glucose 
value and age have a stronger relationship to CVD in women.
The association between all causes of death and 
cigarette smoking, age, and DBP is stronger in men. SBP, 
and casual blood glucose, on the other hand, had a 
stronger relationship to all causes mortality in women. 
The gender differential in mortality will be discussed in 
more detail in Chapter 9*
5. 5, MISSIN.G VALUES
One of the major limitations of these data is the 
large number of missing values for blood glucose. There 
are U t613 (30.3%) cases which are missing. In the first 
three sectors of Paisley town the blood glucose was not 
measured. In Renfrew this problem did not exist.
Table 5.11 compares the cardiovascular risk factor 
and age-adjusted mortality rate between blood glucose 
missing and study groups. As shown in Table 5.11 the 10-1 ll 
years all causes, CVD and IHD mortality rate is slightly 
higher in both genders and stroke in males in the blood 
glucose missing group compared to the study group. This
116
CHAPTER 5
difference is statistically significant (Mantel-Haenszel 
chi-square) only in males who died from all causes, CVD
and males and females who died from IHD. Table 5.11 also 
shows the mean levels of various possible CVD risk factors 
in two groups. The study group was slightly older than the 
group with missing blood glucose. Mean SBP and DBP and
mean BMI and proportion of cigarette smokers are slightly
but significantly increased in the group with missing 
blood glucose in males and females but the mean serum 
cholesterol level was significantly higher in the study 
group. The 95% confidence interval (Cl) shows that the
magnitude of differences is not large.
5.6.LATER MORTALITY
The mortality rate in the Renfrew and Paisley study 
population was unexpectedly lower than that for the 
general population (Tables 5.12 and 5*13).
Originally this low mortality represented the effect 
of selection. Whereas it was lower in the respondent part 
of the sample, it was correspondingly higher in the non­
respondent part. This initial difference between 
respondent and non-respondent mortality can reasonably be 
explained by the presumption that persons who were 
seriously ill were less likely to appear for examination 
than persons who were well. However, among the persons who 
gave no reason for not appearing for examination, or 
simply declined to come in, there must also have been some 
who were seriously ill, for this group also had an excess 
mortality at the beginning of follow-up period.
In Renfrew, sixteen people who had died between the
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•time of the census in 1971 and primary screening were 
excluded, as were 152 who were in hospital, ill at home, 
or moved from the district. The situation for Paisley 
remains unknown.
If the lower mortality rates observed in respondents 
can be explained by high mortality in non-respondents an 
estimation of the excess mortality in this group can be 
calculated using national figures. The excess mortality 
for the non-respondent sample that represent indirectly 
through national base mortality was quite large for the 
years 1972 and 197^-76. This was a period when the first 
examination cycle was still in progress -a period, that 
is, when it was difficult to specify whether a person did 
not come in because he had already died or did not come in 
and then died. By 1976. however, the initial examination 
cycle was essentially completed; that is, the non­
respondent group consisting of people who were alive was 
defined without ambiguity. Excess mortality in the non­
respondent sample remained great through 1972 and 197^- 
1976.
In 1977. however, mortality slightly increased in the 
study population but was still less than that for the 
national population as a whole and remained at that level. 
Thus, in the non-respondent group, selection bias seems to 
have become a minor influence by 1977.
The issue, however, is clouded by questions about the 
completeness of mortality follow-up. When a 15% sample of 
the study population was matched with names on the CHI 
(the procedure is described in Chapter 12) we found about 
8.5% of the mortality reported to CHI from 1977 to 1986
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was not in the Renfrew and Paisley data file. If the 
situation was the same and no worse for the years 1972 to 
1976 more missing mortality is expected. Some people were 
transferred from Argyll and Clyde Health Board’s CHI and 
so, the mortality of this group has not been examined in 
this study. Thus, the completeness of mortality follow-up, 
through ’’flagging” with NHSCR, is under question and 
recommended for further investigation. However, this 
mortality report is supported by Isles et al. (1^0), in an 
independent but more limited study of Renfrew and Paisley 
data, who found about 5% shortfall in the flagging system.
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ASSOCIATION BETWEEN ASYMPTOMATIC HYPERGLYCAEMIA ANIL RISK 
QZ CARDIOVASCULAR AND. ALL CAUSES MORTALITY
StJMMARYrA possible association between asymptomatic 
hyperglycaemia and mortality during the subsequent mean 
follow-up of 11.6 years (range 10-14 years) has been 
investigated among 10410 men and women aged 45-64 in the 
west of Scotland. When quintiles of casual blood glucose 
distribution were considered, no trend of age-gender 
adjusted mortality rates was apparent. However, for 
individuals with blood glucose above the 95"th centile 
there was a significantly higher mortality rate compared 
to the lowest 5 percent, excluding known diabetics. 
Multivariate analysis, taking into account age, gender, 
blood pressure, serum cholesterol, BMI and cigarette 
smoking showed the positive association between initial 
casual blood glucose level and subsequent mortality. Age, 
blood pressure, cigarette smoking and gender were also 
significant predictors of subsequent age-gender adjusted 
mortality rates. The data support the hypothesis that 
asymptomatic hyperglycaemia defined as the upper 5% of 
casual blood glucose distribution was a significant risk 
factor for mortality in this population aged 45-64.
CONTENTS
6.1.Introduction
6.2.Analysis 
6.3* Results
6.4.Discussion
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6.1.INTRODUCTION
An increased macrovascular disease mortality 
(coronary, cerebral, aortic and peripheral) in diabetics 
has been shown in several studies (141-147). But the 
association of apparently asymptomatic hyperglycaemia to 
mortality caused by cardiovascular disease still remains 
controversial. It is currently unclear as to whether 
hyperglycaemia increases IHD mortality except among those 
with extremely high postchallenge hyperglycaemia. 
Nevertheless, the relationship of asymptomatic
hyperglycaemia to other forms of occlusive vascular 
disease such as stroke remains unclear. The analysis of 
eleven prospective studies by the International Collabora­
tive Group (148) reveals no consistent relationship 
between asymptomatic hyperglycaemia and IHD mortality. 
However, some studies have shown an increased IHD 
mortality rate at the upper extreme of the blood sugar 
distribution (31). On the other hand, persons with IHD 
have a higher prevalence of hyperglycaemia than members of 
the general population of similar age and gender (29. 30).
In addition, apparently healthy persons with impaired 
glucose tolerance have higher level of a number of 
suspected coronary risk factors than subjects with normal 
glucose tolerance, and differences are partially indepen­
dent of age and adiposity (150-152).
These diverse observations suggest a relationship 
between blood glucose level and development of IHD that is 
non-linear, complex, and possibly mediated through other 
physiological variables.
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In summary, concern with determining whether 
asymptomatic hyperglycaemia is, in fact, a cardiovascular 
risk factor, has been stimulated by at least three sets of 
observations. First, while in most countries, an excess of 
atherosclerotic complications and higher cardiovascular 
mortality rates have been reported for persons with 
symptomatic diabetes, there is evidence that this is not 
true world-wide; for example, in some non-"Western” 
countries with less atherosclerosis (144, 146, 153-155)*
Second, in animal experimental work, although it was 
possible to produce both hyperglycaemia and clinical
diabetes, this was not accompanied by an intensification 
of atherogenesis (155)* Third, evidence is scant to 
support the view that because clinical diabetes has been 
commonly (although not universally) associated with excess 
atherosclerotic morbidity and mortality, it therefore 
follows that this is also true of asymptomatic
hyperglycaemia.
One means of elucidating this important unsolved 
question is through epidemiological investigation, in
large population groups, of possible associations of 
asymptomatic hyperglycaemia with an excess of IHD, CVD and 
stroke morbidity and mortality.
Hawthorne and Gilmour (44) found no association 
between asymptomatic hyperglycaemia and coronary mortality 
after 6 years in 1,134 men screened in the Burgh of 
Renfrew, Scotland. This study as well as most of the other 
International Collaborative Studies was based on 
relatively few mortality data and years of observation. 
Mortality follow-up, in particular, requires either large
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numbers or many years of observation if meaningful 
comparisons are to be made. However, caution is required 
in drawing conclusions.
This chapter is concerned with the association 
between casual blood glucose concentration and 
subsequent 10 to 14 years CVD globally and IHD and CVA 
separately and overall mortality in 10,410 men and women 
in Burghs of Renfrew and Paisley age 45-64 in the west of 
Scotland. In this report it is postulated that 
hyperglycaemia and interaction of high blood glucose level 
with other factors increases the risk of cardiovascular 
mortality especially IHD mortality in the general
population.
In addition, the relationship between factors 
measured at baseline and subsequent mortality from IHD, 
CVD, stroke and all causes in the asymptomatic 
hyperglycaemics have been re-analysed.
6..2.*AMAL.YSXS
To evaluate the relationship of casual blood glucose 
levels at baseline to 10-14 years mortality, univariate 
quintile analyses were carried out. Bivariate analyses
were also done; continuous variables were dichotomized at 
arbitrary cut points that could be considered "high” and 
also the men and women classified by smoking habits at 
entry. For glucose, the cut point divides the upper 5% of 
the baseline glucose distribution from the remaining 95%* 
The statistical significance of differences in rates by
glucose quintiles in univariate and bivariate analysis
were tested by chi-square or F-test. The chi-square test
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procedures described by Mantel and Haenszel (156) was 
applied for statistical comparisons of the rates in the 
four 5 year age group.
.6 «3juRJSSULTS
6.3*1-Baseline Characteristics
In addition to analyses of the possible association 
between asymptomatic hyperglycaemia at baseline and 
follow-up mortality, data on those with and without known 
diabetes were examined. Table 6.1 displays the data for 
those with diabetes and those without diabetes at 
baseline. Only 39 (men 15, women 24) of 126 known
diabetics died during the mean follow-up of 11.6 years.
Age, gender adjusted death rates for all cardiovascular 
and coronary causes are higher among the 126 individuals 
(men 62, women 64) known as diabetic than among the 10,410 
(men 4 ,6 9 6 , women 5.714) non-diabetics in this univariate 
analysis. This difference was considerably higher in
female diabetics than males. Also, age-adjusted death
rates for all causes and cerebrovascular causes are 
considerably higher in female diabetics but not male 
diabetic subjects. These differences were statistically 
significant only for female all causes, CVD, IHD and
stroke mortality (Mantel-Haenszel chi-square, df=l, 
P<0.001). Female known diabetic subjects experienced all 
causes, all cardiovascular, coronary and cerebrovascular 
age-adjusted death rates 3*5. 5*1. 4.7 and 10.8 times
higher than those without diabetes respectively. The 
figures for known male diabetics were 1.0, 1.2, 1.5 and
0.8 respectively. The number of cerebrovascular death was 
relatively small and caution must be taken in the
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interpretation of the results. The greater mortality of 
men relative to women for non-diabetic and the greater 
mortality of women relative to men for diabetics are 
observed in all four mortality groups. The small number of 
cases does not allow further conclusions.
Known diabetics at baseline are omitted from the
remaining analysis of mortality and the final study
population by age and gender is shown in Table 4.2. The
distribution of casual blood glucose in the total
population of men and women aged 45-64 year is shown in
Figure 6.1 and is skewed to the right. Those 498 (280 men
and 218 women) subjects at the extreme upper 5% of blood
glucose, with blood glucose in the range of 126 mg/dl and
above have been called "asymptomatic hyperglycaemics". The
prevalence rate of asymptomatic hyperglycaemia was 6 % for
males and 3*8% for females. This difference is
2
statistically significant (X =26.6, df=l, PC0.001) and 
increases with age in both genders.
Table 6.2 presents means, standard deviations, and 
ranges of major variables measured at baseline for the
10,410 (4,696 men and 5«7l4 women) individuals age 45-64. 
Simple correlation coefficients (non-parametric) of these 
variables with casual blood glucose are also shown, with 
age, SBP, DBP and BMI showing positive
significant correlations as expected, and with serum 
cholesterol showing a negative significant correlation in 
both genders. Although these correlations were
statistically significant, they were of low order except 
with SBP.
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As indicated in Table 6.3« the level of blood sugar 
increased steadily with advancing age, and the linearity 
is statistically significant in both genders, and males 
have a higher level of blood glucose than females in all 
age groups. This finding is compatible with other studies 
(157-161).
The smoking status at baseline is shown in Table 6.4. 
About 45% (male 49% and female 41%) of subjects smoked 5 
or more cigarettes per day, with 80% of these smoking 10 
to 20 cigarettes daily. Table 6.4 also displays the mean 
glucose values for the smoking strata. The mean casual 
blood glucose value was higher in never smokers and ex­
smokers than current smokers. Although these differences 
were statistically significant, they are small (male, 
F=7•7 P<0.0005; female , F=9-9 PC0.0001).
Table 6.5 displays the age, gender adjusted 
prevalence rates for different smoking classes by quintile
and top and bottom 5% and 2% of casual blood glucose. The
2
prevalence of smokers decreased (male X =20.4, PC0.01,
2
female X =26.3, PC0.0001) and the prevalence of never
2
smokers increased with the glucose level (male X =11.4,
2
PC0.05, female X =19.6, PC0.001) in this material. There
was an excess of current smokers in the lowest quintile of
2 2 
casual blood glucose (male X =12.2, PC0.01, female X =21.8
PC0.01, bottom quintile compared with the corresponding
upper quintile). In the lowest 5% compared to highest 5%
again these differences exist but in lowest 2% compared to
top 2% the difference was not significant, probably due to
small numbers of individual in these percentiles. Also,
when age adjustment was made by summing up the chi-square
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analyses in four 5 year age groups, there appeared to be 
significant correlation between smoking prevalence and 
blood glucose quintile.
6.3-2.Ten to Fourteen Year Mortality Data
Table 6.6 shows the results of univariate quintile 
and extreme values analyses in relation to 10 to 14 years 
age-adjusted mortality rates for all causes, CVD, IHD and 
stroke. A non-linear relationship was found between blood 
glucose levels and the 10 to 14 years mortality from all 
causes, CVD, stroke and IHD. There was a doubling of IHD
mortality rate at the top 5% compare to the bottom 5%. The
mortality rates in the top 5% or 2% of blood glucose were 
significantly higher than the corresponding mortality
rates in the lower 5% or 2% for female overall causes 
males and females IHD and CVD. After age adjustment, for 
male, the Mantel-Haenszel chi square test revealed that 
only for CVD and IHD did the data indicate that the
highest 5% and 2% of sugar distribution had a
significantly higher death rate than the corresponding
lowest 5% and 2% (for all causes of death the highest 2%  
of sugar distribution was of borderline significance, 
PC0.1); for female it was significant for CVD and all 
causes for the upper 2% of glucose distribution, but for 
the highest quintile it was not significant. For stroke 
none of the upper extreme values were significant.
However, the number of stroke mortality events was not
large, so that rates using this cross classification 
method must be recognized as unstable. The major
variables are dichotomized at arbitrary cut-points that
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could be considered "high”. For glucose, the cut-point 
divides the upper 5% of the baseline glucose distribution 
from the remaining 95%.
Table 6.7 present further univariate analysis. The 
relative risk of IHD, CVD and all causes death for those 
"high" on such variables as blood glucose, SBP, DBP and 
serum cholesterol is considered. When the top 5% of blood 
glucose distribution is considered, those with blood 
glucose 126 mg/dl or greater had a relative risk of 
coronary death of 1.47 for males and 1.69 for females 
compared with those with under 126 mg/dl. Also, to a 
lesser extent the relative risk for CVD and overall causes 
mortality was higher in males and females. There is thus 
evidence for a non-linear relationship between blood 
glucose and IHD as well as CVD and overall death, with a 
significant increase in mortality occurring at the higher 
extreme of the blood glucose distribution.
6.3-3-All Causes CVD, IHD and Stroke Mortality by Other 
Risk Factors
Bivariate analyses were carried out to examine the 
effect of SBP, DBP, serum cholesterol, BMI or smoking 
habits on the relationship between blood sugar levels and 
mortality. In Tables 6 .8 , 6.9* 6 .1 0 , 6.11 age adjusted
overall causes, CVD, IHD and stroke mortality rates are 
given for the normoglycaemic and asymptomatic 
hyperglycaemic groups according to possible CVD risk 
factors. Mortality from all causes, CVD and IHD was higher 
in the top 5% of blood glucose irrespective of the level 
of SBP, DBP, serum cholesterol, BMI or smoking habits. For 
male stroke mortality it is not consistent due to very
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small numbers of deaths In hyperglycaemic group during the
follow-up period* For continuous variables - cholesterol,
SBP, DBP, BMI- and the categorical variable -smoking-
mortality rates are given for subjects above and below the
selected cut-off points-i.e. 250 mg/dl for cholesterol,
2
160 mmHg for SBP, 95 mmHg for DBP, 27 kg/m for BMI. For 
overall causes of death current cigarette smoking in both 
genders and high DBP in females do not confer as high a 
relative risk of all death in the asymptomatic
hyperglycaemic group as in the normoglycaemic one. For 
CVD, high SBP and cigarette smoking in both genders and 
high DBP in male and high cholesterol in females do not 
confer as high a relative risk of CVD death in the
asymptomatic hyperglycaemic groups in the normoglycaemic 
one. For IHD, a high SBP and DBP and current cigarette 
smoking in males and females do not confer as high a
relative risk of IHD mortality in asymptomatic
hyperglycaemic group as in the normoglycaemic one. For 
stroke, a high cholesterol and SBP for male and current
cigarette smoking in female do not confer as high a
relative risk of stroke death in the asymptomatic
hyperglycaemic group as in the normoglycaemic one. 
However, for high BMI in both genders, the relative risk 
of CVD, stroke and overall death is greater in the
asymptomatic hyperglycaemic group. For high BMI in 
females, the relative risk of IHD death is greater in the 
asymptomatic hyperglycaemic group. For high cholesterol in 
both genders, the relative risk of overall, IHD and stroke 
mortality is greater in the asymptomatic hyperglycaemic
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group. For high cholesterol in males, the relative risk of 
CVD mortality is greater in the asymptomatic 
hyperglycaemic group. For high SBP in both genders, the 
relative risk of overall death is greater in the 
asymptomatic hyperglycaemic group. For high SBP in female, 
the relative risk of stroke death is greater in the 
asymptomatic hyperglycaemic group. For high DBP in both 
genders, the relative risk of stroke mortality is greater 
in the asymptomatic hyperglycaemic group. For high DBP in 
males, the relative risk of overall death is greater in 
asymptomatic hyperglycaemic group. For high DBP in
females, the relative risk of CVD mortality is greater in 
asymptomatic hyperglycaemic group. Comparison of relative 
risk of hyperglycaemic and normoglycaemic groups in this 
bivariate analysis suggests the presence of interaction 
between glucose and other variables. To remove this 
interaction effect multivariate logistic regression with 
interaction terms between glucose and the rest of
variables has been done.
As shown in Table 6.12, the 10-1& year IHD, CVD and 
overall causes mortality rate is increased above the 95th
centile of blood sugar, for both genders. Deaths from CVD
accounted for 63-1 (male 5 8 .7 * female 7 0 .0 ) percent of all 
deaths in asymptomatic hyperglycaemic group, whereas only 
4-7. ll (male 5 1 .6 , female k 1 .3 ) percent of all deaths were 
attributed to this cause in the normoglycaemic group. 
Table 6.12 also shows the mean levels of various possible 
CVD risk factors above and below the blood glucose 95th 
centile cut points. The mean age was significantly higher 
for women with asymptomatic hyperglycaemia than for
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normoglycaemic women. In men age was higher in the 
asymptomatic hyperglycaemic group than normoglycaemic 
group, but the difference was not statistically 
significant. Mean SBP is significantly increased above 
these limits in males and females and mean BMI is 
significantly increased in males, but there are no 
significant differences in mean DBP or lower mean serum 
cholesterol, or the lower proportion of cigarette smokers
in the asymptomatic hyperglycaemic group (Table 6.12).
6.3.ft.Multiple Logistic Analysis
The univariate and bivariate findings clearly 
indicate that the role of asymptomatic hyperglycaemia as a 
risk factor for death can be properly evaluated only by 
taking account of the confounding effects of other risk 
factors. Therefore, the independent contribution of blood 
glucose level to the risk of 10-lft year mortality was
assessed by a series of multivariate logistic analyses. 
The mean and standard deviation of the variables for 
persons who died from overall causes, CVD, IHD or stroke 
are compared to those who live (Table 6.13)* Persons who 
died from IHD and CVD had higher mean levels of all 
variables measured at baseline than those who survived. 
Individuals who died from all causes and stroke had higher 
mean levels of blood glucose, blood pressure and they were 
older than those who survived.
The MLR analyses of mortality data (Table ‘6. 13),
shows a significant positive contribution of age, gender, 
SBP, DBP, blood glucose and cigarette smoking and a 
negative contribution of BMI and serum cholesterol to the
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all causes mortality. For IHD, and to a lesser extent, for 
cardiovascular causes, age, gender, blood pressure, blood 
glucose, serum cholesterol and cigarette smoking contri­
bute positively to mortality. For cerebrovascular disease, 
blood glucose, age, DBP and smoking contribute positively 
and BMI negatively to mortality. In all regression proce­
dures all variables were entered as continuous variables 
except gender and current smoking habits (yes and no). In 
the model with interaction terms, there is a significant 
association between sugar and gender as a predictor vari­
able for all causes, CVD and IHD. From the coefficient 
from the logistic model for any difference in mortality by 
age, gender, degree of blood glucose, SBP, DBP, obesity 
or smoking a ratio can be calculated expressing the rela­
tive odds of death in the 10-lft year period. The adjusted 
odds ratio of all causes, IHD, CVD and stroke mortality 
has been calculated. This adjusted estimated relative risk 
of blood glucose for IHD and CVD death is approximately 
12% and lft%, for all causes and stroke mortality, 9 % and 
16% respectively increase with a change by an amount equal 
to its standard deviation. Several of the possible CVD 
risk factors are significantly correlated with each other 
and with blood sugar (36). To assess the independent 
relationship of each variable with IHD, CVD, stroke and 
overall death, another MLR analysis has been carried out 
for the normoglycaemic and asymptomatic hyperglycaemic 
groups separately (Table 6.1ft). For the normoglycaemic 
group gender, age, SBP, DBP, and smoking were significan­
tly related to IHD, CVD, stroke and all causes death. 
Serum cholesterol was not related to stroke mortality. BMI
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was not related to CVD and IHD death. Blood sugar was not 
a significant predictor of CVD, IHD, overall causes death 
and stroke mortality in normoglycaemic group. In asympto­
matic hyperglycaemic group blood glucose and age were 
significantly related to IHD, CVD, stroke and overall 
causes of death. DBP was also significantly related to 
stroke and CVD mortality and SBP to all causes and IHD 
deaths. Cigarette smoking also was significantly related 
to all causes, CVD and IHD mortality. Gender was also 
significantly related to CVD and IHD mortality 
6.ft.DISCUSSION
In this chapter, the role of asymptomatic hypergly- 
caemia as a possible risk factor for CVD, IHD, stroke and 
overall causes of death has been examined in the middle- 
aged population of Renfrew and Paisley in the west of 
Scotland.
Several studies have shown that clinically manifest 
diabetes mellitus is connected with an increased risk of 
premature death, especially from CVD, and particularly in 
diabetic women (lftl-lft7). The diabetic men and women in 
the Renfrew and Paisley survey were also found to have an 
excess mortality from all causes as well as from CVD and 
IHD as compared with non-diabetic control subjects. This 
difference was considerably higher in female diabetics 
than male. In an earlier report from the Framingham study 
(162), "diabetes" was a significant independent predictor 
for IHD in both men and women but in a more recent 
analysis (1 6 3 ) of a cohort aged 50 years and above, this 
is true only for the women. Also, the Evan County
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prospective population-based study (16ft) suggests that 
diabetes predicts heart disease only in women after 
adjustment for covariates. Findings of this study support 
the finding of the Framingham Study (16 5) that diabetic 
women experience higher cardiovascular mortality than men. 
The reason for the greater susceptibility of women to 
these cardiovascular sequelae of diabetes is not clear 
(lftl, 166).
In this study, as expected, the casual blood glucose 
correlated with blood pressure, obesity, and age. The 
negative relationship of serum cholesterol and blood 
glucose level was also expected. The inverse correlation 
of smoking habits and casual blood glucose level was 
somewhat unexpected. Obesity may be one of the explanatory 
factors, because it is well established that in population 
studies smoking habits and obesity tend to be in inverse 
correlation. Similar results were obtained in the Helsinki 
Policemen study (ft2) in 2-hr post load blood glucose and 
this association was found to persist after controlling 
for age and BMI. In the Social Insurance Institution Vs 
Coronary Heart Disease study smoking showed an inverse 
relationship to 1-hr post-load blood glucose but this 
association was found to be almost entirely explained by 
the opposite trends of smoking prevalence and blood 
glucose with age (ftl). In the same analysis we found in 
the multivariate analysis model using an interaction term 
that there was a significant inter-relationship between 
BMI and smoking as a predictor variable for all causes and 
IHD death.
In the Renfrew and Paisley cohort study, univariate
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analyses showed a positive non-linear relationship between 
blood glucose and the 10 to 1ft years mortality from all
k*
causes, CVD, IHD and stroke with the top quintile or 5% or 
2% showing linear trends. The Whitehall study (ft3) 
suggests a threshold of risk rather than a graded or 
linear relationship as observed here. It is possible that 
for glycaemia (unlike cholesterol and blood pressure) the 
relationship to mortality risk, particularly CVD risk, is 
a threshold rather than a linear or curvilinear one i.e. 
consistently positive association between the highest 
level of asymptomatic hyperglycaemia (e.g. the upper 2-5% 
of distribution) and IHD or CVD. Similarly, in the 
population based study of Busselton, Australia (1 6 7 ), 12-
year CVD mortality for men over 60 years of age was 
significantly higher (more than double) in men with 
baseline 1-hour post-load glucose exceeding 200 mg/dl 
(highest 2 .5%) than in those with a glucose level below 
the mean. On the other hand, there was no significance in 
mortality when the top quintile of glucose was compared 
with the lower level. In the International Collaborative 
Group, they do not consistently show evidence for a 
threshold relationship. In the present study, men and 
women with asymptomatic hyperglycaemia (upper 5% o f  
glucose distribution) showed distinctly higher mortality 
rates than those for men and women in the bottom 95% o f  
blood sugar distribution. Age-adjusted mortality rates 
from all causes were about 70% higher in the top 2% of 
casual blood glucose than in the bottom 2%.
On the other hand, the relationship of asymptomatic
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hyperglycaemia to CVD morbidity and mortality is more 
controversial. In two cross-sectional population-based 
studies from Bedford, England (31) and Tecumseh, Michigan, 
U.S.A. (30), there was a significant association between 
hyperglycaemia defined by elevated post load glucose 
levels and the prevalence of IHD. This association was 
noted even in the range of borderline or moderate 
hyperglycaemia, and remained significant when blood 
pressure (in both studies) as well as serum cholesterol 
(in Tecumseh) were taken into account. However, in a 
report from the International Collaborative Group, rather 
inconsistent results have been shown on the relationship 
of blood glucose to IHD prevalence as indicated by 
electrocardiographic abnormalities, and to overall, CVD 
and IHD mortality. In this project the age-adjusted 
mortality rate for all causes, CVD and IHD were related to 
the quintile of baseline blood glucose level. Furthermore, 
the independent role of blood glucose for the risk of 
mortality was assessed by MLR analysis taking account of 
other cardiovascular risk factors such as age, blood 
pressure, BMI, serum cholesterol and cigarette smoking 
(36).
In the International Collaborative Group, 11 studies 
presented mortality data with long-term follow-up, varying 
from four to 15 years. In univariate analysis, the 
relative risk for overall mortality, when the top quintile 
of glucose level was compared with the bottom quintile, 
was greater than 1.0 in nine studies, although it reached 
2.0 or greater only in two studies. For CVD and IHD 
mortality, the relative risk of approximately 2.0 or
136
CHAPTER 6
greater was noted ±n four studies. In multivariate 
analysis, however, a significant association of the 
baseline glucose level with subsequent mortality was noted 
for all causes in three studies, for CVD in two studies 
and for IHD in only one study. Thus, the results of this 
collaborative project do not indicate a consistent and 
strong association between asymptomatic hyperglycaemia and 
mortality. This is especially true when the confounding 
effects of other risk factors are taken into account.
Age-adjusted mortality rates in the Renfrew and 
Paisley middle-aged populations from all cardiovascular 
disease and from IHD separately were 2.5 times higher in 
the upper 2% than in the lower 2 % of casual blood glucose 
in both genders and in stroke it was ft times higher in 
males and three times higher in females. In a 5-yea3? 
follow-up study of Whitehall individual with blood glucose 
above the 98th centile, there was about a doubling of IHD 
mortality, this increase being independent of age and 
blood pressure (ft3). Also, in the 7.5 year follow-up, the 
upper 5% of the blood glucose distribution was associated 
with a doubling of IHD mortality, independent of other 
risk indicies (35). Again, the 10 year mortality data 
confirm the sharp doubling of risk of IHD above the 95th 
centile of the blood glucose distribution found in the 7-5 
year mortality analysis and this increased risk persisted 
after adjustment for other associated variables (168). In 
the Bedford survey, age corrected mortality rates, from 
all causes and coronary heart disease were higher in 
"borderline" diabetes but when adjustment was made for
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other risk factors the differences were significant only 
for all death in women (31). Similarly, those with the 
highest glucose values in Tecumseh exhibited a weak but a 
statistically significant positive association with IHD 
mortality (169). Also, in the Paris Prospective Study (7) 
in univariate analysis the overall death rate was two and 
half times higher in the upper 2.5% than the mortality 
rate in the whole group. Also, Yano et al. (170) in their 
study of nine-year mortality in Japanese men in Hawaii 
found age-adjusted mortality for death from all causes, 
CVD, IHD and causes other than CVD and cancer were signi­
ficantly higher in men with glucose intolerance, defined 
by either medication for diabetes or 1-hour post load 
serum glucose level above the 90th percentile cut-point 
(225 mg/dl) at baseline examination, than in
normoglycaemic men. This finding as well is in accord with 
those in the Chicago Peoples Gas Company Study (39) which 
was the only group in the International Collaborative 
Project showing a significant relationship of 1-hour post­
load glucose consistently with overall, CVD, and IHD 
mortality, even after controlling for other risk factors. 
It is not clear why such inconsistent results have been 
shown in different studies. However, one of the reasons 
may be that there is a non-linear relationship between 
blood glucose and mortality.
Multivariate analyses using the MLR model carried out 
to determine the impact of asymptomatic hyperglycaemia on 
all causes, CVD, IHD and stroke mortality, taking other 
risk factors into account, show an independent positive 
relationship of blood glucose with IHD, stroke, all
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cardiovascular and overall causes of death. As judged by 
the size of the SOR of all causes, CVD, IHD and stroke 
mortality on the various risk factors, although blood
glucose level is significant, it is of low order. Age, 
smoking and blood pressure appeared to be significant risk 
factors for overall, CVD, IHD and stroke mortality, as 
expected. Also serum cholesterol was a significant risk 
factor for CVD and IHD death. BMI has not been a risk 
factor for CVD and IHD whereas it has a negative relation­
ship with stroke and overall mortality in this study.
Investigation into the operation of other possible CVD 
risk factors in the asymptomatic hyperglycaemic group
(Table 6.8-6.11) showed that an increased serum 
cholesterol, SBP and DBP in males, and overweight in both 
genders, are associated with a higher relative risk of 
overall mortality than that in normoglycaemic individuals. 
In CVD, an increased BMI in both genders, and in IHD an 
increased serum cholesterol in both genders and BMI in 
females and in stroke an increase of BMI and smoking in 
males and serum cholesterol and blood pressure and BMI in 
females than that in the normoglycaemic individuals was 
found. However in the MLR analysis (Table 6.1ft), BMI, 
gender, serum cholesterol, smoking habit and SBP do not 
appear as significant independent predictors in 
asymptomatic hyperglycaemia in any of the mortality 
groups. Only blood glucose and age appear as significant 
independent predictors in the asymptomatic hyperglycaemic 
group in all four mortality outcomes. Also DBP was a 
significant predictor of CVD and stroke mortality. Most of
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•the International Collaborative Studies found the 
positive association of blood glucose and subsequent ECG 
abnormalities. The results of eight of the International 
Collaborative Group studies were negative or showed a 
slight association between glucose tolerance and IHD 
mortality (lft8), whereas three studies showed a relative 
risk of two or more for those in the top glucose quintile. 
In most of the International Collaborative Studies because 
of insufficient mortality data and a short follow-up 
period for meaningful statistical analyses, the upper 5 
and 2% of glucose values were not calculated. However in 
multivariate analysis, only one of these three studies 
showed a significant relationship between glucose level 
and IHD mortality, when other risk factors had been 
controlled. In the Helsinki Policemen study (ft2) only in 
univariate analyses a positive non-linear relationship 
between blood glucose and 10-yr mortality from all causes, 
CVD and IHD was found. Therefore, it is quite possible 
that this non-linear trend of IHD mortality with blood 
sugar may not be detectable in prospective studies with 
smaller overall numbers because a sufficient number of IHD 
deaths has not occurred in such an extreme range of the 
blood sugar distribution. This non-linearity probably 
explains why blood sugar did not appear as a significant 
predictor of IHD in the MLR analysis of some of the Inter­
national Collaborative Studies, who found the association 
in univariate analysis.
If, indeed, asymptomatic hyperglycaemia itself was a 
risk factor, then perhaps a simple measurement of casual 
blood glucose might serve to identify individuals with
lftO
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subclinical atherosclerosis or with increased risk of 
developing cardiovascular manifestations. The finding of 
this survey support the encouragement to that view. When 
known diabetics were excluded, rates of subsequent 
mortality of major cardiovascular events were 
significantly higher in this group.
Diabetics could be prone to premature cardiovascular 
deaths because of a higher prevalence of other risk 
factors for cardiovascular disease among them. In this 
study, after excluding diabetics, casual blood glucose was 
significantly correlated with blood pressure, age, gender, 
BMI and smoking status. However, it should be noted that 
survivors in 1986 with low blood sugar value in 1972-1976 
had particularly low values of blood pressure, and they 
were younger, thinner and perhaps non or ex-smokers.
Bivariate analysis of the data shows that blood 
pressure, use of cigarette, serum cholesterol and casual 
blood glucose were higher among ft5-6ft year old men and 
women who died from cardiovascular disease in the next 10- 
lft years. These factors were risk factors for death from 
overall causes as well. Serum cholesterol measured at the 
age of ft5~6ft was not found to be a statistically 
significant risk factor for overall causes of death within 
a span of about a single decade. In MLR analyses, 
including baseline casual blood glucose values, blood 
pressure, smoking habits and serum cholesterol were again 
found to be independent risk factors for death from CVD, 
IHD and stroke mortality events. However a word of caution 
is needed. The problem is whether casual blood glucose is
lftl
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a sufficiently sensitive measure. These arbitrary criteria 
are at variance with those for diabetes and impaired 
glucose tolerance based on fasting blood sugar levels or 
the standard glucose tolerance test that has been proposed 
by the National Diabetes Data Group (171) and recommended 
by the World Health Organization (172). However, in an 
epidemiological investigation examining a large cohort of 
people in a community, it is rather difficult to require 
that all subjects arrive in the fasting state or to 
require that they remain for 2 hours after glucose 
challenge, plus it is seldom practical to determine 
several glucose values from economical point of view. On 
the other hand, casual and various post-challenge glucose 
determination yield remarkably similar results in 
different studies (ftl, ft3. Ift3t 167).
Diuretics used in antihypertensive therapy may 
influence the level of glucose. Medication history 
obtained at baseline did not differentiate between 
diuretics and other hypotensive drugs. However, a large 
proportion of hypertensives were on drug treatment, and 
Hawthorne and Gilmour both included and excluded these 
groups and found no difference (ftft). So, hypertensive men 
and women on drug therapy were not excluded from this 
study.
Clinical observation has found CVD to be common among 
diabetics. In addition, retrospective case-control studies 
have found hyperglycaemia to be more common in those with 
IHD than in the normal population. These observed associa­
tions between blood glucose and CVD are supported by the 
present prospective study, that individuals with above
lft2
CHAPTER 6
threshold blood glucose values have higher incidence of 
IHD, CVD, stroke and overall causes of death. The 
prospective findings of this survey support the idea of 
elevated blood glucose being an independent risk factor.
At the extreme upper 3% range of blood glucose
concentration, defined as asymptomatic hyperglycaemia, 
there were higher levels of mean SBP for males and females 
and BMI for males (Table 6.11). As has been noted in other 
studies (31, 173), there was a significant positive
correlation between blood glucose and SBP over the whole 
blood glucose range (17*0* The proportion of current
cigarette smokers was lower for individuals above the 95th 
centile of blood glucose distribution. This difference 
was not statistically significant. Thus, this finding does 
not support the finding of other workers (175. 176) who
have suggested that increased cigarette smoking may
explain in part the increased arterial disease in 
diabetics. This finding supports the same results from 
the Bedford and Whitehall Studies (31. **3)*
Asymptomatic hyperglycaemic individuals, in general, 
have higher level of CVD risk factors than normoglycaemic 
individuals. Asymptomatic hyperglycaemic men and women in 
the Paisley and Renfrew cohort study had higher SBP and 
were more obese. However, they smoked less and had lower 
serum cholesterol. This finding is compatible with the 
finding of the Framingham Study in diabetic men *(165). 
Although the higher level of SBP in the asymptomatic 
hyperglycaemic group might suggest it, the excess risk of 
cardiovascular sequelae in asymptomatic hyperglycaemia is
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not entirely a function of a higher level of SBP. In the 
present study the association between asymptomatic 
hyperglycaemia and stroke mortality in men and women was 
inconsistent. This could be due to small number of stroke 
deaths at such extreme values. It is recommended that this 
be re-tested after sufficient mortality data is collected.
In summary, these prospective analyses -univariate, 
bivariate and multivariate- yield reasonably consistent 
results indicating an association between glycaemia and 
coronary, cardiovascular and overall mortality outcome. 
These findings suggest that this association may depend on 
gender. Men and women in the upper 5% and 2 % of casual 
blood glucose (level of 126 and 1 lik mg/dl) had especially 
marked increases in mortality rates, this increased risk 
persisted after adjustment for other associated variables 
(Table 6.13). In conclusion, the IHD, CVD, stroke and all 
causes mortality risk due to hyperglycaemia is small for 
the 95% of the population whose casual blood glucose are 
below the 95 centile. The risk of IHD death more than 
doubled for the small proportion of the population with 
blood glucose level above this cut-off point, and study of 
this group of asymptomatic hyperglycaemic individuals 
provides clues to the aetiology of atherosclerosis in 
symptomatic diabetic subjects, and perhaps, in the 
normoglycaemic population as Jwell.
The detection and adequate treatment of people with 
the combined risk factors of asymptomatic hyperglycaemia, 
raised arterial pressure, and also, mass anti-smoking 
campaigns may prove to be of important in preventive 
medicine.
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.CHAPTER Z
GENDER DIFFERENTIAL I K  MORTALITY EEQM CARDIOVASCULAR 
DISEASE AND ALL. CAUSES I K  ASYMPTOMATIC HYPERGLYCAEMICS
SUMMARY:There have been few prospective epidemiological 
studies of asymptomatic hyperglycaemia as a risk factor 
for cardiovascular disease mortality in women. Gender- 
specific mortality rates and relative risks for
asymptomatic hyperglycaemics (top 5%) have been compared 
to normoglycaemics (bottom 95/0. Univariate analysis 
showed that asymptomatic hyperglycaemia was associated 
with increased risk of all causes, CVD, IHD and stroke 
mortality in both genders. The degree of this association 
was greater in women than in men. Using MLR analysis to 
take account of differences in age, SBP, DBP, serum
cholesterol, BMI, and cigarette smoking, high casual blood 
glucose levels was still a risk factor for cardiovascular 
disease mortality in both genders. It was also a risk 
factor for all causes, IHD and stroke mortality in women 
but not in men. This study shows that to a lesser degree 
asymptomatic hyperglycaemia shows the same gender 
differentials in risk of mortality as have been
demonstrated amongst known diabetics (162, 164).
CONTENTS
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7.1.,INTRODUCTION
In industrialized communities, women live longer than 
men and their age-specific death rates are lower for most 
causes of death, particularly for IHD (9*0. a difference 
which is not completely explained by demographic, 
psychosocial, behavioural, or biochemical differences 
between the genders (53. 5**-. 177). Several studies have
shown that clinically manifest diabetes mellitus is 
connected with an increased risk of premature death, 
especially from CVD, (1*H-1**7. 173) that is not entirely
explained by differences in blood pressure or plasma lipid 
(1*1*0. In spite of some controversies in the literature, 
most studies (162, 16*1, 179. 180) show that female
diabetics have a larger excess of IHD mortality than male 
diabetics, in comparison with the general population, 
whereas the excess of cerebrovascular disease mortality of 
diabetics is equal for both genders. The reason for the 
greater susceptibility of diabetic women to cardiovascular 
mortality is not clear (l8l, 182). However, diabetes
appears to reduce the favoured status of women (1*17. 183).
Indeed diabetes (16*1, 18*0 and glucose intolerance (36)
appear to be weak risk factors for men while for women 
diabetes is a potent risk factor -even when allowing for 
other standard cardiovascular risk factors (16*0 18*0.
Among asymptomatic hyperglycaemic subjects evidence for 
gender differences is scant and contradictory. Most of the 
prospective epidemiological studies concern asymptomatic 
hyperglycaemia as a probable CVD risk factor only in men, 
and literature for women is scant. Few prospective
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epidemiological studies have addressed themselves to the 
gender differences in coronary, cardiovascular, stroke or 
all causes mortality among asymtomatic hyperglycaemic 
individuals. Because relatively fewer women are studied, 
any possible difference between the genders may be 
overlooked. For example, of the 15 studies participating 
in the International Collaborative Study examining the 
role of blood glucose as a risk factor for CVD, all of 
them include only men. The Bedford (1 7 8) study showed a 
higher cardiovascular and overall causes death rate in 
females than in male ’’borderline diabetics” and diabetics, 
particularly in women beyond &5 years of age, the relative 
excess of IHD mortality associated with impaired glucose 
tolerance being more marked in men than women. The 10 year 
follow-up of the Bedford cohort found that borderline 
post-challenge hyperglycaemia (120-199 mg/dl) carried an 
excess risk of IHD mortality, but only in women (31)- in 
Tecumseh (1 8 5) cross-sectional studies found the relative 
excess of IHD mortality associated with impaired glucose 
tolerance to be more marked in men than women. The Chicago 
Heart Association Detection Project In Industry (186) 
indicates that symptomless hyperglycaemia was associated 
with an increased risk of death from IHD. The extent of 
this association was greater in women than men with regard 
to relative risk.
The present study examined gender differential in 
overall, CVD, IHD and stroke mortality among asymptomatic 
hyperglycaemic subjects compared to normoglycaemic 
individuals, while simultaneously controlling for several
IU7
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risk factors analysed in the previous chapter. This study 
focusses on whether asymptomatic hyperglycaemia displays 
the gender differences as found in diabetes or the 
mortality rates found in the general population,
independent of established major risk factors.
7.2.ANALYSIS
The gender differential in mortality is assessed by the 
ratio of male-to-female age-adjusted rates. Two types of 
statistical analyses are presented in this chapter: 
relative risks based on age-adjusted mortality rates and 
independent relative risks determined by a multivariate 
technique which simultaneously adjusts for other
covariables. Significance levels for the former analyses 
are based on Mantel-Haenszel chi-square statistics (156).
To determine if the increased mortality in women was 
due to a greater prevalence of risk factors at baseline, 
the gender specific prevalence and mortality rates for all
causes, CVD, IHD and stroke were determined for each
category of risk factor, as was the gender ratio of
mortality rates. For this analysis, age was included as a 
continuous variable, while the other risk factors were 
dichotomized according to frequently used arbitrary out­
points in the following way: Blood glucose (<126 mg/dl,
^126 mg/dl), SBP, (<160 mmHg, ^1.60 mmHg), DBP, (<95 mmHg,
^95 mmHg), serum cholesterol (<250 mg/dl, ^.250 mg/dl), BMI 
2 2
(<27 Kg/m , ^27 Kg/m ), cigarette smoking habit (smoker,
non-smoker).
7.3.RESULTS
There were 277 asymptomatic hyperglycaemic and 
normoglycaemic men and 21*1 asymptomatic hyperglycaemic and
1U8
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5,500 normoglycaemic women in the study population. 
Gender specific characteristics of the asymptomatic
hyperglycaemic group and normoglycaemic group have already 
been shown in Table 6.12. Asymtomatic hyperglycaemic women 
were older (PC0.001) and had a higher SBP (PC0.001) than 
normoglycaemic women. Asymptomatic hyperglycaemic men were 
slightly older (PC0.08), had a higher SBP (PC0.001) and 
also greater BMI (PC0.05) than normoglycaemics. There are 
no significant differences between asymptomatic
hyperglycaemics in men or women for mean DBP, mean serum 
cholesterol or proportion of cigarette smokers. In both 
groups men were more likely than women to smoke cigarettes 
(PC0.01) and to have low cholesterol levels (PC0.01).
As shown in Table 7«1 there were 880 deaths in the
male normoglycaemic group of which 454 (51.6%) were
attributed to CVD and 329 (37.4%) to IHD and 76 (8.6%) to 
stroke. Among asymptomatic hyperglycaemic men, 37 o f the 
63 deaths (58.7) were attributed to CVD and 32 (50.8%) to 
IHD and 3 (4.8%) to stroke. Among females there were 591 
deaths in normoglycaemics of which 244 (4l.3%) were
attributed to CVD and 162 (27-4%) to IHD and 68 (11.7) *0
CVA. Among female asymptomatic hyperglycaemics, 28 of the 
40 deaths (70%) were attributed to CVD, and 12 (30%) to
IHD and 5 (12.5%) to stroke. Both asymptomatic
hyperglycaemic men and women had an increased risk of 
death from overall causes as well as CVD and IHD. 
Asymptomatic hyperglycaemic men had 1.11 times the age- 
adjusted overall death rate of normoglycaemic men and 1.25 
times the age-adjusted CVD death rate and 1.47 times the
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age-addusted IHD death rate and 0.70 times the age- 
adjusted stroke death rate. Asymptomatic hyperglycaemic 
women were generally at greater risk compared to 
normoglycaemic women, with a risk ratio of 1.55 for all 
causes, 1.57 for CVD, I.69 for IHD and 1.58 for stroke.
There was no significant difference in the total
mortality rate amongst asymptomatic hyperglycaemic men vs.
asymptomatic hyperglycaemic women (l.lll age-adjusted risk
ratio), while normoglycaemic men had almost twice the
death rate of normoglycaemic women (Mantel-Haenssel 
2
X =1 7 6, df=l PC0.0001). However, both asymptomatic 
hyperglycaemic and normoglycaemic men were at 
significantly greater risk of death from CVD, IHD, and 
stroke than women, in accordance with the well established 
fact that men are much more vulnerable to all causes, CVD, 
IHD, and stroke than women. The gender differential was 
somewhat smaller for the asymptomatic hyperglycaemic 
group. Asymptomatic hyperglycaemic men had almost twice 
the CVD and 2.5 times the IHD death rate of asymptomatic 
hyperglycaemic women (13-9/6.9=2.0 CVD age-adjusted risk 
ratio, 12.1/&.9=2.&7 IHD age-adjusted risk ratio), while 
normoglycaemic men had almost 2.5 times the CVD and 2.8 
times the IHD death rate of normoglycaemic women 
(11. 1/li. 4 = 2 . 52 CVD age-adjusted risk ratio, 8.2/2.9 = 2.83 
IHD age-adjusted risk ratio).
Chi-square statistics reveal the difference in 
percentages of SBP in male and female hyperglycaemics and 
male smokers and the obese compared with normoglycaemics 
as statistically significant as noted in Table 7-2. Table 
7.2 also shows that the percentage of smokers and BMI^27
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is higher in male hyperglycaemics while the percentage of
serum cholesterol and SBP is higher in the high risk
category for female hyperglycaemics. In the normoglycaemic
group the percentage of DBP, cigarette smokers and BMI in
the high risk categories were higher in males than females
while the percentage of serum cholesterol and SBP was
»
higher in females than males.
7-3-1-Multiple Logistic Regression Analysis
In the first analysis using MLR, blood glucose was 
studied as a predictor of mortality without adjustment for 
other important cardiovascular risk factors but with age- 
adjustment (Table 7*3). The crude logistic coefficient for 
blood glucose showed an association with all four 
categories of death for both genders. There was a stronger 
association for females judging by the level of 
significance and the larger logistic coefficients. After 
age-adjustment the regression coefficients were less in 
both genders and blood glucose showed an association with
while the association with all causes and stroke mortality 
in males was not quite statistically significant (P<0.1). 
After age-adjustment females still show stronger associa­
tions judging by level of significance and larger logistic 
coefficients.
Table 7*4 contains the results of MLR analysis when 
both genders are considered separately with adjustment for 
other confounding factors. The purpose in adjusting for 
multiple risk factors was to examine the possible role of 
these traits in explaining any observed difference in age-
and CVD deaths in both males and females
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adjusted mortality among both genders. In comparison with 
the data in Table 7*3 (which does not take into account
the effect of associated factors) shown that blood glucose
contributes to CVD mortality independent of the other risk 
factors in both genders. Casual blood glucose contribute 
to overall causes, IHD and stroke mortality independent of 
the other risk factors only in women. After adjustment for 
other cardiovascular risk factors the regression
coefficient for blood glucose decreased minimally for
males and females. Very little of the effect was lost when 
other major risk factors were taken into account judging 
from the modest reduction in the regression coefficient in 
the multivariate as compared to the univariate analysis. 
Most of the decreased effect was caused by age-adjustment. 
After adjustment for age and six other CVD risk factors 
high blood glucose levels had an excess in CVD mortality 
when compared to low blood glucose levels and the excess 
was greater in women (estimated risk ratio=l.17) than in 
men (estimated risk ratio=l.10). As seen in Table 7*^ 
casual blood glucose along with age, cigarette smoking and 
blood pressure was one of five statistically significant 
independent predictors of CVD mortality in both genders
while for all causes IHD and stroke blood sugar was 
significant only in women. In this model, the contribution 
of casual blood glucose to CVD mortality was greater in 
women. Using the same adjustment to assess all causes, IHD 
and stroke mortality risk in high blood glucose level vs.
low blood glucose level results showed once more that the
relative risk was greater in women than men (estimated 
relative risk=1.05. 1.09. 1.13 for men and 1.15* 1.21,
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1.20 for women all causes, IHD and stroke mortality 
respectively).
Blood glucose level was an independent contributor to 
IHD mortality, along with age, serum cholesterol, SBP and 
cigarette smoking in women (Table In men age, SBP,
DBP, serum cholesterol and cigarette smoking were 
independent contributors to IHD mortality. Blood glucose 
level was also an independent contributor to stroke 
mortality, along with age, DBP, cigarette smoking and BMI, 
while in males only age, SBP, DBP and cigarette smoking 
contributed to stroke mortality.
However, the risk for high blood glucose was not 
significantly different after adjustment from that of low 
blood glucose in men who died from all causes, IHD and 
stroke. These findings indicate that asymptomatic 
hyperglycaemia is probably associated with an increased 
risk of all causes, IHD and stroke death due largely to 
changes in risk factor status. Results of MLR (Table 7**0 
agree with the above finding in that asymptomatic 
hyperglycaemia was not independently associated with all 
causes IHD and stroke mortality in men when other risk 
factors were taken into account. The relative risk of 
hyperglycaemic women was also reduced with multiple risk 
factor adjustment, but remained significantly greater than 
1 . 0 .
Ratios of risk for gender were determined for 
asymptomatic hyperglycaemics (upper 5% of casual blood 
glucose distribution) only, in order to determine the 
contribution of female gender to mortality in symptomless
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hyperglycaemics. As was shown in Table 6.14, gender was a 
statistically significant risk factor for CVD (P<0.05) and 
IHD (PC0.05) mortality with an estimated adjusted ratio of 
risk for gender of 1.99 for CVD and 2.39 for IHD 
mortality. However, gender was not a statistically 
significant predictor of overall causes of death and 
stroke mortality.
7*4 i.DISCUSSIQJf
In autopsy studies (181, 182) as well as clinical
(104, 187, 188) and epidemiological (31, 141, 179. 180)
studies a greater excess of IHD mortality in diabetic 
women than in diabetic men is shown. However, the extent 
to which women lose their marked relative protection seems 
to vary a great deal among studies. In some circumstances 
the protection was completely removed (189)* In others, 
diabetes exerted a similar impact on men and women (190). 
Many of the early studies were based on patients 
identified in hospital, leading to doubts as to the 
representativeness of the sample. The few population-based 
prospective studies (164, 165, 186, 191) yielded data
indicating that the relative impact of diabetes on IHD 
mortality is greater for women than men.
Inconsistency was also noted in multivariate analyses 
in terms of the independent effect of diabetes. While the 
Framingham study (165) showed an independent effect only 
for women, the Chicago Heart Association Detection Project 
in Industry (186) and Rancho-Bernardo Study (191) found 
that diabetes appeared to be independently associated with 
IHD mortality in both men and women. In spite of the 
inconsistencies mentioned, these studies agree that
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Impaired glucose tolerance is a greater cardiovascular
risk factor in females, compared to males.
Most epidemiological studies of symptomless hypergly­
caemia and mortality were based on male populations. All 
of the Collaborative Group studies were based on male 
populations (36). The only prospective population based 
study of asymptomatic hyperglycaemia in United Kingdom 
which include both genders was the Bedford study (178). 
The Bedford study (1 7 8), showed a higher CVD and overall 
death rate in females than males in "borderline diabetics" 
and diabetics, particularly in women beyond 45 year of 
age. In the Busselton Study (1 6 7) in Australia the age
and gender specific upper 20th percentile levels for the 
one-hour blood sugar showed a borderline significant risk 
ratio only for women aged 60-69 (12 years IHD and CVD 
mortality) and for men of all ages (12 years CVD 
mortality). Higher risk ratios and significance levels are 
achieved when the cut-off point chosen approaches the
diabetic level (200 mg/dl). It must be stated however,
that in the Busselton Study a MLR was not performed and so 
the independence of blood sugar as a risk factor was not 
demonstrated, nor was there any evidence that lowering 
blood sugar levels improved the outlook in relation to 
mortality or morbidity from CVD.
The role of asymptomatic hyperglycaemia as part of
the risk of developing IHD has been extensively studied, 
with inconsistent results (3 6 , 144, 184). It is not clear
whether asymptomatic hyperglycaemia is an independent risk 
factor for cardiovascular disease. The inconsistencies may
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be due in part to the different methods used for 
characterising an individual's glucose level and to the 
high degree of misclassification into hyperglycaemic and 
normoglycaemic groups. It has been demonstrated (192) that 
one fasting or post load plasma glucose is limited in its 
ability to validly characterise a person's glycaemic 
status, because its intra-individual variation is 
relatively large in comparison to its inter-individual 
variation. Nevertheless, the univariate and bivariate 
analyses of the present paper showed in a cohort of 
middle-aged men and women that asymptomatic hyperglycaemia 
defined by the upper 5% of single casual blood glucose 
distribution, is associated with an increased risk of all 
causes, CVD, IHD and stroke mortality in both genders. The 
degree of this association was greater in women than in 
men in regard to relative risk. This finding is confirmed 
by the Chicago Heart Association Detection Project in 
Industry (186) for IHD mortality. However, male/female 
age-adjusted relative mortality risk was of greater 
magnitude in men than in women except for hyperglycaemic 
subjects who died from stroke. Of course the number of 
stroke deaths in hyperglycaemic group was too small and 
statistical analysis was unstable. In multivariate 
analysis the risk of CVD mortality for both men and women 
and overall causes, IHD and stroke mortality only for 
women with high blood glucose level was significantly 
greater than that for those with low blood glucose level 
after taking into account age SBP, DBP, serum cholesterol, 
BMI, and cigarette smoking: -i.e casual blood glucose was
apparently an independent risk factor for CVD mortality in
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both genders and for all causes, IHD and stroke mortality 
in women, although not in men. The independent effect of 
diabetes was consistently illustrated in women, but not in 
men. The fact that asymptomatic hyperglycaemia was an 
independent risk factor for cardiovascular in women, but 
not in men, underscores the above conclusion.
Standardisation for age, SBP, DBP, serum cholesterol 
level, cigarette smoking and blood glucose level reduced 
the overall mortality, CVD and IHD gender differential, 
giving an adjusted relative risk of 1.05 for men and 1.15 
for women who died from all causes 1.10 and 1.17 for men 
and women who died from CVD and 1.09 and 1.21 for males 
and females who died of IHD and 1.13 and 1.20 for those 
who died of stroke. However, in a gender specific MLR 
model, blood glucose was an independent predictor of all 
causes, IHD and CVA only in women. In CVD mortality it was 
a predictor of death for both genders. For single casual 
blood glucose measurement and its association with an 
increased all causes, IHD and stroke mortality for women 
-but not for men- the effect was explained by the other 
risk factors.
The excess mortality in women could not be explained 
totally by differences in blood pressure or smoking habits 
at baseline, though it remain possible that other risk 
indices not measured might have accounted for the observed 
excess mortality. The reason why asymptomatic 
hyperglycaemic women show a greater vulnerability to CVD 
mortality remains unclear. In reviewing all the possible 
contributing factors, it was not possible to explain the
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gender difference. Even accounting for all of the relevant 
factors together we can not explain entirely why 
asymptomatic hyperglycaemia in general and women in 
particular show a greater incidence of IHD, CVD, and 
overall mortality. Multivariate analysis taking these into 
account, shows the gender as a predictor of CVD, IHD and 
all causes mortality. The interaction term for the whole 
study group showed that there was interaction between 
gender and blood glucose, but not in the model for 
asymptomatic hyperglycaemic group.
This study confirms that the gender differential of 
the upper 5% of casual blood glucose distribution in the 
less extent follows the pattern of gender differences of 
diabetics as reported by Framingham (162) and Evan County 
(164) rather than H h e  general population.
The present report demonstrates in a 10-14 year 
follow-up an excess risk of CVD mortality amongst the 
upper 5% of casual blood glucose distribution, and that it 
is of greater magnitude in women than men.
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INTERACTION BETWEEN ASYMPTOMATIC HYPERGLYCAEMIA AND BODY 
MASS. INDEX IN THE. PREDICTION OR "ALL CAUSES” AND. 
CARDIOVASCULAR MORTALITY RISK
SUMMARY: The association between blood glucose level and
cardiovascular and all causes of death according to BMI 
has been analysed. Associations between BMI and all causes 
of death were U-shaped. There was no relationship between 
BMI and CVD deaths for both normoglycaemics and hypergly­
caemics.
An MLR analysis was used to test the interaction of 
casual blood glucose level and Quetelet Index in the 
prediction of death, particularly cardiovascular risk. 
These analyses showed that BMI on initial examination is 
not a predictor of cardiovascular deaths or IHD deaths 10- 
14 years later independently of age, gender, serum 
cholesterol, SBP, DBP, cigarette smoking and blood glucose 
level. BMI was slightly negatively associated with overall 
causes of death and CVA deaths. This relationship was 
dependent on smoking as an interaction term for overall 
causes and gender and age for cerebrovascular disease 
deaths. This analysis demonstrates no significant interac­
tion between BMI and casual blood glucose level. This 
suggests that an increasing trend of relative risk of 
cardiovascular death with increasing BMI is not further 
supported by the data when adjustment has been made. 
Intervention in corpulent subjects to well established 
risk factors such as cigarette smoking, hypertension, 
hyperglycaemia and hypercholesterolaemia, appear to be 
more advisable goals than purely reducing weight, in the 
primary prevention of cardiovascular death.
CONTENTS
8.1.Introduction
8.2.Analysis 
8.3* Results 
8.4.Discussion
159
CHAPTER 8
8.1.INTRODUCTION
Many studies have shown that the incidence of certain 
types of CVD, particularly IHD and stroke is greater in 
heavier people (112, 193-197)- Obesity is associated with
elevated blood pressure, blood lipids and blood glucose 
(198-203)* and changes in body weight are coincident with 
changes in these risk factors for disease (204, 205)-
Nevertheless, it is the well-known relationship of other 
cardiovascular risk factors with obesity that makes a 
positive association of obesity with the risk of IHD 
biologically plausible.
Obesity has long been implicated in the aetiology of 
type 2 (non-insulin-dependent) diabetes mellitus and 
impaired glucose tolerance (144, 171. 172, 206-208). Thus,
the consensus has been that the increased risk among obese 
people is primarily due to the influence of the associated 
risk factor profile and not to the degree of obesity per 
se. As shown by the results of some epidemiological 
studies, blood glucose level could be a cardiovascular 
risk factor (3 6 ).
On the other hand, in spite of the univariate 
positive association of BMI with CVD risk, weight is 
generally not an independent predictor when blood glucose 
and other risk factors are considered simultaneously. A 
notable exception is the significant independent 
association between BMI and CVD mortality reported in the 
Framingham study after a 26 years follow-up (209)- A 
question which has not yet been fully answered is whether 
the strength of the relationship between the degree of
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asymptomatic hyperglycaemia and CVD Is independent of 
weight.
In this report, this question was considered by 
analysing cardiovascular mortality in relation to casual 
blood glucose level and BMI in a representative sample of 
a middle aged Scottish population in the west of Scotland. 
8. 2,ANALYSIS
In both genders and in each of the 10 groups defined 
by the quintile of BMI (males <22.9. -24.8, -26.5, -28.4,
^28.4 and females <22.0, -24.0, -26.0, -28.7, ^28.7) and
the presence or absence of hyperglycaemia, the death rate 
is the number of deaths divided by the number of person 
years of observation in that group. In each quintile of 
BMI, the relative risk associated with hyperglycaemia is 
the ratio of death rates in the presence or absence of 
hyperglycaemia. Mortality ratios for each of the higher 
quintiles were relative to mortality in the lowest 
quintile.
8.3.RESULTS
In females, BMI increased slightly with age, from a
2
mean of 25-1+SD 4.0 Kg/m at ages 45-49 up to 26.3i,4.7 
2
Kg/m at ages 60-64. In males, the mean BMI did not depend 
on age, overall mean for males was 25-8±3«4. The mean BMIs 
were slightly higher in males than females until age 55, 
after which females had a slightly higher mean BMI.
Table 8.1 shows the number of individuals at base­
line, the number of deaths during the period of follow-up, 
the age-adjusted death rate and rate ratio and the blood 
glucose characteristics of the subjects in each quintile
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of BMI for males and females.
Overall age-adjusted death rates have a U-shaped 
distribution, being highest in the lowest quintile and 
lowest in the fourth quintile of BMI for males and the 
third quintile for females. The patterns at different ages 
were distinctive, but were however, approximately similar 
in both genders. As shown in Figure 8.1, in the 45-49 year 
age group overall mortality decreased from the lowest to 
the highest quintile of BMI. The U-shaped distribution 
became apparent after the age of 50. Increasing age was 
accompanied by an increasing relative risk for the 
thinnest men and women. Table 8.1 also shows higher 
mortality in the top and bottom quintiles of BMI for males 
and females for CVD deaths and IHD deaths but less so for 
CVA deaths. The mortality ratio of the age adjusted rate 
for males rose with increasing overweight, IHD mortality 
in the highest quintile being 45# higher than in the 
lowest. In females, the IHD mortality in the highest 
quintile was the same as in the lowest. However as noted 
in Figure 8.1 the pattern of IHD mortality in different 
ages was distinctive. In the 45-49 year age group 
mortality increased from the lowest to highest quintile of 
BMI in males but not in females, the excess mortality in 
the heaviest women became apparent after the age of 5 0 - 
The prevalence of hyperglycaemia also gives a J-shaped 
distribution being lowest in third quintile in ' both 
genders. The mean level of blood glucose is significantly 
higher in the 5th quintile of BMI. Table 8.2 demonstrates 
the overall death rates and CVD death rates, IHD death 
rates and stroke death rates in normoglycaemic and hyper-
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glycaemic males and females by quintlles of BMI and the 
corresponding relative risk in the study. The relative 
risks for total and CVD and IHD death rates show an
inconsistent association with quintile of BMI in both
genders. The number of deaths caused by stroke in the
hyperglycaemic group is too small to make any statistical 
inference, but again relative risk was inconsistent with 
BMI. The differences of the death rates between quintiles 
of BMI are statistically significant for all causes, CVD 
and IHD for normoglycaemic subjects. There were no 
significant differences of death rates between quintiles 
of BMI for stroke or hyperglycaemics.
BMI is related to blood pressure, cholesterol concen­
tration, cigarette smoking and blood glucose level. Since 
the relative risks have not been adjusted for these
confounding variables, they are considered now.
For this adjustment and also to test the possible 
interaction between BMI and further confounding variables, 
MLR analysis was undertaken. This was to ascertain
whether the relationship between BMI and mortality would 
persist after adjustment for the influence of the 
coexisting levels of the major CVD risk factors. These
include age, gender, SBP, DBP, serum cholesterol,
cigarette smoking (no, yes) and blood glucose level.
Table 6.13 of Chapter 6, gives the result of the MLR 
analysis for four death categories. According to the model 
without interaction, BMI is a significant negative 
predictor for overall causes of death and CVA deaths but 
not for cardiovascular and IHD deaths. In the model with
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an interaction term, there is a significant association 
between BMI and smoking as a predictor variable for all 
causes and IHD death. There is also an association 
between BMI, gender and age for stroke deaths. There is 
no interaction between BMI and blood glucose level in 
either analysis and both variables have independent 
effects. Because of a possible quadratic (U-shaped) asso­
ciation between BMI and all causes, CVD and IHD mortality, 
the MLR analysis is repeated entering BMI in a quadratic 
form (BMI*BMI). Again, there was no association between 
BMI and CVD and IHD mortality, but a slight negative 
association with overall death persisted.
8.U .DISCUSSION
This chapter has shown that the degree of obesity in 
the west of Scotland middle-aged men and women was not an 
important independent risk factor for CVD and IHD deaths 
in the absence of other risk factors. It was a long term 
predictor of overall mortality, dependent on smoking, and 
CVA dependent on age and gender. Some claim that the 
observed J or U-shaped relationship with BMI is due to the 
effects of smoking on body weight (210, 211) but others
disagree (212, 213)* There was no interaction between
blood glucose level and BMI, when standardised for other 
confounding variables. The highest overall mortality in 
thin subjects shown in this study was also found by the 
Whitehall study (213) "the American Cancer Society Study 
(212), Framingham Study (21&) and others (215* 216). This
highest mortality in leanest individuals could be due to 
cancer or other causes of mortality which were not studied 
in this chapter. In the Seven Countries Study (217) a
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prospective study of 15 cohorts of men aged llO to U9 
years, the 10 year incidence of mortality attributed to 
IHD or overall mortality was negatively correlated with 
BMI, relative weight, or skinfold thickness; none of the 
coefficients was significantly different from zero. A more 
recent analysis, based on the 15-year* follow-up of the 
cohort in the Seven Countries Study, again failed to show 
a significant positive relationship of relative weight to 
IHD in any population. Relative weight was in fact, a 
significant negative risk factor in Southern Europe (218). 
Population studies of obesity and heart disease in North 
American and European men have been variously interpreted. 
Keys (218) reviewed data from 13 prospective studies and 
concluded that only 1 showed a definite univariate 
relationship between overweight and IHD. Larsson et al. 
(215) reviewed 37 cross-sectional and prospective studies 
(including most of those reviewed by Keys) and interpreted 
most as showing an increased risk of IHD in obese persons, 
although their own prospective study of 50-year-old men in 
Sweden found no association of obesity with myocardial 
infarction or death. More recently Hubert (219) reviewed 
10 prospective studies and concluded that 6 showed an 
independent relationship of some measure of obesity in men 
with subsequent IHD or myocardial infarction. Barrett- 
Connor (220) reviewed several of the North American 
studies which also showed an inconsistent relationship of 
overweight to the risk of manifest IHD. The Pooling 
Project (lb) reviewed data from 12,381 white men aged bo 
to 6b years in eight populations in the United States, who
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had been followed proepectively from ft. 9 to 9.6 years. The 
pooled data from five cohorts showed a statistically 
significant linear relationship of relative weight to 
subsequent IHD, but results for individual cohorts were 
different. There is little or no association in the 
Chicago Western Electric Company or the Los Angeles Heart 
Studies, a shallow U-shaped association in the Chicago 
Peoples Gas Study, a threshold effect in Albany and 
possibly the Minnesota Study of American railroad workers, 
and a stepwise increase in standardised incidence ratio by 
increasing relative weight was seen only in the Framingham 
Study. Although there is an excess risk in the heaviest 
weight group in five cohorts, confidence limits for risk 
ratios include 1.0 in four of the risk cohorts. Keys et 
al. (2 2 1), studying the relationship of obesity to the
incidence of coronary heart disease in three cohorts of
men (American railroad workers, North European men and 
Southern European men) found that those with a BMI of 27 
or greater, relative weight of 110% or greater, or sum of 
skinfolds of 36 mm or greater had no significant excess 
risk of death from IHD or definite myocardial infarction.
All studies seem to agree on the risks of severe 
obesity. With regard to CVD and IHD our results initially 
support those studies which suggest that obesity is a risk 
factor. However, obesity is related to blood pressure, 
hyperlipidaemia and diabetes and impaired glucose
tolerance (20ft) and association with IHD is therefore
expected. When controlling for these confounding variables 
together with smoking habits, age and gender, we found 
that the independent effect of obesity was negligible.
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This is In agreement with the Whitehall Study (213) and 
also with several others (36).
In International Collaborative Group studies (36) 
blood glucose level showed statistically significant asso­
ciations with other risk factors, in particular with BMI 
and blood pressure, and therefore multivariate analyses 
were carried out to see whether or not the relationship 
between blood glucose level and prevalence of ECG 
abnormalities was independent of these other factors. In 
the majority of the studies, an independent relationship 
between blood glucose and the prevalence of ECG 
abnormalities did not persist in multivariate analyses.
In the multivariate analysis, BMI does not appear as 
a significant independent predictor in either the CVD or 
IHD categories.
This report shows that the important independent risk 
factors for all categories of death were as expected. 
These were smoking habits, age, gender, blood pressure 
and blood glucose, plus serum cholesterol for CVD and IHD 
mortality and a negative association of BMI with stroke 
and overall causes of death.
The lack of association between obesity and 
cardiovascular death in the MLR model used in this study 
could be due to an indirect relationship of both obesity 
and risk of cardiovascular death to other factors. 
Overeating may be such a factor, because it is known that 
overeating results not only in obesity, but also in 
hyperinsulinaemia, hyperlipidaemia, hyperglycaemia and 
perhaps hypertension. Another alternative explanation, as
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mentioned by Bjorntorp (210), is that ** only part of the 
obesity syndrome is associated with risk of CVD. If this 
is correct, the risk might be so ’diluted* in the total 
obese population as to be difficult to discover**. However, 
the influence of obesity as a predictor of cardiovascular 
mortality is less clear. In this study it did not 
contribute to prediction when casual blood sugar level, 
age, gender, serum cholesterol and blood pressure were 
taken into account.
In conclusion, the results presented in this chapter 
show that in middle aged men and women in Renfrew and 
Paisley a substantial decrease in the recommended levels 
of BMI is unwarranted. Although blood glucose and BMI are 
predictors of overall death, and blood glucose level is 
also a predictor of CVD, IHD, and stroke mortality, there 
is no interaction between them.
168
CHAPTER 2.
GENDER DIFFERENTIAL IN. MORTALITY FROM CARDIOVASCULAR
DISEASE. AND. ALL. CAUSES
SUMMARY: The gender differential in mortality from all
causes, CVD, IHD and stroke during the mean follow-up of
11.6 years (range 1 0 - l U years) was examined among /J.,696 
men and 5»71& women aged U 5-64. at entry in West of
Scotland.
A MLR model was used to control the Influence of 
gender, along with seven other cardiovascular risk factors 
simultaneously. The risk factors considered were age, SBP 
and DBP, serum cholesterol, casual blood glucose, BMI and
cigarette smoking. Both the prevalence of risk factors 
and relative mortality risk associated with them differ by 
gender.
Adjustment slightly reduced the gender differential 
in overall mortality from 2 to 1.9 and from 1.5 to l.tl for 
stroke deaths. Multivariate adjustment increased minimally 
the gender differential for mortality from 2 . ll to 2.8 for
CVD and from 2.8 to 3*& for IHD, suggesting that these
cardiovascular risk factors do not account for the overall 
gender difference in mortality rates.
Assessment of other environmental and behavioural 
risk factors, gender-linked inheritance and differences in 
hormonal balance and other biological variables and their 
interaction with each other may more fully explain the 
gender differential in mortality.
CONTENTS
9-1.Introduction 
9*2.Analysis 
9.3* Results
9. 4-. Discussion
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.91 l.i.XNTRQD,U.CTION
In Scotland, as in other industrialized communities, 
women live longer than men. Their age-specific death rates 
are lower for most causes of death, particularly IHD. 
Several explanations have been proposed to account for 
this gender differential in mortality. The higher death 
rate for men may be due to biological variation (72, 222),
gender linked-inheritance, psychosocial factors or to 
differences in hormonal balance, environment, or habits 
(55-57. 223, 224). Women are considered to be biologically
"more fit" than men (72, 222) and second, men behave in
ways more damaging to health (55, 223). However, some risk
factors may be of different importance in men and women. 
It may be questioned whether this difference between the 
genders can be explained by differences in known 
cardiovascular risk factors.
The present study examines the gender differential in 
mortality from all causes, CVD, IHD and CVA while 
simultaneously controlling for several cardiovascular risk 
factors.
9.2.ANALYSIS
The analytical procedure performed in this chapter is 
the same as in chapter 7*
9.3.RESULTS
After ten to fourteen years follow-up from the 
initial examination 945 men had died, equivalent to 
19*4/1,000 person years of observation. 492 deaths (52%) 
were attributed to CVD, 362 (38%) to IHD, and 79 (8.3%) to
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stroke. Among women 631 (40%) deaths, or 10.8/1000 person 
year of observation, occurred during the same period, 272 
(43.1%) of which were attributed to CVD and 174 (2 7 .6%) to 
IHD and 73 (11.6%) to stroke.
Age, gender-specific, overall age mortality rates and 
gender differential for all causes, CVD, IHD and stroke 
mortality for men and women aged 45-64 years at entry are 
presented in Table 9*1* As expected, men have higher 
mortality rates than women and mortality rates increase 
sharply with age. One measure of the gender differential 
in mortality is the age-adjusted ratio of male to female 
death rates. In this study population, the age adjusted 
relative risk of mortality for men compared to women are 
2.0 for all causes, 2.4 for CVD, 2.8 for IHD and 1.5 for 
stroke deaths. Men have approximately twice the overall 
death rate and three times higher IHD death rates than
women over the 10-14 years follow-up.
To be a confounding variable, a risk factor must be
distributed differently among men and women. Differences
in distribution of several risk factors among men and 
women are shown in Table 9*2. A significantly higher 
proportion of men had smoked cigarettes and had higher 
than cut-off levels of DBP and of casual blood glucose; 
while a higher percentage of women had higher SBP and had 
higher levels of serum cholesterol. There were no gender 
differences in obesity and the ages of the two gender
groups were similar.
The age-adjusted gender differential in mortality for 
each category of risk factor is presented in Table 9*3* 
For deaths due to all causes, CVD, IHD or stroke, the
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relative mortality risks in both high and low categories 
of risk factors for men compared to women were greater 
except in the high category of casual blood glucose which 
showed a lower stroke mortality rate in men. The number of 
deaths in this category is too small to make a valid 
statistical inference.
All causes. Men and women in the high-risk categories 
of SBP and DBP and cigarette smokers had a greater overall 
risk of dying from all causes while women, but not men, in 
the high risk category of casual blood glucose were at 
greater risk of death.
All cardiovascular disease. Mortality rates for. all 
CVD were significantly greater for smokers compared to 
non-smokers, for those with higher SBP and DBP, and for 
men with higher casual blood glucose.
Ischaemic heart disease. Men and women in the high 
risk categories of SBP and DBP were at greater risk of 
dying from IHD, while men, but not women, in the high risk 
category of casual blood glucose, and women who smoked 
cigarettes or obese, were at greater risk of IHD death.
Stroke. Mortality rates for stroke were significantly 
higher for men and women who were in the high risk 
category for DBP and who smoked cigarettes, and for men 
who were in the high category of SBP. Only one factor, 
casual blood glucose, showed a lower mortality rate in men 
than women (relative risk=0.7)*
9*3-1.Multiple logistic regression analysis
To determine if the gender differential in mortality 
is merely a product of difference in the distribution of
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risk factors, all eight variables were controlled 
simultaneously by means of a MLR analysis. The MLR coeffi­
cient and approximate relative mortality risks (odds 
ratio) of each risk factors including gender are presented 
in Table 6.13 of Chapter 6.
All Causes Mortality: Controlling for age and six other 
cardiovascular risk factors slightly reduced the gender 
differential in overall mortality from 2 to 1.9 (PC0.001).
CVD and XHD Mortality: Controlling for age and other 
confounding variables increased the gender differential in 
CVD and IHD from 2.4 and 2.8 to 2.8 and 3*4 respectively.
Stroke Mortality. After adjustment for age and other 
confounding variables slightly reduced the gender 
differential in stroke mortality from 1.5 to 1.4.
Each of the seven variables associated with mortality 
risk and distributed differently among men and women are 
potentially confounding variables in the analysis of the 
gender differential in mortality. However, for each 
subcategories of these variables, women have lower age- 
adjusted death rates than men. To remove the possible 
effect of clustering of these seven cardiovascular risk 
factors, a MLR analysis was performed for all seven 
variables for each gender. Through this analysis, the 
association of each variable with mortality can be 
determined, independent of the distribution of the other 
variables.
All Causes: Gender specific MLR analyses of all
causes, CVD, IHD, and stroke mortality showed (Table 7.4 
of Chapter 7) age, cigarette smoking and SBP to be signi­
ficant predictors of all causes mortality for both men and
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women. Of the factors which demonstrate a statistically 
significant influence on mortality in both genders, women 
have higher relative risks except cigarette smoking and 
age, for overall causes mortality. DBP was a statistically 
significant predictor only for men while BMI was 
negatively, and casual blood glucose positively, 
predictive of overall mortality only in women.
Cardiovascular Disease:. For CVD, analyses
demonstrated age, SBP, DBP, blood glucose and cigarette 
smoking to be significant predictors of mortality for both 
genders. Serum cholesterol were statistically significant 
predictors of CVD death only for men.
Ischaemic heart disease. Gender specific MLR analyses 
of IHD mortality showed age, SBP, serum cholesterol and 
cigarette smoking to be significant predictors of IHD 
mortality for both males and females. DBP was 
statistically significant only for males and blood glucose 
only for females.
Stroke: The gender specific MLR analyses for stroke
mortality showed age, DBP and cigarette smoking to be 
significant predictors of stroke mortality for both 
genders; SBP, only for males; and blood sugar and BMI 
(negatively) only for females.
9.4.DISCUSSION
In this analysis of the middle aged population drawn 
from Renfrew and Paisley, the cardiovascular risk factors 
considered do not account for the gender differential in 
mortality risk over a 10-14 years follow-up period. 
However it does confirm the findings of others who have
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shown the predictive value of the measure of risk factors, 
age, gender, blood pressure, serum cholesterol, and 
cigarette smoking.
To understand how the net influence of CVD risk 
factors can actually increase the mortality risk of males 
to females, it is necessary to understand how each 
variable individually affects the gender differential. To 
be a confounding variable, the CVD risk factors must both 
be associated with mortality and distributed differently 
among men and women. All of the seven variables tested are 
independently associated with mortality except serum 
cholesterol for stroke death, BMI for CVD and IHD, and SBP 
for stroke. Among these seven variables, three high risk 
characteristics are more common in men (smoking, raised 
DBP and blood glucose levels), while two are more common 
among women (raised SBP and serum cholesterol). These 
results reflect those in the Framingham population (224) 
in which cholesterol level and SBP were higher in women 
and glucose intolerance was higher in men. In the Rancho 
Bernardo study (54) cholesterol levels were higher in 
women and SBP and fasting plasma glucose higher in men. 
Obesity was not significantly different between the two 
genders and the ages of the two gender groups in this 
study were similar. It has also been suggested that high 
serum cholesterol may be as strong a risk factor in women 
as in men. The higher relative risk for smoking among men 
than women in the west of Scotland has been reported in 
other studies (53-56, 60, 111, 224, 225).
Because of established gender differences in mortality 
in diabetes and higher prevalence of cardiovascular risk
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factors (1&4), these men and women were not included in
this analysis.
In the present study, the sender differential in age- 
adjusted mortality from all causes is slightly reduced 
from 2.0 to 1.9 by multivariate adjustment for 
cardiovascular risk factors. Among variables, the 
estimated relative risks for all causes mortality for male 
smokers is considerably higher than female. These 
differences may reflect higher lung cancer mortality in 
male smokers. Hammand (60) has examined the gender
differences in relation to smoking behaviour utilizing
data from the American Cancer Society. He adjusted only 
for age, concluding that smoking is a risk factor for both 
genders, but more so for men.
The present study reported a greater than twofold 
gender difference in CVD and a threefold difference in IHD 
mortality after multivariate adjustment.
The gender differential in CVD and IHD mortality 
increased from 2. k and 2.8 to 2.8 and 3.& respectively. 
This does not mean that cardiovascular risks do not
influence the gender differential. On the other hand, many 
of the variables have a marked effect on gender 
differential. Some increase, while others decrease, the 
gender differential. However, none of the variables 
entirely account for the gender differences in mortality. 
Adjustment for risk factors that are more common among men 
decreases the gender differential, while adjustment for 
those that are more common among women increases the 
difference. If the gender differential in mortality is
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merely a product of variations in risk factors, the 
introduction of all appropriate adjustments should result 
in a male to female mortality ratio that approaches unity. 
However simultaneous adjustment for seven cardiovascular 
risk factors slightly decreases the gender differences in 
estimated overall mortality and stroke mortality risk, 
while increasing the estimates for CVD and IHD relative 
risk. Using Framingham data, Johnson (6l) adjusted for 
age and several biological measurements (e.g., blood 
pressure and cholesterol), and similarly concluded that
IHD mortality for male smokers is considerably higher than 
for female smokers. Also Waldron (55) suggested that men 
have higher death rates for arteriosclerotic heart disease 
in large part because they smoked cigarettes more and 
because they more often develop aggressive, competitive, 
coronary-prone behaviour patterns. This finding is not 
supported in this study. Cigarette smoking is a risk
factor for both males and females, but gender
differentials of age-adjusted relative risk for all 
causes, CVD, IHD, and stroke mortality risks for smokers 
and non-smokers were not different. Smoking may be more 
severe for men because men who smoke are more likely to 
drink alcohol while women do either one or the other. 
After multivariate adjustment the estimated relative 
risks of CVD, IHD and stroke mortality for female smokers 
are higher.
Gender differentials in mortality will remain after 
adjustment for cardiovascular risk factors if women have 
lower death rates than men for subcategories of the risk 
factors (this is true for all seven variables), or if the
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relative risk associated with the variable is higher Tor 
men. The gender differential that remains may reflect 
either an inherent biological difference between the 
genders, a difference in behavioural factors or 
differences in hormonal status or environment, or an 
interaction of these factors.
Waldron (55) reported that the largest differences 
between male and female death rates occur for IHD, 
accidents, suicide, lung cancer and cirrhosis of the 
liver. She suggested that these causes of death are linked 
to behaviours which are encouraged or more accepted in 
males (e.g., smoking, drinking alcohol and work at 
hazardous dob). Bengtsson et al. (104) also reported 
similar results in their study of gender differential in 
IHD in 50-54 year old Swedish men and women. They conclude 
that men’s higher rate of IHD are related to their higher 
rates of smoking and drinking alcohol, higher aggression 
and achievement scores and greater self reported stress. 
These authors believe that additional factors also 
contribute to the observed gender differential in IHD. 
Wingard et al. (53* 54) also analysed several demographic,
behavioural and biological factors and found these factors 
do not account for the overall gender difference in 
mortality rates.
A few studies have observed that the male death rate 
is higher even in prenatal life and infancy (62-64). Since 
behavioural factors that increase mortality risk do not 
vary by gender of the foetus, gender differences in rates 
of miscarriage, stillbirth and early infant death are
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presumably due to unspecified biological factors. However, 
foetal mortality is as high for females as for males in a
few geographical areas, for example, Scotland (63)* Among
adults, a possible biological basis for gender 
differentials in mortality has been examined through the 
relationship of hormonal status and IHD. These studies 
(90, 92) reported that IHD mortality increases among women
around the age of menopause and varies by pregnancy 
history, suggesting that changes in oestrogen or prolactin 
levels may be the cause. However, increased morbidity and 
mortality among those receiving oestrogen supplements does 
not support this hypothesis (93. 94).
The present investigation demonstrates, in a west of 
Scotland population, a two to three times higher relative 
risk for men than for women, for both CVD and IHD. This 
was associated with all the seven cardiovascular risk 
factors considered, either in high or low categories. This 
finding is similar to that of the San Fracisco-Oakland 
study (111).
Several studies (55. 72, 222, 223) have suggested
that biological and behavioural risk factors influence 
mortality risk and the gender differential in mortality. 
In this study, although gender differences in the 
prevalence of cardiovascular risk factors and relative 
mortality risk for each variable are demonstrable, they 
did not explain the gender differential in mortality from
all causes, CVD, IHD and stroke.
Finally, this study confirmed that CVD risk factors 
are better predictors of CVD in women, than in men, as 
suggested by the Framingham Study (183).
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SYSTOLIC AND DIASTOLIC. COMPONENTS QZ BLOOD PRESSURE. AS. 
PREDICTORS OS. ISCHAEMIC HEART DISEASE MORTALITY
SUMMARY:The relative importance of SBP versus DBP in 
predicting risk of IHD mortality is controversial. The 
relative importance of SBP compared to DBP and other 
combinations of SBP and DBP in predicting the risk of IHD 
mortality have been re-examined. In the 10-14 years 
follow-up period there were 553 (372 male and 181 female) 
deaths due to IHD. In a MLR model the predictive value of 
SBP, DBP, MAP, MAI and PP was examined in relation to IHD 
mortality after adjustment for age, BMI, casual blood 
glucose, serum cholesterol and cigarette smoking. While 
all measures were associated with IHD mortality the risk 
of IHD deaths was more strongly associated with MAI and 
SBP alone in both males and females. SBP and DBP together, 
MAP and PP discriminated future IHD mortality not better 
than SBP alone or MAI.
CONTENTS
10.1.Introduction
10.2.Results 
10.3* Discussion
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■10.1. INTRODUCTION
Blood pressure has been Identified as perhaps the 
most universal contributor to all forms of CVD and one of 
the strongest predictors for the occurrence of IHD (108, 
112-118, 123, 227-228). Although both SBP and DBP are
recognized predictors of IHD risk (229, 230) whether SBP
or DBP is more important as a risk factor for this disease 
still remains controversial. Textbooks of clinical 
medicine (231. 232) and others (233) suggest that DBP is
more important.
The assumption that DBP is the chief determinant of 
cardiovascular morbidity from hypertension is not 
illogical. The haemodynamic hallmark of essential 
hypertension is an increase in peripheral resistance that 
is manifested chiefly by a rise in DBP (124, 234, 235).
This viewpoint however, has been questioned and for IHD 
many epidemiological studies (108, 112, 113-119) favour
SBP, although this is not a universal finding (121, 122,
123).
It is possible that both components of the blood 
pressure contribute to the risk of IHD mortality. 
Consequently, the ability of other combinations of SBP and 
DBP to discriminate potential IHD mortality was compared 
with that of each component of the blood pressure. The 
parameters of blood pressure examined in relation to IHD 
mortality in this study included: SBP, DBP, PP (SBP - DBP)
MAP (DBP + one-third the PP) and MAI (one-third DBP + two- 
third SBP). The objective was to compare each of these
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components of blood pressure as predictors of IHD 
mortality.
This study also examines the possible interaction of 
cardiovascular risk factors with the relative strength of 
SBP, DBP, and various combinations of SBP and DBP as 
predictors of death from IHD in males and females 
separately, in a middle-aged cohort from Renfrew and 
Paisley in the west of Scotland.
10, 2 >.RESULTS.
During follow-up after the initial examination 372 
men and 181 women had died from IHD. As expected, the IHD 
mortality rate increased with age in each gender and men 
had a higher mortality rate than women (Figure 10.1). Age- 
adjusted IHD mortality rate in men is about 4 times 
(8.4/2=4.2) higher than females.
10.2.1.Prediction of XHD Mortality Using Blood Pressure 
Quintiles
An examination of the gradients of risk of IHD in 
persons classified according to quintiles of their SBP 
and DBP, MAP, MAI and PP respectively revealed rather 
similar gradients of risk as noted in Figure 10.2. When 
this was adjusted for differences in the age composition 
and gender of each quintile of the distribution of each 
blood pressure component, three facts became apparent:
1) Men have higher mortality rates in each quintile 
than women and the relative risk comparing those in low 
versus high quintile within each gender was as great in 
women as in men. There was an increase of about 3 times in 
age-gender adjusted mortality from the bottom quintile 
compared to top quintile of blood pressure.
182
CHAPTER 10
2) There Is no critical level of blood pressure 
evident, the risk being simply proportional to the level 
from the lowest to the highest recorded, in either gender.
3) Gradient for SBP and DBP, MAP and MAI are quite 
similar with nothing to suggest a closer relationship to 
DBP.
10.2.2.Age and Blood Pressure
Tables 10.1 and 10.2 and Figure 10.3 present the 
effects of age on blood pressure measurements. The 
expected gradient of increasing level of SBP, MAI, MAP and 
PP with advancing age was seen in each category for males 
and females except for the 60-64 year age group in females 
who died from IHD. In people alive after 10-14 years and 
who died from IHD, it rises more steeply in women. 
Females exhibit a lower average SBP, MAI and MAP below age 
50-54, after which they overtake and exceed the pressure 
in males except for PP of survivors which was higher than 
males in all age groups. The smaller rise was also seen in 
females* DBP level and there was no rise with advancing 
age in men who were still alive. The mean DBP rises more 
steeply in women who have a higher mean DBP after age 60 
years before which men have higher DBP. In males who died 
from IHD there was no relationship between the diastolic 
level and age. The mean values for SBP and DBP, MAP and 
MAI were significantly greater for those dying of IHD than 
for those alive after 10-14 years for all age groups in 
men and most age groups in women (Table 10.2). The mean 
standard normal deviate values showed a similar pattern 
but they showed no general increase with advancing age.
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In persons dying of IHD the age-adjusted standard normal 
deviate for SBP, MAP and MAI was slightly but 
significantly greater than that for DBP especially in 
females. Table 10.3 also shows that the mean standard 
normal deviates for SBP, DBP, MAP and MAI were all 
significantly greater for those dying of IHD than for 
those still living. For men and women dying of IHD the 
mean difference between the standard normal deviates for 
SBP and DBP was 0.09 (PC0.06) for males and 0.15 (P<0.05)
for females and the mean difference between the standard 
normal deviates for MAP and DBP was 0.08 (PC0.05) for
males and 0.11 (PC0.001) for females; for MAI and DBP it 
was 0.09 (P<0.05) Tor males and 0.15 (PC0.01) for females 
respectively. Men and women dying of IHD therefore have a 
SBP, MAP and MAI that deviates from the mean for their age 
specific group to a small but significantly greater extent 
than does their DBP. The PP deviate from the mean for 
their age-specific group is not significantly different 
from their DBP. Table 10.4 shows the mortality from IHD 
in the age-specific and age-adjusted upper quintiles of 
SBP (£167). DBP (£95). MAP (£118), MAI (£142) and PP (^77) 
and the ratio of these death rates compared with DBP. In 
males and females at all ages the rate was in favour of 
MAI, and except for males 45-49. also in favour of MAP. In 
males at all ages except 50-54 years the rate was in 
favour of SBP and in females in age group 50-54 and 60-64 
was in favour of DBP; in the age group 55-59 the rate was 
in favour of SBP. In males 45-49 and 60-64 the rate was in 
favour of PP and in age 50-59 in favour of DBP; in females 
in all age groups it was in favour of DBP. After
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adjustment Tor age the mortality rates in the upper 
quintile of SBP and DBP were 13-7 for males and ll. 8 for 
females and 12.8 for males and U .7 for females 
death/1,000/person-year respectively. The Age-adjusted 
rate ratio of 1.07 for male and 1.01 for females suggests 
that only 7 % and 1% more men and women could have been 
identified as being at higher risk of dying from IHD if 
SBP rather than DBP had been measured. The age-adjusted 
rate ratio for male MAP and MAI was 1.08 and 1.07 and for
female was 1.03 and 1.11 respectively.
lO.2.3-Multiple Logistic Regression Analysis
Age, BMI, cigarette smoking habit, serum cholesterol 
and blood glucose level may all have been associated with 
the level of blood pressure at the time of screening in 
those subjects who eventually died of IHD. On the other 
hand, the absence of a demonstrable safe or critical level 
of blood pressure as regards risk of IHD mortality 
suggests that it is more logical to examine the relative 
contribution of each blood pressure component through the 
range of blood pressure rather than in a discrete clinical 
blood pressure category (e.g."normotensive" vs 
’•hypertensive” ). Also SBP and DBP are highly correlated 
(r=0.66) (Table 10.5). making an assessment of the net 
effect of each difficult, if not impossible, employing 
simple categorical cross classification. Consequently, MLR 
analysis was undertaken to assess the relative contribu­
tion of each component of the blood pressure to IHD 
throughout the range of pressure recorded in the popula­
tion sample. In the first analysis using the MLR, the SBP,
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DBP, MAP, MAI and PP were studied separately as predictors 
of IHD mortality, without adjustment for other important 
cardiovascular risk factors (Table 10.6). The logistic 
coefficients for SBP, DBP, MAP, MAI and PP each showed a 
strong relationship with IHD mortality in both genders. 
SBP and MAI show a higher odds ratio than DBP and PP in 
both genders. Table 10.7 contains the result of MLR 
analyses when both SBP and DBP are considered 
simultaneously and each of five blood pressure components 
separately with adjustment for other confounding factors. 
In the first analysis using the MLR risk model, SBP and 
DBP, the PP, the MAP and the MAI were studied separately 
as predictors of IHD deaths for each gender. The logistic 
coefficients for the blood pressure measures were 
determined after adjustment for the effect of age, serum 
cholesterol, blood glucose, cigarette smoking and BMI on 
the IHD mortality. In comparison with the data in Table 
10.6 (which do not take into account the effect of asso­
ciated factors) the SBP, DBP, MAP, MAI and PP contribute 
to IHD mortality risk independent of the other risk 
factors. Except for male DBP, the SOR for 'SBP and DBP, PP, 
MAP and MAI decreased minimally after adjustment for other 
cardiovascular risk factors. Very little of the effect is 
lost when other major risk factors are taken into account 
Judging from the modest reduction in the regression 
coefficient in the multivariate as compared to the 
univariate analysis. This reduction was higher in females 
than males. The logistic coefficients for SBP and DBP, the 
PP, the MAP and the MAI as well as age, cigarette smoking 
habits and serum cholesterol levels each show a strong
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relationship with the IHD death in both genders. Blood 
glucose illustrated an association with the IHD mortality 
only in females. BMI was not found to be a significant 
predictor of the IHD risk in multivariate analysis of
either this study or that of Framingham (28) or the
Western Collaborative Group Study (119. 236). The fact
that all components of pressure contribute to the risk of 
IHD is very likely attributable to their high correlation 
of SBP and DBP. The magnitude of the SORs can give an 
indication of the relative contribution of each component. 
Table 10.8 summarized Table 10.7 from the view point of 
ease of comparison and interpretation of the odds ratio 
of each component of blood pressure. There was interaction 
between DBP and serum cholesterol and MAP and serum 
cholesterol in males and PP and smoking in females. Table 
10.5 shows the coefficients of correlation observed 
between the different blood pressure measures and 
indicates expected close interrelationship. Thus, although 
each of the five blood pressure measures was found to show 
a strong relationship to the risk of IHD after adjustment 
for other risk factors, further joint analysis of the SBP 
and DBP measures is required to determine which measures 
have direct strength. The bottom of Tables 10.7 and 10.8 
also display the results of multivariate analysis using 
the multiple risk model, in which SBP and DBP are
considered together to determine their standardised 
predictive strength for the risk of IHD death in males and 
females. Only minor changes were noted in the predictive 
strength of these adjusted factors compared to the results
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shown for only SBP or DBP analysis. In females, the DBP 
was found to be not significantly associated with IHD 
death. In males there is statistically significant intera­
ction between SBP and DBP. In both males and females 
respectively SBP with odds ratios of 1.27 and 1.22 
(P<0.001) is a slightly better predictor of IHD death than
i
is the DBP with standard odds ratios of 1.2& (PC0.01) and
1.11 (P=0 .2 9 8 2).
10.S.DISCUSSION
Although both SBP and DBP are recognized predictors 
of IHD risk (230, 231). the primary purpose of the present
analysis was to examine the comparative predictive 
strength of each component of blood pressure in males and 
females separately. However, this study as well as most 
other studies (108, 112-119. 123. 227-228, 230, 236)
suggest that the IHD mortality risk is significantly and 
independently related to the antecedent blood pressure 
measurements and that this risk is proportional to the 
blood pressure level. The risk of increased IHD mortality 
appeared to be related even to a single blood pressure 
determination, despite the effects of lability, diurnal 
variation, artifacts of measurements (fat-arm artifacts, 
technical errors in measurement, unconscious digital 
selection (237)) and the response to therapy (108, 238).
At any age and at any blood pressure, IHD mortality 
in men exceeds that in women but this does not mean that 
women tolerate hypertension better than men. This is 
revealed best by an examination of the coefficients for 
the regression of IHD mortality on blood pressure, which 
indicate values almost as large for women as men in both
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univariate and multivariate analysis (Tables 10.6, 10.8).
The reasons for the lower IHD mortality in women are not
clear.
The standard normal deviates were calculated
according to the Whitehall Criteria (120), to provide an 
estimate of the capacity of each component of the blood
pressure in order to discriminate those who died of IHD
from the total population under study. Table 10.9
summarises the standard normal deviate separating
survivors from men who died of IHD and standardised odds 
ratio and mortality in the upper quintile of SBP and DBP 
in this study and the Whitehall study. On the whole, both 
studies agree that SBP appeared to be the better predictor 
than DBP at all ages except age tlO-lltl in the Whitehall 
Study and age 50-5*1 in this study. This .was supported by 
MLR analysis and the comparison of mortality from IHD in 
the upper quintile of blood pressure in both studies. 
Whereas the Framingham Study (115) compared levels of age 
specific mean blood pressure between groups dying of heart 
disease and those still living. Neverthless their finding 
for SBP, DBP, MAP and PP for males and females are similar 
to our findings. However, in this study the differences 
between SBP and DBP for males is small (0.09) but is
neverthless the same as the Whitehall male study (0.07)«
On the whole, SBP appeared to be the better predictor of 
IHD in both genders. This was supported by MLR analysis 
and the comparison of mortality for IHD in the upper 
quintile of blood pressure as well as the Whitehall Study 
(120), the Western collaborative Group Study (119)* the
189
CHAPTER 10
Framingham Study (108) and others (112-118). Univariate 
analysis of mortality from IHD in the upper quintile of 
SBP and DBP were also shown in the IHD, in favour of SBP 
in both genders. In males, when analysed separately, the 
SBP, DBP, MAI and MAP showed essentially the same 
predictive strength, while the PP showed somewhat less 
relationship to IHD mortality. In females, when analysed 
separately, SBP, MAI and MAP were found to be stronger 
predictors of the IHD mortality than the DBP or PP. 
However when each is considered alone, MAP and MAI as a 
measure of blood pressure is a slightly better indicator 
of risk than SBP, but all SBP and MAI and MAP were better 
predictors of risk than DBP alone. When either SBP or DBP 
is adjusted for the others, the standardised odds ratio 
becomes 1.27 and 1.22 for males and females* SBP and 1.2U 
and 1.11 (not significant) for males and females* DBP with 
interaction between SBP and DBP in males. In both males 
and females, when analysed separately and both together, 
SBP was found to be a slightly stronger predictor of the 
IHD death than the DBP, although the differences in 
predictive strengths were not large. There are some 
factors which may contribute to the observation that SBP 
is slightly superior to DBP as a predictor of death from 
IHD as stated by the most of the same studies. One 
explanation is that the greater variability of SBP, 
causing a larger standard error of its measurement, does 
not allow the statistical separation of the IHD and non- 
IHD group. With ageing a proportionally greater increase 
in SBP than DBP occurs. The greater difference in mean SBP 
between the groups compensates for the larger variance in
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the measurement of SBP. As systolic level depend partly on 
arterial compliance (239) they may provide a better 
reflection of the degree of underlying arterial disease. 
The failure of DBP to excell in predicting IHD may in part 
be due to the greater inaccuracy in measuring DBP and to 
the narrower range of values available compared to SBP.
An interaction term was introduced between each
component of blood pressure and BMI in addition to age, 
serum cholesterol concentration, blood glucose level, 
cigarette smoking habits in MLR model; under this
circumstances and running the analysis separately for men 
and women the interaction term between BMI and the blood 
pressure component was non-significant in both males and 
females. Hence, this study does not support findings of 
those (122, 2U0) that claimed an interaction between blood
pressure and BMI.
This results supported findings of other workers 
(108, 112-119) who have suggested that SBP may be a
better predictor of IHD mortality.
The present data do not suggest a declining
importance of DBP, but suggest an increase in importance
of SBP and MAI in both males and females for IHD.
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SYSTOLIC Aim DIASTOLIC COMPONENTS QZ BLOOD PRESSURE AS. 
PREDXCIPRS. QZ STROKE MORTALITY
SUMMARY: The relative importance of SBP versus DBP in the 
prediction of stroke have been re-examined.
In the follow-up period 10-1*1- years; (mean 11.6) there 
were 160 deaths (80 male; 80 female) from stroke. SBP and 
DBP are strongly correlated in both genders (r=0.66,
PC0.001) but in the relationship with stroke mortality
there was difference in males and females.
In a MLR model the predictive value of SBP, DBP, MAP,
MAI and PP was examined in relation to cerebrovascular 
disease mortality, after adjustment for age, gender, BMI, 
casual blood glucose, serum cholesterol and cigarette 
smoking. All blood pressure measures were associated with 
stroke mortality; in females the risk of stroke mortality 
was more strongly associated with DBP; in males SBP and 
DBP have the same predictive strength for stroke death and 
MAP and MAI have stronger association than either SBP and 
DBP.
These findings suggest that the predictive strength 
of SBP and DBP for stroke mortality may depend on age and 
gender. In middle-aged men and women in Renfrew and 
Paisley, Scotland, the general concept that DBP is more 
important than SBP is supported by data on stroke death in 
women, while in men the DBP was as good a predictor of 
stroke mortality as SBP.
CONTENTS
11.1.Introduction
11.2.Results 
11.3* Discussion
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11.1,INTRODUCTION
Blood pressure Is the most potent risk factor for the 
development of stroke (108, 125. 197. 229. 241-243).
Although both the systolic and diastolic components of 
blood pressure are recognized predictors of stroke risk 
(125. 229. 230), whether SBP or DBP is more important as a 
risk indicator still remains controversial.
The assumption that DBP is the most important predictor 
of cardiovascular morbidity from hypertension is supported 
by the fact that essential hypertension is associated with 
an increase in peripheral resistance which is manifested 
chiefly by a rise in DBP (234, 235). This viewpoint
however, has been questioned (125. 126, 244-249) and for
cerebrovascular disease two epidemiological investigations 
(124, 126) have favoured SBP as the strongest predictor.
In a longitudinal study of a well-population of 
10,541 men and women in middle life we have re-examined 
the predictive value of several combinations of SBP and 
DBP measurements, made at entry to the study, for stroke 
mortality.
11.2.RESULTS
11.2.1.Blood Pressure and Stroke Death
Age and Blood Pressure: Tables 11.1 and 11.2 and
Figure 11.1 indicate the relationship of age to blood 
pressure measurements. In survivors at follow-up the 
expected age-related gradients of SBP, MAP, MAI and PP, at 
entry, was seen in each category for both males and 
females. This relationship is stronger for females than
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females. This relationship is stronger for females than 
males. In persons who died from stroke the mean SBP, MAP
and MAI levels, at entry, were widely separated and
approximately parallel in males and females in the younger
age groups and closer, or crossover with lower levels, in 
older males. In those who were dead at follow-up males 
showed higher pressure levels at entry, except for PP 
which was higher in females in all age groups apart from 
the extreme ages. In survivors, entry DBP was lower in 
females than males up to the 55-59 age-group. In males who 
died from stroke, there was no consistent relationship 
between the DBP level and age, while in females higher 
levels were associated with advancing age. Overall the 
mean values for SBP, DBP, MAP, MAI and PP at entry, were 
significantly greater for those dying of stroke than for 
survivors after 10-14 years. The most marked age-specific 
differences were for males aged 55-59 and 60-64. But for 
MAP and DBP the mean values were very high for younger 
ages too.
The mean SND values showed a similar pattern to the 
blood pressure component but no consistent increase with 
increasing age. In both men 'and women who died from
stroke the overall age-standardized normal deviates for 
DBP were slightly greater than SBP, MAI and PP, but there 
is nothing to suggest that DBP was a better predictor of 
stroke death than MAP (Table 11.3). The mean SND for SBP, 
DBP, MAP and MAI were all significantly greater for those 
dying of stroke than for those still living at the time of 
follow-up. Both men and women dying of stroke have a DBP 
that deviates from the mean for their age-adjusted group
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to a small and not significantly greater extent than does
their SBP, MAP, and MAI, except PP in men.
Prediction of Stroke Mortality Using Blood Pressure 
Quintiles: Table 11.4 shows the mortality from cerebrovas­
cular disease in the age specific and age-adjusted upper 
quintiles of SBP (£167), DBP (£95). MAP (£118), MAI (£142) 
and PP (£77). and the ratio of these death rates to those 
associated with DBP. In males, at all ages except 55-59. 
the death rate was most closely related to MAP. Similarly, 
except for the 45-49 age-group, the death rates were more 
closely related to MAI and SBP than to DBP. In females at 
all ages, except 55-59 years, the death rates were most
closely related to DBP compared to SBP or MAI. The age-
adjusted rate ratio of using SBP, MAP and MAI to predict 
death rates suggests that 26%, 10% and 18% more men
respectively could have been identified as being at higher 
risk of dying from stroke than if DBP had been used alone. 
For females, using DBP alone suggests that respectively 
34%, 5%. 22% and 31% more women could have been identified
as being at higher risk of dying from stroke than if SBP, 
MAP, MAI, or PP had been used.
1.2.2.Multiple Logistic Regression Analysis
Age, BMI, cigarette smoking, serum cholesterol and 
blood glucose level may all have been associated with the 
level of blood pressure at the time of screening in those 
subjects who eventually died of stroke. On the other -hand, 
the high correlation between SBP and DBP estimates 
(r=0.66) (Table 10.5), makes an assessment of the net 
effect of each difficult, if not impossible, by employing
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simple categorical cross tabulation.
MLR analysis was undertaken to assess the relative 
contribution of each blood pressure variable to stroke 
mortality throughout the range of pressure recorded in the 
population sample. First the SBP, DBP, MAP, MAI and PP 
were studied separately as predictors of stroke mortality, 
without adjustment for other main cardiovascular risk 
factors (Table 11.5). The logistic coefficients for SBP, 
DBP, MAP, MAI and PP each showed a strong relationship 
with stroke in both genders. The SOR are largest for SBP 
and MAI in men followed by MAP and DBP. In women the SOR 
is highest for MAP followed by DBP, MAI and SBP, whereas 
PP is associated with the least excess risk in both 
genders.
It is conceivable, although unlikely because of the 
strength of the relationship, that the association of
elevated blood pressure with increase risk of stroke
mortality derives at least in part from factors related 
both to blood pressure and to the risk of stroke
mortality. This was assessed by including age, serum
cholesterol, blood glucose, BMI and cigarette smoking 
habit in the MLR. The results (Table 11.6) indicate that 
except PP in females, all components of blood pressure 
are potent independent predictors of stroke mortality, 
after allowing for the effects of other risk factors.
The SORs provide an indication of the relative 
contribution of each component.
When both SBP and DBP considered simultaneously, 
there was interaction between DBP and age and SBP and 
cigarette smoking in females. The fact that all components
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of pressure contribute to risk of stroke mortality is very 
likely due to the high correlation between SBP and DBP. 
Table 10.6 shows the coefficients of correlation observed 
between the different blood pressure measures and 
illustrates the expected close interrelationship. Thus, 
although each of the five blood pressure measures was 
found to show a strong relationship to the risk of stroke 
after adjustment for other risk factors, further joint 
analysis of the SBP and DBP measures is required to 
determine which measure has the most power. Interpretation 
of the results at the foot of Table 11.6 is focussed on 
the analysis which include both SBP and DBP. Although 
major changes were noted in the predictive strength of 
these adjusted factors compared to the results shown for 
only systolic and diastolic analysis, the overall results 
are the same. In females SBP was not a statistically 
significant predictor of stroke death and there was an 
interaction between DBP and age. However, in males DBP, 
with a SOR of 1.41 (P<0.05)« shows the same predictive 
strength for stroke death as SBP, with a standard relative 
risk of 1.39 (PC0.05). For females, DBP with SOR of 1.78 
(PC0.001) is a better predictor of stroke deaths than SBP 
with a SOR of 1.02 (P=0.78).
11.3.DISCUSSION
Both SBP and DBP are recognized predictors of stroke 
risk (229, 230) but many authors have considered the
diastolic component to be the most important. Recently 
this view has been questioned. The purpose of the present 
analysis was to examine the comparative predictive
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strength of each component of blood pressure in males and 
females separately. The results, as in most other studies 
(108, 197. 226. 227, 229. 230, 241-243) suggest that the
risk of stroke death is significantly and independently 
related to the level of antecedent blood pressure. The 
risk of increased stroke mortality appeared to be related 
even to a single blood pressure determination made during 
the initial health examination, despite the effect of 
lability, diurnal variation, artifacts of measurements 
(obese arm, technical errors, digit preference and other 
sources of variation (237)) and the response to therapy 
(108).
The standardized normal deviates, calculated accord­
ing to the Whitehall Criteria (120), provide an estimate 
of the capacity of each component of the blood pressure to 
predict those who were at high risk of stroke death in the 
total population under study. On the whole, there was no 
significant difference in predictors of stroke mortality 
between DBP and SBP, MAP or MAI for both genders and PP in 
women. Generally, an examination of the mean SND for all 
blood pressure variables in men reveals a larger deviation 
for DBP than for SBP, MAI and PP. MAP and MAI did not 
predict stroke deaths any better than the DBP, although 
they were generally better than the SBP or PP. The
observation that MAP and DBP and MAI and SBP as single 
measures predict stroke mortality to the same extent may 
derive from the fact that MAP and MAI are combinations of 
both SBP and DBP and reflect the effect of DBP and SBP
respectively. There is nothing to suggest that MAP is
better predictor than MAI in both genders. It is also
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consistent with the hypothesis that both components of the 
blood pressure are not making a greater contribution than 
either alone.
Univariate analyses of mortality from stroke, in the 
upper quintile of SBP and DBP also favoured SBP as 
predictor for males and DBP for females.
Multivariate analyses indicate that in females, when 
SBP and DBP are analysed either separately or together, 
DBP was found to be a stronger predictor of stroke 
mortality than SBP. In males, when SBP and DBP analysed 
separately and simultaneously the SBP and DBP showed 
essentially the same predictive accuracy for stroke.
Another way to examine the possibility that both
components of the arterial pressure contribute
independently to risk is to determine if prediction of 
stroke mortality is better achieved by employing a combi­
nation of both SBP and DBP values rather than either 
alone. The MLR analysis revealed that in males both MAP 
and MAI are better predictors than SBP or DBP alone; there 
was no significant difference between MAP and MAI. In 
women, MAP and MAI were not better than DBP alone but 
achieved more than SBP alone, and MAP achieved more than 
MAI.
In conclusion, DBP predicts stroke death more 
strongly than SBP for women, while in men SBP and DBP 
predict stroke mortality to the same extent. In men MAP 
and MAI may be better predictors than either SBP or DBP
alone, while in women, DBP alone was a better predictor
than any other combination of SBP and DBP.
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COMMUNITY HEALTH INDEX AML GENERAL PRACTITIONER RECORD.
LINKAGE ZQR CQHQRT FOLLOW-UP PUREQ.SES
SUMMARY: Medical record linkage provides a powerful tool
for investigators in a variety of health related discip­
lines, in particular, extensive use of morbidity and 
mortality record linkage is made by epidemiologists
conducting studies of the incidence and prevalence of
disease, disease aetiology, treatment effects, health 
service evaluation and adverse effects of drugs. The use 
of medical record linkage for epidemiological investiga­
tions offers many advantages: it allows a relatively large
number of cases to be followed, relatively inexpensively 
and provides the opportunity for longitudinal studies. 
However, for a record to be used as a valid tool in epide­
miological studies, it is essential that it contain data
of high quality as well as completeness and validity.
The development of the feasibility of following-up a 
cohort through record linkage using the Midspan registry, 
CHI and GP records is described. The follow-up methodology 
used in contacting 981 residents and their GPs in a urban 
community in the west of Scotland is presented. They were 
sampled from the upper, middle and lower 5% of blood 
glucose distribution. The current address of patients can 
be found by using the name, gender and date of birth from 
the Midspan file and searching the computer-based CHI of 
Argyll and Clyde Health board. Attempts were made to 
contact 937 matched individuals, identified in this way, 
who were asked to complete a questionnaire about their 
current diabetes status. Thirty two (3*4%) individuals 
had moved to other health board areas, 65 (6 .9%) could not 
be traced, and 97 (10.3?O did not reply. the follow-up 
response to three sets of mailings totalled 80%. The 
availability of this system makes such large scale studies 
feasible and economical.
CONTENTS
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12..1...INTRQDUCTIQN
The long-term follow-up of community based 
populations poses unique problems. These problems include 
declining response rates at re-examinations, the cost and 
time needed to conduct re-examination on large populations 
and the accuracy and completeness of data. In the 
epidemiological investigation of chronic diseases, 
putative risk factors may precede disease onset by many 
years, and long-term follow-up of study subjects is 
essential. Since no statistical technique can adequately 
correct for the effect of non-respondents on study 
results, it is important to contact as many subjects as 
possible (250-252). In today’s highly mobile society, this 
can be a difficult task. To overcome this problem and to 
ensure as complete coverage as possible for the protracted 
period of years needed to observe the development of new 
disease in those originally healthy, follow-up has been by 
an indirect method of surveillance called medical record 
linkage.
Follow-up methods for persons with disease, for 
occupational groups, and for school alumni have been 
described (253-255)- Individuals with disease may be 
easily located when they have been identified in public 
health records, such as disease registries. Company 
records, and alumni offices can often provide recent 
address information for contacting study subjects. 
However, many population based studies recruit total 
communities, consisting primarily of asymptomatic
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participants, for long term follow-up. The Framingham 
study of cardiovascular disease in the United States of 
America (257) and others (1-1&) are examples of such 
studies. This study describe the methodology used in 
follow-up of another community based population study in 
the west of Scotland.
Today record linkage is accepted as a necessary tool 
for epidemiological research and the term is in general 
use, particularly in the detection of associations between 
variables or exposures and outcomes of interest. 
Especially in chronic disease epidemiology, no single 
record made in one place at one time can describe the 
evolution of disease (258). Assuming that the routine
record systems exist, upon which record linkage may be 
based, periods of follow-up can be extended for as long as 
desired; record linkage may be the only method suitable 
for the detection of new chronic events which take many 
years to develop. The Scottish Morbidity and mortality 
Record system is amongst the most advanced in Europe. A 
great deal of information is collected on many aspects of 
health related disciplines, and while used primarily for 
manpower and resource planning, it provides a valuable
resource for epidemiological research.
Medical record linkage involves assembling several 
records into a meaningfull array. Records of illness,
treatments, immunisations, delivery, birth and death are 
made routinely in the course of medical pradtice. 
Normally, these are dispersed among records departments of 
the agencies that initiated them. Outcomes in cohort
studies can be validly assessed by using computerised
202
CHAPTER 12
record linkage techniques to improve the completeness of 
follow-up and to economise in resources, but there are 
methodological problems which vary between different type 
of linkage.
While record linkage provides an excellent mechanism 
for epidemiological studies, it usefulness is governed by 
the quality as well as quantity of recorded data. The 
objectives of this chapter are to describe the concept of 
medical record linkage in terms of definitions, types, 
uses, methods and problems and to present the feasibility 
of linking the CHI and GP's records for follow-up cohort 
studies.
JHE C.QM.CJBLEX Q£L RECORD LINKAGE
12.2.1.Definition: A number of definitions have been
suggested for the term "record linkage". One dictionary 
(259) defines "record" as "an account of an event or piece 
of information which is kept in writing or some other 
forms so that it is available for people to refer to" and
"linkage is the act or process of Joining two things or
ideas so that they become connected in someway". The term 
record linkage was first used by Dunn (260) in 19&6 to
denote a comprehensive approach to linking events of
significance for health. In the words of a speech by Dunn: 
"each person in the world creates a book of life. This 
book starts with birth and ends with death. Its pages are 
made up of the records of the principal events in life. 
Record linkage is the name given to the process of
assembling the pages of this book into a volume”. Acheson 
(258) in his book on medical record linkage defined it as
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" a system of linked health records which bring together 
selected data of biological interest for a whole
population commencing with conception and ending in death, 
in a series of personal community files, the files being 
organized so that they can be assembled in family groups. 
The term record linkage may apply specially to the
techniques of assembling the files in spite of errors and 
omissions in the identifying particulars, or may be used 
in a more general sense to apply to the organization 
involved". Newcombe (261) defined record linkage as the 
bringing together of separately recorded data relating to 
an individual or family in spite of discrepancies or 
omissions in the identifying particular. Skegg (262)
defined record linkage as method of systematic linkage of 
records about every individual in a large population. 
Finally, record linkage refers to the method of bringing 
together information about a single individual or family 
from different records. This can be done ad hoc in the 
execution of a research project, or systematically for 
whole population. Although there are differences in 
emphasis and wording there is also much in common.
12.2.2.Type: Over a long period, records of several
episodes of illness or similar "events" may be linked 
together to form a person's medical history.
Records relating to individuals may be linked or 
assembled into groups of particular interest. Record 
linkage can be classified according to the use which is to 
be made. These include: 1) treatment effect 2) adverse
effect of drugs 3) health service evaluation 4) aetiology 
of disease 5) natural history of diseases 6) morbidity and
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mortality following therapeutic trials 7) maternal and 
child health 8) associations between diseases and 9) 
monitoring for occupational hazards.
Rather than approaching record linkage classification 
by use, it is possible to classify record linkage by the 
sources of data. There are nine type of sources for 
medical record linkage that it is possible to link within 
or between them. 1) hospital records 2) NHSCR 3) patient 
registries 4) population-based study 5) school entrant and 
leaver medical examination records 6) CHI 7) the Prescrip­
tion Pricing Authority 8) census and 9) GP records. The 
characteristics of each of these types are as follow:
1) Hospital discharge summaries in Scotland (SMR 
data) are recorded, collected and collated by hospitals 
and the Information Service Division (ISD) of the Scottish 
Health Service Common Services Agency. They include: (a) 
General hospital discharge records (b) obstetric hospital 
discharge records (c) mental and mental deficiency 
hospital admission and discharge. Another source of data 
used in hospital care and recently computerized is Master 
Patient Index (MPI) (263)*
2) NHSCR is a central record of all NHS patients
registered in Scotland. It includes records of births, 
deaths and stillbirths and information on immigration, 
emigration, and other items. Its chief function is to 
ensure complete and accurate data on every individual
registered with a GP, updates for death and, where known,
emigration. In addition it has the purpose of 
facilitating the payment of GP on the basis of a
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capitation fee for each patient registered. Recently, 
NHSCR has participated in the National Cancer Register 
scheme organised centrally by ISD. In Scotland, the GRO 
has been responsible for the registration of vital events, 
but copies of each draft entry of birth and death are also 
sent to the NHSCR at Ladywell House in Edinburgh.
3) patient registries include different chronic and 
infectious diseases such as thyroid (264), cancer (258, 
265). handicapped children (258, 2 6 6), blindness (2 5 8,
267)* mental illness (258, 268), rheumatic fever (2 6 9 ),
burns (270), heart disease (271), child abuse (272), 
trauma (273)- The use of disease registers provides one 
method of record linkage for the study of chronic disease. 
The widespread availability of computers has contributed 
to this trend but the difficulties of maintaining a high 
standard of completeness and reliability of registers' 
data are well described (274).
4) population-based studies are an important method 
of follow-up in epidemiological investigations through 
linkage with morbidity and mortality records.
5) school entrant and leaver medical examination 
records include a medical record of all children who enter 
school; this has been computerized since 1967 in 
Scotland.
6) a CHI is a central record at health board level of 
basic information such as name, address and GP details for 
every individual registered with a GP.
7) The Prescription Pricing Authority is a centre for 
the pricing of prescriptions written in general practice. 
Prescriptions written by GPs always have a GP's name and
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address stamped on them, and identification of the
recipient becomes much easier if the data on the prescrip­
tion can be compared with a list of the name, address and 
age of the patients in the practice concerned or CHI file.
8) Much data of value to medical research workers are 
included in the census such as information about
occupation and industry, birth place, migration and higher 
education, which if linked with mortality and morbidity 
data would be of considerable research value. The data 
recorded about each individual includes full personal 
identification. The GRO is bound by law to disclose no 
data about an identifiable person to any other person or 
to a government department (258).
9) GP records are another important source of data for 
epidemiological research purposes. Everyone in the U.K. 
has a personal doctor and the GP is responsible for 
recording in writing most of the important health events 
which his patient experiences in the home, out-patient
clinic or hospital. The basic clinical records also
contain full name, address, date of birth and NHS number. 
Furthermore, at least in theory, these records should 
follow the patient as he moves about the country. A GP's 
record should thus provide a summary of the cumulative 
health record of the individual including immunisation, 
accounts of important diagnosis, operations, consultant 
opinions, treatment and of drug idiosyncrasies.
12.2.3-Use: Medical record linkage systems have been
used for a wide variety of purposes. Roughly, first to 
ascertain the relationship between separately recorded
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events occurring to the same Individual in different 
places and at different times (personal linkage); second 
to ascertain relationships between individuals which may 
be associated with their health or illness (family 
linkage).
So far, seven main areas of application have yielded 
important results (275):
1) Identification of individuals -to provide the GP 
with access to a large number of individuals with a 
particular condition.
2) Epidemiology of chronic diseases- (a) to provide a 
basis for estimating incidence and prevalence rates for a 
defined population; (b) to permit the natural history of a 
condition to be followed; ~{c) to attempt to identify 
aetiology and outcome of treatment and (d) association 
between diseases.
3) Preventive medicine -screening and identification of 
high risk groups, vaccination and immunisation, follow-up 
surveillance.
4) Planning, operation and evaluation of service -to
make it possible to estimate the need for services and to 
evaluate programme efficiency and effectiveness,
readmission patterns, mortality and morbidity follow-up 
operations, and models of health service function.
5) Evaluation of treatment -to provide the basis for 
calculating the efficacy of various therapeutic
techniques.
6) Genetic - congenital anomalies and their 
relationship to birth order and birth spacing.
7) Social psychiatry -social mobility, parental loss,
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birth order and subsequent, emotional illness in married 
couples.
12.2. il. Method: There are two forms of record linkage
(275):
1) All-or-none linkage by means of a single, 
universally available, completely reliable and checkable 
identifying characteristic. This is simple, economic and 
reliable and when it can be applied is the best method to 
use. The identification characteristics usually take the 
form of a unique number. In some countries (e.g. U.K. and 
Scandinavian countries), such a number has been assigned 
to every member of the population, usually at birth. They 
are often at least partially made up from stable features 
of the individuals such as date of birth, gender and so 
can be reconstructed if lost.
In the U.K., the NHS number is virtually such a 
unique number. Unfortunately, it is not always available, 
it takes various and often complex forms, it is not quite 
unique, it is not completely reliable, and it is extremely 
difficult to check automatically. Nevert^less, it is the 
chief identifier in the NHSCR, and a feasibility study for 
a national medical record linkage system recommended its 
use.
The advantage of a unique number system is that the 
actual linking procedure is easy. The disadvantage is that 
if the number is not accurately recorded, or not 
available, non-unique characteristics such as name must be 
used in a clerical procedure to obtain the number. If the 
proportion of errors or missing numbers is high, the
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special advantages of all-or-none linkage are lost. There 
are circumstances in which the conditions for all-or-none 
linkage can be met. These occur wherever prenumbered 
documentation is practical, as for instance, in some types 
of clinical or administrative records.
2) Probability linkage, based on a group of 
characteristics of varying availability, stability and 
discriminating power. Identification of patients usually 
depends on such information as gender, first name, 
surname, address and date of birth. A decision as to 
whether two documents bearing closely similar sets of 
these items refer to the same person clearly must be based 
on some assessment of probability.
With small files of only a few thousand names as in a 
general practice, the probability of a correct match is 
very high. However, in a larger files, the chances are 
greater of data sets occurring which are almost identical, 
but which refer to different people. Nearly all name 
indexes in hospital medical records systems, which may 
contain records of hundreds of thousands of people, are 
based on simple identification.
The advantages of probability linkage derive from its 
use of a computerised medical database which provides 
convenient, quick and cheap follow-up data. The 
disadvantage of this method is the failure to link records 
which should be linked and linking records which should 
not be linked.
It has been shown that even in small indexes of a few 
tens of thousands of records, accuracy in clerical 
matching is closely related to the amount and quality of
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■the identifying information. Missed and false-positive 
linkages can be virtually eliminated if a fuller 
identifying data set is used.
12.2.5* Problems: While medical record linkage may serve 
a wide variety of uses, there are many problems associated 
with its establishment and maintenance. Foremost among 
these are confidentiality, matching, completeness and 
accuracy. The technical problems of matching mentioned in 
previous sections, confidentiality, completeness, accuracy 
of morbidity and mortality data and validity of technique 
will be discussed.
Any form of record linkage will involve serious 
security and confidentiality risks unless considerable 
care is taken in the design and operation of the system. 
We must be specially careful to establish adequate 
safeguards of individual privacy and identity so that 
there will be little possibility that data available for 
any linkage system will be misused. An individual’s right 
to privacy must be balanced against the valuable knowledge 
that can be learned from a computer-based system that 
includes information on every medical encounter, illness 
and use of resources. The potential threat of a linked 
database, to individual privacy, is likely to increase as 
computer power increases. Record linkage, in the absence 
of a unique identifying number, based on multiple 
individual characteristics is becoming increasingly 
practical. Given this new power to identify individuals 
and their activities, independent of the use of a unique 
identifying number, careful control of access to
211
CHAPTER 12
Information that allows identification of specific 
individuals in a database would seem our strongest 
safeguard against abuse of this information. 
Confidentiality can be achieved by restricting access to 
computer records to authorized personnel, perhaps by 
keeping such records free of names and addresses, if 
clerical records exist they could be stored in a separate 
place and by keeping the files of the matched data
separate from the original file. In Scotland, adequate 
safeguards for the individual appear to exist (276, 277).
and there is no evidence of abuses of this powerful
database yet. With this linked record system, Scotland has 
a significant tool to help in providing care for its
countrymen and to monitor its society’s health.
One of the problems with which all medical record 
linkage must deal is the quality of medical record data. A 
potentially more serious limitation of this system is its 
reliance on the accuracy of coding of discharge diagnoses. 
Although a study by Lockwood (278) found the coding 
accurate for 9 & % of the diagnosis and Martini et al. (279) 
found greater than 9 0 % of recorded principal diagnoses
were correct, others have claimed that higher levels of
error may occur (280, 281). A study by Coid (282) for
assessment of stroke hospital diagnosis found accuracy of 
95%* Recently Heliovaara et al. (283) reported that
although hospital discharge information under-estimates 
morbidity in the population, the data are sufficiently 
valid for many epidemiological purposes. The diagnostic 
accuracy of hospital records was satisfactory.
Mortality data and statements of causes of death on
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death certificates continue to be used as the major source 
of information characterizing the health of the population 
and are frequently used in linkage record systems. However 
comparison of death certificates with clinical and autopsy 
records has led to the conclusion that mortality 
statistics based on cause of death are of dubious 
accuracy. Alderson and Meade (28^) in comparing 1,216 
deaths and the hospital records of the patients, found 39% 
discrepancies in recorded causes of death using two digit 
ICD code accuracy. Beadenkopf et al. (285) studied matched 
autopsy protocols and death certificates and found a low 
specificity and sensitivity for CVD and high concordance 
for malignant neoplasms. Britton (286) reported that 57% 
of causes recorded on death certificates agreed with the 
autopsy diagnosis in a series of U-00 cases. Dorn and 
Cutler (287) studied the death certificate and case 
reports for 22,681 deaths with neoplasm recorded as cause 
and found significant misclassification in the death 
record, particularly for malignant neoplasm of cervix and 
uterine corpus. Fedrick and Butler (288) in a comparison 
of cause of death coded in the British Perinatal 
Mortality Survey and in the GRO, on the same records, 
found major discrepancies in the two records, the implica­
tion being that coding errors constitute an important 
problem. Gwynne (289) reported 58% of death certificates 
were in error when compared with autopsy findings.
Heasman and Lipworth (290) reported that in a major 
study of 9« 501 autopsied deaths occurring in 75 hospitals 
in England and Wales, a new death certificate was
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completed by the clinician without reference to the 
autopsy finding and a second by a pathologist. The 
certificates were coded independently in the GRO and the 
two underlying cause codes compared. In only 45% of the 
records was there complete agreement. James et al. (291)
in a study of 1,889 death certificates and matching 
autopsy records, found 52% agreement using three digit and 
71% using two digits of the ICD. Paton (292) reported on a 
series of 414 cases with post-mortem examination, found 
118 with acute myocardial infarction (AMI) both pre and 
post-mortem, 96 with clinical diagnosis of AMI but no 
autopsy confirmation. This amounts to a false positive 
rate of &5% and false negative rate of 31% using the 
autopsy finding as definitive. Numbers of additional
reports comment on the inaccuracy of death certificate 
reporting of lung cancer (293. 29*0. cerebrovascular
disease (295-297). pulmonary embolism (298), paediatric 
CVD (299). tuberculosis (300), suicide (301-303). 
pulmonary infarction and embolism (30*1, 305), Chronic
respiratory disease (306), uterine cancer (307) and
pericarditis (308). A review of the literature by 
Gittelsohn and Senning (309) on the accuracy of cause of 
death certification documents that major problems exist in 
the quality of the information being collected, coded, and 
tabulated.
The central issue underlying the problem of validity 
of cause of death is the reliability of the diagnostic
process itself.
However, since many theories and even expensive 
research project are established on the basis of
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statistical findings of medical record linkage, it is
important that the quality of records being used should be 
as high as possible.
■12,« 3 .EVALUATION QE MEDICAL RECORD LINKAGE
Two fundamental concerns should govern the evaluation 
of medical record linkage data: completeness and validity.
The completeness of data is defined as the proportion of 
all cases in the target population which appear in the 
medical record database. If a record is population based, 
such as NHSCR and ISD, then all cases of death or 
diagnosed disease for a defined population theoretically 
appear in it. For hospital in-patient records, all cases 
of disease seen at the reporting source should be
included. If completeness is not guaranteed, it is 
necessary to identify those factors which are related to 
the selectivity of case inclusion. The results of
systematic bias in case reporting is the calculation of 
misleading rates of disease. For example, if a record is 
60% complete and the data which are missing come from a 
random group of cases, the extent of disease will be under 
estimated, but the underestimation will be the same for 
all patient subgroups. However, if the missing data are 
concentrated on one case characteristic (for instance, the 
least severe case), the error in the calculation of rates 
would be compound; the extent of the disease would be 
underestimated as before but, in addition, the relative 
frequency of severe cases would be overestimated.
Validity is the second essential component in 
assessing the quality of medical record data. In this
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context validity may be defined as the proportion of cases 
in one record which ’’truely” has been matched with the 
other record. In practice, it is the proportion of 
agreement between two recorded sets of data. The need for 
recorded data with a high degree of validity is obvious; 
case ascertainment may be nearly complete, but the record 
may contain a high proportion of information which is 
incorrect. Once again, the importance of differentiating 
between random errors and systematic errors must be 
stressed. The critical test of effectiveness of any 
linkage system is the sensitivity and specificity of the 
procedure in identifying correctly the cohort having 
subsequent events. Hole et al. (310) considered this 
aspect of the method and found levels of sensitivity of 
66% for mortality and 81% for the inpatient data based on 
the probability linkage method.
12. 4. USE Q Z  £H£ E Q K  ZQLLQ&zUE. PURPOSES
The objective of medical record linkage system is to 
provide an economical system for collecting morbidity and 
mortality events based on routine statistics. One of the 
additional objectives of the Scottish medical record 
linkage is to provide a means whereby individuals can be 
followed up for clinical and epidemiological purposes 
(266). The record linkage through Scottish Hospital In­
patient statistics produces details of diagnosis and 
outcome on hospital admission and, through the Registrar 
General’s mortality records, produces information about 
death. As mentioned earlier the quality of computerized 
databases, may not always fulfil the criteria of validity. 
However, all of the previous record linkage studies are
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limited to hospital in-patient events or mortality out­
come, and so will only be able to detect events causing 
hospitalization or death. But how can we follow patients 
whose outcome of interest generally will not result in 
hospital admission or death, with an acceptable response 
rate? The only known reliable way of follow-up is to 
repeat examination of the subjects, but the problem 
involved in maintaining contact with patients increases 
with time after their baseline examination. The repeat 
examination of individuals has the advantages that the
data collected are accurate and relevant for scientific
purposes, but high cost and feasibility problems may 
prohibit this choice. One way to tackle this problem is 
record linkage with available registers maintained for
other purposes to have access to subjects and their health 
records. CHI is one of these registers. With linkage to 
CHI it is possible to have access to the last known 
address of patients as well as his/her GP's name and 
address and finally can have an access to them as well as 
their G P ’s record.
12. 5. SAMPLING AND. METHOD
This study describes the existing and potential uses 
of the CHI.
There is less experience to date in the use of the CHI 
and GPs* records for epidemiological follow-up studies 
than in the corresponding use of the mortality and 
hospital admission databases.
In this chapter, methodological problems regarding 
this linkage will be discussed. Also discussed are the
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results of a preliminary linkage of the two data files to 
provide a basic facility to follow-up a population based 
cohort for non-hospitalization events and decrease the 
degree of losses to follow-up due to changes of address.
We were required to link a sample of the Paisley file 
with the CHI to find the last known address of the 
subjects and their GPs and follow this up by a mail 
questionnaire and reference to GP practice records, to 
determine the validity and practicability of the method, 
as well as to determine the trends and outcome of 
asymptomatic hyperglycaemic subjects, as defined in 
next chapters (Chapter 13).
12.5.1.Study Subjects
The follow-up survey was conducted as part of the 
Renfrew and Paisley study between October 1987 and April 
1988. The purpose of the survey was to determine the 
diabetes status of subjects who had participated in the 
first phase of the Renfrew and Paisley survey, 10-14 years 
earlier. The study cohort was a sample of 981 residents 
from the original study population consisting of 7.721 men 
and women aged 45-64 years, all with blood glucose 
measurement in 1974-76 in Paisley. The follow-up procedure 
demonstrated in the following flow chart (page 220). They 
had participated in only two phases of the Renfrew and 
Paisley study 12-14 and 9 years earlier and had not been 
contacted since. This study is "flagged” with the NHSCR to 
report mortality outcome monthly. The surname, first name, 
title, address and mass miniature radiography number (MMR) 
of each examinee was recorded on magnetic computer tape at 
baseline*-Using NHSCR or any other register to follow-up
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patients may however involve ethical problems (311). Each 
member of the cohort gave written permission for his or 
her medical record to be examined by the study team for 
research purposes. Written permission was also obtained 
from GP Sub-committee of Argyll and Clyde Health Board 
Area to write to GPs and to patients in the identified 
subgroup. Once records were linked, particular care was 
taken to safeguard confidentiality.
The sample selection was based on upper, lower and 
middle 5% of Renfrew and Paisley blood sugar distribution. 
After the sample selection had been carried out it was 
found that the computer magnetic tape of names and 
addresses belonging to Renfrew study was lost. Thus, we 
decided to consider only the Paisley sample.
The sample comprised 249 cases with asymptomatic 
hyperglycaemia (defined as casual blood glucose ^126 mg/dl 
at baseline). Two control groups have been selected from 
the lowest (468) and middle (264) parts of the glucose 
distribution, to minimize the probability of overlapping. 
The 239 (19.6%) individuals who had died before April 1st, 
1988 and reported by NHSCR, or found during the matching 
procedure with CHI and who were known to be diabetic at 
baseline were excluded.
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Usable Sample 
7,721 (63%)
Paisley Nominal data Tape 
12, 294- (81%)
Renfrew and Paisley 
Sample 
_______16,171
Renfrew and Paisley 
Sample Aged 45-64 
15.205 (94%)
Sample Try to Match 
with CHI 
 981_________
80(33.5%)
Case Controll Control2 Control2
Deceased 
239 (19.6%)
249(25.4%)
Case
264(26.9%)
Controll
Alive 
981 (80.4%)
This Study Sample 
1,220 (15.8%)
Not-Matched with
» ■ » ■ ■ ■ ■  * i
Matched with
CHI CHI
44 (4.5%) 937 (95.5%)
No. of GP No. of Patients
92 (100%) 937 (100%)
Not-Respond Respond Not-Traced Respond
3 (3.3%) 89 (96.7%) 192 (20.5%) 745 (79.5%)
No. of 
Cases 
67 (7.2%)
No. of Transferred Not-traced
Cases
858 (92.7%) 32 (16. 7% )| 65 (33.8%)
Not-replied 
95 (49.5%)
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12.5.2.Community Health Index
One set of collected data at health board level in 
Scotland is a CHI file. A CHI is a list of people who are 
eligible for health services and will usually store the 
name, gender, date of birth, address, marital status, GP*s 
name and address, date of registration with the practice, 
date of removal, NHS number and CHI number. These data are 
computerized and processed by the Argyll and Clyde Health 
Board Area. The health board also provide an alphabetical 
listing of these patients on microfiche. A computer system 
was introduced for CHI in 1977- The coverage of the scheme 
has improved since its inception and from 1 98 0, CHI has 
been available for 100% of the people resident in Argyll 
and Clyde Health Board Area and registered with a GP. 
However the facility exist in the CHI computer system to 
trace patients by combination of name, date of birth and 
gender.
One of the advantages of CHI for the conduct of 
follow-up cohort studies is that every person registered 
with a GP has been allocated a unique number, the so 
called Community Health Number. This number provides the 
method of identification and access to a separate computer 
file which contain patient biographical details, details 
of all hospital discharges, death notifications and- --also 
child development records (312).
12.5* 3* Study Sample and CHI Linkage Method
The linkage method employed was an on-line inquiry 
facility provided by Argyll and Clyde Health Board, which 
allows searching date of birth and gender and then first 
name, surname and address matched visually. For those
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people whose surname and first name could not be found 
using date of birth and gender a search was made of an 
surname alphabetic microfiche. A listing can then be 
produced of all pairings. The surname, first name, address 
and date of birth of a selected sample was extracted from- 
a separate magnetic computer tape prepared at baseline 
examination based on MMR.
The last known addresses and GP's name and address of
those who was needed for follow were identified by this
matching procedure.
Individuals were contacted by mail and the accuracy of 
responses was checked by referring to the G P ’s records. 
Contact by Mall: Survey questionnaires were mailed to a
selected sample and asked to check name, date of birth, 
address and GP's name and address, and if it was not 
correct write in the correction. Subjects who did not 
respond were sent two reminder with about one month 
interval between them. Mailings consisted of an
introductory letter, a questionnaire and a pre-paid self- 
addressed return envelope. The GP records were then
searched by writing to the GP to validate the accuracy of 
the responses from the postal questionnaire. The informa­
tion gathered from patients was sent to the relevant GP 
who was asked to check the accuracy of information and if 
it was wrong write the correction. This study population 
consisted of people registered with 100 GPs in 56 
practices. The practices were mainly in the Renfrewshire 
area and comprised 74 group practices and 26 solo 
practices. Eight GPs were outside Renfrewshire and
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excluded.
The validity of the study results depends on the 
accuracy of the linkage process. To test this accuracy, 
records of 981 individuals of the cohort study were 
matched with the CHI file. The validation first involved a 
search for incorrect matches. A three stage method was 
used, firstly, the surname, first name, date of birth, 
gender and address on the CHI were matched with the cohort 
file and if the first four items were the same but not the 
address then the address of the CHI was taken to be the 
correct one. Secondly, those items were confirmed by the 
patients. Thirdly, GP were also asked to confirm the 
details.
Contact by Telephone: When mailings were finished, 192
(20.5%) of the 937 men and women in the target population 
remained to be contacted. Thirty two (32%) of them were 
transferred to another health board area and 65 (33*8%)
could not traced by mail and 95 (49-5%) did not respond. 
However, all of the not-traced and non-respondent subjects 
were found through GP's records. Eleven (12%) of 92 GPs 
after two mailings also remained to be contacted. However 
after telephone contact 8 GPs responded, further improving 
the response rate of GPs from & & % to the final 9 6 .7%. 
Three GPs have not been contacted anymore, one of them 
refused to participate and two others did not send back 
the questionnaires.
At the completion of the survey, all baseline 
participants were contacted through mailing or GP records.
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12.5.6.Linkage with National Health Service Central 
Registry
The Renfrew and Paisley subjects were "flagged** with 
NHSCR. Flagging is a process by which all individuals in 
the study are identified in the NHSCR file of the Scottish 
population, so that the occurrence of death in a person 
previously notified to the NHSCR can be made known to 
investigators (313). Of the 16,171 subjects examined at 
baseline, 2,797 were known to have died by 1 January 1986. 
The correctness and completeness of mortality flagging 
were established by comparison with death reported as a 
result of manual tagging of the study cohort in the NHSCR. 
In a test sample of 981 persons who thought to be alive at 
1 January 198 6, we found 16 example of failure to notify a 
death. These 16 cases were followed through the Registry, 
as shown in following flow-chart. Three (1 8.7%) cases were 
flagged and notified to Midspan file but they were not 
transferred to computer file. One (6.2%) of the cases died 
in England and flagged at Southport but not reported to 
the Scottish NHSCR. Seven (43*7%) cases were not flagged 
with NHSCR at baseline. Five (31.2%) cases were flagged 
but their deaths were not reported to Midspan by NHSCR. Of 
16 errors, there were 5 (31.2%) errors in NHSCR (4 human 
errors and 1 system error), 1 (6.2%) system error between 
Southport and Edinburgh NHSCR, and 7 (43.7%) errors in 
flagging and 3 (18.7%) errors within the Midspan file.
The NHSCR also provide copies of each certificate and 
of the coding of the cause of death according to the Ninth 
Revision of the International Classification of Disease.
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Midspan File 
Error 
3 (18.7%)
No. of Death Between 1977-86 
and . not reported by NHSCR 
16
Edinburgh and 
Southport "NHSCR 
Flagging System 
Error 
1 (6 .2%)
Not-Flagged 
With NHSCR 
7 (4-3.7%)
Within NHSCR 
Error 
5 (31.2%)
1.2,J6t RESULTS
Of 981 individuals matched with CHI, 44 (4.5%) failed 
to match due to minor differences in the names and mistake 
in date of birth.
Table 12.1 presents the number of linked records. Of 
the 981 Paisley file records sample which could possibly 
be linked, 870 (8 8 .7%) were linked to CHI records by
matching on all four items by computer alone. A further 67 
(6.8%) matched on microfiche giving an overall linkage of 
95*5% of the Paisley sample file. Table 12.2 shows the 
final figure for the survey population. Out of 937 matched 
pairs 62 (6.3%) had died, 16 (1.6%) subjects died before 
January 1st, 1986 and 42 (4.3%) individuals died after 
1986. Of matched individuals 192 (20.5%) could not be 
traced through mail using the identification information 
obtained from the CHI and Paisley records. The commonest 
cause of failure to find them was incorrect or changed 
address, or transfer to another health board area. 32 
(16.7%) of people could not be traced by mail and were 
identified by CHI file to have transferred to another 
health board area, 65 (33*8%) could not be traced and 95
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(49.5%) did not reply. There were 350 (35*5%) subjects who 
had changed their address since baseline examination.
The 937 subjects matched correctly and who were alive 
were followed through postal questionnaires. Table 12.3 
shows the mailing response rate by individuals. The ques­
tionnaire from the first mailing were returned by 589 
(62.9%). An additional 118 (33.9%) of non-respondents 
responded to the second mailing, and increased the
response rate to 75-4% (707). Then a second reminder was
issued and 38 (16.5%) of non-respondents responded to the 
second remainder or third mailing and the final response 
rate became 79.5%. 745 individuals were successfully
contacted. When mailings were finished, 97 (10.3%) of 
questionnaires had been returned by the post office 
stamped *' gone away, no answer, not known at number”. The
remaining 95 (10.1%) subjects had apparently received
mailings but had not responded. The non-traced status was 
checked by CHI again and 32 (16.7%) of subjects were found 
to have transferred to another health board. The non­
respondents status checked by GPs and all of the subjects 
found in GP records.
There was 100% agreement between the Paisley file, 
CHI and patients concerning first name and surname. Only 
in one case was disagreement found between CHI and a 
patient regarding date of birth. About 10 cases moved 
within health board area and their new addresses were not 
found in the CHI file, and 11 cases moved from the health 
board area were successfully contacted. The major 
disagreement between CHI file and patients was over G P ’s
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name. There were 105 (11.2%) cases that patients claimed 
their GP*s name to be wrong but both patients and CHI file 
agree that they are within the same practice. However 
patients registered with one GP often attended other GPs 
in the same practice. Thirty seven cases claimed that 
their GP address was not correct. All of these cases were 
within a big practice which recently moved to new 
premises. Two cases refused to give permission to have 
access to their medical records and 2 cases did not like 
to participate anymore in the study due to ill-health.
12.6.1.Mortality: Linkage of a sample of 135 reported
deaths in the cohort during 1974 to 1986 with the CHI 
generated 98 (72.6%) matches. Only three non-matches died 
after 1979 and 34 cases before 1979- 27.4% of the deaths
were not matched with the CHI file, 25.4% of them died 
before 1979 and this is expected because they occurred 
before complete implementation of the CHI file.
12. ,7, DISCUSSION
By using existing information which has been gathered 
in an independent record system, record linkage can create 
a composite history at considerably lower cost and time 
than would be necessary to follow a cohort of subjects 
through years of vital events and encounters with public 
health services. Record linkage has many potential 
application to following cohorts to detect a new disease 
in a well population, as well as in evaluating health 
services, treatment effects and side effects of drugs 
without physical re-examination. In this study, for the 
first time the description of methodology for assessing 
the feasibility and practicability of follow-up of a
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cohort through linkage between G P ’s records, CHI file and 
the cohort file was considered. The actual results of 
determinating of trends and outcome of asymptomatic hyper- 
glycaemic subjects will be discussed in the next chapter.
However, CHI can be used to acquire information about 
the movement of patients from one area health board to 
another but cannot assign either the name of the new area 
health board to transferred patients, nor the new address 
and name of the GP. This difficulty of maintaining contact 
with certain groups of patients who moved to another 
health board area has been accentuated by the recent 
increasing mobility of populations in Scottish towns and 
cities. Patients may be lost to follow up in this way so, 
if all area health board after computerization are linked 
to each other by a NHSCR, then these transferred patients 
could be followed-up. However as Hedley et al. (311)
stated, if patients are registered with a new 
practitioner, then contact may be reestablished through 
that GP unit providing that the patient’s entry in the 
NHSCR can be located. In this study attempts were made to 
contact 937 individuals identified by the CHI, who were 
asked to complete a questionnaire about their current 
diabetes status. Of the matched individual 20.5% (192)
could not be traced through the mail. 3.4% were due to 
transfer to another health board area, 6.9% could not 
traced and 10.3% did not respond. Not-traced rate is 
considerably lower than the findings of Jones et al. (314) 
of 18% based on the information collected by the Prescrip­
tion Pricing Authority, clinic records or GP records.
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However, In this study, all of the not-traced individuals 
were identified through G P ’s record linkage.
The speed, accuracy and response rate of follow-up 
could increase if it were possible to link the CHI file 
with a computer file of a telephone directory to identify 
telephone numbers of non-respondents and contact them by 
telephone. This is possible in countries such as France 
where the directory is available to any subscriber 
possessing a Minitel computer terminal.
Availability of CHI and GP records as a facility for 
cohort follow-up studies is too recent to have provided 
much experience in its use, but the CHI file and hospital 
in-patient statistics, as well as mortality statistics 
linkage have been actively employed for sometime and the 
demands for its use are increasing (262).
The existence of CHI record linkage in the Argyll and 
Clyde Health Board Area offers the potential for follow-up 
Midspan cohort study through the G P ’s record. Its use for 
this purpose compares very favourably, in term of cost and 
time and ease of procedure, with the alternative of a 
clinical follow-up study of cohort.
The group of 4.5% individuals unmatched with CHI 
resulted from differences in the spelling of given names 
of various types such as letters missing or transposed, 
and names shortened or anglicized, or from mistakes in 
typing the date of birth or both, or from women changing 
their name due to marriage. The chief problem in the 
searching step arises where the sequencing information 
(e.g. the surname, first name, and the date of birth) has 
been stated differently on the two potentially linkable
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records (e.g. the surname and first name may be spelled 
differently, or some part of the birth date may be 
reported differently on one of the records).
Overall there was a large response to our request. 
Only 97 (10.3%) of people who we believe were alive and
received our request did not respond.
The identification of individuals and access to their 
health record using CHI and GP records may raise serious 
questions of confidentiality. Only 2 cases had objections 
to inspection of their health records by our research 
team, but the attitude of the 97 (10.3%) who failed to 
respond to the survey may be important in this respect.
Also there are other posibilities -they may have failed to
respond to the survey because of not receiving the ques­
tionnaire, illness, gone away, and death.
In summary, the follow-up of population cohort
.studies through CHI linkage, and with records of illness
seen by GPs in Scotland is far away from perfection but 
was found to be a practicable method of follow-up.
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COHORT POLLOW-UP USING RECORD LINKAGE TO. MEASURE 
THE. ASSOCIATION BETWEEN HIGH CASUAL BLOOD GLUCOSE VALUE 
AND LATER DEVELOPMENT OF OVERT DIABETES
SUMMARY: The record linkage exercise which enables the
feasibility of studying the association between a single 
casual blood glucose and later development of diabetes has 
already been described in Chapter 12. This chapter 
discussed the epidemiological findings and estimates a 
measure of risk in a cohort consisting of 903 men and 
women. Information on their diabetes status after a 12-14 
year baseline examination was obtained by contacting 
general practitioners and patients through the CHI.
In the Paisley section of the Midspan study 224 people 
were in the top 5% of casual blood glucose distribution 
and non-diabetic compared with 426 individuals in the 
lowest 5% and 253 in the middle 5% of single initial 
glucose distribution. Initial casual blood glucose level 
was related to the development of non-insulin-dependent 
diabetes mellitus in a maximum of 14 years follow-up, and 
the data observed were analysed by the life-table and 
multivariate analysis techniques. Sixteen (14%) men and 12 
(13%) women in the index group compared to 5 (3%) men and 
3 (1%) women in combined comparison groups worsened to
diabetes during this period as estimated by the life table 
analysis. Overt diabetes was found about 9 times more
frequently in men and 15 times more frequently in women 
for initial casual blood glucose of 126 mg/dl and higher 
than for those below 70 mg/dl or equal to 90 mg/dl. The 
prevalence of hypertension and obesity in persons who 
developed diabetes was greater than in those who did not. 
A MLR model was used to control the influence of age, 
gender, SBP, DBP, blood glucose, serum cholesterol, BMI 
and cigarette smoking simultaneously. Both blood glucose 
and BMI were significantly predictive of ultimate
worsening to diabetes. The frequency of high casual blood 
glucose level was higher in males than females, but the 
tendency toward the development of diabetes was more
pronounced in females particularly if they were obese.
The study suggested that follow-up of a cohort by 
means of record linkage with CHI and G P ’s record would be 
a useful epidemiological tool for the detection of asso­
ciations between baseline variables and delayed effects 
which did not require hospitalization. The findings 
suggest new opportunities for evaluation in practice of 
the estimation of a simple risk profile (blood glucose and 
BMI) in subjects in middle life.
CONTENTS
13-1•Introduction 13.3*Results
13*2.Analysis 13*4.Discussion
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13, .1. INXRQDUC.TXON
Individuals with impaired glucose tolerance have been 
assumed to have an early phase of diabetes regardless of 
how blood glucose was measured. However, the possible 
association between and predictive value of high casual 
blood glucose (i.e. non-fasting) and progress to diabetes 
mellitus is not clear. Several studies (315-326) examined 
the value of different diagnostic criteria for asmptomatic 
hyperglycaemia and progress to diabetes. None of them used 
casual blood glucose criteria. In many people, impaired 
glucose tolerance returns to normal spontaneously, while 
in some there is progression to gross hyperglycaemia with 
symptoms. The significance of other factors which 
influence or predict a state of deterioration are also 
controversial (350). In this study the question arises as 
to whether a high casual post-prandial blood glucose level 
allows a reliable prognosis to be made with respect to the 
development of overt diabetes. A series of relevant ques­
tions may be posed: To what extent does the presence or
absence of an arbitrarily defined high single casual blood 
glucose level play a role in the prediction of diabetes 
mellitus? How important are BMI, blood pressure, serum 
cholesterol and cigarette smoking in the prediction of 
diabetes? Is there any gender difference between the 
presence of risk factors and later development of 
diabetes? This chapter attempts to clarify these ques­
tions .
In a prospective study of this kind maintaining
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contact with patients during a long period of time would 
be a daunting task unless it could be achieved by linking 
records collected routinely for other purposes. In 
Scotland, the CHI is one of these registers. With linkage 
with the CHI it is possible to have access to the last 
known address of the patients and the name and address of 
the GP as well. A feasibility study of the follow-up of a 
cohort using CHI and G P ’s records was undertaken (Chapter 
12).
This study was undertaken to elucidate the relation­
ship between certain measurements made at baseline and 
subsequent ’’progress” to clinical diabetes. The study 
group consists of 224 cases identified as asymptomatic 
hyperglycaemics. This was based on casual blood glucose 
of more than or equal to 126 mg/dl (top 5% of distribu­
tion) compared with 679 controls 12-14 years following 
their participation in the Paisley study by means of a 
link with the CHI and G P ’s records.
13.2.ANALYSIS
The population sampling frame and methods of this 
chapter have been described in detail in section 5 of 
chapter 12.
To evaluate the relationship between casual blood 
glucose levels at baseline with 12-14 years and deteriora­
tion to diabetes, bivariate analyses were carried out. 
Continuous variables were dichotomized at arbitrary cut 
points that could be considered ’’high”; also the men and 
women were classified by cigarette smoking at entry to the 
study, with index and comparison groups. The chi-square 
and unpaired Student t-test were used to determine the
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degree of significance of differences between the groups.
The probability of worsening to diabetes was assessed 
by application of life-table techniques (327). This 
actuarial technique, exemplified in Table 13.1. uses 
observed outcomes for each observation interval for each 
patient and estimates cumulative proportion which would 
have been found after all the patients had been followed 
for the full duration of the study.
13.3.RESULTS
The relationship between initial blood glucose levels 
and diabetes by age and gender is examined in Table 13.2. 
At the end of 12-14 years follow-up period 21 (5%) of the 
410 men and 15 (3%) of the 493 women had developed
diabetes. Of these, 16 (76.2%) men and 12 (80%) women were 
in the top portion of the glucose distribution, 3 (14.3%) 
men and 2 (13%) women in middle and 2 (9*5%) men and one 
(7%) woman in lower portion. Two cases were insulin 
treated and 34 cases were non-insulin treated. Two cases 
were diagnosed as diabetes during an initial examination 
and excluded.
The proportion worsening to diabetes was 14% of men and 
11% of women in the index group, 3% of men and 1.3% of 
women in the mid-range comparison group and 1% of men and 
0.4% of women in the lower control group. The proportions 
in the index group were significantly higher than each of 
the comparisons. Neither of the comparisons was 
significantly different. Because of the small number of 
people who progressed to diabetes in the comparison 
groups, they were combined for the rest of the analysis.
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The life-table projections for cases and controls and 
for males and females are shown In Figure 13.1* They show 
that by the 14 years after diagnosis of asymptomatic 
hyperglycaemia, 13*6% of men and 12.5% of women in the top 
blood glucose distribution will have progressed to 
diabetes compared with 3*1% of men and 0.9% of women in 
the combined lower and middle part of blood glucose dis­
tribution.
13*3-1.Influence of Age, Blood Pressure, Body Weight and 
Gender
Age: Assessment of these results requires information
on the comparability of the groups that are under 
consideration. The age composition is of prime importance 
since the prevalence of diabetes increases with age. Table 
13.3 indicates that both mean ages and the distribution in 
cases and controls are sufficiently close to avoid any 
significant effects. In females, but not in males, a 
higher mean age was observed in those who progressed to 
the diabetes compared to those who remained unchanged 
(Table 13.4).
Blood Pressure and Body Weight: In Table 13.4 the
mean values of certain baseline characteristics is 
compared in both the groups who deteriorated and those who 
did not deteriorate to diabetes”. Values from the baseline 
single casual blood glucose, DBP and BMI were 
significantly higher amongst those who deteriorated to 
diabetes in both genders, and age and SBP in females. 
According to Bonferroni’s inequality (328) w h e n K  tests 
are performed, each with significance level P, the 
probability of one or more significance tests by chance
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alone is at most KP. When we applied this coefficient, DBP 
in both genders and BMI in males were no longer 
significant.
Variables were dichotomized to further analyse the
effect of being overweight, hypertensive, having a high
serum cholesterol or being a smoker compared with being
"normal" in relation to progress to diabetes. In Table
13*5 incidence rates and relative risks are given for
individuals worsening to diabetes in different categories
of risk factors. For continuous variables, (cholesterol,
SBP, DBP, BMI) and a categorical variable, (smoking),
incidence rates are given for subjects above and below the
selected cut-off points i.e. 250 mg/dl for cholesterol,
2
160 mmHg for SBP, 95 mmHg for DBP, 27 k/m for BMI. 
Incidence was significantly higher in high categories of 
SBP and BMI in both genders and DBP in males. After 
application of Bonferroni’s inequality, SBP in both 
genders was no longer significant.
Table 13*6 shows the mean and standard error of the 
baseline characteristics in the index group compared with 
the comparison groups. Both males and females in the index 
group have higher SBP and they were slightly more 
overweight than the control group. There were no 
significant differences in the age, DBP or serum 
cholesterol and percentage of cigarette smoking (feniales) 
between the index and the comparison groups. After appli­
cation of Bonferroni’s inequality, the BMI in both 
genders was no longer significant. The positive relation­
ship between the initial casual blood glucose and BMI, SBP
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in both men and women and negative association of DBP in 
women was found to be significant by multiple regression 
analysis which included age, gender, serum cholesterol, 
BMI and blood pressure, as other variables. The negative 
association of DBP is due to interaction between SBP and 
DBP. After application of Bonferroni's inequalities, SBP 
in males was no longer significant.
For further analyses of the effect of SBP, DBP, serum 
cholesterol, BMI or cigarette smoking on the relationship 
between casual blood glucose level and progress to
diabetes, variables were dichotomized in the index and 
comparison groups. In Table 13*7. incidence rates are 
shown for the index and comparison groups according to the 
possible effects of risk factors. As shown in Table 13*7* 
the 12-14 year incidence rate of progress to diabetes is 
remarkably increased above the 95th centile of casual 
blood glucose irrespective of the level of SBP, DBP, serum 
cholesterol, BMI or smoking in both genders, though the 
association was stronger in women. Incidence rates
accounted for 10.5 (male 11.6, female 9-2) per 1,000 PYO 
in the index group, whereas only 0.93 (male 1.3. female 
0.6) per 1,000 PYO were attributed in the comparison
group. Progress to diabetes was found to be about 9 times 
more frequently in men and 15 times more frequently in
women in the index group. For high BMI compared to low BMI 
in women, the relative risk of progress to diabetes is 
significantly greater in the index group, even after 
application of Bonferroni’s inequality. The index-
comparison relative risk for high BMI in both men and 
women and female cigarette smokers is greater, while for
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the rest of the risk factors. In both senders, the index- 
comparison relative risk is greater in the lower risk 
groups.
Table 13*8 shows the sensitivity, specificity and 
positive and negative predictive value of casual post­
prandial blood glucose value to 12-14 years worsening to
diabetes in men and women with BMI greater and less than 
2
27 Kg/m . The positive predictive value of worsening to
diabetes was 7.2# (male 10.4# and women 4.2#) and the
negative predictive value was 99# (male 98.5#* female
2
99*3%) when BMI was less than 27 Kg/m . When BMI was >27 
2
Kg/m , the positive predictive value became 21.7% (male 
19*1%» female 25%) and the negative predictive value 98.4% 
(male 97.9%. female 99%). Comparison of the relative risks 
of the index and comparison groups in this bivariate 
analysis provides evidence of only an association between 
casual blood glucose and BMI. To examine this further a 
MLR with an interaction term between blood glucose and 
rest of the variables was carried out.
Gender: The incidence of progression to diabetes in
males and females in the various subgroups is given in 
Table 13.5. The incidence rates were higher in all 
categories in men rather than women and a higher age
dependency was observed in females than in males. This
gender difference was less marked in high categories of
sugar, SBP and BMI rather than in the low categories. 
However, deterioration occurred more frequently in males 
than females for all subgroups, but the tendency towards 
worsening to diabetes within 12-14 years compared to the
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control group, was more pronounced in females than males 
(Table 13-7).
The mean and standard error of the baseline variables 
for males and females in the index and comparison groups 
were also compared in Table 13*6. There were no gender 
differentials in mean values of baseline variables except 
serum cholesterol which in both groups was higher in 
females than males.
13.3.2.Multiple Logistic Regression Analysis
The univariate and bivariate analyses clearly 
indicate that the role of high casual post-prandial blood 
glucose as a risk factor for progress to diabetes can be 
properly evaluated only by taking account of confounding 
effects of other risk factors. Therefore, the relationship 
of baseline variables with deterioration to diabetes 
within 12-14 years was examined further with a MLR model 
to which the following ’predictors* were fitted: age,
gender, BMI, SBP, DBP, serum cholesterol, cigarette 
smoking and blood glucose. All of the variables were 
dichotomized as before.
The baseline variables most powerfully predicting the
development of diabetes were initial casual blood glucose
2
values greater than 126 mg/dl and BMI above 27 Kg/m , none 
of the other variables approaching conventional 
statistical significance (Table 13.9). When analysis was 
repeated with continuous variables, sugar and DBP became 
significant. In the model with an interaction term, there 
was no significant association between sugar and rest of 
the variables as a predictor variable for worsening to 
diabetes. From the coefficient, from the logistic model,
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for any difference in deterioration to diabetes by age, 
gender, degree of blood glucose, blood pressure, obesity 
or smoking, a ratio can be calculated expressing the 
relative odds of progress to diabetes in the 12-14 year 
period. The SOR of progress to diabetes has been 
calculated. This standardized estimated relative risk is 
approximately 12 times higher in the index than in the 
control group and about 3 times higher in high BMI 
categories than low BMI categories. Several of the risk 
factors are significantly correlated with each other and 
BMI and blood pressure are correlated with blood sugar 
(Table 13*6). To assess the independent relationship of 
each variables with progress to diabetes, another MLR 
analysis has been carried out for the index and comparison 
groups separately (Table 13-10>. For the comparison group 
none of the variables was significantly related to 
progress to diabetes. However in the comparison group, the 
number of diabetes was relatively small and caution must 
be exercised in the interpretation of the results. In the 
index group the most powerful predictor of the development 
of diabetes was BMI. Again, none of the other variables 
approached conventional statistical significance.
13, 4, DISCUSSI.Qtt
The factors predicting metabolic deterioration are 
controversial. Impaired glucose tolerance is of interest 
with respect both to the possibility of its use as an 
early indicator of diabetes and to its relation to CVD 
(329, 330). This chapter concerns aspects related to
diabetes. While the CVD mortality aspect is 'discussed in
240
CHAPTER 13
Chapter 6. To determine the value of a high single casual 
blood glucose in predicting the subsequent development of 
overt diabetes, we preferred to use presence of classic 
diagnostic criteria of diabetes by means of record linkage 
with GP's records. In this study individuals identified by 
high casual blood glucose level were compared with those 
with low blood glucose level and observed for a long time, 
and GP ’s plus others diagnosis of treatments recorded in 
GP records was employed as the sole gauge of previous 
diabetes. The diagnostic criteria for diagnosis of
diabetes by GP were based on unequivocal symptoms or 
signs of diabetes mellitus - and/or standard glucose 
tolerance test (GTT) and were considered sufficiently
reliable to remove any doubt of the presence of diabetes. 
All of the patients were under treatment for diabetes.
We believe that this indirect method of follow-up of 
a cohort has great advantages in a population survey 
study. 1) The entire population can be studied regardless 
of occupation, age, and infirmity or socio-economical
characteristics. 2) A relationship which normally exist 
between doctor and patient encourages the co-operation of 
individuals, which is the largest factor in achieving a 
high response rate. 3) The population is easily studied. 
4) Close involvement of the hospital consultants with the 
participating GP ensures a definite policy in the 
management of those individuals discovered to have a 
diabetic or incidental abnormality. 5) Advice and 
treatment can be administered firmly and consistently. 
There have been several follow-up studies (315-326) on 
unselected populations screened for blood sugar, though
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only four have published data on factors predicting 
metabolic deterioration, and reviewed by Jarrett et al. 
(323). Each of these differs in the methods used and in 
the criteria adopted in defining the development of
diabetes. None of them used casual blood glucose and GP’s 
record linkage to predict deterioration to diabetes as we 
did in this analysis. O ’Sullivan and Mahan in the Oxford 
Massachusetts Survey (315) used post-prandial venous blood 
sugar levels of 140 mg/dl or more, or capillary blood
sugar levels of 170 mg/dl or more. The subjects were
subsequently tested at varying intervals over 17 years, 
during which three markers of new diabetes were recognized 
(a) receiving insulin treatment, (b) people with blood 
sugar persistently exceeding 200 mg/dl post-prandial or 
140 mg/dl fasting and (c) as for (b) except that post­
prandial levels were 170 mg/dl and fasting levels 130 
mg/dl. A control group with initial post-prandial blood 
sugar levels below 140 mg/dl was also studied. The median 
period of follow-up was about 14 years. Compared with the 
control group, diabetes occurred 5 times more frequently 
in people with initial post-prandial blood glucose from 
140-169 mg/dl and 15 times more frequently in those with 
blood glucose of more than 169 mg/dl. Diabetes also 
occurred very much more frequently in people 2 0 % above 
ideal body weight when their initial blood sugar ’level 
exceeded 169 mg/dl, with a smaller excess when blood sugar 
levels were in the range 140-169 mg/dl, a finding which 
this study also supports when casual post-prandial blood 
glucose (venous whole blood) was greater than 126 mg/dl.
CHAPTER 13
Overweight people with Initially "normal” blood glucose 
did not appear to be at greater risk. This finding was 
also supported by the present as well as the Whitehall 
(325) study. In the Birmingham Diabetes Survey (318) 50 g. 
oral glucose tolerance tests were used on 465 people with 
glucosuria and 343 people selected at random from the 
-non-glycoeuric population. Two follow-up reports have 
appeared, one at 5 years (317) and one at 10 years (318). 
"Florid diabetes" was defined as those with fasting blood 
glucose levels exceeding 130 mg/dl and "GTT diabetes" as 
those with fasting levels less than this, but with one- 
hour levels above 180 mg/dl and a 2 hour levels above 120 
mg/dl. 45% of those with GTT diabetes progress to florid 
diabetes in ten years and, in general, the higher the
blood glucose levels in the initial test, the more likely
was a progression to florid diabetes. The authors did not 
relate body weight to subsequent diabetes. O ’Sullivan and 
Mahan (319) studied 352 females identified as "chemical 
diabetes" by one of three criteria -(a) Mosenthal and
Barry, (b) Fajans and Conn, (c) U.S. Public Health Service 
(USPHS). They were followed for 1-12 years. Clinical 
diabetes was diagnosed during follow-up if the fasting 
blood glucose exceeded 120 mg/dl or the post-prandial
blood glucose exceeded 180 mg/dl or the post-prandial
blood glucose within three hours of ingestion exceeded 300 
mg/dl. The USPHS criteria were the best predictors of
worsening to diabetes. The members of the group as a whole 
was overweight when diagnosed as in this study. In those 
overweight there was a significant excess of diabetes in
all three diagnostic groups. Jarrett et al. in the
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Whitehall Study (325) investigated 240 men identified as 
"borderline diabetics" by one of two criteria -(a) a 
survey blood sugar between 110-199 mg/dl and at standard 
GTT, (b) peak blood glucose 180 mg/dl or more and two hour 
blood sugar between 120-199 mg/dl and/or two value 
exceeding 180 mg/dl and/or mean two hours blood glucose 
120 mg/dl or more. Overt diabetes was diagnosed during 
follow-up if there were (a) two successive two hours post­
glucose blood sugar was greater than 200 mg/dl (b) three 
non-successive two-hour blood sugar was greater than 200 
mg/dl (c) there was a development of unequivocal symptoms 
or signs of diabetes mellitus (d) a two-hours blood 
glucose was greater than 200 mg/dl at a standard afternoon 
oral glucose tolerance test. They reported that the levels 
of blood glucose themselves best predict worsening to 
diabetes. Obesity did not contribute to prediction. 
Authors reported that the fasting and two hours post 
glucose tolerance load have approximately the same effect 
upon the logistic function. In this study we used a single 
casual post-prandial blood glucose (whole blood) measured 
at baseline and defined as "asymptomatic hyperglycaemia" 
if blood sugar level 126 mg/dl or more (top 5% of distri­
bution). Clinical diabetes was diagnosed during follow-up 
by the GP or incidentally during hospitalization for other 
causes and were under treatment for diabetes. Overall this 
study and published literature shows that in spite of 
different population groups, selected in different ways 
using different criteria in defining deterioration to 
diabetes, this study and four others (315, 316, 319. 325)
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confirm that the levels of blood glucose are the best 
predictors of subsequent development of diabetes indepen­
dent of how definition of diabetes or the particular 
glucose test used. The influence of obesity as a predictor 
is less clear. The Whitehall study (325) found no 
relationship between BMI and worsening to diabetes, while 
in this study and two American studies (315, 319) obesity
appeared to contribute to prediction. In this study the 
index group as a whole was more overweight than controls, 
comparable with O ’Sullivan and Mahan findings (315, 319,
326), and had higher blood pressure. There were associa­
tions between blood pressure, BMI and blood sugar levels 
independent of age, gender, and serum cholesterol at the 
initial examination as indicated by MLR analysis. Rates of 
deterioration to diabetes in this analysis showed a clear 
relation to the casual blood glucose level and were 
markedly influenced by the presence of obesity and hyper­
tension in bivariate analysis. The effect of hypertension 
was removed, but the effect of obesity remained, when 
multivariate analysis was taken into account. In MLR 
analysis, when continuous rather than categorical 
variables were considered, DBP contributed to the predic­
tion of worsening to diabetes independently, though when 
we analysed for the index group alone, there was no 
further evidence that DBP was a predictor of progression 
to diabetes. This suggests that the level of DBP may be 
more important than selected cut off points. The strong 
association between BMI and diabetes is confirmed, in that 
being grossly overweight and having a high blood glucose 
level at the time of initial examination increased the
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probability of progress to clinical diabetes.
In this study, the higher casual post-prandial blood 
glucose level may be considered meaningful, in terms of 
future overt diabetes, as indications of potential rather 
than actual disease. The alternative end point, that 
higher mortality, in the extreme upper end of the casual 
blood glucose distribution (Chapter 6) confirmed the 
pernicious effect of high symptomless casual blood 
glucose. The trend of progression to higher blood sugar 
levels, and the number that go on to a deteriorated state, 
and higher mortality support this assessment.
CHAPTER 1A
GENERAL DISCUSSION
14. 1^-INTRODUCTION
CVD is a major health problem in most parts of the 
world and leads to more deaths, disability and economic 
loss than any other disease. In industrialized countries 
improving the health of the population depends upon 
controlling CVD. A major goal of epidemiological research 
is to identify factors involved in the aetiology of 
diseases to prevent or control such diseases.
The aims of this study were to examine (1) the quality 
of data available from Renfrew and Paisley survey and 
feasibility of such programmes, (2) to explore its use in 
answering a number of epidemiological questions in rela­
tion to blood glucose level, blood pressure, body weight, 
gender, diabetes and mortality and (3) to evaluate the 
potential for further follow-up studies using CHI.
14.2.FEASIBILITY ££ A SCREENING PROGRAMME SUCH AS. MIDSPAN 
The review of programme feasibility as a whole must be
related, on the one hand, to initial expectations and, on 
the other, to the data collection. The aim was to 
introduce a broad-range multiple screening programme 
gradually developing to its maximum extent, and without 
doubt these expectations were met. The programme was made 
feasible to a great extent because of the active partici­
pation of the population, the health and the voluntary 
organizations and the mass media.
14.3.QUALITY Q E INITIAL DATA
All steps possible, including the use of
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Internationally standardised questionnaires and method of 
laboratory tests as well as anthropometric and clinical 
and physiological measurements, were taken with the aim of 
collecting good quality data. Analysis carried out in this 
project, for example comparisons with the General 
Household Survey and other surveys, by checking ranges and 
distributions of values etc. suggests that the aim of 
collecting good quality data was, on the whole, achieved. 
The one exception to this was the large number of missing 
values for blood glucose, but as this was largely due to 
administrative and financial problems it is unlikely to 
have caused any major bias.
In blood pressure measurement, errors in measurement 
due to large arm size were unpredictable and non-linear. 
The standard commercial cuff of 12X22 cm used in the 
Renfrew and Paisley studies should have been replaced with 
the recommended size of 30 Cm in length (334). However it
seems reasonable to regard the blood pressure
measurements, in general, as being of good quality.
Relatively large samples were used to allow for the 
detection of changes that may not have been significant 
for an individual but were significant for the whole
population. This also allowed a breakdown into subgroups.
We can therefore conclude that the initial data set 
—  provides a valid basis for mortality and morbidity follow- 
up studies.
14. 4. MORTALITY SURVEILLANCE.
Monitoring cardiovascular morbidity and mortality at 
the community level has many problems. The problems in 
monitoring strokes are the same as monitoring heart
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disease. All cardiovascular registers (including stroke 
and heart disease) and diagnostic criteria (defined by
ICD) are purely clinical. However, it has been concluded
that although the sub-diagnosis (type of stroke or heart 
disease) was unreliable, the stroke and heart disease 
diagnoses as a whole were consistent and reliable (332). 
Mortality data for evaluating CVD have known limitations 
for defining cause-specific mortality. This is true espe­
cially in areas such as the west of Scotland where autopsy 
rates are relatively low (333). The observed rates depend 
on physicians habits in completing death certificates. Age 
and gender-specific total mortality rates would be the
most reliable indices under these conditions as used 
throughout this study. However, they lack sensitivity 
because mortality is the end point in the course of CVD, 
and only part of the total mortality is due to CVD.
The standardized mortality ratio in Renfrew and Paisley 
was lower than one, and the number of expected deaths
exceed the observed deaths. This difference was probably 
largely due to under reporting of mortality data by NHSCR. 
On the other hand, the response rate for the initial 
Renfrew and Paisley survey was about 80% and there is the 
likelihood that some people did not participate in the 
study because of illness. This may explain the lower 
standard mortality ratio in the first years of the study. 
As the under-reporting is due to ‘administrative* -errors 
it is likely that the under-reporting affects all patients 
groups equally. Therefore it is unlikely to affect the 
study of risk factors for mortality, however this may well
2U9
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deserve further attention. Cross-sectional studies have
important limitations in study of CVD. Thus, underlying 
severe atherosclerosis may exist with no clinical 
manifestation. In fact, cross-sectional analysis does not 
give an accurate picture of a sequence of events. i.e. it 
cannot determine if the hyperglycaemia preceeded arterios­
clerosis or vice versa. Therefore, in spite of limitations 
of the mortality data as described above, this study 
provides a better test of the association between baseline 
variables and CVD mortality outcome than is possible with 
cross-sectional studies.
- 14.5.RISK FACTORS PREDICTIVE Q E MORTALITY
For the first time, the Renfrew and Paisley study has 
allowed association between various CVD risk factors and 
mortality to be examined. It has produced new findings. 
Variation in mortality risk has been examined while 
adjusting for seven CVD risk factors (age, gender, SBP, 
DBP, serum cholesterol, blood glucose, BMI, and smoking) 
in a series of age-adjusted and MLR analyses.
The main aim has been to re-test the hypothesis that 
high casual blood glucose is a risk factor for all causes, 
CVD, IHD and stroke mortality. A positive association 
between initial casual blood glucose level and subsequent 
mortality was found. Most previously published studies 
of asymptomatic hyperglycaemia had only included males so 
it was decided that gender differences should be analysed 
in more detail. High blood glucose level was a risk factor 
for CVD mortality in both genders. It was also a risk 
factor for all causes, IHD and stroke mortality in women 
but in men was of borderline significance. On the other
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hand, repeating the original MLR analysis and controlling 
the influence of gender, along with seven other cardiovas­
cular risk factors simultaneously showed that those 
cardiovascular risk factors do not account for the overall 
gender difference in mortality rates. Some other studies 
had suggested that blood glucose levels are associated 
with other CVD risk factors, particularly with BMI, so it 
was decided to investigate the extent to which blood 
glucose level interacts with BMI in the prediction of all 
causes and CVD mortality. There was no relationship 
between BMI and CVD deaths neither for normoglycaemics 
nor hyperglycaemics. Lastly, as there was conflicting 
evidence in the literature, the relative importance of SBP 
compared to DBP and other combinations of SBP and DBP in 
predicting the risk of IHD and stroke mortality were re- 
examined. The risk of IHD deaths was more strongly asso­
ciated with MAI and single SBP in both males and females. 
SBP and DBP together, MAP and PP do not predict future IHD 
mortality better than SBP alone or MAI. SBP and DBP are 
strongly correlated in both genders but their relation­
ship with stroke mortality was different among males and 
females. In females the risk of stroke mortality was more 
strongly associated with DBP; in males SBP and DBP have 
the same predictive strength of stroke death.
In this study asymptomatic hyperglycaemia was defined 
as a casual post-prandial blood glucose level above the 
95th percentile cut-point (126 mg/dl). However a word of 
caution is needed. The problem is whether casual blood 
glucose is a sufficiently sensitive measure. These
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arbitrary criteria are at variance with those for diabetes 
and impaired glucose tolerance based on fasting blood 
sugar levels or the standard glucose tolerance test that 
have been proposed by the National Diabetes Data Group
(171) and recommended by the World Health Organization
(172). However, in an epidemiological investigation, 
examining a large cohort of the community, it is rather 
difficult to require that all subjects arrive in the 
fasting state or to require that they remain for 2 hours 
after glucose challenge, plus it is seldom practical to 
determine several glucose values from an economical point 
of view. On the other hand, casual and various post­
challenge glucose determinations yield remarkably similar 
results in different studies (41, 43. 143. 167).
14. 6. RISK FACTORS FOR DJSYJELQEMfiN.T Q E DIABETES
This study showed that an initial casual blood glucose 
level was related to non-insulin-dependent diabetes 
mellitus in a maximum of years follow-up. Of the base­
line variables BMI was also significantly predictive of 
ultimate worsening to diabetes.
The use of a casual blood glucose in Midspan provided a 
new and unique opportunity to examine the usefulness of 
this measurement. Its use for screening in general 
practice seems a cheap and easy method of identifying 
patients at risk.
14.7.FOLLOW-UP QE SURVIVORS
Two methods of record linkage could be used to follow- 
up this cohort based on record linkage with SHIPS (SMR-1) 
files in the ISD and/or by using the CHI and general 
practitioner records.
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SMR-1 data, can be used to produce details of 
diagnosis and outcome on hospital admission. There are 
advantages in being able to conduct long-term follow-ups 
indirectly in this way with relatively little expense and 
no physical re-examination especially when economy is a 
prime consideration. However, there are a number of 
reasons why it may be preferable to use the second method 
of linkage using the CHI and GP records.
1.SMR-1 data obviously only refer to in-patient 
admissions and often little is known about hospitalization 
rates. For example, the proportion of diabetics who are 
hospitalized and recorded as diabetics is small so that 
the number of asymptomatic hyperglycaemics who later had 
diabetes diagnosed could not be estimated.
2.Linkage with SMR-1 data has been tried before (310) 
giving a sensitivity of 81% for in-patient data for one 
year (1973). This is likely to decrease for subsequent 
years because of changes in clinical practice and 
admission policies producing fairly low sensitivity.
This study has shown that record linkage with the CHI 
is feasible and that further studies would be worthwile.
14.8.CONCLUSIONS
Based on the results of 10-14 years follow-up of this 
population-based cohort study in Renfrew and Paisley, the 
following conclusions have been made:
l.The programme was feasible. The participation rate was 
in order of about 80%, and the reactions of the people, 
health personnel and the local administrators and managers 
was generally positive.
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2.There was an association between high casual blood 
glucose defined as the upper 5% of casual blood glucose 
value and subsequent mortality from all causes, CVD, IHD 
and stroke.
3.This association was dependent on gender for all causes, 
IHD and stroke mortality. However, females with high 
casual blood glucose value were more susceptible to 
mortality outcome than men.
4.There was no significant interaction between BMI and 
casual blood glucose level.
5.Considered CVD risk factors do not account for the 
overall gender differential in mortality.
6.The risk of IHD death was more strongly associated with 
SBP than DBP in both genders.
7.The risk of stroke death was more strongly associated 
with DBP than SBP in women, while in men the DBP was as 
good a predictor of stroke mortality as SBP.
8.Follow-up studies looking at morbidity in GP records are 
possible using the CHI and further studies should be 
carried out to identify the test practical approach.
9.Initial high casual post-prandial blood glucose level 
was related to non-insulin-dependent diabetes mellitus 
during the follow-up period. Deterioration, however, was 
also closely related to body weight.
14j-9. jJT.IJRT.HER STUDIES
The Midspan database will only achieve its full 
potential if it is maintained efficiently and effectively, 
a full range of end point information (including 
morbidity) is linked to it, and appropriate access can be 
achieved easily. Preliminary record linkage studies with
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CHI have been very successful with about 95% of patients 
contacted through mail or their GP, but a more systematic 
approach to the use of the CHI needs to be explored.
This study has identified a number of problems. These 
include identification of the underreporting of deaths 
through record linkage with NHSCR, difficulties in 
locating and maintaining archived data tapes and other 
information stores, and continuing problems in the safe 
storage of the original data collection forms.
Further operational studies, on the development and 
assessment of a robust system for the management of 
Midspan, the methodology of which can be applied to any 
similar well-population register are required. These 
further studies include:
a) the identification and detailed description of the 
activities necessary to maintain and manage the register 
within the context of the Scottish Health Service.
b) the identification and analysis of problems in the 
maintenance and use of the register and their possible 
solutions.
c) the further investigation and improvement of record 
linkage with NHSCR and CHI.
d) the development of methods, including manual and 
microcomputer based systems, which will facilitate the use 
of the register and potentially make it available to a 
wider group of research workers.
e) the development of the educational potential of such a 
register for use in the continuing education of epidemio­
logical and health service research workers.
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MAPS, FIGURES AND TABLES
TABLE 1.1.Renfrew and Paisley Midspan Health Survey
Household
Rates.
Census and Examination Response
Paisley Households Reply Individual Response
Sectors Rate (%) Eligible Examined Rate (%)
Glenburn 3, 518 96.8 2, 334 1. 851 79. 3
Foxbar 3, 505 97. 4 - 1,821 1. 435 78. 8
Mossvale 2, 492 96. 5 959 660 68. 8
Hunterhill 1, 658 97. 7 870 672 77. 2
Whitehaugh 4, 527 96. 6 2. 029 1. 512 74. 5
Gallowhill 2, 923 96. 9 1, 756 1. 323 75. 3
Lochfield 4, 008 98.3 2, 214 1. 678 79. 4
Ferguslie 3. 150 92. 9 993 580 58. 4
Bredilands 2,292 96. 5 1, 088 845 77. 7
Central 4, 356 97. 6 1, 949 1. 370 70. 3
10 Sector
Combined 32,429 96. 8 16,013 11,926 74. 5
All non-respondents reinvlted 4, 087 520 12.8
Survey
Combined 32,429 96. 8 15.971 12,446 77. 9
Renfrew 6, 534 99. 1 3, 810 3, 000 78. 8
Combined
Renfrew and
Paisley 38.963 97. 2 19.781 15446 78. 1
Source:(15).
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FIGURE 5.1.Mean Serum Cholesterol Value by Age and 
Gender.
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FIGURE 5.2.Mean Blood Glucose Values by Age and 
Gender.
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MAPS, FIGURES AND TABLES
TABLE 5*6.Coefficient of Correlation Between Age, 
Systolic (SBP), Diastolic (DBP) Blood
Pressure, Blood Sugar, Serum Cholesterol, 
Cigarette Smoking, and BMI in Men and Women.
Variable SBP DBP Serum 
Choles.
Blood
Glucose
BMI
Male
Age
SBP
DBP
Serum Choles. 
Blood Glucose
0.20*** 0.00 -0.06*** 0.0$#** 
0.66*** 0.03* 0.12***
0.07*** 0.02* 
- 0.01
0. 00 
0.20*** 
0 .30***
0.07*** 
0 .16***
Female
Age
SBP
DBP
Serum Choles. 
Blood Glucose
0 .28*** 0 .15*** 0 .16*** 0 .09*** 
0 .67*** 0 .08*** 0 .12*** 
0 .07*** 0 .04** 
0. 00
0.10*** 
0 .29***
o.35*** 
0 .06*** 
0 .07***
*P<0.0 5 « **P<0.01, ***P<0.001
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MAPS, FIGURES AND TABLES
TABLE 5.8.Univariate Logistic Function Analysis of the
10-14 Years Risk of All Causes. CVD, IHD and
Stroke Death Among Men.
Variable Logistic
Coefficient
Standardized 
Odds Ratio©
Z-Test
Crude Age- Crude
Adjusted
Age- Crude
Adjusted
Age-
Adjusted
All Causes 968 Deaths in 4789 men
Age 0.1068 — 1. 82 — 15.35*** —
Systolic BP 0.0146 0.0105 1.39 1.26 9.4l*** 6.52***
Diastolic BP 0.0148 0.0155 1. 21 1. 22 5 .50*** 5.59***
BMI 0.0160 -0.0158 0.95 0. 95 -1. 50 -1. 44
Serum Choi. -0.0032 -0.0021 0 . 89 0 . 92 -3.28** -2.16*
Blood Glucose 0.0033 0.0025 1. 09 1. 06 2 .63** 1. 97*
Cig. Smoking 0.5356 0.6365 2. 92 3. 57 7.32*** 8.41***
Cardiovascular Disease 505 Deaths in 4326 Men
Age 0.1118 1. 85 - 1 2 .21***
Systolic BP 0.0222 0.0183 1.63 1.49 11.21*** 8.95***
.Diastolic BP— 0-.-0300— 0.0304 
BMI 0.0425 0.0440
Serum Choi. 0.0021 0.0034
Blood Glucose 0.0044 0.0039
Cig. Smoking 0.3485 0.4491
1r47— 1.47— 8t 69*** 8762*** 
1.15 1.16 3.08** 3.11**
1.08 1.13 1.65 2.61**
1.12 1.13 2.93** 2.46*
2.01 2.45 3 .66*** 4.60***
Ischaemic Heart Disease 350 Deaths In 4171 Men
Age 0.0963 - 1. 70 - 9.15*** -
Systolic BP ' 0.0206 0.0171 1. 57 1. 45 8.89*** 7.22***
Diastolic BP 0.0274 0.0279 1. 42 1. 43 6.69*** 6 .73***
BMI 0.0427 0.0437 1. 15 1. 15 2.63** 2.64**
Serum Choi. 0.0033 0.0044 1. 13 1. 18 2. 20* 2.94**
Blood Glucose 0.0042 0.0037 1.11 1. 10 2. 32* 1. 95
Cig. Smoking 0.2752 0.3580 1. 73 2. 05 2.46* 3 .15**
Stroke 79 Death in 3900 Men
Age 0.1463 — 2. 23 — 6.38*** —
Systolic BP 0.0296 0.0253 1. 91 1. 74 6.94*** 5 .72***
Diastolic BP 0.0420 0.0413 1. 71 1. 70 5 #67*** 5 #57***
BMI 0.0331 0.0336 1. 11 1. 12 0.99 0 . 98
Serum Choi. -0.0006 -0.0011 0. 98 1. 04 -0.20 -0. 35
Blood Glucose 0.0560 0.0050 1.15 1. 13 1 . 96* 1. 65
Cig. Smoking 0.3667 0.4940 2. 08 2. 68 1. 60 2. 14*
©Odds ratio computed as the antilogarithm of the original 
coefficients for a change in the risk factor by an amount 
equal to its standard deviation.
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TABLE 5*9*Univariate Logistic Function Analysis of the
10-14 Years Risk of All Causes, CVD, IHD and
Stroke Death Among Women.
Variable Logistic Standardized Z-Test
Coefficient Odds Ratio©
Crude Age- Crude Age- Crude Age-
Adjusted Adjusted Adjusted
All Causes 664 Deaths In 5817 Women
Age 0 .1073 - 1 . 80 - 13.31*** -
Systolic BP 0.0130 0 .0077 1. 37 1 . 21 8 .32*** 4 .66***
Diastolic BP 0.0146 0.0086 1. 21 1. 12 4.85*** 2.79**
BMI -0.0023 -0.0167 0. 99 0. 93 -0.24 •1. 74
Serum Choi. -0.0002 -0.0022 1. 01 0 . 91 -0.19 •2. 13*
Blood Glucose 0.0093 0.0078 1. 24 1. 19 7.27*** 6 .13***
Cig. Smoking 0.3329 0.5282 1. 95 2. 87 4.02*** 6.16***
Cardiovascular Disease 289 Deaths in 5442 Women
Age 0.1479 — 2.25 _ 11.64*** _
Systolic BP 0.0209 0.0146 1.66 1. 43 9 .48*** 6.26***
Diastolic BP 0.0324 0.025 1. 53 1. 39 7 .65*** 5 .73***
BMI -0.0171 -0.0021 1. 08 0. 99 -1.28 •0.15
Serum-Chol. -0^0050- 0.0023 1 r23 1.10 3 .62*** 1. 57
Blood Glucose 0.0106 0.0091 1. 27 1. 23 7 .o4*** 6.01***
Cig. Smoking 0.3767 0.6412 2. 12 3. 60 3.11** 5 .12***
Ischaemic Heart Disease 168 Deaths in 5321 Women
Age 0.1322 — 2. 07 — 8.28*** —
Systolic BP 0.0208 0.0153 1.66 1. 45 7.39*** 5.15***
Diastolic BP 0.0281 0.0215 1. 44 1. 32 5 .10*** 3.82***
BMI 0.0352 0.0192 1. 16 1. 09 2. 14* 1. 14
Serum Choi. 0.0074 0.0051 1. 36 1. 23 4.22*** 2.78**
Blood Glucose 0.0120 0.0110 1. 31 1. 28 7.00*** 6.38***
Cig. Smoking 0.2682 0.5009 1. 71 2. 72 1. 70 3.11**
Stroke 80 Death in 5232 Women
Age o .1510 — 2. 29 — 6.36*** —
Systolic BP o .0190 0.0124 1. 59 1. 35 4.66*** 2.87**
Diastolic BP 0.0388 0.0317 1.66 1. 51 5.13*** 4.07***
BMI -o.0363 -0.0556 0 . 85 0. 79 -1.30 -1. 98*
Serum Choi. -0.0016 -0.0048 0. 93 0. 82 -0.58 -1. 71
Blood Glucose 0.0105 0.0091 1. 27 1. 23 4.32*** 3 .61***
Cig. Smoking 0.7649 1. 02 4.62 7. 68 3 .34*** 4.38***
©Odds ratio computed as the antilogarithm of the original 
coefficients for a change in the risk factor by an amount 
equal to its standard deviation.
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TABLE 5.10.Multiple Logistic Function Analysis of the 10-
1*1 Years Risk of All Causes, CVD, IHD and
Stroke Death Among Men and Women.
Male Female
Variable Logistic SOR@ Z-Test Logistic SOR@ Z-Test 
Coefficient Coefficient
All Causes 968 Death in 
5817
H7&9 Men 
Women
and 66*1 Deaths in
Age 0 .1075 1 . 82 1*1.. 69*** 0.1036 1. 79 1 2 .13***
Systolic BP 0.0065 1.17 2. 9*1** 0.0089 1. 22 5.12***
Diastolic BP 0.0120 1.17 3-15** 0. 00*12 1. 06 1. 00
BMI -0.0173 0. 93 -1. *16 -0.0215 0. 93 -2.12*
Serum Choi. -0.0018 0 . 93 -1.83 -0.0020 0. 93 -1. 93
Blood Glucose 0.0027 1. 07 2. 05* 0.0081 1. 2*1 6.22***
Cig. Smokingf 0.3580 2. 05 9.21*** 0.2850 1. 77 6 # 4.3***
CVD 505 Death in H326> Men and 289 Deaths in1 5*1*12 Women
Age 0.1113 1.86 1 1 . *16*** 0.1*11 2. 20 1 0 . *15***
Systolic BP 0.0099 1. 28 3 . Z19*** 0 . 009 1. 22 2.85**
Diastolic BP 0.0215 1. 33 *1. *10*** 0 . 016 1. 23 2.75**
BMI 0 .0174 1. 08 1. 13 -0.025 0 . 92 1. 72
Serum Choi. 0 . 003*^-1.15-— 2—5*1*- 0.002— -1-.-09 — — 1. 56
Blood Glucose 0.0037 1. 10 2. 32* 0 . 009 1. 27 5.91***
Cig. Smokingf 0.3001 1. 82 5 .90*** 0.397 2. 21 6 .15***
IHD 350 death1 in *1171 men and 168 Deaths in 5321 Women
Age 0. 095 1. 70 g.57*** 0. 116 1. 91 6 .77***
Systolic BP 0. 011 1. 28 3.25** 0. 01*1 1. *11 li. 80***
Diastolic BP 0 . 017 1. 25 3.03** 0.008 1. 11 1. 05
BMI 0 . 016 1. 05 0 . 90 0. 002 1. 01 0 . 09
Serum Choles. 0. 00*1 1. 16 2.79** 0 . 005 1.23 2.70**
Blood Glucose 0 . 003 1. 08 1. 72 — 0.Oil 1.32 5 .92***
Cig. Smokingf 0. 239 1. 16 *1. 05*** 0 . 323 1 . 91 3 .91***
Stroke 79 death in 3900 men and 80 Death In[ 523& Women
Age 0. 1*12 2. 21 5 . 9Z1*** 0.150 2. 31 6. 2*1***
Systolic BP 0.015 1. *10 2. *12* 0. 001 1. 02 0. 2*1
Diastolic BP 0 . 027 1. *11 2. 58* 0. 0*1*1 1.79 5.25***
BMI -0 . 005 0 . 98 -0. 1*1 -0. 08*1 0 . 69 --2.86**
Serum Choles. 0. 001 1. 0*1 0. 2*1 -0. 00*1 0. 8*1 1. 53
Blood Glucose 0 . 005 1. 1*1 1. 52 0. 010 1. 29 3 .96***
Cig. Smokingf 0 . 355 2. 03 2.97** 0. 539 2. 9U Zi. *18***
©The approximate relative risk (standardized odds ratio) 
computed as the antilogarithm of the original coefficients 
for a change in the risk factor by an amount equal to its 
standard deviation.
fThe odds ratio calculated for smokers and non-smokers.
*P<0.05» **P<0.01, ***p<o.001
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TABLE 5* 11 .Missing Group Compared to Study Group, 10-14.
Years All Causes, CVD, IHD and Stroke 
Mortality Rate and Possible CVD Risk Factors.
Missing
Group
Study
Group
95% Cl
MALE
Numbers 2186 4783 —
Mean Age (Yr) 54. 0 5 4.9*** 0 .64-1.18
Age-Adjusted Meansf
SBP (mmHg) 15 1.4*** 147. 7 2 .51-4.89
DBP (mmHg) 8 7.2*** 85.5 1. 02-2.38
Schol.(mg/dl) 219.0 2 2 8.3*** 7.11-11.49
BMI (Kg/m) 26.0*** 25. 7 0 .13-0.47
% Smokers 5 5.6*** 49. 2 3.90-8 .90
10-14 Year Age-Adjusted Overall Mortality Rate©
21.1 (444)* 19-8 (959)
10-14 Years Age-Adjusted CVD Mortality Rate©
12.8 (248)** 11.3 (5 0 2 )
10-14. Years Age-adjusted IHD Mortality Rate©
10.0 (191)** 8.5 (371)
10-14 Years Age-Adjusted Stroke Mortality Rate©
2.4 (40) 1.9 (80)
FEMALE
Numbers 2427 5812 -
Mean Age (Yr) 54.3 55.1*** 0.54-1.18
Age-Adjusted Meansf
SBP (mmHg) 1 5 4.6*** 148. 6 4.77-7.23
DBP (mmHg) 86.4*** 84. 4 1.35-2.65
Schol.(mg/dl) 238.7 250.l*** 8.88-13.92
BMI (Kg/m) 2 6 .2*** 25. 6 0.38-0.82
% Smokers 4 5 .5 *** 40. 7 2 .50-7.10
10-14 Year Age-Adjusted Overall Mortality Rate©
11.1 (289) 10.4 (655)
10-14 Years Age-Adjusted CVD Mortality Rate©
5.5 (133) 4.8 (286)
10-14 Years Age-adjusted IHD Mortality Rate©
3.8 (92)* 3.1 (181)
10-14 Years Age-Adjusted Stroke Mortality Rate©
1.1 (25) 1.4 (80)
£Age-adjusted of means by averaging 5-year age group. 
*P<0.05, **P<0.01, ***P<0.001
©Number of death in Brackets, age-adjusted death rate per
1,000 person year of observation, adjusted by direct 
method by population of Scotland in 1981 for the four five 
year age group and differences tested by Mantel-Haenszel 
Chi-square test.
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TABLE 5«12.Trends of Observed/Expected Ratio of Overall
Causes of Deaths in Renfrew and Paisley,
Scotland by Age and Gender, 1972-86.
Year Age Group
All Ages
5 U - 5 U 55-64 65-7^ 75-84
1972 1. 03 0.71
Male
0. 00 1. 00 0 . 78
1973 0. 80 0. 98 0. 00 1. 00 0 . 82
1974 0. 61 0. 62 0 . 16 1. 00 0 . 56
1975 0. 47 0 . 58 0 . 65 1. 00 0. 58
1976 0.66 0 . 83 0. 54 1. 00 0. 74
1977 1. 10 0 . 65 0 . 70 1. 00 0. 74
1978 0. 81 0. 81 0 . 56 1. 00 0 . 72
1979 1. 32 0. 99 0. 72 1. 00 0 . 91
1980 0 . 63 0. 84 0 . 65 1. 00 0. 73
1981 1. 12 0 . 70 0.64 1. 00 0 . 69
1982 1. 24 0.75 0. 73 2. 08 0. 75
1983 0 . 83 0 . 87 0. 76 0. 54 0. 80
1984 1. 36 0. 88 0. 79 1. 08 0 . 83
1985 0. 00 0. 64 0.66 0. 53 0 . 65
1972-1986_ 0. 84 n . 78 0.69 0.72----- ----0. 74
Mean O/E 
1977-86 1. 05 0. 79 0 . 69
v • f *— 
1. 02 0. 76
1972 0 . 30 0 . 30
Female
0. 00 1. 00 0. 28
1973 0 . 96 0. 66 0. 00 1. 00 0 . 65
1974 0 . 71 0. 74 0. 64 1. 00 0 . 72
1975 0. 44 0. 44 0 . 51 1. 00 0 . 45
1976 0 . 50 0. 62 0. 80 1. 00 0. 63
1977 0. 89 0 . 85 0. 55 1. 00 0 . 76
1978 1. 22 0 . 65 0. 57 1. 00 0. 69
1979 1. 21 0 . 83 0 . 56 1. 00 0. 74
1980 1. 16 0. 69 0 . 71 1. 00 0. 73
1981 0. 77 0. 85 0 . 63 1. 00 0 . 72
1982 0. 88 0 . 52 0. 68 0. 00 0. 62
1983 0. 62 0 . 63 0. 66 0 . 55 0. 64
1984 1. 91 0. 82 0 . 85 0 . 27 0 . 81
1985 0. 00 0. 74 0. 75 0. 40 0.71
1972-1986 0. 82 0 . 70 0. 68 0 . 38 0 . 69
Mean O/E 
1977-86 1. 08 0.73 0.66 0 . 69 0 . 71
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TABLE 5-13.Trends of Observed/Expected Ratio of Ischaemic
Heart Disease Deaths in Renfrew and Paisley,
Scotland by Age and Gender, 1972-86.
Year Age Group
All Ages
54-54 55-64 65-74 75-84
1972 1. 52 1. 48
Male
0. 00 1. 00 1. 44
1973 0 . 83 0 . 83 0. 00 1. 00 0. 74
1974 1. 09 0.75 0. 00 1. 00 0 . 76
1975 0. 57 0 . 43 0 . 61 1. 00 0 . 49
1976 0 . 69 1. 06 0. 42 1. 00 0. 86
1977 1. 27 0. 64 0 . 85 1. 00 0. 79
1978 0.79 0.92 0. 68 1. 00 0. 82
1979 1. 79 0.93 0. 79 1. 00 0 . 96
1980 0 . 80 0.90 0. 49 1. 00 0 . 70
1981 2. 00 0 . 72 0 . 76 1. 00 0.81
1982 0 . 52 0 . 71 0. 74 0 . 49 0. 73
1983 0. 97 0 . 95 0 . 69 0. 00 0.79
1984 3.29 0 . 90 0.76 0 . 45 0. 81
1985 0. 00 0 . 61 0. 67 0. 62 0.65
1972- 1986 1. 03 0. 81 0 . 69 0 . 59 0. 78
Mean
1977-
O/E
86 1. 27 0. 81 0 . 71 0. 79 0 . 78
1972 0.00 0. 61
Female
0. 00 1. 00 0. 44
1973 0. 00 0. 00 0. 00 1. 00 0. 00
1974 0. 68 1. 28 2. 16 1. 00 1.33
1975 0. 00 0.29 0. 33 1. 00 0 . 25
1976 0. 71 1. 25 0. 55 1. 00 1. 00
1977 1. 20 0.71 0. 54 1. 00 0.70
1978 1. 10 0. 61 0.70 1. 00 0.68
1979 0 . 63 0. 84 0. 57 1. 00 0. 68
1980 0. 00 0 . 62 0 . 72 1. 00 0.65
1981 3. 85 0.88 0. 94 1. 00 0 . 98
1982 1. 77 0 . 56 0. 54 0. 00 0 . 56
1983 4. 44 0. 84 0 . 63 1. 01 0 . 72
1984 0. 00 0. 67 0. 82 0 . 47 0 . 76
1985 0. 00 0 . 90 0 . 83 0. 20 0 . 78
1972-■1986 0.84 0. 75 0.72 0 . 36 0.73
Mean
1977-
O/E
■86 1. 44 0. 74 0 . 70 0. 74 0.72
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TABLE 6.1.Diabetes at Baseline and 10-14 Years Age, 
Gender Adjusted Mortality Rate by Cause, in 
Men and Women.
Diabetes
Status
Male Female
Mortality Relative 
Rateg Risk
Male/Female
Relative
Mortality Relative Risk 
Rateg Risk
All Causes
Diabetics 19.6
Non-diabetics 19*8 
All 19-8
(15) 0.99 
(945) -
(960) -
35. 3 
10. 1 
10. 4
(24)*
(631)
(635)
3. 49 0. 55
1. 96 
1. 90
Cardiovascular Disease
Diabetics 14.1 (10) 1.25
Non-diabetics 11.2 (492) -
All 11.3 (502)
23-6 (14)** 5-13 0.60
4.6 (272) - 2.43
4.8 (286) - 2.35
Ischaemic Heart Disease
Diabetics 12.7
Non-diabetics 8.4 
All 8.5
(8) 1.51 14.0 (7) ** 4.67 0.91
(362) - 3.0 (174) - 2.80
(370) - 3.1 (181) - 2.74
Stroke
Diabetics 
Non-diabetics 
All
1.6 (1) 0.8 14.1 (7) **10.84 0.11
2.0 (79) - 1.3 (73) - 1.54
1.9 (8 0 ) - 1.4 (80) - 1.36
gRate per 1000 person year of observation, adjusted by 
Scotland population 1981 for the four 5-year age group.
The number of deaths are shown in brackets.
Mantel-Haenszel Test: *P<0.01, **P<0.001
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FIGURE 6.1.The Distribution of Casual Blood Glucose 
in Men and Women.
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Table 6.2.Mean Values, Their Standard Deviations, Range
and Simple Correlation Coefficients with
Glucose at Baseline for 10410 Men and Women.
Variable Mean and Standard Range Simple r
Deviation with Blood
___________________  ___________________  Glucose®
Male Female Total Male Female Total
Age (Yr) 55-0 55.0 55-0 45-65 45-65 45-65 0.0614***
(5-6X5.6)(5.6)
Blood Glucose92.4 90.6 91.4 40-518 41-511 40-518 1.0000
(mg/dl) (24.5)(21.1)(22.7)
Body Mass 25-7 25.6 25-7 14-48 14-68 14-68 0.0703***
Index (3.4) (4.4) (4.0)
Systolic BP 147.4 148.6 148.1 88-249 80-270 80-270 0.1217***
(mmHg) (22.4)(22.9)(23.8) _______________________
Diastolic BP 85-5 84.5 84.9 25-155 44-151 25-155 0.0334*** 
(mmHg) (13.1)(13-2)(13-2)
Serum Choi. 228.3 250.2 240.3 95-463 73-463 73-463 -0.0297*** 
(mmHg) (37-3)(42.1)(41.4)
@The simple correlation for both genders combined and 
separately was similar.
***p<o.001
-The standard deviations are shown in brackets.
This table exclude known diabetics.
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TABLE 6.3-Casual Blood Glucose Level According to Age and 
Gender.
Age (Yr) Number Blood Glucose (mg/dl)
Male Female Male Female
Mean SD Mean SD
u.5-119 1167 1355 90. 6 23. 2 _88.1 1 7 . 0
50-54 1278 1536 92.3 22. 2 8 9. 4 20. 8
55-59 1153 1434 93. 1 28. 0 91. 8 22. 3
60-64 1098 1389 93. 7 24. 5 93- 0 23. 4
Total 4696 5714 92. 4 24. 5 90. 6 21. 1
Differences is statistically significant Male: F=3.5
P<0.01, Linearity F=9-9. PC0.001 Female: F=15.4 P<0.0001,
Linearity F=45-2, PC0.0001.
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TABLE 6.4.Smoking Status at Baseline.
Smoking
Categories
Number (%) Casual Blood Glucose 
Mean and Standard 
Deviation
Male Female Total Male Female Total
Never
Smokers
994 
(21.2)
2872 
(50.3)
3866 
(37.1)
94. 5 
(27.3)
91.7 
(21.4)
92. 4 
(23.1)
Ex-smoker 1381 503 1884 93.2 91. 1 92 . 6__
(2 9 .4) (8.8) (18.1) (25.1) (2 7 .0 ) (25.6)
Current
Smokers
2321 
(49.4)
2339 
(40.9)
4660 
(44.8)
91. 1 
(22.9)
8 9 . 1 
(19.2)
90. 1 
(21.2)
<9 cig­
arette/day
309 
(13.3)
606 915 
(25.9)(19.7)
92. 3 
(27.7)
88. 2 
(1 6 .6 )
89.6 
(21.1)
10-19 Cig­
arette/day
1347
(58.1)
1516
(64.9)
2663 
(6 1 .5)
91. 2 
(23.4)
8 9 . 3 
(20.1)
90. 2 
(21.8)
.^20 Cig­
arette/day
662 
(28.5)
214
(9.2)
876 90.4 
(18.8)(19.2)
89. 5 
(19.0 )
90. 2 
(19.1)
All 4696 
(45.1)
5714 
(54.9)
10410
(100)
92. 3 
(24.5)
90. 5 
(21.1)
91- 3 
(22.7)
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TABLE 6.5.Smoking Habits by Quintiles and percentile 
Casual Blood Glucose In Men and Women.
of
Quintiles 
of Blood 
Glucose
Blood 
Glucose 
Ranee 
(mg/dl)
Number Prevalence Rate® (No.)
Current
Smokers
Never
Smokers
Ex­
smokers
Male
1 40-76 991 53.3**(5 2 9 ) 18.1**(178) 60.9(277)
2 77-85 1036 51. 2 (532) 20. 1 (206) 58.7(294)
3 86-94 773 49. 5 (382) 20. 1 (155) 60.1(234)
4 95-103 883 46. 9 (414) 23. 3 (205) 56.1(262)
5 104-518 1013 46. 1 (464) 23.1 (233) 57.9(314)
Highest 5% 130-518 280 44. 2* (122) 23. 3 (65) 59.1(94)
Lowest 5% 40-65 315 52. 6 (165) 20. 0 (58) 60.0(87)
Highest 2% 148-518 111 43. 5 (47) 28. 0 (32) 50.0(32)
Lowest 2% 40-59 154 48. 8 (75) 24. 6 (38) 51.9(41)
All 40-518 4696 49-4(2321) 21.4 (994) 29-4(1381)
Female
1 41-77 1143 44. 7* (514) 46.5**(524) 15.6(97)
2 78-85 1451 41. 7 (606) 48. 5 (698) 16.8(140)
3 86-92 1075 43. 3 (465) 48.8 (521) 13.3(80)
4 93-102 1025 38. 7 (393) 52. 1 (530) 14.4(89)
5 103-511 1020 37.5 (361) 52. 8 (551) 15.0(97)
Highest 5% 122-511 218 42.5***(82) 50. 9 (115) 12.9(17)
Lowest 5% 41-67 313 48. 7 (153) 42. 9 (133) 15.8(25)
Highest 2% 139-511 88 45. 3 (35) 49. 7* (48) 9.4(5)
Lowest 2% 41-61 114 53.6 (61) 37.0 (42) 20.7(11)
All 41-511 5714 40. 9 (2339) 50. 3 (2872) 8.8(503)
©Prevalence rate per 100 person, adjusted by Scotland 
population of 1981 of the four 5 year age groups.
This table excludes known diabetics.
Mantel-Haenszel chi-square Test: *P<0.05, *#P<0.01,
jtc**p<0.001 (bottom quintile, 5% and 2% compared with the 
corresponding upper quintile, 5% and 2%) .
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TABLE 6.6.Quintile, Highest and Lowest 5 and 2 Percent of 
Casual Blood Glucose Value and 10 to 14 Years 
Age-adjusted Mortality by Cause and Gender.
Quintile No. of 10-14 Year Age-adjusted Mortality Rate©
of Blood Subjects _______________ _____________________________
Glucose at Base- All Causes CVD IHD Stroke
line
No. Rate No. Rate No. Rate No. Rate
Male
1 991 203 21. 1 104 11. 8 79 9.2 18 2.3
2 1036 186 18. 1 98 10. 4 69 7-5 18 2. 0
3 773 170 21. 8 83 11. 7 66 9-5 12 1.8
4 883 171 18. 2 92 10. 5 64 7. 4 13 1.6
5 1013 213 20. 2 114 11. 8 83 8.9 18 2. 0
Highest 5% 280 65 22. 2 39 14.4** 34 12.6** 3 1. 4
Lowest 5% 315 55 18. 0 20 7.3 15 5-6 4 1.6
Highest 2% 111 29 25- 1 22 19.8** 18 16. 6* 3 3. 4
Lowest 2% 154 31 21. 0 10 7. 7 9 _7.0 1 0.-8-
All 4696 943 19. 8 491 11. 2 361 8.4 79 2. 0
Female
1 1143 123 10. 8 52 4.8 30 2. 8 16 1. 5
2 1451 126 8. 1 58 3. 9 36 2. 4 15 1. 1
3 1075 120 10. 2 50 4. 5 33 3. 0 15 1.4
4 1025 122 10. 4 48 4.3 27 2. 4 16 1. 4
5 1020 140 11. 9 64 5. 5 48 4. 1 11 1. 0
Highest 5% 218 40 15. 1 18 6.8 12 4.8 5 1.9
Lowest 5% 313 31 9. 9 13 4. 5 7 2. 5 6 2.2
Highest 2% 88 21 21.7* 13 12.6** 9 9.6 4 3.5
Lowest 2% 114 11 9- 7 5 4.8 4 3.7 1 1. 1
All 5714 631 10. 1 272 4.6 174 3. 0 73 1.3
Difference between quintile and percentile of blood 
glucose, Mantel-Haenszel chi-square Test:*P<0.05.
**P<0.01, ***p<o.001.
Missing Cases=2
This table excludes known diabetics.
©Adjusted death rate per 1,000 person year of observation, 
adjusted by direct method to population of Scotland in 
1981 for the four 5-year age groups.
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TABLE 6.7.Univariate Analysis* Dichotomization of Baseline
Variables and 10 to 14 Year Age, Gender Adjusted
Mortality by Cause, in Men and Women.
Variable No. of 10-14 Year Age-Adjusted 
Subjects
Mortality Rate©
Male Female
Male Female No. Death RR 
of Rate 
Death
No. Death RR 
of Rate 
Death
All Causes
Blood <126 4417 5500 880 19. 7 _ 591 9. 9 _
Glucose £126 277 214 63 21. 8 1.11 40 15. 1 1. 55
Systolic<l60 3534 4115 615 17. 6 - 380 9.0 -
BP £160 1160 1599 328 25. 4 1. 44 251 12. 5 1. 39
Diastolic<95 3739 4643 709 18. 7 - 463 9.4 -
BP £95 955 1070 234 23. 9 1. 28 167 12. 5 1. 33
Serum <250 3420 2926 715 20. 0 - 321 10. 7 -
Choi. £250 1274 2788 228 19. 4 0. 97 310 9.7 0. 91
BMI <27 3116 3891 643 20. 4 - 407 9. 9 -
£27 1578 1823 300 18. 7 0. 92 224 10. 4 1. 05
Use of No 2374 3375 373 14. 7 - 324 8.2 -
Cigaret. yes 2320 2339 570 25. 5 1.73 307 13. 2 1. 61
All 4694 5714 943 19. 8 - 631 10. 1 -
Cardiovascular Causes
Blood <126 3991 5153 454 11. 1 _ 254 4.4 _
Glucose >126 251 202 37 13. 9 1. 25 18 6.8 1. 57
Systolic<l60 3215 3876 292 9-0 - 141 3.6 -
BP £160 1031 1479 199 16. 7 1. 85 131 6. 5 1. 80
Diastolic<95 3367 4354 337 9.7 - 174 3.7 -
BP £95 875 1000 154 16. 9 1. 74 97 7.3 1. 97
Serum <250 3053 2722 348 10. 6 - 117 4.4 -
.-Choi. £250 1189 2633 143 12. 9 1. 21 155 4.9 1.11
BMI <27 2775 3652 302 10. 6 - 168 4. 3 -
>27 1467 1703 189 12. 5 1.18 104 4.8 1. 12
Use of No 2219 3185 218 9. 1 - 134 3. 4 -
Cigaret. Yes 2023 2170 273 13. 8 1. 51 138 6. 4 1. 88
All 4242 5355 491 11.2 - 272 4.6 -
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TABLE 6.7.Continued
Variable No. of 10-14 Year Age-Adiusted Mortality Rate©
Subjects _________________________________________
Male Female
Male Female No. Death RR No. Death RR
of Rate of Rate
Death Death
Ischaemic Heart Disease
Blood <126 3866 5071 329 8. 2 - 162 2.9 -
Glucose >126 246 186 32 12.1 1. 47 12 4. 8 1 . 69
Systolic<l60 31^3 3825 224 6.9 - 90 2. 3 -
BP £160 969 1432 137 12. 2 1. 77 84 4. 2 1 . 83
Diastolic<95 3283 4294 253 7. 4 - 114 2. 4 -
BP >95 829 963 108 12. 4 1 . 67 60 4. 8 2. 0
Serum <250 2953 2677 248 7. 8 - 72 2. 6 -
Choi. >250 1159 2580 113 10. 3 1. 32 102 3. 3 1. 27
BMI <27 2692 3583 219 7. 8 - 99 2. 6 -
BMI £27 1420 1674 142 9. 7 1. 24 75 3- 6 1. 38
Use of No 2168 3142 167 7- 1 - 91 2.3 -
Cigarette Yes 1944 2115 194 10. 1 1. 42 83 3. 8 1. 65
All 4112 5257 361 8. 4 - 174 3.0 -
Cerebrovascular Causes
Blood <126 3613 4977 76 2. 0 _ 68 1. 2 —
Glucose >126 217 179 3 1. 4 0 . 70 5 1.9 1. 58
Systolic<l60 2959 3776 40 1.3 - 41 1. 1 -
BP £160 871 1380 39 3. 7 2. 85 32 1.7 1. 5&
Diastolic<95 3078 4224 48 1.5 - 44 1. 0 -
BP £95 752 931 31 3. 9 2. 60 28 2. 2 2. 20
Serum <250 2768 2640 63 1. 8 - 35 1.3 -
Choi. £250 1062 251^ 16 2. 1 1. 17 38 1.2 0 . 92
BMI <27 2522 3538 49 1.9 - 54 1.3 -
£27 1308 1618 30 2. 1 1. 10 19 0.9 0 . 69
Use of No 2034 3078 33 1. 5 - 27 0. 7 -
Cigarette Yes 1796 2078 46 2.5 1. 67 46 2.3 2. 28
All 3830 5156 79 2. 0 _ 73 1. 3 —
Units as in Table 6.2.
©Death rate per 1,000 person years of observation, age 
adjusted by direct method to 1981 Scotland population for 
the four 5-year age groups.
Missing cases=2
Known diabetics excluded.
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TABLE 6-8.Ten to Fourteen Year Age, Adjusted Overall 
Mortality Rates by Degree of Casual Blood 
Glucose Concentration and Risk Factors Status 
in Men and Women.
Risk Factors Normoglycaemic
Groups
Asymptomatic
Hyperglycaemic
Group
Hyper­
glycaemic
Normo­
glycaemic
Mortality RR 
Rate per (b/a) 
1,OOOf
Mortality 
Rate per 
1,000£
RR
(b/a)
Mortality
Rate
Ratio
(a)S.Choi. <250 20. 0 (669)
Male
1. 0 21. 3 {k6) 1. 1 1. 1
(b)S.Choi. £250 19. 2 (211) - 23- 2 (17) - 1. 2
(a)SBP <160 17. 5 (573) 1. k 18. 5 (36) 1.7 1. 0
(b)SBP £160 25. 2 (301) - 30. 7 (27) - 1. 2
(a)DBP <95 1 8. 7 {66k) 1.3 20. 3 (k5) 1. k 1. 1
(b)DBP £95 23. 7 (216) - 29- 1 (18) - 1.2
(a)BMI <27 20. k (606) 0.9 21. 0 (37) 1. 1 1. 0
(b)BMI >27 1 8 . k (27*0 - 22. 2 (26) - 1.2
(a)Non-Smoker Ik. 6 (3^5) 1.7 17.0 (28) 1.7 1.2
(b)Smoker 25. 4 (535) — 29. 2 (35) — 1. 0
(a)S.Choi. <250 10. k (298)
Female
0.9 16.6 (23) 0.9 1.6
(b)S.Choi. £2 50 9. 5 (293) - 15. 4 (17) - 1.6
(a )SBP <160 8. 8 (361) l.k 13. 6 (19) 1. k 1.5
(b)SBP £160 12. 0 (230) - 19. 8 (21) - 1.6
(a)DBP <95 9. 2 (k3k) .1.3 Ik. 8 (29) 1. 2 1.6
(b)DBP £95 12. 3 (156) - 17. 6 (11) - 1. k
(a )BMI <27 9- 8 (385) 1. 0 13. 9 (22) 1.2 1. k
(b )BMI £27 10. 0 (206) - 16. 8 (18) - 1 . 7
(a)Non-Smoker 7.8 (296) 1.7 15.9 (28) 0. 8 2.0
(b)Smoker 13. 1 (295) — 13- 6 (12) — 1.0
Units as in Table 6.2.
Known diabetics excluded.
£Death rate per 1,000 person year of observation age- 
adjusted to 1981 Scottish population; numbers in 
parenthesis refer to number of deaths.
Asymptomatic hyperglycaemia defined as upper 5% of casual 
blood glucose distribution.
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TABLE 6.9-Ten to Fourteen Year Age, Adjusted Cardiovascu­
lar Mortality Rates by Degree of Casual Blood 
Glucose Concentration and Risk Factors Status in 
Men and Women.
Risk Factors Normoglycaemic
Groups
Mortality RR 
Rate per (b/a) 
1,OOOf
Male
a)S.Choi.<250 10.5 (322) 1.2 13.1 (26) 1.3 1.2
b)S.Choi. £250 12.8 (132) - 16-9 (11) - 1*3
a)SBP <160 8.8 (271) 1.9 11.4 (21) 1.5 1-3
b ) SBP >160 16.6 (183) - 16.9 (1 6 ) - 1. 0
a ) DBP <95 9.5 (311) 1. 8 12.9 (26) 1. 4 1-3
b ) DBP £95 16.7 (1^3) - 18.2 (11) - 1. 1
a) BMI <27 10.5 (284) 1. 2 11.3 (18) 1.5 1. 1
b ) BMI >27 12.2 (170) - 17.1 (19) - 1. 4
a )Non-Smoker 8.9 (200) 1- 5 11.4 (1 8 ) 1.5 1- 3
b )Smoker 13.6 (254) - 17.4 (19) - 1-3
Female
a)S.Choi. <250 4.0 (107) 1. 2 7-7 (1 0 ) 0. 8 1-9
b)S.Choi. >250 4.9 (147) - 6.0 (8) - 1. 2
a ) SBP <160 3.5 (133) 1. 8 5.6 (8) 1.5 1.6
b )SBP >160 6.3 (1 2 1) - 8.7 (1 0 ) - 1. 4
a) DBP <95 3.6 (163) 2. 0 5.8 (11) 2. 1 1.6
b ) DBP £95 7.2 (90) - 12.5 (7) - 1-7
a) BMI <27 4.3 (159) 1. 1 5.6 (9) 1.5 1-3
b ) BMI £27 4.7 (95) - 8.3 (9) - 1. 8
a )Non-Smoker 3.3 (123) 1.9 6.4 (11) 1.3 1-9
b )Smoker 6.2 (131) — 8.3 (7) — 1-3
Units as in Table 6.2.
Known diabetics excluded.
fDeath rate per 1,000 person year of observation, age- 
adjusted to 1981 Scottish population; numbers in 
parenthesis refer to number of deaths.
Asymptomatic hyperglycaemia defined as upper 5% of casual 
blood glucose distribution.
Asymptomatic
Hyperglycaemic
Group
Mortality 
Rate per 
1,OOOf
Hyper­
glycaemic
Normo­
glycaemic
MortalityRR
(b/a) Rate 
Ratio
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TABLE 6.10.Ten to Fourteen Year Age, Adjusted Ischaemic
Heart Disease Mortality Rates by Degree of
Casual Blood Glucose Concentration and Risk
Factors Status in Men and Women.
Risk Factors Normoglycaemic Asymptomatic Hyper-
Groups Hyperglycaemic glycaemic/
Group Normo-
_________________ _________________ glycaemic
Mortality RR Mortality RR Rate 
Rate per (b/a) Rate per (b/a) Ratio 
1,000£ 1,000£
(a)S.Choi. <250 7.6
(b)S.Choi. £250 10. 3
(a )SBP <160 6.8
(b)SBP >160 12. 0
(a )DBP <95 7-2
(b)DBP £95 12. 0
(a )BMI <27 6.1
(b)BMI £27 11. 8
(a)Non-Smoker 6.9
(b )Smoker 9- 8
(226)
Male
1.3 11.1
(103) - 15- 6
(206) 1.8 9-9
(123) - 15- 4
(231) 1-7 11. 5
(98) - 15-2
(165) 1-9 10. 8
(164) - 14. 1
(151) 1. 4 10. 2
(178) - 14. 7
(22) 1. 4 1-5
(10) - 1- 5
(1 8 ) 1-5 1. 4
(14) - 1-3
(23) 1-3 1.6
(9) - 1- 3
(17) 1-3 1. 8
(15) - 1.2
(16) 1. 4 1-5
(1 6 ) — 1-5
a)S.Choi. <250 2. 8 (74)
Female
1.1 4. 0 (5) 1-5 1. 4
b)S.Choi. £250 3- 0 (88) - 5- 9 (7) - 2. 0
a) SBP <160 2. 0 (76) 2. 4 3- 0 (4) 2. 4 1-5
b ) SBP £160 4.8 (86) - 7-1 (8) - 1- 5
a) DBP <95 2. 1 (93) 2.8 4.9 (9) 1-7 2.3
b)DBP £95 6.0 (69) - 8. 3 (3) - 1. 4
a) BMI <27 2.5 (93) 1. 4 3-9 (6) 1-5 1.6
b)BMI £27 3- 5 (69) - 5- 7 (6) - 1.6
a)Non-Smoker 2.3 (78) 1.6 4. 4 (7) 1. 4 1-9
b )Smoker 3-7 (84) - 6. 0 (5) - 1. 6
Units as in Table 6.2.
Known diabetics excluded.
£Death rate per 1,000 person year of observation age- 
adjusted to 1981 Scottish population; numbers in 
parenthesis refer to number of deaths.
Asymptomatic hyperglycaemia defined as upper 5 % of casual 
blood glucose distribution.
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TABLE 6.11.Ten to Fourteen Year Age, Adjusted Cerebrovas­
cular Disease Mortality Rates by Degree of 
Casual Blood Glucose Concentration and Risk 
Factor Status in Men and Women.
Risk Factors Normoglycaemic Asymptomatic Hyper­
Groups Hyperglycaemic glycaemic/
Group Normo­
glycaemic
Mortality RR Mortality RR Rate
Rate per (b/a) Rate per (b/a) Ratio
lOOOf lOOOf
(a)S.Choi.<250 2. 1 (60)
Male
0. 9 1. 8 (3) 0 0. 8
(b)S.Choi.£250 1.9 (1 6 ) - 0. 0 (0) - -
(a)SBP <160 1.3 (38) 2.9 1.3 (2) 0.7 1. 0
(b)SBP >160 3.8 (38) - 0. 9 (1) - 0. 2
(a )DBP <95 1.6 (47) 2. 4 0.7 (1) 6. 1 0. 4
(b)DBP £95 3. 8 (29) - 4. 3 (2) - 1. 1
(a)BMI <27 1.9 (48) 1. 2 0. 6 (1) 4. 0 0. 3
(b)BMI £27 2. 2 (28) - 2. 4 (2) - 1. 1
(a )Non-Smoker 1.6 (32) 1.6 0. 6 (1) 3.7 0. 4
(b)Smoker 2. 6 (44) _ 2.2 (2) - _ 0.8------------
(a)S.Choi.<250 1. 2 (32)
Female
1.1 1.5 (2) 1.5 1. 2
(b )S.Choi.£250 1.3 (36) - 2.3 (3) - 1. 8
(a )SBP <160 1.0 (38) 1. 6 1.3 (2) 2. 0 1.3
(b)SBP £160 1.6 (30) - 2. 6 (3) - 1.6
(a)DBP <95 0. 9 (42) 2. 3 0. 6 (1) 8.3 0. 6
(b)DBP £95 2. 1 (25) - 5. 0 (4) - 2.4
(a )BMI <27 1. 4 (51) 0. 6 2. 0 (3) 0. 9 1. 4
(b)BMI £27 0. 8 (17) - 1.9 (2) - 2.4
(a)Non-Smoker 0. 7 (24) 3- 1 1.7 (3) 1.6 2. 4
(b)Smoker 2.2 (44) — 2.8 (2) — 1.3
Units as in Table 6.2 0
Known diabetics excluded.
£Death rate per 1,000 person year of observation age- 
adjusted to 1981 Scottish population;- numbers in 
parenthesis refer to number of deaths.
Asymptomatic hyperglycaemia defined as upper 5 % of casual 
blood glucose distribution.
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Table 6.12.Upper 5 % of Blood Glucose Distribution, 10-14 
Years All Causes, CVD, IHD and Stroke
Mortality Rate and Possible CVD Risk Factors 
by Gender.
Normoglycaemic Hyperglycaemic
Group$ Group$
Male Female Male Female
Numbers 4419 5500 277 214
Mean Age (Yr) 54.8 55-0 55- 4 56.3***
Age Addusted Means§
Blood Glucose 88. 4 88.0 155.1*** 14 5.0***
Systolic BP 147- 2 148. 3 152.7*** 153-8***
Diastolic BP 85- 4 84. 4 85. 5 83- 9
S.Cholest. 228. 4 250. 3 226.1 246. 2
BMI 25-7 25-5 26. 1* 25- 8
% Current Smokers 49- 8 41.1 43- 7 37- 4
10-1 4 Years Age-addusted Overall Mortality Rate
19-7(880) 9-9(591) 21.8(63) 15-4(40)
10-14 Years Age-addusted CVD Mortality Rate
11.1(454) 4.4(244) 13-9(37) 6.9(28)
10-14 Years Age-addusted IHD Mortality Rate
8.2(329) 2.9(162) 12.1(32) 4.9(12)
10-14 Years Age-addusted Stroke Mortality Rate
2.0(76) 1.2(68) 1.4(3) 1-9(5)
@Age addusted of means by averaging 5-year age group.
*** P<0.001 *P<0.05 
Number of death in brackets, age addusted death rate per
1,000 person year of observation, addusted by direct 
method to population of Scotland in 1981 for the four 5- 
year age groups.
The table excluded known diabetics.
$Hyperglycaemics:upper 5% distribution of casual blood 
glucose value, ^126 mg/dl; normoglycaemics: casual blood
glucose value <126 mg/dl.
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TABLE 6.13*Multiple Logistic Analysis of the Relationship 
Between Eight Variables and 10-14 Year 
Mortality by Cause.
Variable' Logistic Odds Z-Test Non Event Event
Coefficient Ratio© ___________  ________ _
Mean SD Mean SD
All Causes 1582 Deaths in 10472 Men and Women
Blood Glucose 0. 006 1. 09 3.8*** 90.9 21. 0 94. 3 30.7
Gender 0.336 1. 96 11.1*** - - - -
Age 0. 104 1.79 18.6*** 54. 5 5- 5 57. 5 5.1
Systolic BP 0. 007 1. 18 ll. 6*** 146. 9 23. 2 154. 6 26. 0
Diastolic BP 0. 009 1. 13 3. 1** 84. 5 12. 9 87. 2 14. 3
BMI -0.022 0 . 92 2. 8** 25. 7 3.9 25- 5 4.1
Serum Choles. -0.002 0 . 92 2. 2* 241. 3 41. 1 235. 5 43. 2
Smoking Habit 0. 315 1. 88 10.6*** - - - -
Cardiovascular Disease 769 Deaths in 9652 Men and Women
Blood Glucose 0 . 005 1. 12 tl. 1*** 90.9 21. 0 96. 1 37. 3
Gender 0. 514 2.79 11.9*** - - - -
Age 0. 118 1. 94 111. 9*** 54. 5 5. 5 57.9 4.9
Systolic BP 0. 010 1. 27 ll. 5*** 146. 9 23. 2 159- 6 26.1
Diastolic BP , 0. 020 1. 30 5# 2*** 84. 5 12. 9 9 0 . 4 14. 1
BMI -0.006_ 0.9 8 _  0.6 25. 7 3.9 — 26.1 — 4.1
Serum Choles. 0 . 003 1. 13 3. 2** 241. 3 41. 1 242. 3 43. 2
Smoking Habit 0. 342 1. 98 8. &*** - - - -
Ischaemic Heart Disease 502 Deaths in 9385 Men and Women
Blood Glucose 0. 006 1. 14 llm0*** 9 0 . 9 21. 0 96. 2 35. 6
Gender 0. 616 3. 42 1 1 .5*** - - - -
Age 0 . 099 1. 72 10.6 * * * 54. 5 5. 5 57* 5 5. 0
Systolic BP 0. 011 1. 29 H .2*** 146. 9 23- 2 158. 7 25. 6
Diastolic BP 0 . 015 1. 21 3. 2** 84. 5 12. 9 8 9 . 8 13. 6
BMI 0 . 005 1. 02 0. 4 25.7 3. 9 26. 3 4. 2
Serum Choles. 0 . 005 1. 23 ll m 0*** 241. 3 41. 1 243* 8 43. 2
Smoking Habit 0.276 1. 74 5 .7$** - - - -
Stroke 151 Deaths in 9034 Men and Women
Blood Glucose 0 . 007 1. 16 2. 9** 90.9 21. 0 96. 6 48. 4
Gender 0. 184 1. 94 2.2* - - - -
Age 0.150 2. 28 8.7*** 54. 5 5- 5 58. 6 4.7
Systolic BP 0 . 007 1. 18 1.7 146. 9 23. 2 161. 6 27. 7
Diastolic BP 0. 046 1. 82 7 .9*** 84. 5 12. 9 92. 3 1 6. 4
BMI -0.055 0. 81 2. 4* 25.7 3. 9 25. 5 3. 9
Serum Choles. 0. 001 1. 04 0. 5 241. 3 41. 1 239- 8 44. 0
Smoking Habit 0 . 472 2. 57 5 .5*** - - - -
Units as in Table 6.2.
This table excludes known diabetics and cases with 
incomplete data.
Logistic coefficient estimated via maximum likelihood.
©The approximate relative risk (odds ratio) for a change 
in the risk factor by an amount equal to its standard 
deviation.
Abbreviation:BP=Blood Pressure, Choles.^cholesterol. 
***p<o.0001 **P<0.01 *P<0.05
294
MAPS, FIGURES AND TABLES
TABLE 6.14.Multiple Logistic Analysis of the Relationship 
Between Eight Variables and 10-14 Year 
Mortality by Cause, and Normoglycaemic and 
Hyperglycaemic group.
Normoglycaemic Group Hyperglycaemic Group
Variable*: Logistic Odds Z-Test Logistic Odds Z-Test
Coefficient; Ratio§ Coefficient Ratio§
All Causes 1479 Death in 9942 All Causes 110 Death in
Men and Women 530 Men and Women
Blood Glucose 0.0024 1. 03 1.2 0.0060 1 . 32 2 . 9**
Gender 0.3506 2 . 02 1 1 .7*** 0.1487 1. 35 1.3
Age 0.1046 1 . 80 1 8 . 2 * * *  0.0901 1 . 65 4 #1***
Systolic BP 0 .0074 1 . 19 4 .5*** 0.0106 1 . 30 2 . 3*
Diastolic BP 0.0090 1 . 12 3 .0** 0.0012 1 . 02 0 . 1
BMI •0 . 0205 0 . 92 -2.5** -0.0354 0 . 86 -1 . 2
Serum Choles.-•0 . 0016 0 . 94 -2 .1* -0.0019 0 . 92 -0.7
Smoking Habit 0 .3185 1. 89 10.4*** 0.2617 1 . 69 2 . 5*
CVD 711 Death in 9174 Men CVD 58 Death in 478 Men and
and Women Women
Blood Glucose 0.0024 1 . 03 0.8 0.0087 1 . 52 3.8***
Gender 0 .5263 2 . 86 1 1 .7*** 0.3437 1.99 2 .1*
Age 0.1176 1 . 91 14.4*** 0.1261 2 . 03 4.2***
Systolic BP 0 .0105 1 . 28 4.7*** 0.0094 1 . 26__ 1.3
Diastolic BP 0 .0187 1 . 28 4.7*** 0.0294 1 . 48 2 . 6**
BMI -O.0074 0 . 97 -0.7 0.0100 1 . 04 0 . 3
Serum Choles. 0.0032 1 . 14 3.1** 0.0023 1 . 10 0 . 6
Smoking Habit 0 .3363 1 . 96 8 .0*** 0.3335 1 . 94 2 . 1*
IHD 457 Death in 8920 Men IHD 45 Death in 465 Men
and Women ' and Women
Blood Glucose 0 .0029 1 . 04 0.8 0.0078 1 . 41 3 . 0**
Gender 0 .6246 3. 49 H .  2*** 0. 4366 2. 39 2 . 4*
Age 0 .0994 1. 73 10.3*** 0.0966 1 . 72 3 .0***
Systolic BP 0 .0105 1 . 28 3 .8*** 0.0176 1. 55 2 . 7**
Diastolic BP 0 .0159 1 . 23 3.3** 0.0074 1.10 0 . 4
BMI 0.0044 1 . 02 0.3 0.0078 1 . 03 0 . 2
Serum Choles. 0.0046 1 . 21 3.7*** 0.0051 1 . 23 1.2
Smoking Habit 0.2632 1 . 69 5.2*** 0.3568 2 . 04 2 . 1*
Stroke 143 Death in 8606 Stroke 8 Deaths in 428 Men
Men and Women and Women
Blood Glucose -0.0016 0 . 98 0.3 0.0175 2 . 17 3 .8***
Gender 0 .2323 1. 59 2.7** -0.4986 0. 39 -1.0
Age 0.1390 2 . 15 7.8*** 0.3256 6 . 40 2 . 5**
Systolic BP 0 .0107 1 . 28 2 .2* -0.0081 0 . 81 -0 . 4
Diastolic BP 0 .0313 1 . 50 3 .9*** 0.1000 3. 78 2.9**
BMI -0.0556 0 . 80 -2.3* -0.0672 0. 75 -0 . 6
Serum Choles. -0.0002 0 . 99 0.0 -0.0238 0 . 38 -1 . 8*
Smoking Habit 0 .4537 2 . 48 5 .0*** 0.6827 3. 91 1.5
This table excludes known diabetics and cases •with
incomplete data.
Logistic Coefficient estimated via maximum likelihood.
§The approximate relative risk (odds ratio) for a change 
in the risk factor by an amount equal to its standard 
deviation.
Abbreviation:BP=Blood Pressure, Choles.=cholesterol. 
*P<0.001, ***P<0.05.
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TABLE 7.1.10-14 Year Age, Gender Adjusted Mortality and 
Age-Adjusted Relative Risk of Asymptomatic 
Hyperglycaemia Compared to Euglycaemia by Cause 
of Death, in Men and Women.
Variable No. of 10-14 Year Age-Adjusted Mortality Rate 
Subjects
Male Female Male Female
________________   Gender
No. Rate RR No. Rate RR Ratio
------------------------ All Causes
Normogly. 4417 5500 880 19.7 - 591 9.9 - 2.00
Hypergly. 277 214 63 21.8 1.11 40 15.4 1.55 1.41
Cardiovascular Disease
Normogly. 3991 5153 454 11.1 - 244 4.4 - 2.52
Hypergly. 251 202 37 13-9 1.25 28 6.9 1.57 2.01
Ischaemic Heart Disease
Normogly. 3866 5071 329 8.2 - 162 2.9 - 2.83
Hypergly. 246 186 32 12.1 1.47 12 4.9 1.69 2.47
Cerebrovascular Disease
Normogly. 3613 4977 76 2.0 - 68 1.2 - I .67
hypergly. 217 179 3 1.4 0 .70 5 1.9 1.58 0.74
Death rate per 1,000 person year of observation, age- 
adjusted to 1981 Scottish population by four 5-year age 
groups.
Known diabetics excluded.
Abbreviation:Normogly.=Normoglycaemia,
Hypergly.=Asymptomatic hyperglycaemia, RR=Relative Risk.
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TABLE 7*2.Percentage of Hypertension (^160 mmHg Systolic 
or ^95 mmHg Diastolic) Cigarette Smoking, Serum 
Cholesterol Level (^250 mg/dl) and BMI (^27 
Kg/m2) Among Asymptomatic Hyperglycaemic and 
Euglycaemic Men and Women.
Variables Male Female
(High Risk ______________ _______ __________________________
Categories.)_ Hyper------Normo---------Hyper------- Normo-
glycaemics glycaemics glycaemics glycaemics
No % No % No % No %
Systolic BP 
^160 mmHg 88 31.8** 1073 24. 3 91 42 . 5** 1508 27* 4
Diastolic BP 
>95 mmHg 63 2 2 . 7 892 2 0 . 2 47 2 2 . 0 1023 18.6
Serum Choi. 
>250 mg/d 70 25. 3 1206 27* 3 97 45* 3 691 48. 9
BMI
>27 109 39* 4* 1470 33* 3 80 37* 4 17^3 31*7
Cigarette
Smokers 121 43* 7 2200 49* 8* 80 37* 4 2259 41. 1
The difference between hyperglycaemics versus
Normoglycaemics: *P<0.05. **P<0.01.
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TABLE 7 * Multiple Logistic Coefficients and Standardised 
Odds Ratio of Seven Cardiovascular Risk Factors 
and 10-14- Year Mortality by Cause and Gender.
Male Female
Variables Logistic Odds Z-Test Logistic Odds Z-Test 
Coefficient Ratiof Coefficient Ratiof
All Causes 951 Males and 638 Females Deaths in 4-724 Men
and 5748 Women
Age 0.1065 1. 81 14.5*** 0.1005 1.75 11. 6s*4**
Systolic BP 0.0071 1.17 3. 2** 0.0095 1. 26
Diastolic BP 0.0109 1. 12 2. 8** 0.0045 1. 06 1.0
BMI 0.0154 0.95 -1.3 -0.0239 0 . 90 -2. 3*
Serum Choi. -■0. 0018 0.93 -1. 8 -0.0016 0.93 -1.5
Blood GlucoseO.0021 1. 05 0.0067 1.15 ll t 0***
Smoking© 0.3538 2. 03 9 .0*** 0.2839 1. 76 6.3***
Cardiovascular Disease 494 Male and 275 Female Deaths in
4267 Men and 5385 Women
Age 0.1104 1. 85 11.5*** 0.1367 2. 15 1 0 .0***
Systolic BP 0.0101 1. 25 3 .5*** 0.0095 1. 26 2 . 9**
Diastolic BP 0.0209 1. 31 ll. 2*** 0.0168 1. 25 2. 8**
BMI 0.0182 1. 06 1.2 0.0277 1. 12 1.8
Serum Choi. 0.0034 1. 13 2. 6** 0.0026 1. 11 1.7
Blood GlucoseO.0040- 1.10 2.3** 0.0075 1. 17 3 .6***
Smoking© 0.3023 1 . 83 5 .9*** 0.4079 2. 26 6 # 2***
Ischaemic Heart Disease 341 Male and 161 Female Deaths In
4114 Men and 5271 Women
Age 0.0930 1. 67 8 .3*** 0.1116 1. 85 6 #5***
Systolic BP 0.0108 1. 27 3. 3** 0.0152 1. 45 ilt 9***
Diastolic BP 0.0165 1. 23 2. 8** 0.0094 1. 13 1.2
BMI 0.0160 1. 05 0.9 -0.0055 0 . 98 0. 3
Serum Choi. 0.0045 1. 18 2. 9** 0.0047 1. 22 2. 5**
Blood GlucoseO.0037 1. 09 1. 8 0.0095 1. 21 3.7***
Smoking© 0.2347 1. 60 ll. 0*** 0.3314 1. 94 ll, 0***
Stroke 78 Male and 73 Female Deaths in 3851 Men and
5183 Women
Age 0.1462 2. 23 6#1*** 0.1453 2. 22
Systolic BP 0.0152 1. 39 2. 4* 0.0019 1. 05 0.3
Diastolic BP 0.0275 1. 42 2. 6** 0.0454 1. 81 5 #2***
BMI -0.0037 0. 99 -0. 1 -0.0886 0. 68 -2. 8s*4*
Serum Choi. 0.0002 1. 03 0. 2 -0.0028 0 . 89 -0. 9
Blood GlucoseO.0050 1. 13 1. 4 0.0095 1. 20 2. 4**
Smoking© 0 .3652 2. 07 3 .0*** 0.5739 3.15 H #5***
This table excludes known diabetics and cases with
-incomplete data.
Logistic coefficient estimated via maximum likelihood.
£The approximate relative risk (odds ratio) for a change
in the risk factor by an amount equal to its standard
deviation.
©The odds ratios were calculated for smoker and non-
smokers .
Abbreviation:BP=Blood Pressure, Choles.=cholesterol. 
*P<0.05. **P<0. 01, #>fcJHp<0. 001.
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TABLE 8.1.Mortality and Casual Blood Glucose Level by
Quintile of Body Mass Index, in Males and
Females.
Quintile of Body Mass Index
1 2 3 4 5
Male
No. of Subjects at 
Baseline
9^0 939 935 953 929
Total No. of Death 228 174 187 167 187**
All Death Rate© 23*8 18.5 19-9 16. 7 2 0 . 3
Mortality Rate Ratio$ 1.00 0.77 0 . 84 0.70 0 . 85
No. of CVD Deaths 90 80 100 96 125*
CVD Death Rate©* 10.7 9.2 1 1 . 6 1 0 . 2 14. 4
Mortality Rate Ratio$ 1.00 0.86 1 . 08 0 . 95 1 . 34
No. of IHD Deaths 67 62 66 66 100**
IHD Death Rate© 8.1 7.4 7-9 7.2 1 1 . 8
Mortality Rate Ratio$ 1.00 0.91 0.97 0 . 89 1 . 45
No. of CVA Deaths 14 10 20 18 17
CVA Death Rate© 1.8 1.2 2.6 2 . 1 2 . 1
Mortality Rate Ratio$ 1.00 0.66 1 . 44 1 . 16 1.16
-Mean-Blood ________ ___91.2 90.7 91. 2 92. 3 9 6 . 4*
Glucose (SD) (21.8)(19.3)(21.5)(26. 4) (31.4)
Prevalence of 
Hyperglycaemiaf
5.5% 5.4% 
Female
4. 9% 6.1 % 7. 8%*
No. of Subjects at 
Baseline
1148 1149 1137 1146 1134
Total No. of Death 156 104 102 122 14.7***
All Death Rate© 13- 2 8.8 8.3 8.6 11.1
Mortality Rate Ratio$ 1.00 0.66 0.63 0.65 0. 84
No. of CVD Deaths 67 35 42 59 59***
CVD Death Rate© 6.0 3.1 3.6 4.7 5.1
Mortality Rate Ratio$ 1.00 0.52 0. 60 0.78 0 . 85
No. of IHD Deaths 40 17 28 42 47***
IHD Death Rate© 3-6 1.4 2. 4 3. 4 3.6
Mortality Rate Ratio$ 1.00 0.38 0.67 0. 94 1. 00
No. of CVA Deaths 21 15 10 14 13
CVA Death Rate© 1.9 1.4 0. 9 1.1 1.0
Mortality Rate Ratio$ 1.00 0.73 0. 47 0 . 58 0. 53
Mean Blood 89.4 8 9 .7 9 0. 1 90. 2 93. 4*
Glucose (SD) (18.7)(17.4)(19.6)(19.6) (26.7)
Prevalence of 
Hyperglycaemiaf
4.1 % 3-5# 2. 9% 3. 1 % 5. 5 % *
Differences between quintiles of BMI *P<0 .05, **P<0.01
***p<0.ooi
fHyperglycaemia defined as upper *>% of casual blood 
glucose distribution, greater than 126 mg/dl.
The standard deviation of means shown in brackets.
©Death rate per 1000 person years of observation, age 
adjusted to 1981 Scottish population.
$Age adjusted mortality rate ratios for each of the higher 
quintiles were relative to age-adjusted mortality rate in 
the lowest quintile.
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TABLE 8.2.Total Deaths, CVD Deaths, IHD Deaths and CVA 
Deaths In Normoglycaemic and Hyperglycaemic 
Individuals by Quintile of BMI, in Males and 
Females.
Male
Quintile of BMI
Female
Quintile of BMI
Overall Causes Deaths
Normoglycaemics:
No. of Deaths 219 162 175 156 168 145 100
Age-Adjusted 24.0 18.2 19.8 16.7 18.5 12.8 8. 
Death Rate 
Hyperglycaemics :Jc
No.of deaths 9 12 12 11 19
Age-Adjusted 19.4 24.2 21.3 18.2 25 
Death Rate 
Relative Risk® 0.8 1.3 1.1 1.1 1.4
Cardiovascular Disease Deaths 
Normoglycaemics:
No. of Deaths 87 74 94 87 112 62
9.0 11.6 10.0 14.1
11 4
6 23.7 9.
96 118 132 
9 8.0 9.2 10.4
6 4 15
0 14.2 9.0 18.7
1.8 1.0 1.8 1.0 1.8
Age-Adjusted 
Death Rate
10 . 8
35 
5.8 3.
39 58 60
2 3.4 4.8 4.7
Hyperglycaemics:£ 
No. of Deaths 3 
Age-Adjusted 8. 
Death Rate 
Relative Risk@ 0.8
6 6 9 13 5 0
14.0 13.1 15-6 19.3 9.6 0
3 1 9
7.9 4.1 10.4
1.5 1.1 1.6 1.4 1.6 0 2.3 0.8 2.2
Ischaemic Heart Disease Deaths 
Normoglycaemics:
No. of Deaths 64 56
Age-Adjusted 8.1 7*0
Death Rate 
Hyperglycaemics:£
No. of Deaths 3 6
Age-adjusted 8.4 14.0
Death Rate 
Relative Risk® 1.0 2.0
61 58
7.8 6.8
8
90 37
11.6 3
10
17 
5 1
25 42 41
5 2.2 3.5 3.3
11.9 14.1 14.8 5.1 
1.3 1.41.5 2.1
Cerebrovascular Accident Deaths
3 0 
7.9 0
3 . 6 0
Normoglycaemics:
No. of Deaths 14 10 19 17 16 19 15 10 13
Age-Adjusted 1.9 1.3 2.6 2.1 2.2 1. 8 1.5 0.9 1.1
Death Rate 
Hyperglycaemics:£
No. of Deaths 0 0 1 1 1 2 0 0 1
Age-adjusted 0 0 1.5 1.9 2.1 4. 4 0 0 4.1
Death Rate 
Relative Risk® 0 0 0. 6 0.9 0.9 2. 4 0 0 3. 7
6
7.4
2.2
11
©Ratio of the age-adjusted death rates in hyperglycaemics 
and normoglycaemics.
£Hyperglycaemia defined as upper 5% of casual blood 
glucose distribution, greater than 126 mg/dl.
Death rate per 1,000 person years of observation, age 
adjusted to 1981 Scottish population.
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TABLE 9 .2.Differences in the Distribution of Risk Factors 
Among Men and Women.
Variables Percentage and Number in High Risk Category
(High Risk   P*
Category) Male Female
Number Percentage Number Percentage
Age 55-64 Years 2251 47. 9 2823 49- 4 NS
Blood Glucose^l26 277 5.9 214 3-7 P<0.001
Systolic BP^l60 1160 24. 7 1599 28. 0 P<0.001
Diastolic BP^95 955 20. 3 1070 18. 7 P<0.05
Serum Choles.^250 1274 27. 1 2788 48.8 P<0.001
BMI£27 1578 33- 6 2339 31- 9 NS
Cigarette Smoker 2320 49- 4 2339 40. 9 P<0.001
♦Test of the difference in the distribution of risk 
factors among males and females.
NS, not significant.
MAPS, FIGURES AND TABLES
TABLE 9.3*Univariate Analysis, Dichotomisation of Baseline 
Variables and 10 to 14. Year Age, Gender Adjusted 
Mortality and Gender Differential by Cause, in 
Men and Women.
Variable No. of 10-14 Year Age-adjusted Mortality Rate 
Subjects ___________ __________ ____________________ _
Male Female Male/Female
________   Rate Ratio
Male Female No. Rate No. Rate
of of
Death Death
All Causes
Blood <126 4417 5500 880 19. 7 591 9.9 2.0
Glucose £126 277 214 63 21.8 40 1 5.1** 1 . 4
Systolic<l60 3534 4115 615 1 7. 6 380 9.0 1.9
Pressure^l60 
D i as 101i c<9 5—
1160 1599
“4643“
328 2 5.4*** 251 1 2 .5*** 2 . 0
3739 709 1 8 . 7 463 9. 4 2 . 0
Pressure £95 955 1070 234 2 3 .9*** 167 1 2 .5*** 1. 9
Serum <250 3420 2926 715 2 0 . 0 321 1 0 . 7 1.9
Cholest.£250 1274 2788 228 19. 4 310 9.7 2.0
BMI <27 3116 3891 643 2 0 . 4 407 9- 9 2 . 1
£27 1578 1823 300 1 8 . 7 224 1 0 . 4 1 . 8
Use of No 2374 3375 373 14.7 324 8 . 2 1 . 8
Cigarette Yes 2320 2339 570 2 5 .5** 307 13.2** 1. 9
All 4694 5714 943 19. 8 631 1 0. 1 2.0
Cardiovascular Causes
Blood <126 3991 5153 454 11.1 254 4.4 2 . 5
Glucose £-126 251 202 37 13. 9* 18 6.8 2 . 0
Systolic<l60 3215 3876 292 9 . 0 141 3.6 2 . 5
Pressure£l60 1031 1479 199 1 6 .7*** 131 6 .5*** 2.6
Diastolic<95 3367 4354 337 9.7 174 3. 7 2 . 6
Pressure £95 875 1000 154 1 6 .*** 97 7. 3** 2 . 3
Serum <250 3053 2722 348 1 0 . 6 117 4.4 2 . 4
Cholest.£250 1189 2633 143 1 2 . 9 155 4.9 2.6
BMI <27 2775 3652 302 1 0 . 6 168 4. 3 2 . 5
>27 1467 1703 189 12. 5 104 4.8 2.6
Use of No 2219 3185 218 9. 1 134 3. 4 2 . 7
Cigarette Yes 2023 2170 273 1 3 .8*** 138 6 .4*** 2 . 1
All 4242 5355 491 1 1 . 2 272 4.6 2 . 4
MAPS, FIGURES AND TABLES
TABLE 9«3.Continued
Variable No. of 10-14 Year Age-addusted Mortality Rate
Subjects  ______________ _______________________
Male Female Male/Female
_____________  __________  ____________  Rate Ratio
Male Female No. Rate No. Rate 
of of
Death Death
Ischaemic Heart Disease
Blood <126 3866 5071 329 8. 2 162 2.9 2. 8
Glucose £126 246 186 32 12. 1* 12 4.8 2.5
Systolic<l60 3143 3825 224 6.9 90 2.3 3. 0
Pressure^l60 969 1432 137 12.2*** 84 H #2*** 2.9
Diastolic<95 3283 4294 253 7. 4 114 2. 4 3. 1
Pressure £95 829 963 108 12.4*** 60 il # 8*** 2.6
Serum <250 2953 2677 248 7.8 72 2.6 3.0
Cholest. >250 1159 2580 113 10. 3 102 3. 3 3. 1
BMI <27 2692 3583 219 7-8 99 2. 6 3. 0
>27 1420 1674 142 9—7 75 —3.6*-- 2.7---------- -•—
Use of No 2168 3142 167 7. 1 91 2.3 3. 1
Cigarette Yes 1944 2115 194 10. 1 83 3.8*** 2.6
All 4112 5257 361 8.4 174 3.0 2.8
Cerebrovascular Causes
Blood <126 3613 4977 76 2. 0 68 1.2 1.7
Glucose £126 217 179 3 1. 4 5 1.9 0.7
Systolic<l60 2959 3776 40 1.3 41 1.1 1. 2
Pressure^l60 871 1380 39 3 .7*** 32 1.7 2.2
Diastolic<95 3078 4224 48 1.5 44 1. 0 1. 5
Pressure £95 752 931 31 28 2.2*** 1.8
Serum <250 2768 2640 63 1.8 35 1.3 1. 4
Cholest. £250 1062 2514 16 2. 1 38 1. 2 1.7
BMI <27 2522 3538 49 1. 9 54 1.3 1. 5
£27 1308 1618 30 2. 1 19 0.9 2.3
Use of No 2034 3078 33 1.5 27 0.7 2. 1
Cigarette Yes 1796 2078 46 2. 5* 46 2.3*** 1.1
All 3830 5156 79 2.0 73 1.3 1.5
Death rate per 1,000 person years of observation, age 
adjusted by direct method to 1981 Scotland population for 
the four 5-year age groups.
Missing cases=2
Known diabetics excluded.
Significantly different from low risk category *P<0.05,
**P<0.01, ***P<0.001. .PA
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TABLE 10.1.Systolic and Diastolic Blood Pressure, Mean 
Arterial Pressure, Mean Arterial Index and 
Pulse Pressure and Standard Normal Deviate by 
Age Group, for Men Who Were Still Alive and 
Who Died of Ischaemic Heart Disease After 10- 
14 Years of Follow-up.
Died of Ischaemic Heart Disease Alive at End of Study
45-49 50-54 55-59 60-64 All Ages 45-49 50-54 55-59 60-64 All Ages
No. of 34 95 113 130 372 1084 1063 904 748 3799
Cases
Systolic Blood Pressure
Mean 150.8*150.3*158.5***l62.2***157-0***l42.0 144.8 147-1 151.9 145.9 
SD 21.4 19.8 21.8 21.8 24.0 19-9 21.2 21.8 22.5 21.5
SND 0.43 0.22 0.45 0.35 0.43 -0.01 -0.03 -0.08 -0.09 -0.07
SD 1.06 0.92 1.01 1.17 1.07 0.99 0.98 1.01 0.95 0.96
Diastolic Blood Pressure
Mean 90.6*89.3**91.3***88.9***89.9*** 85.2 85.0 84.9 84.6 84.9
SD 12.3 12.3 13.0 13.7 13.0 12.8 12.2 12.9 13.3 12.8
SND 0.41 0.29 0.42 0.26 0.34 -0.005 -0.05 -0.06 -0.05 -0.04
SD 0.95 0.98 0.99 1.02 1.00 0.99 0.97 0.98 0.98 0.98
Mean Arterial Pressure
Mean 110. 7*109. 6**113. 7***H3- 3***112. 3***104.1 104.9 105-6 107-0 105-3
SD 14.1 13-3 15-3 16.7 15-0 14.1 13.8 14.6 14.8 14.3
SND 0.45 0.29 0.47 0.34 0.42 -0.01 -0.04 -0.07 -0.07 -0.05
SD 0.99 0.94 0.95 1.09 1.02 0.99 0.97 0.97 0.97 0.97
Mean Arterial Index
Mean 130.8**130.0**136.1***137-8***134.6***123-1 124.9 126.4 129-5 125-6
SD 17-3 16.0 17.5 21.8 19-0 16.6 17-1 17-8 18.1 17.5
SND 0.45 0.26 0.46 0.35 0.43 -0.01 -0.04 -0.08 -0.08 -0.0€
SD 1.03 0.92 0.96 1.14 1.05 0.99 0.98 0.97 0.95 0.9*
Pulse Pressure
Mean 60.2 61.0 67.2**73-4** 67-1*** 56.7 59-8 62.2 67-3 61.0
SD 15-8 15-8 17-3 21.7 19-2 14.1 16.3 16.1 17-4 16.3
SND 0.24 0.07 0.24 0.25 0.30 -0.00 -0.00 -0.06 -0.07 -0.06
SD 1.15 0.97 1.03 1-19 1.13 0.99 0.99 O.96 0.95 0.96
*P<0.05» **P<0.01, ***P<0.001 (Comparing "deceased” with
"survive")
Missing=l
Abbreviations: SD=standard deviation, SND=standard normal
deviate.
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TABLE 10.2.Systolic and Diastolic Blood Pressure, Mean 
Arterial Pressure, Mean Arterial Index and 
Pulse Pressure and Standard Normal Deviate by 
Ace Group, for Women Who Were Still Alive and 
Who Died of Ischaemic Heart Disease, After 10- 
14 Years of Follow-up.
Died of Ischaemic Heart Disease Alive at End of Study
H 5-49 50-54 55-59 60-64 All Aces 45-49 50-54. 55-59 60-64 All Aces
No. of 11 
Cases
31 58 81 181 1303 1420 1263 1140 5126
Systolic Blood Pressure
Mean 132.6 153.2* 167.4***l65.1**161.8*** 139-3 144.9 151.0 157-0 147-7
SD 17-0 24.0 30.3 25.5 27-5 21.3 22.9 25-0 24.7 24.3
SND -0.32 0.36 0.59“ 0.29 0.53 -0.005 0.002 -0.05 -0.04 -0.04
SD 0.33 1-05 1.18 1.01 1.11 1.00 1.00 0.97 0-98 0.98
Diastolic Blood Pressure
Mean 78.2* 87-1 89-9** 91-6***89-5*** 81.7 83.6 85-1 86.5 84.1
SD
SND
SD
8.1 16.4
-0.28 0.27
0.66 1.30
16.6 12.5 14.5 12.3 12.5 13-2 13-2 13-0
0.33 0.33 0.38 0.006 -0.005 -0.21 -0.03 -0.02
1.18 0.90 1.17 1.00 1.00 0.97 0-97 0.98
Mean Arterial Pressure
Mean 96.3* 109-1 115-8***116.1***113-6***100.9 104.1 107.1 110.0 105-3
SD 5-0 18.0 19-1 14.9 17-2 14.0
SND -0.33 0.34 0.50 0.34 0.50 -0.00
SD 0.36 1.22 1.19 0.93 1.10 1.00
14.6 15.7 15-7 15-4
-0.00 -0.04 -0.04 -0.03 
0.99 0.98 0.98 0.98
Mean Arterial Index
Mean 114.5** 131-2* 141.6***l40.6**137-7***120.1 124.5 129-0 133-5 126.5
SD 4.4 20.7 24.2 19-6 21.9 17-3 18.3 19-9 19-2 19-4
SND -0.33 O.36 0.56 0.31 0.53 -0.00 0.00 -0.05 -0.04 -0.0*1
SD 0.26 1.13 1-18 0.98 1.10 1.00 1.00 0.97 0.98 0.9£
Pulse Pressure
Mean 5*1-. 4 
SD 12-5 
SND -0.21 
SD 0.79
66.1 77.5*** 73-5
14.4 22.6 21.1
0.29 0.55 0.13
0.85 1.16 1.07
72.4*** 57.6 
20.9 15-7
0. 44
1 . 12
61.3 65.8
17-1 18.7
0.00 -0.01 -0.05 
0.99 1.01 0.96
70. 4 
19- 0
63- 5 
1 8 . 2
-0.02 -0.04 
0.96 0.97
*P<0.05* **P<0.01, ***P<0.001 (Comparine "deceased” with
"survive”)
Missinc=l
Abbreviations: SD=standard deviation, SND=standard normal
deviate.
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TABLE 10.3.Mean (SD) Standard Normal Deviates Adjusted for 
Age for Systolic and Diastolic Pressure, Mean 
Arterial Pressure, Mean Arterial Index and 
Pulse Pressure and Their Difference with 
Diastolic Pressure by 10-14. Year Mortality 
Outcome in Males and females.
Persons Who Died of IHD Alive at the End of Study
Male Female Male Female
No.
SBP
DBP
MAP
MAI
PP
of Cases 372
0.43(1.0 7 ) * * *  
0.34(1.00)*** 
0. 42(1. 02)*** 
0.43(1.05)***
181
0.53(1.11)*** -0
0.38(1.17)*** -0 
0.50(1.10)*** -0 
0.53(1.10)*** -0
3799
07(0.96) 
04(0.98) 
05(0.97) 
06(0.96)
5126 
-0.04(0.98) 
-0.02(0.98) 
-0.03(0.98) 
-0.04(0.98)
0.30(1.13)*** 0.44(1.12)*** -0.06(0.96) -0.04(0.97)
SBP-DBP 0.09(0.92) 0.15(0.91)* -0.03(0.80)*-0.02(0.79)
MAP-DBP 0.08(0.44)*** 0. I K  0. 73 ) *** -0. 01 ( 0. 64 )*-0. 01 ( 0. 39 )*
MAI-DBP 0.09(0.74)* 0.15(0.73)** -0.01(0.38)*-0.02(0.64)
PP—DBP -0.03(1.45) 0.05(1.42) -0.02(1.31) -0.02(1.25)
Two sample T-test value for persons deceased compared to 
persons surviving at the end of study and paired T-test to 
compared the difference between mean of each component of 
blood pressure and diastolic pressure from zero: *P<0.05.
**P<0.01, ***P<0.001.
Abbreviations, SBP=systolic blood pressure, DBP=diastolic 
blood pressure, MAP=mean arterial pressure, MAI=mean 
arterial index, PP=pulse pressure.
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TABLE 10.4.Ischaemic Heart Disease Mortality in Upper Age,
Gender Specific and Adjusted Quintile* of
Systolic and Diastolic Blood Pressure, Mean
Arterial Pressure, Mean Arterial Index and
Pulse Pressure.
Age Group
45-49 50-54 55-59 60-64
All
Ages
Age-
adjusted
Rate©
Male
Diastolic Blood Pressure 
No. of Deaths 8
Death Rate 3* 2
Systolic Blood pressure 
No. of Deaths 6
Death Rate 4.4
Rate Ratio SBP/DPB 1.40 
Mean Arterial Pressure 
No. of Deaths 5
Death Rate 2.5
Rate Ratio MAP/DBP 0.78 
Mean Arterial Index 
No. of Deaths 6
Death Rate 3-9
Rate Ratio MAI/DBP 1.23 
Pulse pressure 
No. of Deaths 
Death Rate
5
4.9
Rate Ratio PP/DBP 1.54
24 
10. 3
17 
9.8
0. 96
23 
10. 8
1. 07
20 
10. 3 
1. 02
11 
6.6 
0 . 65
Female
43
1 9 . 0
37
19. 4 
1. 02
46 
21 . 2 
1. 11
38
19. 3 
1. 02
33
17-7 
0. 93
38
19- 7
113 
12. 5
113 
12. 8
48 108 108
22.4 11.4 13*7
1.14 0.91 1.07
47 121 121
22.7 14.5 14.1
1.10 1.16 1.08
50 114 114
23.2 15.0 13-9
1.13 1.20 1.07
50 99 99
21.1 14.3 12.3
1.03 1.15 0.95
Diastolic Blood Pressure
No. of Deaths 0 10 22 28 60 60
Death Rate 0.0 4.0 7-1 8.3 5-5 4.7
Systolic Blood pressure
No. of Deaths 0 9 28 36 73 73
Death Rate 0.0 3-4 8.0 8.1 6.0 4.8
Rate Ratio SBP/DPB 1.00 0.85 1.13 0 .98 1.09 1.01
Mean Arterial Pressure
No. of Deaths 0 10 27 36 73 73
Death Rate 0.0 3-7 8.1 8.9 6.2 5-1
Rate Ratio MAP/DBP 1.00 1.07 1.20 1.09 1.19 1*3
Mean Arterial Index
No. of Deaths 0 10 28 37 75 75
Death Rate 0.0 3-7 7-9 8.8 6.2 5-0
Rate Ratio MAI/DBP 1.00 1.06 1.17 1.07 1.19 1.11
Pulse pressure
No. of Deaths 1 7 23 30 61 61
Death Rate 0.6 2.6 6.5 6.8 4.9 4.0
Rate Ratio PP/DBP - 0.74 0.95 0.82 0.94 O .89
©Death rate per 1,000 person year of observation age- 
adjusted to 1981 Scottish population.
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Table 10.5.Coefficients of Correlation Between Blood 
Pressure Measures, in Men and Women.
Diastolic Mean Arterial Mean Arterial Pulse 
BP Pressure Index Pressure
Male
Systolic BP 0.657 0.896
Diastolic BP 0.924
Mean Art. pres.
Mean Art. Index
o. 983 
0 . 782 
o. 961
0. 816 
0. 101 
0. 553 
0. 699
Female
Systolic BP 0.672 0.908 0.986 0.851
Diastolic BP 0.920 0.785 0.182
Mean Art. Pres. 0.965 O .553
Mean Art. Index 0.752
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TABLE 10.6 .Univariate Multiple Logistic Coefficients® and 
Odds Ratio of Ischaemic Heart Disease Mortality 
on Various Components of Blood Pressure in 10- 
14 Years Follow-up by Gender.
Blood Pressure Male Female
Component_____ ___________________  ___________________________
Logistic Odds Z-Test Logistic Odds Z-Test
Coefficient§ Ratio Coefficient Ratio
Systolic BP 0 . 020 1 . 62 8 .9*** 0 . 021 1. 67 7 .4***
Diastolic BP 0 . 027 1 . 4-2 6 .7*** 0 . 028 1 . 44 5,1***
Pulse Pressure
(SBP-DBP) 0 . 021 Our\H 6 .7*** 0 . 024 1. 55 6 .3***
Mean Arterial Pressure
(DBP+PP/3) 0 . 030 1 . 56 8 . 0.031 1 . 62 6 .8***
Mean Arterial Index
<2*SBP+DBP)/3 0 . 026 1.64 8 .9*** 0 . 026 1 . 61 7.3***
gWalker-Duncan evaluation of logistic parameters (139)*
*P<0. 5« **P<0. 01, *K,k}fcp<0. 001
£The odds ratio for a change in the risk factor by an 
amount equal to its standard deviation.
315
MAPS, FIGURES AND TABLES
TABLE 10.7*Multiple Logistic Coefficients and Standardised 
Odds Ratio of Systolic and Diastolic Blood 
Pressure and Five Other Risk Factors for 10-14 
Years Mortality from IHD by Gender and Single 
Systolic or Diastolic and Both Systolic and 
Diastolic Blood Pressure.
Male Female
Variables Logistic Odds Z-Test Logistic Odds Z-Test 
Coefficient Ratiofi Coefficient Ratio6
Single Systolic Blood Pressure
Age 0. 088 1. 62 8.16*** 0.116 1 . 89 6 .77***
Systolic BP 0. 017 1. 45 7.22*** 0. 014 1. 41 4.80***
Serum Choles. o. oo4 1. 16 2.84** 0.005 1. 23 2.70**
Blood Glucose 0. 003 1. 08 1. 29 0. 011 1. 28 5.92***
Cig. Smokingf 0. 210 1. 52 3 .64*** 0 . 323 1. 91 3 .91***
BMI 0. 029 1. 10 1 . 65 0. 002 1. 01 0. 12
Single Diastolic Blood Pressure
Age 0. 103 1. 76 9.61*** 0.126 2. 00 7 .52***
Diastolic BP 0. 030 1. 47 7 .09*** 0. 022 1. 33 3 .95***
Serum Choles. o. oob 1. 16 2.90** 0 . 005 1. 23 2.66**
Blood Glucose 0. 004 1. 11 2. 16* 0. 011 1. 28 6.32***
Cig. Smokingf 0. 257 1. 67 4.42*** 0. 334 1. 95 4.05***
BMI 0. 016 1. 05 0 . 90 0. 002 1. 01 0.13
Single Mean Arterial Pressure
Age 0. 096 1 . 69 8.92*** 0. 120 1. 93 7 .06***
MAP 0. 029 1. 52 7 .84*** 0 . 023 1. 43 4.79***
Serum Choles. 0. 004 1. 16 2 .79** 0 . 005 1. 23 2.64**
Blood Glucose 0. 003 1. 08 1. 75 0. 011 1. 28 6.07***
Cig. Smokingf 0. 239 1. 61 4.12*** 0.335 1.95 4.05***
BMI 0. 016 1. 05 0. 88 0 . 003 1. 05 0. 16
Single Mean Arterial Index
Age 0. 091 1.64 8.41*** 0.117 1. 90 6.84***
MAI 0. 023 1. 50 7 .66*** 0 . 019 1. 45 4.91***
Serum Choles. 0. 004 1. 16 2.81** 0 . 005 1. 23 2 .67**
Blood Glucose 0. 003 1. 08 1. 51 0. 011 1. 28 5 .95***
Cig. Smokingf 0. 223 1. 56 3.85*** 0 . 329 1. 93 3 .98***
BMI 0. 021 1. 07 1. 22 0. 001 1. 00 0 . 05
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TABLE 10.7*Continued
Male Female
Variables Logistic Odds Z-Test 
Coefficient Ratiog
Logistic
Coefficient
Odds Z-Test 
Ratiog
Single Pulse Pressure
Age 0 . 091 1 . 64 8 .31*** 0.119 1 . 92 6 .97***
Pulse Pressure 0 . 013 1 . 24 4.02*** 0 . 014 1 . 29 3.52***
Serum Choles. 0 . 004 1 . 16 2 .71** 0 . 005 1 . 23 2 .82**
Blood Glucose 0 . 003 1 . 08 1 . 41 0 . 011 1 . 28 6 .05***
Cig. Smokingf 0 . 212 1. 53 3 .62*** o. 298 1 . 81 3 .6***
BMI 0 . 048 1 . 17 2 .81** 0 . 016 1 . 07 0 . 95
Both Systolic and Diastolic 3Blood Pressure
Age 0 . 095 1 . 69 8 .57*** 0 . 116 1 . 89 6 #77***
Systolic BP 0 . 011 1 . 27 3.25** 0 . 014 1 . 41 4 .80***
Diastolic BP 0 . 017 1 . 24 3.03** 0 . 008 1 . 11 1 . 05
Serum Choles. 0 . 004 1 . 16 2.79** 0 . 005 1 . 23 2 .70**
Blood Glucose 0 . 003 1 . 08 1 . 72 0 . 011 1 . 28 5 .92***
Cig. Smokingf 0. 239 1 . 16 ll m 05*** 0.323 1 . 91 3. 91
BMI 0 . 016 1 . 05 0 . 90 0 . 002 1 . 01 0 . 09
©The approximate relative risk (odds ratio) for a change
in the risk factor by an amount equal to its standard
deviation.
£The odds ratio calculated for smokers and non-smokers. 
*P<0.05. **P<0.01, ***p<o.001
168 deaths in 5321 female and 350 death in 4171 males.
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TABLE 10.8 .Multiple Logistic Coefficients and Standardised 
Odds Ratio of Systolic and Diastolic Blood 
Pressure Mean Arterial Pressure, Mean Arterial 
Index and Pulse Pressure for 10-14 Years 
Mortality from IHD by Gender and Single 
Systolic or Diastolic or Mean Arterial Pressure 
or Mean Arterial Index, or Pulse pressure and 
Both Systolic and Diastolic Blood Pressure.
Male Female
Variables Logistic Odds Z-Test Logistic Odds Z-Test
Coefficient Ratio© Coefficient Ratio©
Single component of Blood Pressure
Systolic BP 0 . 017 1 . 45 7 * 22*** 0 . 014 1 . 40 4.80***
Diastolic BP 0 . 030 1 . 47 7 .09*** 0 . 022 1.33 3.95***
MAP 0 . 029 1 . 52 7 .84*** 0 . 023 1 . 43 ll # g***
MAI 0 . 022 1 . 48 7 .6*** 0. 019 1 . 45 4.9***
PP 0 . 013 1 . 24 ll m o*** 0 . 014 1 . 29 3 # 5***
Both Systolic: and Diastolic Blood Pressure
Systolic BP 0 . Oil 1 . 27 3-25** 0 . 014 1 . 22 4.80***
Diastolic BP 0 . 017 1 . 24 3.03** 0 . 008 1 . 11 1 . 05
©The approximate relative risk (odds ratio) for a change 
in the risk factor by an amount equal to its standard 
deviation.
£The odds ratio calculated for smokers and non-smokers.
*P<0.05, **P<0.01, ***P<0.001
168 deaths in 5321 female and 350 death in 4171 males. 
Abbreviations: BP=blood pressure, MAP=mean arterial
pressure, MAI=mean arterial index, PP=pulse pressure.
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TABLE 10.9-Summary of Standard Normal Deviate Separating 
Survivors from Men Who Died of IHD and
Standardised Odds Ratio and Rate Ratio of Age- 
Adjusted and Crude Death Rate in Upper
Quintile of Systolic and Diastolic Pressure in 
Present Study and Whitehall Study.
Age Renfrew and Paisley Study Whitehall Study
Group   ■______________________
Systolic Diastolic Systolic Diastolic
Standard normal deviate
40-44 - - 0.01 0.20
45-49 0.43 0.41 0.54 0.50
50-54 0.22 0.29 0.34 0.28
55-59 0.45 0.42 0.47 0.44
60-64 0.35 0.26 0.42 0.24
All Ages 0.43 0.34 0.42 0.35
Standardised Odds Ratio for Single Systolic and Diastolic
Pressure
1. 50 1. 48 1.37 1. 31
Standardised Odds Ratio for Both Systolic and Diastolic
Pressure
1.27 1.24 1.29 1.09
Systolic and Diastolic Rate Ratio of Age-Adjusted and 
Crude Mortality In Upper Quintile
Adjusted 1.06 1.05
Crude 1.22 1.15
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Aee
(Yr>
4 5-49 
50-54 
55-59 
60-6/1
IX 5-49 
50-54 
55-59 
60 - 6/1
ll 5-/19 
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60-64
45-49
50-5/1
55-59
60- 6/1
TABLE 11.1.Systolic and Diastolic Blood Pressure, Mean 
Arterial Pressure, Mean Arterial Index and 
Pulse Pressure and Standard Normal Deviate by 
Ace Group, For Men Who Survived and Who Died 
of Stroke After 10-14 Years of Follow-up.
Alive at End of Study Died of stroke
NO. of Mean (SD) Standardized No. of Mean (SD) Standardized
Cases Normal Devi. Cases Normal Devi.
(SD) (SD)
Systolic Blood Pressure
1084 142.0(19.9) -0.01(0.99) 3
1063 144.8(21.2) -0.03(0.98) 15
904 147.1(21.8) -0.08(1.01) 33
748 151.9(22.5 -0.09(0.95) 29
145-7(40.1) 0.17(1.99)
154.9(25.8) 0.44(1.20)
166.9(28.5)*** 0.82(1.32)*** 
166.3(29.4)* 0.52(1.24)*
Diastolic Blood Pressure
1084 85.2(19.9) -0.01(0.99) 3
1063 85.0(12.2) -0.05(0.97) 15
904 84.9(12.9) -0.06(0.98) 33
748 84.6(13.3) -0.05(0.98) 29
95-3(18.5) 0.78(1.43)
90.4(15.5) 0.38(1.23)
96.0(17.5)*** 0.78(1.33)*** 
90.0(16.4)* 0.35(1.22)*
Mean Arterial Pressure
1084 104.1(14.1) -0.01(0.99) 3
1063 104.9(13.8) -0.04(0.97) 15
904 105.6(14.6) -0.07(0.97) 33
748 107.0(14.8) -0.07(0.97) 29
112.1(25.4) 
111.9(18.5)
0.55(1.79) 
0.45(1.30)
119.0(20.0)*** 0.85(1.33)*** 
115.4(19.5)* 0.47(1.28)*
Mean Arterial Index
1084
1063
904
748
123.1(16.6 ) 
124.9(17-1) 
126.4(17-8) 
129.5(18.1)
-0.01(0.99) 3
-0.04(0.98) 15 
•0.08(0.97) 33 
-0.08(0.95) 29
128.9(32.7) 0.34(1.95)
133.4(22.0) 0.45(1.27)
143.0(23.8)*** 0 .8 3(1.3 0)*** 
140.9(24.1)*** 0.51(1.27)***
1084
1063
904
748
56.7(14.1 ) 
59.8(16.3) 
62.2(16.1 ) 
67.3(17.4)
Pulse Pressure
•0.00(0.99) 3
-0.00(0.99) 15 
•0.06(0.96) 33 
■0.07(0.95) 29
50.3(23.0 ) 
64.5(13.5) 
70.5(18.7)* 
76.2(19.7)*
-0.45(1.62) 
0 .2 8(1.2 2) 
0.43(1.11)*
0 .41(1.0 8)*
*P<0.05. **P<0.01, ***P<0.001 (Comparim "deceased” with
"survive").
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Ace
(Yr)
TABLE 11.2.Systolic and Diastolic Blood Pressure, Mean 
Arterial Pressure, Mean Arterial Index and 
Pulse Pressure and Standard Normal Deviate by 
Age Group, for Women Who Survived and Who Died 
of Stroke After 10-14 Years of Follow-up.
Alive at End of Study Died of stroke
NO. of Mean (SD) Standardized No. of Mean (SD) Standardized
Cases Normal Devi. Cases Normal Devi.
(SD) (SD)
Systolic Blood Pressure
45-49 1303 139-3(21.3) 0.0 0(1.00) 7
50-54 1420 144.9(22.9) 0.00(1.00) 10
55-59 1263 151.0 (25.0 ) -0.05(0.97) 18
60-64 1140 157.0(24.7) -0.04(0.98) 45
141.3(21.1) 
147-8 (25.2) 
163.0(25.4)* 
163.7(25.1)
0.09(1;0 1) 
0.13(1.11) 
0.42(0.99)*
0 .2 3(1 .0 0)
Diastolic Blood Pressure
45-49 1303 81.7(12.3) 0.0 1(1.00) 7
50-54 1420 83.6(12.5) 0 .00(1.00) 10
55-59 1263 85.1(13.2) -0.02(0.97) 18
60-64 1140 86.5(13.2 ) -0.03(0.97) 45
82.6 (16.2) 
84.2(11.6) 
88.9(14.3)
0.0 8(1.3 1)
0.04(0.9 2)
0.26(1.05)
95.9(15.5)*** 0.64(1.11)***
Mean Arterial Pressure
45-49 1303 100.9(14.0) 0.00(1.00)
50-54 1420 104.1(14.6) 0.00(0.99)
55-59 1263 107.1(15.7) -0.04(0.98)
60-64 ll40 110.0(15.7) -0.04(0.98)
7 102.1(16.5) 0.09(1.65)
10 105.4(15.2) 0.09(1 .03)
18 113.6(16.6) 0.37(1.03)
45 118.5(16.9)*** 0.49(1.06)***
Mean Arterial Index
45-49 1303 120.1(17.3) 0.00(1.00)
50-54 1420 124.5(18.3) 0 .00(1.0 0)
55-59 1263 129.0(19.9) -0.05(0.97)
60-64 1140 133.5(19.2) -0.04(0.98)
7 121.7(18.3)
10 126.6(19.9)
18 138.3(20.0) 
45 141.1(20.4)*
0.09(1.06) 
0.11(1.0 9)
0.41(1.02) 
0.34(1.01)*
Pulse Pressure
45-49
50-54
55-59
60-64
1303
1420
1263
1140
57-6(15.7) 
61.3(17.1) 
65.8(18.7) 
70.4(19.0)
0.00(0.99) 
-0.01(1.01) 
-o.05(0 .96) 
-0.02(0.96)
7
10
18
45
58.7(15.2) 
63.6(17.9) 
74.0(20.1) 
67.8(19.6)
0.58(1.47) 
0.14(1.06) 
0.37(1.03) 
-0.16(0.99)
*P<0.05, **P<0.01, ***P<0.001 (Comparing "deceased" with "survive”)
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TABLE 11. 3* Mean (SD) Standard Normal Deviates Adjusted*:
for Age for Systolic (SBP) and Diastolic 
Pressure (DBP), Mean Arterial Pressure (MAP), 
Mean Arterial Index (MAI) and Pulse Pressure
(PP) and Their Difference with DBP by 10-14
Year Mortality Outcome, in Men and Women.
Blood Male Female
Pressure
Components Alive at the Died of Alive at the Died of
End of Study Stroke End of Study Stroke
No. of Cases 3799 80 5126 80
SBP -0.05(0.96) 0.49(1-28)*** -0.02(0.98) 0.22(1.00)***
DBP -0.04(0.98) 0.57(1* 29)*** -0.01(0.98) 0.25(1.17)***
MAP -0.05(0.97) 0. 58(1.3 3 )*** -0.02(0.98) 0.26(1.11)***
MAI -0.05(0.96) 0.53(1.31)*** -0.02(0.98) 0.24(1.06)***
PP -0.03(0.96) 0.17(1.12)** -0.02(0.97 0.23(1.00)*
SBP-DBP -0.01(0.80) -0.08(0.86) -0.01(0.79) -0.03(0.91)
MAP-DBP -0.01(0.38) 0.01(0.41) -0.01(0.39) 0.01(0.43)
MAI-DBP -0.01(0.64) -0.04(0.69) -0.01(0.64) -0.01(0.73)
PP-DBP 0.01(1.31) -0.40(1.43)** -0.01(1.25) -■0. 02(1. 49)
Two sample t-test value for persons died compared to 
persons alive at the end of study and paired t-test to 
compare the difference between mean of each component of 
blood pressure and diastolic pressure from zero: *P<0.05. 
**P<0. 01, ***p<o. 001.
£Age-adjusted mean standard normal deviate by averaging 
five year age-group.
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TABLE 11.ft.Cerebrovascular Disease Mortality in Upper 
Age, Gender Specific and Adjusted Quintile of 
Systolic and Diastolic Blood Pressure, Mean 
Arterial Pressure, Mean Arterial Index and 
Pulse Pressure.
Age Group 
45-49 50-54 55- 59 60
All Age- 
Asces Adjusted 
-64 Rate
Diastolic Blood Pressure
No. of Deaths 2
Male
3 18 8 31 31
Death Rate 0.8 1.3 8. 6 4. 5 3.6 3. 8
Systolic Blood pressure 
No. of Deaths 1 4 18 13 35 35
Death Rate 0.8 2. 4 10. 0 6.1 5.2 4. 8
Rate Ratio SBP/DPB 0.94 1. 80 1. 16 1.34 1. 43 1. 26
Mean Arterial Pressure 
No. of Deaths 2 4 17 10 33 33
Death Rate 1.0 2. 0 8. 6 5. 4 4. 2 4. 2
Rate Ratio MAP/DBP 1.25 1. 47 0. 99 1.19 1.16 1. 10
Mean Arterial Index 
No. of Deaths 1 4 17 12 34 34
Death Rate 0.7 2.2 9.3 6.1 4. 8 4.5
Rate Ratio MAI/DBP 0.83 1. 61 1. 07 1.35 1. 32 1. 18
Pulse pressure
No. of Deaths 0 2 14 12 28 28
Death Rate 0.0 1. 2 8. 1 5.6 4.3 3. 7
Rate Ratio PP/DBP 0 0 . 92 0. 94 1. 23 1.19 0. 97
Diastolic Blood Pressure 
No. of Deaths 1
Female
2 5 24 30 30
Death Rate 0.5 0. 8 1.7 6.7 2.8 2. 3
Systolic Blood pressure 
No. of Deaths 0 2 6 19 27 27
Death Rate 0.0 0.7 1.8 4. 5 2.3 1. 7
Rate Ratio SBP/DPB 0.0 0. 93 1. 06 0.67 0 . 81 0. 73
Mean Arterial Pressure 
No. of Deaths 1 2 8 20 31 31
Death Rate 0.6 0.7 2.5 5-2 2.7 2. 2
Rate Ratio MAP/DBP 1.13 0. 93 1.49 0.78 0.97 0. 95
Mean Arterial Index 
No. of Deaths 0 2 8 19 30 30
Death Rate 0.0 0.7 2.3 4.7 2.6 1. 9
Rate Ratio MAI/DBP 0 0 . 92 1. 40 0 . 70 0 . 91 0. 82
Pulse pressure
No. of Deaths 1 3 7 15 26 26
Death Rate 0.6 1. 1 2.0 3. 5 2. 1 1. 7
Rate Ratio PP/DBP 1.13 1.35 1. 20 0 . 52 0.76 0. 76
Death rate per 1,000 person years of observation age- 
adjusted to 1981 Scottish population by four five year 
age-groups.
324
MAPS, FIGURES AND TABLES
TABLE 11.5•Univariate Logistic Regression Coefficients© 
and Odds Ratiof of Cerebrovascular Disease
Mortality on Various Components of Blood
Pressure in 10-14. Years Follow-up by Gender,
Blood Male Female
Pressure __________________________  __________________________
Component Logistic Odds Z-Test Logistic Odds Z-Test
Coefficient Ratio Coefficient Ratio
Systolic BP 0 . 030 1* 93 6 .9*** 0. 019 1* 59 ll # 7 He He He
Diastolic BP 0 . 04-2 1 . 71 5 # 7*** 0 . 039 1 . 67 5 # i He He He
Mean Arterial Pressure
(DBP+PP/3) 0 . 04-3 1 . 85 6 #8*** 0 . 034 1 . 69 5* 3***
Mean Arterial Index
(2*SBP+DBP/3) 0 . 037 1 . 92 7 # 0$ He He 0 . 025 1 . 63 5 . 0 He He He
Pulse Pressure
(SBP-DBP) 0 . 030 1.64 4.. 9 H5 He He 0 . 015 1 . 32 2 . 6**
gWalker-Duncan evaluation of logistic parameters (139)* 
£The approximate relative risk (standardized odds ratio) 
for a change in the risk factor by an amount equal to its 
standard deviation.
*P<0.5, **P<0 .0 1 , ***p<o.001
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TABLE 11.6.Multiple Logistic Coefficients and Standardised 
Odds Ratio of Systolic (SBP) and Diastolic 
Blood Pressure (DBP) Mean Arterial Pressure 
(MAP), Mean Arterial Index (MAI) and Pulse
Pressure 
Stroke by 
or PP and
(PP) for 10—14- Years 
Gender and Single SBP 
Both SBP and DBP.
Mortality from 
, DBP, MAP, MAI
Blood Male Female
Pressure
Variables Logistic Odds Z-Test Logistic Odds Z-Test
Coefficient Ratio© Coefficient Ratio©
Single component of Blood Pressure
SBP 0 . 027 1.81 5 .91*** 0 . 015 1.44 3.40***
DBP o. 045 1.78 6 .03*** 0 . 044 1.78 5-2 5 * * *
MAP 0 . 043 1.86 6 .50* * * 0. 035 1.72 4.90***
MAI 0 . 035 1.85 6 .30*** 0 . 023 1.57 4.12***
PP 0. 020 1*39 3* 20** 0 . 005 1.10 0.77
Both Systolic and Diastolic Blood Pressure
SBP 0.015 1.39 2.42* 0. 001 1.02 0.24
DBP 0 . 027 1.41 2.58* 0. 044 1.78 5-2 5 * * *
©The approximate relative risk (odds ratio) for a change 
in the risk factor by an amount equal to its standard 
deviation.
*P<0.05, **P<0. 01, ***p<o. 001
80 deaths in 5*232 female and 79 death in 3.900 males.
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TABLE 12.1. Number of Linked cases
Number Percent
Total linked 981 100. 0
Matched by Computer 870 88. 7
Matched by Microfiche 67 6. 8
Not Matched 44 4.5
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TABLE 12.2.Distribution of Individuals Identified and not 
Identified by Postal Contact.
Number Percent
Total no. matched with CHI 937 100. 0
No. identified 7^5 79. 5
No. not identified 192 20. 5
Not traced 65 33. 8
No reply to questionnaire 95 49. 5
Transferred 32 16.7
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TABLE 12.3-Distribution of Response Rate by Case and 
Control.
Total Response
Issue ___________________________________________
Original First Second Total
Reminder Reminder
No. (%> NO. <#> No. (%) No. (%)
Case 238 1H9 (62.6) 25 (28.0) 10 (15.6) isa (77.3)
Control 1 llll 3 27b (61.8) 59 (3a.9) 21 (19-1) 35a (79.9)
Control 2 256 166 (6a.8) 3a (37.8) 7 (8.a) 207 (80.8)
Total 937 589 (62.9) 118 (33.9) 38 (1 6 .5) 7 b 5 (79.5)
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TABLE 13. 1.Follow-up Data and Life-Table Projections of
Progress to Diabetes Among 2&4 Men and Women
with Casual Post-Prandial Blood Glucose Above
126 mg/dl •
Male Female
O W D I O W D I
X z n z n z z z n z n z z
0 114 0 0 0 108 0 0 0
1 11 4 0 0 0 108 0 2 1.8
2 114 0 0 0 106 0 0 1.8
3 i m 0 0 0 106 0 0 1.8
4 n n 0 3 2. 6 106 0 1 2. 8
5 i n 0 3 5. 3 105 0 1 3.7
6 108 0 2 7.0 104 0 2 5- 6
7 106 0 0 7. 0 102 0 1 6.5
8 106 0 2 8. 8 101 0 1 7- 4
9 104 0 H 12. 3 100 0 1 8.3
10 100 0 0 12. 3 99 0 0 8. 3
11 100 0 1 13. 6 99 0 0 8.3
12 99 59 0 13. 6 99 60 ' 3 12. 5
13 40 39 1 13. 6 30 30 0 12. 5
X=Year after diagnosis of asymptomatic hyperglycaemia; 
0=Number observed X or more year after diagnosis; W=Number 
last observed without worsening between X and next stated 
X year; D=number worsening between this X and next stated 
X year I=estimated cummulative percent incidence of 
worsening at X year.
D 
n z
1 =  1 -  ______________
O W
z - 1/2 n z
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TABLE 13*4.Comparison of Baseline Variables in Those Who 
Did or Did Not Developed Diabetes (Mean and 
Standard Error in Each Group).
Variable Developed
Diabetes
Not Developed 
Diabetes
9 5 % Confidence 
Interval
MALE
Number
Sugar
Age
SBP
DBP
BMI
Cholest
22.0 388.0 
174.3(23.0)*** 89.6(1.8)
54.0(0.3) 
154.5(5-2) 
91.0(3.0)* 
27.6(0.8)* 
229-0(7.3)
Smoking(%) 31.8
54.0(1.3) 
144.0(1.0) 
83.0 (0.6 ) 
25.6 (0 .2 ) 
231.0(1.8) 
44. 8
39.5-129.9
2-14 
0.4-3-6
FEMALE
Number
Sugar
Age
SBP
DBP
BMI
Cholest
16.0 477.0
175.5(23.5 ) * * * 87.4(1.5)
57.7(1.0)* 
162.6 (6.6)* 
89-2(2.6)* 
29..0(1. 2)** 
252.1(8.1 )
Smoking(^) 37-5
54.7(0.2) 
143.7(1.0) 
82.1 (0.6 ) 
25.1(0 .2 ) 
252.5(2.3 ) 
44. 7
42.0-134.2 
0.9-5.1
5.8-32
1.9-12.3 
1.5-6.3
Significantly different 
**P<0.01, ***p<o.001.
from non-diabetics. *p<0.05.
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TABLE 13.5•Bivariate Analysis, Dichotomization of 
Baseline Variables and 12 to 14 Year 
Incidence Rate of Deterioration to Diabetes 
and Risk Factor Status, in Men and Women.
Risk Factor Male Female
________________________   Gender
Incidence Relative Incidence Relative Ratio 
Rate/1000@ Risk (a/b) Rate/1000@ Risk (a/b)
(a)Blood ^126 11. 6 (16) 8.92*** 9.2 (12) 15.3*** 1.3
(b)Glucose <126 1.3 (5) - 0. 6 (3) - 2. 2
(a)Systolic>l60 7.7 (8) 2. 41* 4.8 (7) 2. 82* 1.6
( b )BP <160 3. 2 (13) - 1.7 (8) - 1.9
(a)Diastolic>95 10. 4 (9) 3.71** 3. 2 (3) 1. 39 3. 2
( b ) BP <95 2. 8 (12) - 2.3 (12) - 1. 2
(a)Serum >250 4. 8 (7) 1. 26 1. 8 (6) 0. 58 2.7
(b)Chol. <250 3. 8 (14) - 3. 1 (9) - 1. 2
(a)BMI >2 7 6.3 (11) 2. 10* 6.1 (10) 1.0
(b) <27 3. 0 (10) - 1. 1 (5) - 2.7
(a)Use of Yes 3- 0 (7) 0. 60 2.2 (6)
00o 1. 4
(b)Cigarette No 5.0 (14) - 2. 6 (9) - 1. 9
All 4. 1 (21) _ 2. 4 (15) _ 1.7
©Incidence rate per 1,000 person year of observation. 
Number in brackets refer to number of diabetes.
335
MAPS. FIGURES AMD TABLES
TABLE 13.6.Comparison of Baseline Variables in Index and 
Comparison Groups for Males and Females (Mean 
and Standard Error in Each Group) As Reported 
at Time of Their Participation In Midspan 
Survey and Multiple Correlation Coefficients 
with Blood Sugar.
Variable Index Comparison 95% Cl Regression
Group Group Coefficient
with Blood 
Glucose
Male
Numbers 115 295
Sugar 153-4 (4.6)*** 71.0 (0.8) 72.9-91.2
Age 54.9 (0.5) 53.7 (0.3)
SBP 150.5 (2.2)*** 142.3 (1.1) 3.4-13
DBP 83.7 (1.4) 83.3 (0.7)
BMI 26.3 (0.3)* 25.5 (0.2) 0.1-1.5
Cholest 231.6 (3.0) 
Smoking{%) 34.8
230.6 (2.1 ) 
47. 8*
0
0.
-0
0.
0
4030
1241*
0835
1390**
0008
Female
Numbers
Sugar
Age
SBP
DBP
BMI
Cholest
109
150.2 (3 .6 )***
55.6 (0.5) 
153.4 (2.5)***
83.7 (1.2)
25.9 (0.4)*
254.3 (4.5)
Smoking(%) 39.4
384
73.3 (0.7)
54.6 (0.3) 
141.8 (1.1) 
82.0 (0.6 ) 
25.0 (0.2 ) 
252.0 (2.6 )
45. 8
73.1-80.7 
6 .1-16.7 
0.0-1.8
-0 . 0076 
o.3963***
-0.2364*** 
0.1324**
0.0045
The correlation coefficient calculated based on multiple 
regression model.
The standard error shown in bracket.
Significantly different from comparisons, *P<0.05»
**P<0.01, ***P<0.001.
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TABLE 13.7•Bivariate Analysis, Dichotomization of Baseline 
Variables and 12 to 14 Year Incidence Rates of 
Deterioration to Diabetes and Risk Factor 
Status, in Index and Comparison Groups, in Men 
and Women.
Risk Factor Index Group Comparison Group Index-
Compa-
Incidence
Rate/1000©
RR
(a/b)
Incidence
Rate/1000©
RR
(a/b)
rison
Rate
Ratio
(a)Systolic£l60 14. 8 (6)
Male
1. 44 3. 1 (2) 3. 10 4.77
(b )BP <160 10. 3 (10) - 1. 0 (3) - 10. 62
(a)Diastolic£95 23. 2 (7) 2. 76 3. 5 (3) 3. 72 6. 62
(b )BP <95 8. 4 (9) - 0.9 (2) - 8. 93
(a)Serum £250 11. 7 (5) 1. 01 1.9 (2) 1. 72 6. 16
(b)Chol. <250 11. 6 (11) - 1. 1 (3) - 10. 5k
(a)BMI £27 1 6 . 6 (9) 1. 98 1.7 (2) 1. 42 9.76
(b) <27 8. 4 (7) - 1.2 (3) - 7. 00
(a)Use of Yes 12. 7 (5) 1. 29 1.5 (2) 1. 36 8. k7
(b)Cigarette No 9. 8 (11) - 1.1 (3) - 8. 91
All 11. 5 (1 6 ) 1. 3 (5) - 8. 92
(a)Systolic£l60 11. 5 (6)
Female
1. 4-9 1. 1 (1) 2. 20 10. k5
(b )BP <160 7.7 (6) - 0. 5 (2) - 15. 40
(a)Diastolic£95 13. 2 (3) 1. 57 0. 0 (0) - -
(b )BP <95 8. 4 (9) - 0.7 (3) - 1 1 . 67
(a)Serum £250 5.7 (4) 0. 59 0. 8 (2) 2. 00 7. 50
(b)Chol. <250 9. 6 (8) - 0. 4 (1) - 21. 82
(a)BMI £27 21. 9 (9) 6. k k * * 0 . 8 (1) 1. 4 7 27. 04
(b) <27 3. 4 (3) - 0. 5 (2) - 6. 18
(a)Use of Yes 9 • 6 (5) 1. 07 0. 4 (1) 0. 60 21. 33
(b)Cigarette No 9. 0 (7) - 0.7 (2) - 12. 00
All 9. 2 (12) - 0.6 (3) - 15.33
©Incidence rate per 1,000 person year of observation. 
Number in brackets refer to number of diabetes. 
**P<0.01, 9 5 % confidence interval 2.9-20.5.
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TABLE 13.8.Predictive Value of Casual Post-Prandial Blood
Glucose Value to 12-ia Years Worsening to
Diabetes Mellitus in Men and Women with BMI%
Greater and Lesser than 27 Kg/m.
Item Male Female
BMI<27 BMI^27 BMI<27 BMI>27
Number in Population 
Worsening to Diabetes 
Non-diabetics 
Sensitivity (%) 
Specificity (%)
Positive Predictive Value 
Negative Predictive Value
266 
10 
256 
70 
76. 6 
(%) 10.H 
(%) 98.5
lll2 
11 
131 
81. 8 
71
19.1 
97. 9
358
5
333
60
80. U 
H. 2 
99. 3
13^
10
12^
90 
78. 2 
25 
99
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TABLE 13•9•Multiple Logistic Regression Analysis of the 
Relationship Between Eight Variables and 12-14 
Year Progress to Diabetes.
Variable Logistic
Coefficient
Odds
Ratio
Z-Test 9 5 % Confidence 
Interval
Blood Glucose 1. 24 1 1. 96 6.1*** 5-45-26.1
Gender 0.1660 1. 40 0.9 -
Age 0.1694 1. 40 0 . 9 -
Systolic BP 0.1254 1. 28 0. 6 -
Diastolic BP 0.3294 1. 93 1.7 -
BMI 0.5701 3. 13 3. 2** 1.57-6.24
Cholesterol 0.0381 1. 08 0. 2 -
Smoking 0.0203 1. 04 0 . 1 —
**P<0.01, ***P<0.001.
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TABLE 13•10.Multiple Logistic Analysis of the Relationship 
Between Eight Variables and 12-14 Year 
Progress to Diabetes, in Index Group.
Variable Logistic
Coefficient
Odds
Ratio
Z-Test 95% Confidence 
Interval
Gender 0.2680 1. 71 0.1 -
Age 0.0239 1. 05 0. 1 -
Systolic BP 0.1353 1. 31 0. 0 -
Diastolic BP 0.3544 2. 03 1. 65 -
BMI 0.6893 3. 96 2. 9** 1.75-8.97
Cholesterol -0.1279 0.77 -0.6 -
Smoking 0.0491 1. 10 0.2 —
**P<0.01, ***p<o.001.
340
&SPSRSNCSS
1.Reid DDf Brett GZ, Hamilton PJS, et al:
Cardiorespiratory disease and diabetes among middle aged
male civil servants; a study of screening and
intervention. Lancet 197&; l:&69-4-7&.
2.Welborn TA, Cumpston GM, Cullen KJ et al; The
prevalence of coronary heart disease and associated
factors in an Australian rural community. Am J Epidemiol
1969; 89:521-536.
3-Hollnagel H, McCartney P: Relationship of fasting and
post-load serum glucose to prevalence of ECG abnormalities 
in forty year old men. From the Glostrup Population Study. 
J Chron Dis 1979; 32:709-719.
/l.Pyorala K, Punsar S, Siltanen P et al; Cardiovascular 
survey of policemen in Helsinki. Prevalence of
electrocardiographic abnormalities (abstract). Scan J Clin 
Lab Inves 1 9 6 9 ; 23 (suppl 108):5 3.
5.The North Karelia Project: Community control of 
cardiovascular disease. World Health Organization Regional 
Office for Europe, Copenhagen, 1981.
6.Reunanen A, Pyorala K, Punsar S, et al: Predictive
value of ECG finding with respect to coronary heart 
disease mortality. Adv Cardiol 1978; 21:310-312.
7•Ducimetiere P, Eschwege J, Richard J, Claude J, 
Elgrishi I: Relationship of glucose tolerance to
prevalence of ECG abnormalities and to annual mortality 
from cardiovascular disease: Results of the Paris
Prospective Study. J Chron Dis 1979; 32:759-766.
8.Silva AD, Widner LK, Ziegler HW, Nissen C, Schwlizer W:
3U1
REFERENCES
/
The Basle longitudinal Study: report on the relationship
of initial glucose level to baseline ECG abnormalities, 
peripheral artery disease and subsequent mortality. J 
Chron Dis 1979; 32:797-803.
9.Matheson FAL, Varnam GS: Abnormal electrocardiograms in
apparently healthy people. A long-term follow-up study. 
Circulation I960; 21:196-203-
10.Gordon T, Moore FE, Shurtleff D, Dawber TR: Some 
methodological problems in the long-term study of 
cardiovascular disease -observations in the Framingham 
Study. J Chron Dis 1959; 10:186.
11.Rosenman RH, Friedman M, Straus R, et al.: A predictive 
study of coronary heart disease. JAMA 196&; 189:15- 
12.Stamler J, Rhombery P, Schoenberger JA, et al.: 
Multivariate analysis of the relationship of seven 
variables to blood pressure: finding of the Chicago Heart 
Association Detection Project in Industry 1967-7 2 . J Chron 
Dis 1975; 28:527-
13-Criqui MH, Barrett-Connor E, Austin M: Differences
between respondents and non-respondents in a population- 
based cardiovascular disease study. Am J Epidemiol 1 97 8; 
108:367-372.
l*J..The Pooling Project Research Group: Relationship of
blood pressure, serum cholesterol, smoking habit, relative 
weight and ECG abnormalities to incidence of major 
coronary events: Final report of the Pooling Project. J
Chron Dis 1978; 31:201-306.
1 5 .Hawthorne VM: Tuberculosis and cardio-respiratory
mortality in the Renfrew District of Scotland. A report of
3^2
REFERENCES
the trustees of the Renfrewshire King Edward Memorial
Trust, 1985.
16.International Statistical Classification of Disease, 
Injuries and Cause of Death, Eighth Revision, WHO, Geneva, 
1965:390-&58.
17.WHO Epidem. Vit. Stat. Rep. 1967; 20:535-
18.WHO Chronicle: International work in cardiovascular
diseases. 1969; 23:351-
1 9 .World Health Stat. Annual (1969) Vol. 1 WHO, Geneva, 
1972.
20.Fulton M, Adams W, Lutz W, Oliver MF: Regional
variations in mortality from ischaemic heart disease in 
Britain. Br Heart J 1978; 4-0:563-568.
21.Hawthorne VM, Greaves DA, Beevers DG: Blood pressure in 
a Scottish Town. Br Med J 197^; 3:600-603-
22.Registrar General Scotland Annual Report part 1, 
Mortality Statistics, No. 118, HMO, Edinburgh 1972.
2 3 .MOH Annual Report, Corporation of the City of Glasgow, 
1972.
24-. Howe GM: National Atlas of Disease Mortality in the
United Kingdom, revised edition, the Royal Geography
Society. London: Thomas Nelson and Sons, 1970.
2 5 .Blackburn H: Ischaemic heart disease perspectives for 
prevention. Heart Bull 1971; 2:94-97-
26.Greaves DA, Hawthorne VM, McCartiney HN, Murdoch RM: The 
collaborative study on smoking in Scotland. A preliminary 
report on prevalence rates and values in 10,000 subjects 
by occupation and general population group. University of 
Glasgow, Dept. of Epidemiology and Preventive Medicine, 
1973-
3^3
REFERENCES
27-Miall WE, Brennan PJ: A pilot trial of treatment for
mild hypertension, interim report of the Medical Research 
Council’s Trial in Britain. Clin Sci Mol Med 1975*
[suppl.] 48:165•
28.Truett J, Cornfield J, Kannel W. A multivariate 
analysis of the risk of coronary heart disease in 
Framingham. J Chron Dis 196 7; 20:511.
29.Keen H, Rose GA, Pyke DA, Boyns D, Chlouverakis C, 
Mistry S:Blood sugar and arterial disease. Lancet 1965; 
2:505-508.
30.Ostrander LD, Jr., Francis T, Jr., Hayner NS, Kjeisberg 
MO, Epstein FH: The relationship of cardiovascular disease 
to hyperglycaemia. Ann Intern Med 1 96 5; 62:1188-1198.
31.Jarrett RJ, McCartney PM, Keen H:The Bedford Survey:Ten 
year mortality rates in newly diagnosed diabetics, 
borderline diabetics and normoglycaemic controls and risk 
indices for coronary heart disease in borderline
diabetics. Diabetologia 1982; 22:79-84.
32.Epstein FH: Glucose intolerance and coronary heart
disease incidence -recent observations. Horm Metab Res 
(Suppl 4) 174-180; 1974.
33.Framingham Study, An Epidemiological Investigation of 
Cardiovascular Disease (Section 29); Some Characteristics 
Related to the Incidence of Cardiovascular Disease and 
Death -Framingham Study , 16 Year Follow-up. Washington
DC: U.S. Government Printing Office , 1970.
34.Goodkin G. Mortality Factors in Diabetes. J Occup Med 
1975; 17:716.
35-Fuller JH, Shipley M J , Rose G, Jarrett RJ, Keen 
H:Coronary heart disease risk and impaired glucose
344
REFERENCES
tolerance. Lancet 1980; 1:1373-1376.
36.Stamler R, Stamler J eds. Asymptomatic hyperglycaemia 
and coronary heart disease. J Chron Dis 1979* 32:683-691*
37»Schroll M, Hagerup L: Relationship of fasting blood
glucose to prevalence of ECG abnormalities and 10-yr risk 
of mortality from cardiovascular disease in men born in 
191^: from Glustrop population studies. J Chron Dis 1972;
32:699-707.
3 8 .Stenhouse N, Murphy BP, Welborn TA: Busselton
population study: risk associated with asymptomatic
hyperglycaemia. J Chron Dis 1972; 3 2 :693-6 9 8.
39.Stamler R, Stamler J, Lindberg HA, et al.: Asymptomatic
hyperglycaemia and coronary heart disease in middle aged 
men in two employed populations in Chicago. J Chron Dis 
1979; 32:805-815.
H O .Stamler R, Stamler J, Schoenberger JA et
al.: Relationship of glucose tolerance to prevalence of
ECG abnormalities and to 5-year mortality from 
cardiovascular disease: Findings of the Chicago Heart
Association Detection Project in Industry. J Chron Dis 
1979; 32:817-837.
41.Reunanen A, Pyorala K, Aromaa A, Maatela J, Knekt 
P:Glucose tolerance and coronary heart disease in middle- 
aged Finnish men: Social Insurance Institution's Coronary
Heart Disease Study. J Chron Dis 1979; 32:7**7-756.
*12. Pyorala K, Suvolainen E, Lehtovirta E, Punsar S, 
Siltanen P: Glucose tolerance and coronary heart disease:
Helsinki Policemen Study. J chron Dis 1979; 32:729-7**5«
*13. Fuller JH, McCartney P, Jarrett RJ, et al:
3**5
REFERENCES
Hyperglycaemia and coronary heart disease: The Whitehall
Study. J Chron Dis 1979; 32:721-728.
H U .Hawthorne VM, Gilmour WH: The relationship of glucose 
to prevalence of ECG abnormalities at baseline and to 6-yr 
mortality in Scottish males aged 45-64 yr. J Chron Dis 
1979; 32:787-796.
*15. Eschwege E, Ducimetiere P, Papoz L, Claude JR. Richard 
JL: Blood glucose and coronary heart disease. Lancet 1980,
2:472.
46.Pyorala K, Savolainen G, Kaukola S, Haapakoski J: High 
Plasma Insulin As Coronary Heart Disease Risk Factor. In: 
Eschwege E, ed-Advances in Diabetes Epidemiology. IN SERM 
Symposium No:22. Amsterdam :Elsevier Biomedical Press, 
1982:143.
47.Hickey N, Mulahy R, Daly L, Bourke G, Moriarty J: The
relationship between blood glucose and prevalence of 
coronary heart disease: A study in the Republic of
Ireland. J Chron Dis 1979; 32:767-772.
48.Farinoro E, Panico S, Oriente P, Mancini CM: The
Olivetti Survey: Asymptomatic hyperglycaemia and ECG
abnormalities at baseline. J Chron Dis 1979; 32:773-777.
49.Sakuma K, Hashimoto T, Maeda Y, Kusano S, et al.: 
Report of hyperglycaemia in middle-aged male Japanese 
National Railway Workers. J Chron Dis 1979; 32:779-786.
50.Gordon T, Kannel W B: Predisposition to
atherosclerosis in the head, heart, and legs., The 
Framingham Study. JAMA 1972; 221:661.
51.Fuller J H, Shipley M J, Rose G: Stroke mortality and 
impaired glucose tolerance. The Whitehall Study. 
Diabetologia 1981; 21:272.
346
REFERENCES
52.Sowder WT, Bond JO, William Jr., EH, Fleming EL: Man 
to man talk about women....and men. Florida state Board of 
Health. Monograph Series No. 10. Jacksonville. 1966. 
53-Wingard DL: The sex differential in mortality rates: 
demographic and behavioral factors. Am J Epidemiol 1982; 
115:205-216.
54.Wingard DL, Suareze L, Barrett-Connor E: The sex
differential in mortality from all causes and ischaemic 
heart disease. Am J Epidemiol 198 3; 117:165-172.
55*Waldron I: Why do women live longer than men? So Sci
Med 1976; 10:349-62.
5 6.Retherford RD: The changing sex differential in
mortality. Studies in population and urban demography £ 1. 
Greenwood Press, Westport. CT, 1975-
57*Burbank FUS: Lung cancer death rates begin to rise
proportionately more rapidly for females than for males: a
dose response effect? J Chron Dis 1972; 25:473-
58.Khosla T, Lowe Cr: Obesity and smoking habits by
social class. Br J Prev Med 1972; 26:24-9-256.
59.Cahalan D, Cisin IH, Crossley HM. American drinking 
practices: national study of drinking behaviour and 
attitude. New Brunswick, NJ: Rutgers Centre of alcohol 
studies, 1968.
60.Hammand EC. Smoking in relation to the death rates of 
one million men and women. Nat Cancer Inst Monogr I960; 
19:127.
61.Johnson A: Sex differential in coronary heart disease: 
the explanatory role of primary risk factors. J Health Soc 
Behav 1977; 18:46-54-
REFERENCES
62.Hammoud El: Studies in fetal and infant mortality. Am
J Public Health 1965? 55:1152-1163.
63-Teitelbam MS: Male and female components of perinatal
mortality: international trends, 1901-63* Demography 1971; 
■8:541.
64.McMillen MM: Differential mortality by sex in fetal 
and neonatal death. Science 1979; 204:89-91.
6 5 .Hamilton JB: The role of testicular secretions as 
indicated by the effects of castration in man and by 
studies of pathological conditions and the short life span 
associated with maleness. Recent Prog Horm Res 1948; 
3:257.
66.Ricklefs RE: Fecundity, mortality and avian 
demography. Breeding Biology of Birds (Edited by D.S. 
Farner), PP. 370-390. National Academy of Science, 
Washington, 1973.
67.Caughley G: Mortality patterns in mammals. Ecology 
1966; 47:906.
68.Stolnitz GJ: A century of international mortality
trends: II. Pop Stud 1956; 10:17.
69.Tricomi V, Serr O, Solish C: The ratio of male to 
female embryos as determined by the sex chromatin. Am J 
Obstet Gynecol 196 9; 79:504.
70.Donaldson RS, Kohl SG: Perinatal mortality in twins by
sex. Am J Public Health 1965; 55:1411.
71.Scheinfeld A: The mortality of men and women. Scient Am
1958; 198:22.
72.Madigan FC. Are sex differentials biologically caused? 
Milbank Mem Q 1957; 35:202-223-
73.Hamilton JB, Mestler GE. Mortality and survival:
REFERENCES
Comparison of eunuchs with intact men and women in a 
mentally retarded population. J Gerontol 1969; 24:395.
74.London WT, Rosenberg SE, Draper JW, Almy TP: The 
effect of oestrogens on arthriosclerosis. Am Intern Med 
1961; 55:63.
75-Gerther MM, White PD: Coronary heart disease in young
adults. Harvard University Press. Cambridge, 1954.
7 6 .Furman RH. Endocrine factors in atherogenesis. In 
Atherosclerosis (Edited by F. G. Schottler and G.S. Boyd), 
PP. 375-409- Elsevier Amsterdam, 196 9.
77.Berkson DM, Stamler J, Cohen DB. Ovarian function and 
coronary atherosclerosis. Clin Obstet Gynecol 1964; 7:504.
78.Ask-Upmark E: Life and death without ovaries. Acta Med
Scand 1962, 172:129.
79-Parrish H, Carr CA, Hall DG, King TM: Time interval
from castration in premenopausal women to development of 
excessive coronary atherosclerosis. Am J Obstet Gynecol 
1967; 99:155.
80.Higano N, Robinson RW, Cohen WD: Increased incidence
of cardiovascular disease in castrated women. N Engl J Med 
1963; 268:1123.
81.Ritterband AB, Jaffe IA, Densen PM et al.: Gonadal 
function and the development of coronary heart disease. 
Circulation 1963; 27:237.
82.William TJ, Novak ER: Effect of castration and 
hysterectomy on the female cardiovascular system.
Geriatrics 1963; 18:852.
83.Beavis ELG, Brown JB, Smith MA: Ovarian function after 
hysterectomy with conservation of the ovaries in
349
REFERENCES
premenopausal women. J Obstet Gynaecol Br Commonw 1969; 
76:9 6 9.
84.Baker MG: Psychiatric illness after hysterectomy. Br
Med J 1968; 2:91.
85*Jenkins CD. Psychologic and social precursors of 
coronary disease. New Engl J Med 1971; 284:244-255.
86.Davis ME, Jones RJ, Jarolim C. Long-term oestrogen 
substitution and atherosclerosis. Am J Obstet. Gynecol 
1961; 82:1003.
87-Stamler J, Gest MM, Turner JP: The status of hormonal
therapy for the primary and secondary prevention of 
atherosclerotic coronary heart disease. Prog Cardiovasc 
Dis 1963; 6:220.
88.Veterans Administration Cooperative Urological 
Research Group. Treatment and survival of patients with 
cancer of the prostate. Surgery, Gynecol & Obstet 1967; 
124:1011.
89*Blackard CE, Doe RP, Mellinger GT, Byar DP: Incidence
of cardiovascular disease and death in patients receiving 
diethylstilbestrol for carcinoma of the prostate. Cancer 
1970; 26:249.
90.Winkelstein W Jr., Stenchever MA, Lilienfeld AM: 
Occurrence of pregnancy, abortion, and artificial 
menopause among women with coronary artery disease: a
preliminary study. J Chron Dis 1958; 7:273-86.
91.Kannel WB, Hdortland MC, McNamara PM, et al.: 
Menopause and risk of cardiovascular disease. The 
Framingham Study. Ann Intern Med 197 6; 85:447-52.
92.The Coronary Drug Project. Finding leading to 
discontinuation of the 2.5 mg/day oesterogen group. JAMA
350
REFERENCES
1973; 226:652-7.
93.Mann JI, Vessay MP, Thorogood M, et al.: Myocardial
infarction in young women with special reference to oral 
contraceptive practice. Br Med J 1975; 2:241-249.
94.Heller RF, Jacobs HS: Coronary heart disease in
relation to age, sex and the menopause. Br Med J 1978; 
1:472-474.
95.Haynes SG, Feinleib M, Kannel WB: The relationship of 
psychosocial factors to coronary heart disease in the 
Framingham Study. III. Eight-year incidence of coronary 
heart disease. Am J Epidemiol 1980; 111:37-58.
9 6 .Waldron I, Zyzanski S, Shekelle RB, et al.: The 
coronary prone behavior pattern in employed men and women. 
J Human Stress 1977; 3:2-18.
97.Rosenman RH, Friedman M: Association of specific 
behaviour pattern in women with blood and cardiovascular 
findings. Circulation -1961; 24:1173.
98.Maccoby EE, Jacklin CN: The Psychology of sex
differences. Stanford University Press. Stanford, 1974.
99.Dentan RK. The Semai -A non-violent people of Malaya. 
Holt, Rinehart & Winston, New York, 1968.
lOO.Saario TN, Jacklin CN, Tittle CK. Sex role 
stereotyping in the public schools. Harvard Educ Rev 1973; 
43:386.
101.Bart P: Why women see the future differently from men. 
Learning for tomorrow: The role of the future in education 
(Edited by A. Toffler), PP. 33-55. Random house, New York, 
1972.
102.U*Ren MB: The image of women in textbooks. Women in
351
REFERENCES
Sexist Society (Edited by V. Gormick and R.K. Moran) PP. 
318-328. New American Library, New York, 1971*
103.Rosenman RH: The role of behavior patterns and 
neurogenic factors in the pathogenesis of coronary heart 
disease. Stress and the Heart (Edited by R.S. Eliot). PP. 
123-141. Futura Publ, Mount Kisco, N.Y. 1974.
104.Bengtsson C: Ischaemic heart disease in women. Acta
Med Scand 1973; (Suppl.):549.
105.Gove WR: Sex marital status and mortality. Am J Sociol
1973; 79:45.
106.Wilhelmsen L, Bengtsson C, Elmfeldt D, et al.: 
Multiple risk prediction of myocardial infarction in women 
as compared with men. Br Heart J 1977; 39:1179-1185.
107*Gordon T: Coronary heart disease in young women -
incidence and epidemiology. In: Olive MF, ed. Coronary
heart disease in young women. Edinburgh, London, New York: 
Churchill Livingstone 1978:12-19.
108.Kannel WB: Role of blood pressure in cardiovascular
morbidity and mortality. Prog Cardiovas Dis 1974; 17:5-24.
109•Johansson S, Bergstrand R, Ulvenstam G, et al.: Sex 
differences in preinfarction characteristics and long-term 
survival among patients with myocardial infarction. Am J 
Epidemiol 1984; 119:610-623.
110.Dick TBS, Stone MC: Prevalence of three major risk
factors in random sample of men and women and in patients 
with ischaemic heart disease. Br Heart J 1978; 40:617-26.
111.Friedman GD, Dules LG, Ury HK: Mortality in middle- 
aged smokers and non-smokers. N Engl J Med 1979; 300:213- 
217.
112.Pauli O, Lepper MH, Phelon WH, et al.: A longitudinal
352
REFERENCES
study of coronary heart disease. Circulation 1963; 23:20-
31-
V*
113* Morris JN, Kagan A, Pattison DC, Gardner MJ : Incidence
and prediction of ischaemic heart disease in London 
busmen. Lancet 196 6; 2:553-559*
llii.Keys A, Taylor HL, Blackburn H, Brozek Jt Anderson JT, 
Simonson E: Mortality and coronary heart disease among men 
studied for 23 years. Arch Intern Med 1971; 128:201-21^.
115-Kannel WB, Gordon T, Schwartz MJ: Systolic versus
diastolic blood pressure and the risk of coronary heart 
disease. The Framingham Study. Am J Cardiol 1971; 27:335- 
3&6.
116.Keys A, Arevonis C, Blackburn H, et al.: Probability
of middle aged men developing coronary heart disease in 5 
years. Circulation 1972; 4-5: 815-82 8.
117*Wilhelmsen L, Wedel H, Tibblin G: Multivariate
analysis of risk factors for coronary heart disease. 
Circulation 1973; 38:950-958.
ll8.Lebrach G, Schodel M, Seltzer M, Hart A: Assessing
incidence and risk factors in myocardial infarction. 
Geriatrics 1975; 30:79-93*
119*Roseman RH, Shotz MS, Brand RJ: A study of comparative 
blood pressure measures in predicting risk of coronary 
heart disease. Circulation 1976; 5^:51-58.
120.Lichenstein MJ, Shipley MJ , Rose G: Systolic and 
diastolic blood pressures as predictors of coronary heart 
disease mortality in the Whitehall study. BMJ 1985; 
291:2^3-2^5*
121.Cotton CG, Nixon JM, Carpenter RG, Evans DW: Factors
353
REFERENCES
discriminating men with coronary heart disease from 
healthy controls. Br Heart J 1972; 34:458.
122.Aagetverdal A: Systolic and diastolic blood pressure
as predictors of coronary heart disease in middle aged 
Norwegian men. Br Med J 1987; 294:671-673*
123* Kleenbaum DG, Kupper LL, Cassel JC, Tyroler HA: 
Multivariate analysis of risk of coronary heart disease in 
Evan County, Georgia. Arch Intern Med 1971; 128:943-948.
124.Rabkin SW, Mathewson AL, Tate RB: Predicting risk of
Ischaemic heart disease and cerebrovascular disease from 
systolic and diastolic blood pressure. Ann Intern Med 
1978; 88:342-345*
125*Kannel WB, Wolf PA, Verter J, McNamara PM: 
Epidemiologic assessment of the role of blood pressure in 
stroke. JAMA 1970; 214:301-310.
126.Kannel WB, Dawber TR, Sorlie P, Wolf PA: Component of
blood pressure and risk of artherothrorabotic brain 
infarction: The Framingham Study. Stroke 1976; 7:327-331*
127*Evans PH: Relation of longstanding blood pressure
levels to atherosclerosis. Lancet 1965; 1:516-519.
128.Medical Research Council Committee on chronic 
bronchitis questionnaire on respiratory symptom and 
instruction in its use. Medical Research Council, London, 
1966.
129*Rose G, Blackburn H: Cardiovascular Survey Methods. WHO 
Monograph Series No. 56, Geneva, WHO 1968.
e130.Rose GA, Holland WW, Crowly EA: A sphygmomanometer for
A
epidemiologists. Lancet 1964; 1:296.
131*Rose GA: Standardization of observers in blood pressure 
measurement. Lancet 1965; 1:673*
354
REFERENCES
132.Annon W, Isherwood DM: An automated method for the
direct determination of total serum cholesterol. J Med Lab 
Tech 1969; 26:202-211.
133-Kaddish AH, Little RA, Sternberg JC:A new and rapid 
method for the determination of glucose by measurement of 
rate of oxygen consumption. Clin Chem 1968; 14:116-131- 
134.Garthur (London) LTD. an introduction to routine lung
function tests with the Gathur Vitalograph Brochure No.
J49A. 1st edition, London 1 9 6 3.
135-Manual of the International Statistical Classification 
of Disease, Injuries and Cause of Death. Ninth Revision, 
Genova: World Health Organization 1977-
136.Annual Report of the Regitrar General for Scotland, 
1979- Edinburgh Her Majesty’s Stationary Office. 
137-Elveback LR: How high is high? A proposed alternative
to the normal range. Mayo Clin Proc. 1972; 47:93-
138.Dixon WJ: Biomedical Data Processing (BMDP)
Statistical Software, University of California Press, 
1983-
139-Walker SH. and Duncan DB: Estimation of the
probability on events as a function of several independent 
variables. Biometrika 1967; 54:167-179-
140.Isles CG, Walker LM, Beevers GD et al: Mortality in
patients of Glasgow blood pressure clinic. Journal of 
Hypertension 1986, 4:141-156.
141.Kessler II:Mortality experience of diabetic patients. 
Am J Med 1971; 51:715-724.
142.Pell S, D'Alonzo CA: Factors associated with long-term 
survival of diabetics. JAMA 1970; 214:1833-1840.
355
REFERENCES
143.Jarrett RJ, Keen H: Diabetes and atherosclerosis In: 
Keen H, Jarrett J (eds) Complications of Diabetes. Edward 
Arnold, London 1975; PP. 179-204.
144.West KM: Epidemiology of diabetes and its vascular
lesions. New York:Elsevier, 1978; 159.
145.Liebow IM, Hellerstein HK:Cardiac complications of 
diabetes mellitus. Am J Med 1949; 7:660-670.
146.Katz LN, Stamler J:Experimental atherosclerosis.
Springfield: Charles C.Thomas 1953.
147.Camerini-Du*valos, Cole HS (Eds):Vascular and 
neurological changes in early diabetes. New York: Academic 
Press 1973*
148.International Collaborative Group:Summary and joint 
discussion.J chron Dis 1979; 32:829-837.
149•Ostrander LD Jr., Lamphiear DE:Coronary risk factors 
in a community:Findings in Tecumseh, Michigan. Circulation 
1976; 53:152-156.
150.Kannel WB, McGee DL:Diabetes and cardiovascular risk 
factors:The Framingham Study. Circulation 1979; 59:598-
612.
151.Ostrander LD Jr., Lamphiear DE, Block WD, Williams GW, 
Carman WJ:Physiological variables and diabetic 
status:Findings in Tecumseh Michigan. Arch Intern Med 
1980; 140:1215-1219.
152.Snapper I:Chinese Lessons to Western Medicine. New 
York:Interscience 1941.
153.Shaper AG, Lee KT, Scott RF, Goadale F, Thomas 
WA:Chemico-anatomical studies in the geographic pathology 
of atherosclerosis: Comparison of adipose tissue fatty
acids and plasma lipids in diabetics from East Africa and
356
REFERENCES
the United States with different frequencies of myocardial 
infarction. Am J Cardiol 1962; 10:390-399.
154.McGill HC Jr. (Ed):Geographic pathology of
atherosclerosis. Baltimore: Williams & Wilkins, 1968. 
155.Stamler J, Pick R, Katz LN: Influence of thyroid
pancreatic and adrenal hormones on lipid metabolism and 
--atherosclerosis in animals. In: Hormones and
Atherosclerosis. Proc. Conf. Pincus G (Ed) New 
York:Academic Press, 1959.
1 5 6.Mantel N, Haenszel W:Statistical aspect of the 
analysis of data from retrospective studies of disease. 
Journal of National Cancer Institute 1959; 22:719-748.
157.Gordon T: Glucose tolerance of adults, United States,
1960-68: Diabetes prevalence and results of glucose
tolerance test, by age and sex. National Centre for Health 
Statistics. Vital and Health Statistics, Series 1 No.2. 
Washington, DC: U.S. Government Printing Office, 1964.
158.Hayner NS, Kjelsberg MO, Epstein FH, Francis 
T:Carbohydrate tolerance and diabetes in a total 
community, Tecumseh, Michigan.1.Effects of age, sex and 
test condition on one hour glucose tolerance in adults. 
Diabetes 1965; 14:413.
159.Phillips N, Duffy T:Effect of age, hours since last 
food, time of day, and ketonuria on one-hour glucose 
tolerance. Health Ser Resp 1972; 87:649*
160.Andres R: Aging and diabetes. Med Clin North Am 1971;
55:835.
161.O * Sullivan JB: Age gradient in blood glucose levels:
magnitude and clinical implications. Diabetes 1974;
357
REFERENCES
23:713.
162.Garcia MJ, McNamara PM, Gordon T, et a l M o r b i d i t y  and 
mortality in diabetics in the Framingham population. 
Diabetes 1974; 23:105-111.
1 6 3.Gordon T, Castelli WP, Hjortland MC, et al.:Diabetes 
blood lipids, and the role of obesity in coronary heart 
disease risk for women. The Framingham Study. Ann Int Med 
1977i 87:393-397.
164.Heyden S, Heiss G, Bartel AG, et al.:Sex differences 
in coronary mortality among diabetics in Evan County, 
Georgia. J Chron Dis 1980; 33:265-73-
165-Kannel WB, McGee DL:Diabetes and glucose tolerance as 
risk factor for cardiovascular disease: The Framingham 
Study. Diabetes Care 1979; 2:120-126.
166.Hayward RE, Lucera BC: An investigation into the
mortality of diabetics. J Instit Actuar 1965; 91:286-336.
167-Welborn TA, Wearne K: Coronary heart disease incidence 
and cardiovascular mortality in Busselton with reference 
to glucose and insulin concentrations. Diabetes care 1979; 
2:154-160.
168. Fuller J, Shipley M, Rose G, Jarrett RJ, Keen H: 
Mortality from coronary heart disease and stroke in 
relation to degree of glycaemia: The Whitehall Study. Br 
Med J 1983; 287:867-870.
1 6 9.Butler WJ, Ostrander LD Jr., Carman WJ, Lamphiear DE: 
Mortality from coronary heart disease in the Tecumseh 
Study. Long-term effect of diabetes mellitus, glucose 
tolerance and other risk factors. Am J Epidemiol 1985; 
121:541-547.
170.Yano K, Kagan A, McGee D, Rhoads GG: Glucose
358
REFERENCES
Intolerance and nine-year mortality in Japanese men in 
Hawaii. Am 'J Med 1982; 72:71-80.
171* National Diabetes Data Group: Classification and
diagnosis of diabetes mellitus and other categories of 
glucose intolerance. Diabetes 1979; 28;1039.
172.WHO Expert Committee on Diabetes Mellitus: Second
report. WHO Tech Rep Ser No. 645, 1980.
173*Stamler J, Stamler R, Rhomberg P, et al.: Multivariate 
analysis of the relationship of six variables to blood 
pressure: Finding from Chicago Community Survey, 1965-
1971. J Chron Dis 1975; 28:499-525.
174.Jarrett RJ, Keen H, McCartney M, et al.:Glucose 
tolerance and blood pressure in two population samples: 
Their relation to diabetes mellitus and hypertension. Int 
J Epidemiol 1978; 7:15-24.
175-Nilsen R, Persson G:Smoking habits in diabetics. Lancet 
1972; 1:1283-1284.
176.Czyzyk A, Krolewiski AS:Is cigarette smoking more 
frequent among insulin-treated diabetics? Diabetes 1976; 
25:717-718.
177.Verbrugge LM: Sex differentials in morbidity and
mortality in the United States. Soc Biol 1976; 23:275-96.
178.Jarrett RJ.:Diabetes and heart: Coronary heart disease.
Clin Endocrin Metab 1977; 6:389-402.
179.Keen H: Factors influencing the progress of 
artheriosclerosis in diabetics. Acta Diabetol Lat 1971;
8 (Suppl.):444.
180.Keen H, Jarrett RJ: The effect of carbohydrate 
tolerance on plasma lipids and artheriosclerosis in man.
359
REFERENCES
In: Atherosclerosis. Jones RJ (ed. ). New York: Springer,
P. 453. 1976.
181.Thomas WA, Lee KT, Rabin ER: Fatal acute myocardial 
infarction in diabetic patients. Arch Intern Med 1956; 
98:489-94.
182.Clawson BJ, Bell ET: Incidence of fatal coronary 
disease in non-diabetic and in diabetic patients. Arch 
Pathol 1949; 48:105-6.
183-Gordon T, Castelli WP, Hjortland MC, et al.: 
Predicting coronary heart disease in middle-aged and older 
persons. The Framingham Study. JAMA 1977; 238:497-9. 
l84.Stamler J: Artheriosclerosis coronary heart disease.
In: Sussman KE, Metz RJS, eds. Diabetes mellitus, 4th ed.
New York: American Diabetes Association, 279-41, 1975.
1 8 5.Epstein FH: Glucose intolerance and coronary heart
disease incidence recent observations In: Lipid
Metabolism, Obesity and Diabetes Mellitus: impact upon
atherosclerosis. Hormone and Metabolic Research. Suppl. 
Series No. 4 Levine R. Pfeiffner EF (eds.). Stuttgart. 
Thieme. 1974.
186.Pan WH, Cedres LB, Liu K, et al.: Relationship of 
clinical diabetes and asymptomatic hyperglycaemia to risk 
of coronary heart disease mortality in men and women. Am J 
Epidemiol. 198 6; 123:504-516.
1 8 7.Bailey RR, Beaven DW. Diabetes mellitus and myocardial 
infarction. Aust Ann Med 1 9 6 8; 17:312-4.
l88;Soler NC, Bennett MA, Pentecost BL, et al. Myocardial 
infarction in diabetics. Q J Med 1975; 44:125-32.
l89.Aarseth S: Cardiovascular-renal disease in diabetes
mellitus: A clinical study. Acta Med Scand 1953; Suppl
360
REFERENCES
281:1-252.
190.Krolewski AS, Czyzk A, Janeczko D et al.: Mortality
from cardiovascular disease among diabetes. Diabetologia 
1977; 13:345-50.
191.Barrett-Connor E, Wingard D: Sex differential in
ischaemic heart disease mortality in diabetics. A
prospective population-based study. Am J Epidemiol 1 9 8 3; 
118:489-4-96.
192.Liu, Stamler J, Stamler R, et al.: Methodological
problems in characterising an individual’s plasma glucose 
level. J Chronic Dis 1982; 35:475-85.
193*Robkin SW, Mathewson FA, H su* PH: Relation of body
weight to development of ischaemic heart disease in a 
cohort of young North American men after a 26 year 
observation period. The Manitoba Study .Am J Cardiol 1977; 
39:452.
194.Robertson TL, Kato H, Gordon T, et al.: Epidemiologic 
studies of coronary heart disease and stroke in Japanese 
men living in Japan , Hawaii and California. Am J Cardiol 
1977; 39:244.
195.Chapman JM, Coulson AH, Clark VA, Borun ER: The 
differential effect of serum cholesterol, blood pressure 
and weight on the incidence of myocardial infarction and 
angina pectoris. J Chron Dis 1971; 23:631.
196.Petitti DB, Wingerd J, Pellegrin F, Ramcharan S: Risk 
of vascular disease in women. Smoking, oral
contraceptives, noncontraceptive oestrogens, and other 
factors. JAMA 1979; 242:1150.
197-Heyman A, Karp HR, Heyden S, et al.: Cerebrovascular
361
REFERENCES
disease in the biracial population of Evan County,
Georgia. Arch Intern Med 1971; 128:94-9-955.
198.Chiang BN, Perlman LV, Epstein FH: Overweight and
hypertension. A review. Circulation 1969* 39:4-03. 
199-Kannel WB, Gordon T, Castelli WP: Obesity, lipids, and
glucose intolerance. The Framingham Study. Am J Clin Nutr 
1979; 32:1238.
200.Garrison RJ, Wilson PW, Castelli WP, Feinleib M,
Kannel WB, McNamara PM: Obesity and lipoprotein
cholesterol in the Framingham offspring study. Metabolism
1980; 29:1053.
201. Noppa H, Bengtsson C, Bjorntorp P, Smith U, Tibblin E: 
Overweight in women-metabolic aspects. The population 
study of women in Gotenborg 1968-196 9. Acta Med Scan 
1978; 203:1359.
202.Leren P, Askevald EM, Foss OP, et al.: The Oslo Study. 
Cardiovascular disease in middle aged and young Oslo men. 
Acta Med Scan (Supp 5 8 8):1977*
2 0 3 .Stamler J :Overweight, hypertension, hypercholesterol­
emia and coronary heart disease In: Mancini M, Lewis B,
Contaldo F, eds. Medical complications of obesity. London: 
Academic Press, 191-216, 1979*
204-. Noppa H:Body weight change in relation to incidence of 
ischaemic heart disease and change in risk factors for 
ischaemic heart disease. Am J Epidemiol 1980; 111:693*
205.Ashley FW, Kannel WB:Relation of weight change to 
changes in atherogenic trait: The Framingham Study. J 
Chron Dis 1974; 27:103.
206.Joslin EP: The prevention of diabetes mellitus. JAMA 
1921; 76:79-84.
362
REFERENCES
207-John HF: A summary of findings in 1100 glucose
tolerance estimation. Endocrinology 1929; 13:388-392.
208.Zimmet P: Type 2 (non-insulin-dependent) diabetes -an
epidemiologic overview. Diabetologia 1982; 22:399-411.
209.Hubert HB, Feinleib M, McNamara PM, et al.: Obesity as 
an independent risk factor for cardiovascular disease: a 
26-year follow-up of participants in the Framingham Heart 
Study. Circulation 1983; 67:968-77*
210.Bjorntorp P: Obesity and risk of cardiovascular
disease. Acta Med Scan 1985; 218:145-7*
211.Garrison RJ, Feinlib M, Castelli WP, McNamara PM: 
Cigarette smoking as a confound of the relationship 
between relative weight and long-term mortality: The
Framingham Study. JAMA 1983; 249:199-202.
212.Lew EA, Garfin Kel L: Variation in mortality by weight 
among 750,000 men and women. J Chron Dis 1979; 32:563-576.
213.Jarrett RJ, Shipley MJ, Rose G: Weight and mortality 
in the Whitehall Study. Br Med J 1982; 285:535-537. 
2l4.Sorlie P, Gordon T, Kannel WB: Body build and 
mortality: The Framingham Study. JAMA 1980; 243:1828-31*
215.Larsson B, B^orntorp P, Tibblin G: The health
consequences of moderate obesity. Int J Obs 1981; 5:97-116.
216.Garn SM, Hawthorne VM, Pilkington JJ, Pesick 
SD: Fatness and mortality in the west of Scotland. Am J
Clin Nutr 1983; 38:313-319*
217.Keys A: Seven Countries: A multivariate analysis of
death and coronary heart disease, Cambridge,
Massachusetts, and London, England: Harvard University
Press, 1980.
363
REFERENCES
218.Keys A: Overweight, obesity, coronary heart disease
and mortality. Nutr Rev 1980; 38:297-307.
219*Hubert HB: The nature of relationship between obesity
and cardiovascular disease. Int J Cardiol. 1984; 6:268-74.
220.Barrett-Connor EL: Obesity, atherosclerosis, and
coronary artery disease. Ann Intern Med 1985; 103:1010-
1019.
221.Keys A, Aravanis C, Blackburn H, et al: Coronary heart 
disease, overweight and obesity as risk factors. Ann 
Intern Med. 1972; 77:15-27.
222.Herdon G. Causes of excess mortality in man. Acta 
Genet 1952; 3:351-75.
223.Enterline PE: Causes of death responsible for recent
increases in sex mortality differentials in the United 
States. Milbank Mem Fund Q 1961; 39:312-28.
224.Yerushalmy J. - Factors in human longevity. Am J Publ 
Health 1 9 6 3; 53:148.
225.Report of the Royal College of Physicians. Smoking and 
health now. Pitman, London, 1971.
226.Epstein FH, Ostrander SD, Johnson BC, et al.: 
Epidemiologic studies of cardiovascular disease in total
community- Tecumseh, Michigan. Ann Intern Med 1965;
62:1170-1187.
227.Stamler J, Berkson DM, Mordonner L, et al.: 
Epidemiologic studies on atherosclerosis, coronary heart 
disease, causative factors and consequent preventive 
approaches. Prog Biochem Pharmacol 1968; 4:30-49- 
228. Doyle JT, Heslin AS, Hilleboe HE, Formel PF: Early
diagnosis of Ischaemic heart disease. N Eng J Med 1959;
261:1096-1101.
364
REFERENCES
229*Build and blood pressure study, 1959 Vol 1. Chicago, 
Society of Actuaries, 1959.
230.Oberman A, Harlan WR, Smith M, Graybiel A:The 
cardiovascular risk associated with different levels and 
types of elevated blood pressure. Minn Med 1969; 52:1283- 
231-Friedberg CK: Disease of the heart, 3rd ed.
Philadelphia W.B. Saunders Co., 1966 P 1475.
232.Harrison TR: Principal of Internal Medicine, 7th ed.
New York, McGraw-hill, 1974. P 1236.
233-Report of the joint National Committee on detection, 
evaluation and treatment of high blood pressure. Arch 
Intern Med 1980; 140:1280-1285.
234.Finfillman S, Worcel M, Agrest A: Hemodynamic pattern 
in essential hypertension. Circulation 1965; 31:356-3 6 8 .
235.Frochlich ED, Tarazi RC, Dustan HP: Reexamination of 
the hemodynamics of hypertension. Am J Med Sci 1969; 
257:9-23.
236.Brand RJ, Rosenman RH, Soltz RT, Friedman M: 
Multivariate prediction of coronary heart disease in the 
Western Collaborative Group Study compared to the finding 
of Framingham Study. Circulation 1976; 53:348-355-
237.Page LB, Sidd JJ: Medical management of primary 
hypertension (part 1). N Engl J Med 1972; 2 8 7 :960-9 6 7 .
238.Veterans Administration Cooperative Study Group on 
Antihypertensive Agents. Effect of treatment on morbidity 
in hypertension: Results in patients with diastolic blood 
pressure averaging 115 through 120 mmHg. JAMA 1967; 
2 0 2:102 8.
239.Randall OS: Effect of arterial compliance on systolic
365
REFERENCES
blood pressure and cardiac function. Clin Exp Hypertens 
[A] 1982; 4:1045-57.
240.Cambient F, Chretien JM, Ducimetiere P, Guize L, 
Richard JL: Is the relationship between blood pressure and 
cardiovascular risk depend on body mass index. Am J 
Epidemiol 1985; 122:434-42.
241. Kannel WB: Current status of the epidemiology of brain 
infarction associated with occlusive arterial disease. 
Stroke 1971; 2:295-318.
242.Chapman JM, Reeden LG, Rowen ER, Clark VA, Coulson 
AH: Epidemiology of vascular lesions affecting the central 
nervous system: The occurrence of stroke in a sample
population under observation for cardiovascular disease.
Am J Public Health I960; 56:191-201.
243*Berkson DM, Stamler J: Epidemiological findings on
cerebrovascular disease and their implications. J
Atheroscler Res 1965; 5:189-202.
244.Gubner RS: Life expectancy in the young hypertensive.
In: Brest AN, Moyeer JH, eds. Hypertension: Recent
advances. Philadelphia: Lea & Febiger, 1961: 18-23-
245-Gubner RS: Systolic hypertension. A pathogenetic
entity. Significance and therapeutic considerations. Am J 
Cardiol 1962; 9:773-76.
246.Kannel WB, Dawber TR: Hypertension as an ingredient of 
a cardiovascular risk profile. Br J Hosp Med 1974; 11:508-
23.
247-Wolf PA: Hypertension as a risk factor for stroke.
Whisnant JP, Sandok BA, eds. Ninth Princeton Conference, 
Cerebral Vascular Disease. New York. Grune and stratton, 
1975: 105-13.
366
REFERENCES
248.Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, 
Castelli WP: Systolic blood pressure, arterial rigidity 
and risk of stroke. The Framingham Study. JAMA, 
1981;245:1225-29.
249.Fisher CM: The ascendancy of diastolic blood pressure
over systolic: Lancet, 1985: 1349-50.
250.MacMahon B, Pugh TF: Epidemiology: Principles and
Methods. Boston, Little Brown and Co. 1970, PP 218-220, 
224-226.
251-Modan B: Some methodological aspects of a
retrospective follow-up study. Am J Epidemiol 1965; 
82:297-304.
252.Sims AC: Importance of a high tracing rate in long­
term medical follow-up studies. Lancet 1973; 2:433-435- 
253-Theodore A, Berger AG, Palmer CE: Follow-up study of
tuberculosis in former student nurses. J Chronic Dis 1956; 
3:499-520.
254.Boice JD: Follow-up methods to trace women treated
for pulmonary tuberculosis. Am J Epidemiol 1978; 107:127-
139-
255.Redmond CK, Smith EM, Lioyd JW et al.:Long-term
mortality study of steelworkers. III. Follow-up. J Occup 
Med 1969; 11:513-521.
2 5 6.Paffenbarger RS, Wing AL, Hyde RT: Physical activity
as an index of heart attack risk in college alumni. Am J 
Epidemiol 1978; 108:161-175-
257-Dawber Tr, Kannel WB, Lyell LP: An approach to
longitudinal studies in a community: The Framingham study.
Ann NY Acad Sci 1963; 107:539-556.
367
REFERENCES
258.Acheson ED: Medical record linkage. London, Oxford
University Press, 1 96 7.
259. Collins Cobuild English Language Dictionary. The 
University of Birmingham, Collins Publishers, London 1987.
260.Dunn HL: Record linkage. Am J Public Health 1946;
36:1412.
261.Newcombe HB, Kennedy JM, Axford SJ, James AP: Automatic 
linkage of vital records. Science 1959; 130:954.
262.Skegg DCG: Medical record linkage. In: Monitoring for
drug safety, Inman WHD (ed) 19SO, pp 337-348, Lancaster, 
MTP press.
2 6 3 .Jones RB, Hedley AJ: Improving the quality of data in
a computerised patient master index: implications for
costs and patient care. Effective Health Care 1984; 2:97-
102.
264.Jones SJ, Hedley AJ, Curtis B, Allison SP: Do we need 
thyroid follow-up registers? A cost-effective study. 
Lancet 1982:1229-1233-
2 6 5 .Waterhouse J, Muir C, Correa P et al: Cancer incidence 
in five continents. Volume 3- Lyon, France, IARC, 1976.
266.Heasman MA, Clark JA: Medical Record Linkage in 
Scotland. Health Bull. (Edinb.) 1979; 37:97-103-
2 6 7 .Graham PA, Wallace J, Welsby E et al: Evaluation of
postal detection of registrable blindness. Br J Prev Soc 
Med 1968; 22:238-241.
268.Bahn AK: Psychiatric case register conference, 1965- 
Public Health Rep 1966; 81:748-54.
269.Gordis L, Lilienfield A, Rodriguez R: A community wide 
study of acute rheumatic fever in adults. JAMA 1969; 
2 1 0 :862-6 5 .
368
REFERENCES
270.Feller I, Crane KH: National burn Information
exchange. Sure Clin North Am 1970; 50:1^25-36.
271.Pole D J : Myocardial infarction incidence: Methods,
validity and preliminary experience of a coronary 
register. Med J Aust 1972; 2:1^81-8^1.
272.Whitie L: The central registry for child abuse cases:
Rethinkine basic assumptions. Child Welfare 1977; 5 6 :761- 
67.
273*Charters AC, Bailey JA: Experience with a simplified
trauma registry: Profile of trauma at a university
hospital. J Trauma 1979; 19:13-17.
27^•Goldberg J, Gelfand HM, Levy PS: Registry evaluation 
methods: A review and case study. Epidemiologic Review
198 0; 2 :210-2 2 0.
275-Baldwin JA: Medical record linkage. Medicine 197^;
35 :20^8-2050.
276.Department of Health and Social Security and Scottish 
Home and Health Department, (1973). Security of the census 
of population. Cmnd 5365. London, HMSO.
277.Scottish Home and Health Department (1978). 
Confidentiality of medical records held on computers. NHS 
Circular 1978 (GEN) 23.
2 7 8.Lockwood E: Accuracy of Scottish hospital morbidity 
data. Br J Prev Soc Med 1971; 25:76-83.
279.Martini CJM, Hughes AD, Patton V: A study of the 
validity of the hospital activity analysis information. 
British Journal of Preventive and Social Medicine 1976; 
30:180-186.
280.Patel AR, Gray G, Lang GD, Baillie FGH, Fleming L,
369
REFERENCES
-Wilson GM: Scottish hospital morbidity data-2. An attempt
to improve the standard of diagnositic entries and records 
in a medical unit. Health Bull (Edinb) 1976; 34:221-227.
281.Patel AR, Gray G, Lang GD, Baillie FGH, Fleming L, 
Wilson GM: Scottish hospital morbidity data-3- some
suggestions for improvement of the accuracy. Health Bull 
(Edinb) 1976; 34:227-228.
282.Cold DR: Assessment of cerebrovascular morbidity in 
Fife. Public Health 1988, 102:141-1/15.
283-Heliovaraa M, Reunanen A, Aromaa A, Knekt P, Aho K, 
Suhonen O: Validity of hospital discharge data in a
prospective epidemiological study on stroke and myocardial 
infarction. Acta Med Scand 1984; 2 1 6:309-1 5 .
284.Alderson MR, Meade TW: Accuracy of diagnosis on death 
certificates compared with that in hospital records. Br J 
Prev Soc Med 1967; 21:22-29.
2 8 5 .Beadenkopf WG, Abrams M, Daoud A et al: An assessment
of certain medical aspects of death certificate data for 
epidemiologic study.of arteriosclerotic heart disease. J 
Chron Dis 1963; 16:249-262.
286.Britton M: Diagnostic error discovered at autopsy.
Acta Med Scand 1974; 196:203-210.
2 8 7.Dorn HF, Cutler SS: Comparison of death certificates
and case reports in morbidity from cancer in the United 
States. Pub Health Mon 1959; 56:117-124.
288.Fedrick J, Butler NR: Accuracy of registered causes of 
neonatal deaths in 1958. Br J Prev Soc Med 1972; 26:101- 
105.
289.Gwynne JF: The unreliability of death certificates. N
Z Med J 1974; 80(526):336.
370
REFERENCES
290.Heasman MA, Lipworth 1: Accuracy of certification of
cause of death: Studies on medical and population
subjects. HMSO. London No 20, 1 96 6.
291*James G, Patton RE, Heslin AS: Accuracy of cause of
death statements on death certificates. Pub Health Rep 
1955; 70(1):39-51*
292.Paton BC: The accuracy of diagnosis of myocardial
infarction: A clinicopathologic study. Am J Med 1957;
23:761-68.
293*Bonser GM, Thomas GM: An investigation of the validity 
of death certification of cancer of lung in leeds. Br J 
Cancer 1959; 13(1):1-12.
294.Rosenblatt MB, Teng PK, Kerpe S, et al: Causes of
death in 1,000 consecutive autopsies. New York State J Med 
Sep. 15. 1971; 2189-2193.
295-Flory C, Du V, Senter MG, et al: A study of validity
of diagnosis of stroke in mortality data II: Comparison by
computer of autopsy and clinical records with death 
certificates. Am J Epi 1969; 89(1):15-24.
296.Kuller L, Blanch T, Havlik R: Analysis of validity of
cerebrovascular disease mortality statistics in Maryland. J 
Chron Dis 1967; 20:841-51.
297.Schoenberg BS and Powell JM: Statistics on stroke: A
pilot study of the clinical evidence justifying the 
reporting of stroke on death certificates in Alameda 
County, California. Cal Med 1968; 109(1):19-23.
2 9 8.Gorham LW: A study of pulmonary embolism. Part 1A.
Clinicopathological investigation of 100 cases of massive 
embolism of the pulmonary artery: Diagnosis by physical
371
REFERENCES
signs and differentiation from acute myocardial 
infarction. Arch Int Med 196I; 108:8.
299.Hook EB, Farina MA, Hoff MB: Death certificate reports
of cardiovascular disorders in children: Comparison with
diagnoses in a paediatric cardiology registry. J Chron Dis
1977; 3 0 :383-9 1.
300.Khoury SA: Death certificate and tuberculosis register 
cards. A correlation study of 108 cases. Am Rev Respir Dis 
1971; 104(6):936-37.
301.McCarthy PD, Walsh D: Suicide in Dublin: I. The under
reporting of suicide and the consequences for national 
statistics. Br J Psychiatry Apr 1975; 126:301-8.
302.Walsh G, Walsh D, Whelan B: Suicide in Dublin: II. The
influence of some social and medical factors on coroner’s 
verdicts. Br J Psychiatry Apr 1975; 126:309-12.
3 0 3 .Ross D, Kreitman N: A further investigation of
differences in the suicide rates of England and Wales and 
Scotland. Br J Psychiatry Dec 1975; 127:575-82.
304.Miller RW: Childhood cancer and congenital defects. A
study of United States death certificates during the 
period 1960-1 96 6. Pediatr Red 1969; 3(5)*389-97. 
305*Rossman I: True incidence of pulmonary embolization
and vital statistics. JAMA 1974; 230(12):1677-79-
306.Mitchell RS, Maisel JC, Dart GA, et al: The accuracy
of death certificate in reporting cause of death in 
adults: With special reference to chronic bronchitis and
emphysema. Am Rev Resp Dis 1971; 104:844-50.
307.Murphy T: Certification of death from cancer of the 
uterus. J Irish Med Assn 1967; 6 0 (3 6 3):385-88.
308.Rose G, Oxon DM: Errors in the classification of fatal
372
REFERENCES
pericarditis. Lancet 1966; 851.
309. Gittelsohn A, Senning J: Studies on the reliability of 
vital and health records: I. Comparison of cause of death 
and hospital record diagnoses. Am J Public Health 1979; 
69:680-89.
310.Hole D J, Clarke JA, Hawthorne VM, Murdoch RM: Cohort 
follow-up using computer linkage with routinely collected 
data. J Chron Dis 1981; 34:291-297.
311.Hedley AJ, McMaster W: Use of the National Health 
Service Central Register for medical research purposes. 
Health Bulletin 1988; 46:63-68.
312.Angus J, Cameron L, Finlayson CF, Hopkins RT, Martin 
KB, Scott JH: The Tayside master patient index. Dundee: 
Tayside Health Board 1978.
313.Hedley AJ, Alexander EA, Innes G: Patient
identification and documentation of causes of death in a 
follow-up register. Health Bulletin 1977; 35:73-77.
314. Jones R, Hedley A, Gale E: Identification of diabetic 
patients treated with insulin or oral hyperglycaemics 
within a defined population. Community Medicine 198 6; 
8:104-10.
315.O'Sullivan JB, Mahan CM: Blood sugar levels,
glycosuria, and body weight related to development of 
diabetes mellitus. JAMA 1965; 194:117-122.
3 1 6.Diabetes Survey Working Party: A diabetes survey. Br 
Med J 1962; 1:1497-1503.
317.Diabetes Survey Working Party: Five-year follow-up 
report on Birmingham Diabetes Survey of 1962. Br Med J 
1970; 111:301-305.
373
REFERENCES
318.Diabetes Survey Working Party: Ten-year follow-up
report on Birmingham Diabetes Survey of 1961. Br Med J 
1976; 11:35-57.
319.O ’Sullivan JB, Mahan CM: Prospective study of 352
young patients with chemical diabetes. N Engl J Med 1968; 
278:1038-1041.
320.Stowers JM: Treatment of chemical diabetes with
chlorpropamide and the associated mortality. Adv Metab 
Disord 1973; [Suppl.] 2:549-555.
321.Feldman RF, Craword D, Elashoff R, Glass A: Progress 
report on the prophylactic use of oral hyperglycaemic 
drugs in asymptomatic diabetes: neurovascular studies. Adv 
Metab Disord 1973; [Suppl.] 2:557-567*
322.Carlstrom S, Lundquist A, Lundquist I, Norden A,
Schersten B, Wollmark G: Studies in subjects with positive
post-prandial Clinistix test. Acta Med Scand. 1971;
189:415-422.
323.Kobberling J, Kattermann R, Arnold A: Follow-up of
"non-diabetic” relatives of diabetics by re-testing oral 
glucose tolerance after 5 years. Diabetologia 1975; 
11:451-456.
324.Jarrett R J, Keen H: Hyperglycaemia and diabetes
mellitus. Lancet 1976; 11:1009-1012.
325*Jarrett R J , Keen H, Fuller JH, McCartney M: Worsening
to diabetes in men with impaired glucose tolerance 
("borderline diabetes"). Diabetologia 1979; 16:25-30.
326.O ’Sullivan JB, Hurwitz D: Spontaneous remissions in
early diabetes mellitus. Arch Int Med 1966; 117:769-774.
327.Merrell M, Shulman LE: Determination of prognosis in
chronic disease, illustrated by systemic lupus
374
REFERENCES
erythraatosus. J Chron Die 1955; 1:12-32.
328.Ingelfinger JAf Mosteller F, Thibodeau LA, Ware JH: 
Biostatistics in clinical medicine. Macmillan Publishing 
Co., INC., New York, Toronto, London.
329.Epstein FH: Hyperglycaemia. A risk factor in coronary
heart disease. Circulation 1967; 3 6 :60 9.
330 .Keen H, Jarrett RJ: Modern concepts in the diagnosis
of diabetes. In: The management of stable adult diabetes, 
ed. C. Weller; Chapter 1, P 3 . Thomas, Springfield, III. 
1969.
331-Dornan C, Fowler G, Mann JI, Marhus A, Thorogood M: A
community study of diabetes in Oxfordshire. J R Coll Gen 
Pract 1983; 37:151-155.
332.Hatano S: Observer variations in the diagnosis of 
stroke. WHO Collaborative Study on the Control of Stroke 
in the Community. JPN Heart J 1977; 18:171-177.
333.Cameron HM, McGoogon ES, Clarke J, Wilson B: Trends in
hospital necrospy rate: Scotland 1961-74. Br Med J 1977;
1:1577-1580.
334. Kirkendall WM, Burton AC, Epstein FH, et al.: 
Recommendations for human blood pressure determination by 
sphygmomanometer. Circulation 196 7; 3 6 :980-9 8 8.
335-Uemura K, Pisa Z: Recent trends in cardiovascular
disease mortality in 27 industrialized countries. World 
Health Statistical Quarterly 1985; 38:142-162.
336.Haberman S, Capildeo R, Rose FC:The changing mortality 
of cerebrovascular disease. QJ Med 1978; 47:71-88.
337.Acheson RM: Mortality from cerebrovascular accidents 
and hypertension in the Republic of Ireland. Br J Prev Soc
375
REFERENCES
Med I960; 14:139-147.
338.Recent trends ±n mortality from cerebrovascular 
disease. Stat Bull Metropol Life Ins Co 1975; 56(11):2-4. 
339.Soltero I, Liu K, Cooper R. Stamler Jt Garside D: 
Trends in mortality from cerebrovascular diseases in the 
United States,i960 to 1975. Stroke 1978; 9:549-558.
340.Tanaka H, Tanaka Y, Hayashi M, et al.: Secular trends 
in mortality for cerebrovascular diseases in Japan ,1960 
to 1976. Stroke 1982; 13:574-581.
341.Whisnant JP: The decline of stroke. Stroke 1984; 
15:160-8 .
342.Alfredsson 1, VonArbin M, DeFaire U: Mortality from 
and incidence of stroke in Stockholm. BMJ 198 6; 292:1299- 
1303.
343.Anonymous: Why has stroke mortality declined?
[Editorial]. Lancet 1983; 1:1195-6.
344.Soltero I, Cooper R: Improved hypertension control and
decline in cardiovascular mortality. Comper Ther 1980; 6:60-
64.
345.Levy RT, Moskowitz J:Cardiovascular Research: Decade
of progress, a decade of promise. Science 1982; 217:121-9*
346.Bonita R, Beaglehole R: Does treatment of hypertension 
explain the decline in mortality from stroke. Br Med J 
1986; 292:191-192.
347.Jackson RT, Beaglehole R, Stewart AW: Blood pressure 
levels and treatment of hypertension in Auckland , NZ Med 
J 1983; 96:751-4.
348.Annual Report of the Registrar General for Scotland, 
1968 and 1979. Edinburgh, Her Majesty’s Stationery Office.
349.Draep N, Smith H: Applied regression analysis. 2nd
376
REFERENCES
ed. New York: John Wiley and Sons, 1981.
350.Armitage P: Statistical methods in medical research. 
Oxford: Blackwell Scientific Publications, chapter 9 and
12, 1971.
350.Annual Report of the Registrar General for Scotland 
1 98 5. Edinburgh, Her Majesty’s Stationery Office.
351.Lilienfeld AM: Foundation of Epidemiology. New York:
Oxford University Press. Chapter 5. 1976.
352.Yate PO: A change in the pattern of cerebrovascular 
disease. Lancet 1964; 1 :65-6 9 .
353.Israel RA, Klebba AJ: A preliminary report on the
effect of eighth revision ICDA on cause of death 
statistics. Am J Public Health 1969; 59:1651-1660.
354.Florey CDV, Senter MG, Acheson RM: A study of the 
validity of the diagnosis of stroke in mortality data. I. 
Certificate analysis. Yale J Biol Med 1 96 7? 40:148-163.
355.Peodoe HT. Stroke In: Miller DL, Farmer RD, eds.,
Epidemiology of Diseases, Blackwell Scientific
Publication Chapter 9, 136-145, 1 9 8 2.
356.Kurtzke JF: Epidemiology of cerebrovascular disease,
cerebrovascular survey report for joint council 
subcommittee on cerebrovascular disease. National
Institute of Neurological and Communicative Disorders and 
Stroke and National Heart and Lung Institute (revised), 
Jan 1976, Rochester, Minn, Whiting Press PP 213-242.
357.Moriyama I, Kruger DE, Stamler J: Cardiovascular 
diseases in the United States, Cambridge, Harvard 
University Press 1971.
358.Kuller et al.: Nationwide cerebrovascular mortality
377
REFERENCES
study (IV): comparison of the different clinical types of
cerebrovascular disease. Am J Epidemiol 1969; 90:567-578.
359.Manton KG, Baum HM: CVD mortality, 1968-
1978: Observations and implications. Stroke 1984; 15:451-
7.
3 6 0 .Editorial: Cerebral Infarction and Myocardial
Infarction : A similar aetiology? Lancet 1978; 1:1239-
1246.
361. Annual Report of the Registrar General in Scotland 
1977. Edinburgh, Her Majesty’s Stationery Office.
362.Garraway WM, Whisnant JP, Drury I: The changing
pattern of survival following stroke. Stroke 1983; 14:699- 
703.
363.Kannel WB, Gordon T, (eds):The Framingham Study -An 
Epidemiological Investigation of Cardiovascular Disease. 
Section 30: Some characteristics related to the incidence
of cardiovascular disease and death: Framingham Study; 18-
year follow-up. US Wash. DC. DHEW, Public Health Service. 
National Institute of Health, 1970.
364.Risk factors in stroke due to cerebral infarction, 
statement by the Council on Cerebrovascular Disease, 
American Heart Association. Stroke 1971; 2:423-428. 
365*Haberman S, Capideo R, Rose FS: Epidemiological
Aspects of Stroke. In: Greenhalgh RM. Rose FC eds.
Progress in Stroke Research. Tunbridge Wells: Pitman
Medical 3-14;1979-
3 6 6.Subcommittee on Risk Factors and Stroke of the Stroke 
Council. Risk Factors in Stroke. Special Report. Stroke 
1984; 15:1105-11.
367.Kannel WB: Epidemiology of cerebrovascular disease.
378
REFERENCES
•In: Russell, RWR, ed. Cerebral arterial disease. Edinburgh 
Churchill Livingstone, 1976.
368.The General Household Survey, Office of Population 
Census and Surveys, Social Survey Division, London: Her
Majesty’s Stationery Office 1972-84.
369-General Household Survey, OPCS Monitor GHS 83/3 Issued 
5 July 1983. Office of Population Census and Surveys. 
Information Branch, London: St. Catherines House, 10
Kingsway, London WC2B 5JP.
370.Lee PN, ed: Statistics of smoking in the United
Kingdom. Tobacco Research Council, Research paper No. 1, 
7th ed. London: Tobaco Research Council, 1976.
371-Florey CDV, Melia RJM, Darby SC: Changing mortality
from ischaemic heart disease in Great Britain 1968-1976. 
Br Med J 1978; 1:635-677.
372.Veteran Administration Cooperative Study Group on 
Antihypertensive Agents. Effect of treatment on morbidity 
in hypertension: results in patients with diastolic blood 
pressure averaging 115 through 125 mmHg. JAMA 1967; 
202:1143-52.
373.Hypertension Detection and Follow-up Programme 
Cooperative Group. Five year finding of the hypertension 
detection and follow-up programme. III. Reduction in 
stroke incidence among persons with high blood pressure. 
JAMA 1982; 247:633-8.
379
APPENDIX A
THE RENFREW AN£> PAISLEY QUESTIONNAIRE Aim 
COPE SCHEDULE
380
CONFIDENTIAL
mid span health plan
conducted by the
Renfrewshire King Edward Memorial Trust.
Glasgow M M R Cardiorespiratory Screening Unit and the 
Department of Epidemiology and Preventive Medicine 
of the University of Glasgow.
C *  - 3 o $ *  9^ )
VI
VI
For official use only
1.01 1.02 1.03 1.04 1.05
*
1.06 1.07
M M R reference number
Questionnaire and 
Health Record
This form may look a little long and difficult, but in fact 
it takes only a few minutes to answer.
PA iS'LE.y 
C N  *
( v ? D O  ha r u i . )
Vi c£g/v\. PAtJ If v&
Please answer all the questions in this health record and 
bring it with you when you come to the unit 
Write a tick ( \ / )  in the appropriate answer box.
If you cannot give an exact answer, give the best guess you can.
1 Surname (Mr.. Mrs., Miss) . .  . .  .<.......................................
(BLOCK LETTERS)
If married or divorced woman—
Birth Surname (Maiden Name) ................................................
First N am e(s) ..................................................................
Address...........................................................................................i
Home Telephone Number ........................................... .............
National Health Service Number................................................
(if known)
Place of B irth ................................................................................
2  Sex...........................................  , P ' 2- ' )
3 Are you
1 □  Married? 3 □  Single?
2 □  Widowed? 4 □  Other?
4 What is your date of birth?
Day of Month Month Year
1.08 1.09 1.10 1.11 1.12 1.13 1.14
1.15 1.16 1.17 1.18 1.19 1.20
1.21
1.22
***■»
1.23 1.24 1.25 T 26 1.27 ,1.28
I ~Z •KJ ■?
For official use only
5 What is your usual occupation?
If retired, please give last full-time occupation.
If you are a whole-time housewife, what is your husband's occupation ? . 
Please describe as fully as possible.
1.29 1.30 1.31
t
6 Family Doctor. Dr 
Address.....................
7 How much walking altogether do you do on the way to and from work on 
an average day? If you are a housewife, how much walking altogether do 
you do to and from the shops ? :
minutes
8 Do you usually bring up any phlegm from your chest first thing in the 
morning in the winter?
1 □  Yes 2 □  No
If 'No', go to question 11.
9 Do you bring up phlegm like this on most days for as much as three 
months in the winter each year?
1 □  Yes 2 □  No
10 In the past three years have you had a period of increased cough and 
phlegm lasting for three weeks or more?
1 □  Yes— 1 period 3 □  No
2 □  Yes— 2 or more periods
11 Do you get short of breath walking with people of your own age on 
level ground?
1 □  Yes 2 □  No
12 Does your chest sound wheezy or whistling on most days (or nights) ? 
1 □  Yes 2 D  No
13 Does the weather affect your breathing ? 
a 1 □  Yes 2 □  No
If 'No', go to question 14.
b If'Yes':
1 Specify type of weather
2 Does it make your breathing
1 □  worse? 2 □  better?
3SZ
1.32 1.33
A
1.34
o
1.35
Q
1.35
1 C
1.37
/?
1.38
ir.
1.39
J?
1.40
\ n
1.41
14 Do you smoke more than 5 cigarettes each day now? 
a 1 □  Yes 2 □  No
' b if Y e s :
1 How many cigarettes do you usually smoke on an average day ?
2 At what age did you start smoking ?
3 Do you inhale? 
1 D  Ves 2 □  No
15 If you do not smoke cigarettes now. did you ever smoke more than 5 a 
day regularly?
a 1 □  Yes 2 □  No. never
b if Yes':
1 At what age did you start smoking ?
2 At what age did you stop smoking ?
3 What is the most you ever smoked per day for as long as a year?
16 a Have you ever had any pain or discomfort in your chest?
1 O' Yes 2 □  No (If 'No', goto question 17)
b Dp you get this pain or discomfort when you walk uphill or hurry?
1 0  Yes 2 □  No
c Do you get it when you walk at an ordinary pace on th4 level ?
1 □  Yes 2 0  No
d When you get any pain or discomfort in your chest what do vou do?
1 □  Stop
2 [Q^SIowdown
3 □  Continue at the same speed
e Does it go away when you stand still ?
1 Er Yes 2 □  No
f  If ye  s', how soon ?
1 0  10 minutes or less
2 □  More than 10 minutes
g Where do you get this pain or discomfort? Mark the place(s) with X 
on the diagram
Right side Left side
17 Have you ever had a severe pain across the front of your chest lasting 
for half an hour or more? /
1 □  Yes 2 E  No
1 1.45
'
o
■J
1.48
w
For official use only
'P« w'
1.43 I 1.44
It'
• 1
1.43 1.50
I
1.51
2
i
1.52
2
1.53
/
1.54
1.55
* L !
1.56
1.57
1.58
/
1.59 
* t\
1.60
~CjJ
1.61
1.62
18 Are you. or have you ever been diabetic?
1 □  Yes
2 □  No
3 □  Do not know
19 Have you ever been in hospital ? 
a 1 □  Yes 2 □  No
If Yes' please give the following information for each time you went 
into hospital.
b Year Nature of illness or what was wrong ?
1     ......................
2  .. ............
3 ......................................................................... ............................................
4 ...................... ......................
(Continue on a separate sheet of paper if necessary.)
20 1 Have you ever had a stroke (shock) ?
1 □  Yes 2 □  No
2 Have you ever, without warning:
a suddenly lost the power of an arm ?
1 □  Yes 2 □  No
b suddenly lost the power of a leg ?
1 □  Yes 2 □  No
c suddenly been unable to speak properly ?
1 □  Yes 2 □  No
d suddenly lost consciousness ?
1 D  Yes 2 □  No
3 Do you ever complain of headaches on one side of your head ? 
1 □  Yes 2 □  No
21 Are you under the doctor for heart or blood pressure ? 
1 □  Yes 2 □  No
22 Do you suffer from, or have you ever suffered from: 
a Asthma ?
1 □  Yes 2 □  No
b Hay fever? ^  
1 □  Yes 2 □  No
I understand that everything which could identify me will be treated 
as strictly confidential.
I do not object to any of my hospital records being looked at by 
members of the ('■jam to help them in the survey.
0
r—:— —- — r-r the results of my examination to be sent I do not wish
to my family doctor.
Signature
Thank you for your help
For official use only
1.63 
<*■> **
1.64
•*%
1.65 1.66 1.67 1.68
1.69
3 ^
1.70
1.71
* *  f
1.72
1.73
1.74
Vi
1.75
1.76
4 i
1.77
1.78 1.79
1.80
For official use only
2.04 2.05 2.052.01 2.02 2.03 2.07
M.M.R. reference number
2.122.08 2.09 2.112.10 2.13
Date
BLOOD PRESSURE
2.14 2.16
1 Systolic
2.17 2.18 2.19
2 Diastolic
2.20 2.21
n»Blood Pressure Observer
CHEST X-RAY 2.22 2.23
HISTORY
TINE TEST 
Self reading
2.25
I 2.26 
! tr<
Tine tester 2.27 2.28
Tine Test Observer 2.302.29
SPUTUM
Direct
2.31
2.32Culture
BLOOD
Serum cholesterol
2.34 2.352.33
2.36 2.38
Sugar
2.402.39
Blood sampler
''Yxnoojy.vC (jovofrt-
2.442.42 2.43
2.45
& 9
2.46 2.47 2.48ANTHROPOMETRY 
Height (without shoes) cms.
2.522.512 49
Weight (indoor clothing) kilos.
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E.C.G. i
IV
VII VIII
E.C.G. Summary 
Operator 
Coder 
Adjudicator
in
VI
IX
M.M.R. reference number
3.01 3.02 3.03 3.04 3.05 3.06 3.07
RESPIRATORY FUNCTION 
F.E.V. 1.0
3.08 3.03 3.10
F.V.C.
3.11 3.12 3.13
Respiratory Function Tester 3.14
9
3.15
I
i 2.55 2.56 ii 2.57 2.58 ii 2.59 2.60
iv 2.61 2.62 v 2.63 2.64 vi 2.65 2.66
vii 2.67 2.68 viii 2.69 2.70 i* 2.71 2.72
2.73
2.74
4
2.75
*>
2.76
4
2.77
>
2.78
4
2.79
8
2.80
2
CATEGORY
3.16 3.17
2.
Interviewer or questionnaire checker
Coder
Checker
3.18 3.19
3.20 3.21
3.22 3.23
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Secondary Screening
Date
Systolic
Diastolic
Observer
Serum Cholesterol
Sugar
Blood sampler 
Time of sample
E.C.G. i
IV
vit VIII
in
VI
IX
E.C.G. Summary 
Operator
Coder
Adjudicator
V
3.24 3.25
3
3.26
?
3.27 3.28 3.29
5"
3.30 3.31 3.32
3.33 3.34
n
3.35
3.36 3.37
3.38
<
3.39
w
3.40
3.41 3.42
7 ?
3.43
3.44 3.45
3.46 3.47
3
3.48 3.49
i 3.50 3.51 ii 3.52 3.S3 ii 3.54 3.55
iv 3.56 3.57 v 3.58 3.59 Vi 3.60 3.61
vii 3.62 3.63 viii 3.64 3.65 ix 3.66 3.67
3.68
3.69 3.70
3.71 3.72
3.73 3.74
3.75 3.76 3.77 3.78 3.79
'A;-\L'
w*». 
♦ .
S
.* * * ) >
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3.E0
3
M.M.R. reference number
Number of Contacts
Contacts X-rayed
4.01 ' 4.02 4.03 4.04 4.05 4.06 4.07
Contacts
Positive X-rays
Contacts Tine Tested
Positive Tine Tests
Contacts sputa
direct
culture
FINAL CATEGORY
C.O.D.
Group C.O.D.
Survey No.
of U . '^ 6  - H :&t
Serial Obs. No. TcvNrc h- - i+ m ULt. (F *?. i)
J  0 ' 8 5 " 1
X m  i; X i T il 4-* ‘ k ?
388 % , « ? .  ^
4.08 4.09
4.10 4.11
4.12 4.13
4.14 4.15
4.16 4.17
4.18 4 19
I 4.20 4.21
! 4.22
i
4.23
4.24s4.252
4.26 4.27
82
4.28 4.29
4.30
8U
•
4.31 4.32 4.23
4.34 4.35
4 26 4.37 4.38 4.39 4.40 4.41 4.42
4.43 4.44 4.45 4.4 C 4.47 4.48 4.4D
4.80
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2. CARD 1 : QUESTIONNAIRE CODES
Question
No. Item Code Box
'M.M.R. RECORD NO. X-Ray Ref. Number 1.01 - 1.07 (7) v
1. NATIONAL HEALTH SERVICE NO. Standard 13-Digit 
Number
1.08 - 1.20 (13)
2. SEX
Male
Female
1
2 1.21 a w
3. MARITAL STATUS Pre-coded 1.22 (1) V>
i
4. DATE OF BIRTH
Day
Month
Year
01 - 31 
01 - 12
Last two digits
1.23 - 1.24 
1.25 - 1.26 
1.27 - 1.28
(2)
( 2 W
(2)*/
5. OCCUPATION From Registrar- 
General 's 
Classification
1.29 - 1.31 (3) ✓
7. EXERCISE ON WAY TO WORK 
BRONCHITIS
Code No. of 
minutes
1.32 - 1.34 (3)*/
8. PHLEGM Pre-coded 1.35 (1)
9. PERSISTENT PHLEGM Pre-coded 1.36 (1)
10. PHLEGM INFECTION Pre-coded 1.37 (1)
11. DYSPNOEA Pre-coded 1.38 (1)
12. HYPERSECRETION Pre-coded 1.39 (1)
13(a) SUSCEPTIBILITY TO ATMOSPHERIC 
POLLUTION
No effect 
Code 2
1.40 (1)
13(bl) CODE 3 CODE 4 CODE 5 If yes, look (1.40)
Fog Cold Rain 
Mist Cool damp Damp 
Smog Frost Humid 
Winter, wind
at 13b and 
codo 3-7 as 
appropriate
390 J
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CARD 1
1 Question 
No. I ten*. Code Box
13(bl) 
(Contd.)
CODE 6 
Sun
Exceptionally, or very warm or hot
Warm Summer
Warm
Windless Humidity 
Dry Summer Heat 
Airless or Sultry 
Clammy, heavy or close.
(1.40)
%
s '
CODE 7 
Other
Sunny and showery 
Before rain
All weather except sunny days 
Climatic position
Where more than one condition code 
according to priority - e.g.,
Code 3 preferred to Code 4, etc.
If yes, look at 
13b and code 3-7 
as appropriate
(1.40)
■
13(b2) Effect on breathing
CIGARETTES
Pre-coded 1.41 C D
14(a) SMOKER Pre-coded 1.42 (i) ✓
14(bl) NUMBER Code actual 
number smoked 
(99 = 100 or 
more). If 
range use mean 
01 - 99 1.43 - 1.44 (2) J
14(b2) AGE WHEN SMOKING BEGAN Code age given. 
(For ages up to 
nine years, code 
01, 02, etc.) 1.45 - 1.46 ( 2 K
14(b3) INHALATION
EX-SMOKERS
Pre-coded 1.47 (1) '
15(a) SMOKING Pre-coded 1.48 (1) ^
*5(bl) AGE WHEN SMOKING BEGAN Code age given. 
(For ages up to 
nine yoars, codo 
01, 02, etc.) 1.49 " 1.50 (2 ) '
15(b2) AGE WHEN SMOKING STOPPED Code age given 1.51 - 1.52 (2)S
15(b3) MAXIMUM SMOKED Code as for 14(bl) 1.53 - 1.54 (2)'/
391
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CARD 1
| Question 
No.
•
I tom Code Box |
16(a)
ISCHAEMIC HEART DISEASE 
GENERAL CHEST PAIN Pre-coded 1.55 '
%
(1) -
16(b) PAIN ON MARKED EXERTION Pre-coded 1.56 (1)/
16(c) PAIN ON EXERTION Pre-coded 1.57 a y
16(d) ACTION ON PAIN Pre-coded 1.58 a)*/
16(e) EFFECT ON PAIN Pre-coded 1.59 (i)'
16(f) DURATION OF PAIN Pre-coded 1.60 (1) v
16(g) LOCATION OF PAIN:
Sternum (upper/middle third) 1 1.61 ( D -
17
Sternum (lower third) 
Left chest and left arm 
Left chest only 
Left arm only 
Other
(Priority in order) 
SEVERE CHEST PAIN
2
3
4
5 .
6
Pre-coded
(1.61)
(1.61)
(1.61)
(1.61)
(1.61)
1.62 (i) >'
18
DIABETES 
DIABETES ~ EXISTENCE OF Pre-coded 1 .63 a)*'
19(a)
HOSPITAL HISTORY 
HOSPITAL ADMISSION Pre-coded 1.64 (i)
19(b) NUMBER OF ADMISSIONS
Enter total number of admissions 
ni (9 = 9 or more) opposite appro­
priate heading, as follows:-
NUMBER OF ADMISSIONS FOR BRONCHITIS, 
PNEUMONIA, AND OTHER CHEST DISEASES, 
INCLUDING INFLUENZA. 1.65 (i) ✓
NUMBER OF ADMISSIONS FOR HEART 
DISEASE n2 1.66
NUMBER OF .ADMISSIONS FOR PEPTIC 
(GASTRIC OR DUODENAL) ULCER n 3 1.67 (i) "
NUMBER OF ADMISSIONS FOR RHEUMATIC 
FEVER, CHOREA, AND OTHER CONDITIONS, 
INCLUDING INJURIES n4 1.68 ( l ) J
392
CARD 1
Question
No.
20 /1
20/2(a)
(b)
(c)
(d)
20/3
21
22(a)
22(b)
I tem
STROKE
STROKE - EXISTENCE OF
LOSS OF POWER
Arm
Leg
Speech
Consciousness
HEADACHES
HEART OR BLOOD PRESSURE 
DOCTOR CONSULTATION
ASTHMA AND HAY-FEVER 
ASTHMA ~ EXISTENCE OF 
HAY-FEVER - EXISTENCE OF
No. of years of residence at 
stated address.
CARD SERIAL NUMBER PRINTED 1
Code
Pre-coded
Pre-coded 
Pre-coded 
Pre-coded 
Pre-coded
Pre-coded
Pre-coded
Pre-coded
Pre-coded
Act. No. of years 1.78 - 1.79 (2)
(rounded up)
Box
1.69
1.70
1.71
1.72
1.73
1.74
1.75
1.76
1.77
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
/
J
'/
Pre-printed 1 .80 (1)
393
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3. CARD 2 : • HEALTH CHECK CODES
Item
OBJECTIVE DATA
M.M.R. RECORD NO.
DATE
Code day 
Code month 
Code year
BLOOD PRESSURE
SYSTOLIC
DIASTOLIC
BLOOD PRESSURE OBSERVER
CHEST X-RAY 
STANDARD M.M.R. CLASSIFICATION
31. No abnormality
01. Abnormalities of the Bony Thorax
and Soft Tissues - congenital 
to include abnormalities of 
Ribs 
Spine 
Sternum 
Bifid Ribs or Depressed 
Sternum
e.g. depressed sternum 
spina bifida 
wedge vertebrae.
02. Abnormalities of the Bony Thorax
and Soft Tissues - acquired 
e . g . fractures
malformation due to polio 
osteo-chondritis of the 
dorsal spine 
tuberculosis 
Paget's disease 
actinomycosis 
Fracture of rib, Scoliosis, 
Kyphoscoliosis.
qo /i
Code
As on Questionn­
aire
1.01 - 1.07
01 “ 31 
01 -  12
Last two digits
Code actual read­
ing
Code actual read­
ing
Observer's code 
number
01 - 31
31
01
02
Box
2.01 - 2.07 (7)
2.08 - 2.09 (2) f
2.10 - 2.11 (2) 
2.12 - 2.13 (2) 'Y
2.14 - 2.16 (3)
2.17 - 2.19 (3) >'
2.20 - 2.21 (2)
2.22 - 2.23 (2)
(2.22 - 2.23) 
(2.22 - 2.23)
(2.22 - 2.23)
- 7 -
CARD
Item Code Box
03. Tumours of the Bony Thorax - prim­
ary and secondary: 
e.g. osteo-chondromata 
chondromata 
fibromata 
sacromata 
reticulosis
04. Congenital malformations of the
lungs:
to include lobar malformations 
accessory lobes 
azygos lobe 
agenesis
ectopic segments 
haercartoma 
haemangiomas 
arterio-venous 
aneurysms
05. Bacterial and virus infection of
the lungs: 
to include lung abscess 
pneumonitis 
pneumonia 
to exclude infections secondary to 
malignancy and all aspiration 
chemical pneumonias.
06. Other infections of the lungs:.
to include hydatid disease 
syphilis
fungus infection 
histoplasmosis
07. Bronchiectasis
08. Honeycomb lung
09. Emphysema
to-include hypertrophic 
bullous 
obstructive 
interstitial
10. Pulmonary fibrosis - non tuber­
culous 
to include asthma
bronchitis
post-infective fibrosis 
secondary to pneumon­
itis (suppurative 
pneumonias) and chemical 
pneumonias, oil achalas­
ia fumes,etc.
Fibrosis and bronchial 
thickening.
03
04
05
06
07
08 
09
10
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23) 
(2.22 - 2.23) 
(2.22 - 2.23)
(2.22 - 2.23)
395
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CARD 2
Item
11. Pneumoconiosis 
Asbestosis 
Inhalation fibrosis
12. Spontaneous pneumothorax
13. Benign tumours of the lungs and
mediastinum:
to include pulmonary fibromas 
endothiliomas 
neurofibromas 
substernal thyroid 
all mediastinal cysts 
exastosis of the rib
14. Carcinoma or other malignant disease
of the lung and mediastinum, (neo­
plasm)
15. Metastases in the lung and mediastinum
16. Enlarged mediastinal and bronchial
glands - non tuberculous 
to include reticulosis
glandular fever and other 
rare causes except 
Hodgkin’s disease 
enlarged roots 
hilar adenitis 
lymph adenitis 
enlarged cervical 
g]ands
17. Sarcoidosis and collagenous diseases
to include glandular and pulmonary 
stages.
18. Pleural thickening or calcification
(non tuberculous) to include 
sequelae of empyema (adhesions) 
liaemothorax etc. 
pleurisy
calcification of the 
pleura 
pleural effusion.
19. Abnormalities of the diaphragm and
oesophagus - congenital and acquired: 
to include all types of hernia 
cardiospasm
oesophageal strictures 
diverticula
eventration of.diaphragm
Code
11
12
13
14
15
16
17
18
19
Box
(2.22 - 2.23)
(2.22 - 2.23) 
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23) 
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23)
396
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CARD 2
.Item
20. Congenital abnormalities of heart and
vessels:
to include abnormal venous drainage 
dextro-cardia 
right-sided aorta, etc. 
Congenital malformation of heart 
Unfolded aorta 
Cardiac enlargement
21. Acquired abnormalities of heart and
vessels:
to include aneurysms
haemosiderosis, etc.
acquired
mitral stenosis 
hypertension 
restricted pericardium
22. Miscellaneous:
to include empyema
foreign body in lung etc.
pne umonec tonty
embolism
23. Pneumoconiosis with tuberculosis 
2-1. Pulmonary tuberculosis. Active
25. Pulmonary tuberculosis. Of doubtful
activity but requiring observation.
26. Tuberculous pleural effusion without
demonstrable pulmonary lesion 
(tuberculous pleurisy)
27. Tuberculosis - inactive and healed -
primary
calcified glands 
healed primary 
calcified pleural plaque 
calcified arch of aorta
28. Tuberculosis - inactive and healed -
post primary 
inactive P.T. 
tuberculoma
29. For Chest Clinic.use
30. Not yet diagnosed.
Code
20
21
22
23
24
25
26 
27
28
29
30
Box
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23) 
(2.22 - 2.23) 
(2.22 - 2.23)
(2.22 - 2.23) 
(2.22 - 2.23)
(2.22 - 2.23)
(2.22 - 2.23) 
(2.22 - 2.23)
397
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CARD 2
•
Item
- ---------  _. ,..
Code Box
HISTORY
from M.M.R. Card .
(Code first disease 2.24 (1)
given)
Chest disease including T.B. 1 (2.24) J
Coronary disease 2 (2.24)
Heart disease other than coronary 3 (2.24)
Hypertension 4 (2.24)
Peripheral vascular disease 5 (2.24)
Diabetes 6 (2.24)
Other 7 (2.24)
. TINE TEST
SELF-READING 1 - 6 2.25 (1)
Nothing to see 1 (2.25)
Very pale reaction 2 (2.25)
1 - 4  raised dots 3 (2.25) i
4 raised red dots running into each I
other 4 • (2.25)
A raised red lump £ inch or more across 5 (2.25)
Other 6 (2.25)
OESERVER READING Code as above 1 - 6 2.26 (i)
TINE TESTER Tester's code 2.27 - 2.28 (2)
number
TINE TEST OBSERVER Observer's code 2.29 - 2.30 (2)
number
SPUTUM
DIRECT
Negative 1 2.31 (1)
Positive 2 (2.31)
CULTURE
Negative 1 2.32 (1>
Positive 2 (2.32)
BLOOD
SERUM CHOLESTEROL in mem. per cent. Code actual 2.33 - 2.35 (3) ^
val ue
SUGAR Code actual 2.36 - 2.38 (3)-"
value
BLOOD SAMPLER Sampler's code 2.39 - 2.40 (2)
. number
IEAET MEASUREIjENT n 2.41 - 2.42 (2)
H , 398 2.43 - 2.44 (2)
- 11 - 
CARD 2
• I tem Code Box
ANGINA
GRADE 4 
No to IS(a) 4 2.45
. %
(1)
GRADE 1
Yes to 16(a) and 16(b) and 
No to 16(c), and 
Stop or Slow down to 16(d) and 
Yes to 16(e\ and 
10 minutes or less to 16(f), and 
’X* on sternum or left anterior 
chest + left arm 1 (2.45)
GRADE 2
As grade 1, but 
Yes to 16(c) 2 (2.45)
GRADE 3
Yes to 16(a) + any other answers 3 (2.45)
HEIGHT Code cms. 2.46 - 2.48 (3)^
WEIGHT Code kilos 2.49 - 2.52 ( 4 H
OBSERVER Observer’s code 
number 2.53 - 2.54 (2)
E.C.G.
MINNESOTA CODE Code actual read- 
• ing for each 
number in the 
corresponding 
two boxes
2.55 “ 2.72 (18)
E.C.G. SUMMARY
a. 1:1, 1:2, 7:1
b. 1:3, 4:1, 4:2, 4:3, 5:1, 5:2, 
5:3
c. All other codes except those 
in code 1 and code 2
d. If (i) = 1.0
1
2
3
9
2.73
(2.73)
(2.73)
(2.73)
(1)
OPERATOR Operator's code 
number 2.74 - 2.75 (2)
CODER Coder's code 
number 2 . 76  - 2 . 77 ( 2 )
ADJUDICATOR
1
Adjudicator’s code 
number 2.78 - 2 . 7 9 (2)
CARD SERIAL NO. PRINTED 2 j Pre-printed 2.80 (1)
- 12 -
4. CARD 3 : HEALTH CHECK CODES (Contd.)
Item
M.M.R. RECORD NO.
RESPIRATORY FUNCTION
F.E.V. 1
F.V.C.
RESPIRATORY FUNCTION TESTER
CATEGORY
If only screened once - enter code in 
box 3.17. If recalled for secondary 
screening enter 9 in box 3.17 and 
code in box 4.25. 9 in box 3.17
will indicate a recall for secondary 
screening. 9 in box 4.25 will 
indicate that the person concerned 
has died between primary and second­
ary screening.
Bl
Who treat 
Who control 
C
D
NOT E : Any person who does not fit 
into the above categories 
will be left blank. O will 
not be used.
INTERVIEWER OR QUESTIONNAIRE CHECKER
CODER
CHECKER
Code
As in Questionnaire 
Boxes 1.01 - 1.07
Box
3.01 - 3.07 (7)
Code actual figure 3.08 - 3.30 (3)
Code actual figure I 3.11 - 3.13 (3)
Tester’s code 
number
01
02
03
04
05
06
07
08
Checker's code 
number
Coder's code
Checker’s code 
number
3.14 - 3.35 (2)
3.16 - 3.17 
(3.16 - 3.17) 
(3.16 - 3.17) 
(3.16 - 3.17)
(3.16 - 3.17) 
(3.16 - 3.17) 
(3.16 - 3.17) 
(3.16 - 3.17) 
(3.16 - 3.17)
(2)
3.18 - 3.19 (2)
3.20 - 3.21 (2)
3.22 - 3.23 (2)
400
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CARD 3
Item Code Box
SECONDARY SCREENING
*
DATE.
Code day 
Code month 
Code year
01 - 31 
0 1 - 1 2
Last two digits
3.24 - 3.25 
3.26 - 3.27 
3.28 - 3.29
(2)-' 
(2) ' 
(2) "
BLOOD PRESSURE
SYSTOLIC Code actual read­
ing
3.30 - 3.32 (3 y
DIASTOLIC Code actual read­
ing
3.33 - 3.35 (3)y
BLOOD PRESSURE OBSERVER Observer’s code 3.36 - 3.37 (2)i-
number
BLOOD •
SERUM CHOLESTEROL in m g m . per cent. Code actual value 3.38 ~ 3.40 (3)o
SUGAR Code actual value 3.41 - 3.43 (3)-'
BLOOD SAMPLER Sampler’s code 
number
3.44 - 3.45 /(2)
TIME OF SAMPLE Code hour and min­
ute using 24-hour 
clock
3.46 - 3.49 (4)
E.C.G.
MINNESOTA CODE Code actual read­
ing for each num­
ber in the corres­
ponding two boxes.
3.50 - 3.67 (18)
E.C.G. SUMMARY
a. 1:1, 1:2, 7:1
b. 1:3, 4:1, 4:2, 4:3, 5:1, 5:2, 
5:3
c. All other codes except those 
in code 1 and code 2
d. I I U ) =  1.0
1
2
3
9
3.68
(3.G8)
(3.68)
(3.68)
(1)
i
OPERATOR Operator’s code 
number 3.69 - 3.70 (2) i
1
401
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CARD 3
I lera
CODER
ADJUDICATOR
Area of Residence 
SPARE
CARD SERIAL NUMBER PRINTED 3
402
Code
Coder's code number
Adjudicator’s code 
number 
1 or 2
Pre-printed
Box
3.71 - 3.72 » (2)
3.73 - 3.74
3.75
3.76 - 3.79 
3.80
(2)
(1)
(4)
(1)
1^. CARD 4 : HEALTH ClfECK CODES (Contd.)
Item Code Box
M.M.R. RECORD NO. Code Number in 
questionnaire 
boxes 1.01 - 1.07 4.01 - 4.07 (7)
CONTACTS
NUMBER OF CONTACTS Code number 4.08 - 4.09 (2 )y
CONTACTS X-RAYED Code number 4.10 - 4.11 (2)
'■ POSITIVE X-RAYS Code number 4.12 - 4.13 (2)
CONTACTS TINE-TESTED Code number 4.14 - 4.15 (2)
POSITIVE TINT: TESTS Code number 4.16 - 4.17 (2)
CONTACTS
SPUTA Code number 4.18 - 4.19 (2)
DIRECT Code number 4.20 - 4 . 2 1 (2)
CULTURE Code number 4.22 - 4 . 2 3 (2)
FINAL CATEGORY
If only screened once - enter in 
box 3.17. If recalled for second­
ary screening enter 9 in box 3.17 
and code in box 4.25. 9 .in box 
3.17 will indicate a recall for 
secondary screening. 9 in box 
4.25 will indicate that the person 
concerned has died between primary 
and secondary screening.
4.24 - 4.25 (2)-/
A 01 (4.24 - 25)
Bl 02 (4.24 - 25)
B2 03 (4.24 - 25)
D 3 04
(4.24 - 25)
Who treat 05 (4.24 - 25)
Who control 06 (4.24 - 25)
C 07 (4.24 - 25)
D 08 (4.24 - 25)
NOTE: Any person who does not fit 
into the above categories 
will be left blank. 0 will 
not be used.
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CARD 4
Item
DECEASED
C.O.D.
This is a three figure number, but 
in some cases may be subdivided, 
e.g., 286.2. Therefore the first 
three boxes are the three figure 
numbers, and the fourth box is 
the sub-division.
GROUP CLASSIFICATION OF DECEASED
Coronary Heart Disease + hypertension
Cerebral Vascular Disease + hyper­
tension ~
Other Vascular Disease
Lung Cancer
Chronic Bronchitis
Respiratory Infarctions
Other
Unknown
SURVEY NUMBER
SERIAL OBSERVATION NO.
DATE OP DEATH 
RISK SCORE
*Na/CO
*K
02
Hb. (mark in RED on front
questionnaire results of 
10 and under)
CO
*Pb
♦Treatment
SPARE 
NEUROSIS 
CARD SERIAL NO. 
PRINTED 4
40*i
Code
Use International 
Classification of 
Diseases. Eighth 
Revision
CODE DAY
CODE MONTH
CODE YEAR
CODE ACTUAL VALUE
to 1 decimal place
Negative = 1 
Positive = 2 
PRE-PRINTED
Box
4.26 - 4.29 (4 :
4.30 (1)
(4.30)
(4.30)
(4.30)
(4.30)
(4.30)
(4.30)
(4.30)
(4.30)
4.31 - 4.33 (3)
4.34 - 4.35 (2)
4.36 - 4.37 (2)
4.38 - 4.39 (2)
4.40 - 4.41 (2)
4.42 - 4.44 (3)
4.45 - 4.47 (3)
4.48 - 4.49 (2)
4.50 - 4.52 (3)
4.53 - 4.55 (3)
4.56 - 4.58 (3)
4.59 - 4.61 (3)
4.62 - 4.63 (2)
4.64 - 4.78 (15)
4.79 (1)
4.80 (1)
APPENDIX R
FOLLOW-UP Q.UESTIQNNAIRE. AND REMINDER LETTERS.
University of- Glasgow 
Department of Community Medicine 
2 , Lilybank Gardens,
Glasgow G12 8QQ.
MIDSPAN HEALTH PLAN
FOLLOW-UP SURVEY CONDUCTED BY THE DEPARTMENT OF COMMUNITY MEDICINE,
UNIVERSITY OF GLASGOW
Dear
You may remember that about 10-14 years ago, you participated in a research 
project (called MIDSPAN) in which you completed a questionnaire and had a 
medical check-up. We wish to follow-up this study to find out more about 
the health of these people now. We hope you will be able to help us in 
this research by answering all the following questions and returning the 
questionnaire in the prepaid envelope.
All information will be used only by the doctors engaged in this survey and 
will not be available to any other person.
Yours sincerely,
A.J. Hedley.
Professor of Public Health.
Please could you check these details, ticking the left hand column if 
correct, or writing corrections in the right hand column if incorrect.
TICK BOX IF CORRECT OR . ENTER CORRECTIONS HERE
f 1 ......................
[ ] ......................
[ ] ......................
[ ]      .....
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Please tick W l  the appropriate box or answer in the space provided. If 
you can not give the exact answer, please give the best guess you can.
The first few questions are about diabetes. We are interested to find out 
how many people who were known not to have diabetes at the time of the 
earlier survey have since developed it
1. Did a doctor ever tell you that you had diabetes (that is Sugar Diabetes 
or sugar in your urine)?
[ ] YES [ ] NO [ ]  DON’T KNOW.
When ? ............... .................
If you have diabetes, please answer questions 2-4.
If not, then go to question 5»
2. Have you ever been admitted to hospital for diabetes? 
[ ] YES [ ] NO
When ?......................  For how long ?.........
At which hospital? ..................................
3. Have you ever had any treatment for diabetes?
[ ] NO [ ] YES If yes, which (Insulin injections []
type of (Tablets []
treatment? (Others ...............
(specify)
If you have never been treated for diabetes, go to question 5*
4. In which year were you first treated for diabetes ? 19_[___ ]
Do you still receive treatment for diabetes? [ ]YES [ ] NO
If not, in which year did you stop being treated? 19 [ _]
5. What is your weight now? [ ] Stones [ ] pounds
(Indoor clothes and without shoes)
6. What is your height now (without shoes)? [ ] Feet [ ] Inches
I DO NOT OBJECT TO MY MEDICAL RECORDS BEING LOOKED AT BY A MEMBER OF THE 
HEALTH TEAM TO HELP THEM IN THE SURVEY.
SIGNATURE :
YOU HAVE COMPLETED THE QUESTIONNAIRE. THANK YOU VERY MUCH FOR YOUR HELP. 
PLEASE RETURN IT IN THE PREPAID ENVELOPE
UNIVERSITY OF GLASGOW
Department of Community Medicine
2 Lilybank Gardens 
Glasgow G12 8QQ 
Telephone: 041-339 8855 
Direct Dialling: 041-330 5013 
Telex: 777070 UNIGLA
Bnry Meehan Chair of Public Health & Head of Department 
rofessor A J Hedley MD FRCP FFCM
RBJ/17. 
January, 1988,
Dear
MIDSPAN HEALTH PLAN
A few weeks ago, we wrote.to you hoping that you would be able to help 
us with a research project by completing and returning a 
questionnaire. So far we have not received a reply from you. In case 
you did not receive our original request we enclose a further copy of 
the original letter and questionnaire and hope that you will be able 
to help us.
With best wishes.
Yours sincerely,
A.J. Hedley,
Professor of Public Health.
UNIVERSITY OF GLASGOW
Department of Community Medicine
2 Lilybank Gardens 
Glasgow G12 8QQ 
Telephone: 041-339 8855 
Direct Dialling: 041-330 5013 
Telex: 777070 UNIGLA
lenry Meehan Chair of Public Health & Head of Department 
jrofessor A J Hedley MD FRCP FFCM
RBJ/17.
March, 1988.
Dear
ARGYLL & CLYDE HEALTH BOARD 
MIDSPAN HEALTH PLAN
A few weeks ago, we wrote to you hoping that you would he able to help 
us with a follow-up enquiry to the "Midspan" health examination of the 
1970’s. So far we have not received a completed questionnaire from 
you. In case you did not receive our original request we enclose a 
further copy of the original letter and questionnaire. We hope that 
you will be able to help us with this health survey.
With best wishes.
Yours sincerely,
A.J. Hedley,
Professor of Public Health.
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2 Lilybank Gardens 
Glasgow G12 8QQ 
Telephone: 041-339 8855 
Direct Dialling: 041-330 5013 
Telex: 777070 UNIGLA
RBJ/17.
Dear Dr.
ARGYLL & CLYDE HEALTH BOARD 
FOLLOW-UP TO MIDSPAN SURVEY
In the mid 1970’s, this department, in collaboration with others, 
carried out a survey of all 45-65 year olds in Renfrew and Paisley. 
The project went under the name MIDSPAN. The survey population has 
been followed up in the subsequent period by notification of deaths 
from the central registry.
Last October, we applied to the GP Sub-Committee of Argyll & Clyde 
Health Board for permission to send postal questionnaires to a sample 
of patients; the Committee agreed to our request. Our aim is to 
assess the predictive value of a random blood glucose measurement for 
the subsequent development of diabetes.
We have now completed our patient survey and we wish to check the
accuracy ' of data obtained from the patient questionnaires. A 
summary of replies from your patients is enclosed. Would you be able
to confirm that the details we have been given are correct and add
amendments where necessary? All information will, of course, be 
handled with the utmost confidentiality.
If you wish to receive a summary of the results of this study when
completed, please tick the relevant box on the attached form.
We enclose a prepaid envelope.
Thank you very much for your help in anticipation.
Yours sincerely,
UNIVERSITY OF GLASGOW
Department of Community Medicine
enry Meehan Chair of Public Health & Head of Department 
rofessor A J Hedley MD FRCP FFCM
A.J. Hedley, 
Professor.
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2 Lilybank Gardens 
Glasgow G12 8QQ 
Telephone: 041-339 8855 
Direct Dialling: 041-330 5013 
Telex: 777070 UNIGLA
RBJ/27.
Dear Dr.
Argyll & Clyde Health Board 
Follow-up to MIDSPAN survey
We wrote to you recently to seek your help with this follow-up 
study of subjects at-risk of developing diabetes. A copy of our
original letter is enclosed. As we have not yet heard from you,
I hope you will not mind if we approach you once more with this 
reminder. We have had an excellent response from our general 
practitioner colleagues but would, of course, hope to make our 
sample complete.
I would be very grateful if you could find time to complete the
attached enquiry form and return it to us.
Thank you for your help.
Yours sincerely,
A.J. Hedley.
M
UNIVERSITY OF GLASGOW
Department of Community Medicine
Henry Meehan Chair of Public Health & Head of Department 
Professor A J Hedley MD FRCP FFCM
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TRENDS XU MORTALITY FROM STROKE JR. SCOTLAND
19.50 TO. 1 9 3 3  -
The purpose of this study was to compare stroke 
mortality trends in Renfrew and Paisley cohort and 
national basis to evaluate the effect of the hypertension 
control clinic established in Renfrew and Paisley on 
trends of stroke mortality. Due to the small number of 
stroke-related deaths in this cohort the stroke mortality 
trend could not be determined. However, for consistency of 
text this paper has been put in a separate 'appendix.
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TRENDS IN. MORTALITY EROM STROKE IN. SCOTLAND, 195.0 TO.
19.8-6.
SUMMARY: The Scottish Registrar General’s Annual Reports
have been used to study trends in stroke mortality in
Scotland during 1950-1986 in those aged 45 to 74-* In 1950 
the age-adjusted mortality rate for cerebrovascular
disease was 347*4 per 100,000 population for men and
360.8 for women falling to 199*6 for men and 155*8 for 
women in 1986; higher rates were observed at older ages 
for both men and women. This downward trend has
accelerated from 1976 for males. The average annual 
decline in age-adjusted mortality from stroke over the 37 
year period was 4.0 per 100,000 in males and 5*5 in 
females. This reduction in death rates was proportionally 
higher, in all age groups over 55 years, and in women
rather than men. There are no data documenting a decline 
in the prevalence of hypertension in the population, but 
both detection and the ability to treat and control 
hypertension have improved markedly over recent years. A 
concomitant decrease in the severity of epidemic 
respiratory infection, improved diet and social and 
economic changes, better diagnosis and treatment of stroke 
and associated hypertension, and a decrease in smoking may 
have contributed to the improvement in recorded death 
rates from stroke. Trends in mortality can be used in the 
evaluation of the impact of community based CVD prevention 
programme.
CONTENTS
Introduction
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INTRODUCTION
Cerebrovascular diseases are now the third leading 
cause of death in most developed countries and in addition 
lead to serious disability in the survivors. Analysis of 
mortality statistics undertaken in several countries 
during the past two decades suggests that deaths due to 
stroke are on the decline (335-338). This trend 
accelerated in the mid 196o*s in U.S.A. (339) and early 
1970 in Japan (340) but the reasons have not yet been 
fully explained. The decline could have been caused by a 
decrease in the incidence of stroke or improved survival 
rates or both. The most plausible explanation is that the 
incidence has fallen , although the evidence is as yet 
incomplete (340-342). Many workers attribute the decline 
to advances in the treatment of high blood pressure (343- 
345). Other factors suggested include changes in lifestyle 
and improvements in medical care (343). Antihypertensive 
drugs have been available since the early 1950s, although 
the range of agents and their acceptability have increased 
considerably over the past 15 years (346). In several 
countries the detection, treatment, and control of 
hypertension have improved considerably over the past two 
decades (344, 347). This report presents data on the
secular trends in stroke mortality in Scotland, during the 
period of 37 years from 1950 through 1986 and discusses 
possible causal factors.
POPULATION AND METHOD
Population: Between 1950 and 1986 a total of 71,031
men and 81,445 women aged 45 to 74 died from stroke. Table
419
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1 shows the total number of deaths from stroke by year of 
occurrence in Scotland. Death rates for persons aged 45-74 
were examined to assess the impact of premature mortality 
from stroke. On the other hand, because of the problems of 
diagnostic reliability in the elderly, deaths amongst 
people over 75 years have been excluded. People aged under 
45 are excluded from the analysis presented since the 
number of deaths is too small at these ages to form the 
basis of a reliable statistical analysis.
Method: The data on deaths for the years from 1950 to
1986 were obtained from the Registrar General's Annual 
Statistical Report for Scotland (Registrar General 1950- 
86). The Sixth Revision (1950 to 1958 ), Seventh Revision 
(1959 to 1967)* Eighth Revision (1968 to 1978) and Ninth 
Revision (1979-86) of the International Classification of 
Diseases and Injuries and Cause of Death (ICD) had been 
used for cause of death in mortality statistics. The Sixth 
and Seventh Revision rubric for stroke included ICD Nos. 
330-334, (Vascular Lesions Affecting the Central Nervous 
System) and was transferred, in the Eighth and Ninth 
Revision, to ICD Nos. 430-438 (Disease of Circulatory 
System, cerebrovascular diseases). The comparability ratio 
for the change of classification from the Seventh to 
Eighth and Eighth to Ninth Revisions was estimated as 
O .988 and 1.043 respectively by the Registrar General in 
Scotland (348). The comparability ratio was not used for 
this analysis and the data was considered as a part of 
continuous trend. The denominator population used was that 
calculated by the Registrar General on the basis of census
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data, updated yearly by the use of birth and death 
notifications and information on migration.
Regional variation: To examine regional variations in 
mortality trends from stroke, Scotland can be divided into 
four geographical divisions based on Health Board Areas. 
These are made up as follow.
North Division: Highland, Orkney Islands, Shetland
Islands.
West Division: Argyll and Clyde, Ayrshire and Arran,
Western Isles and Greater Glasgow.
East Division: Grampian, Tayside, Fife, Lothian, Borders. 
Central Division: Forth Valley, Lanarkshire, Dumfries and
Galloway.
Mortality data for each of the fifteen health board 
areas were combined to form the four geographical regions. 
The figures were extracted for each year from 1974-1986, 
taking into account the introduction of a new regional 
structure, making a thirteen year period in total.
ANALYSIS
Mortality rates were adjusted for age and gender by 
the direct method using the 1981 Scottish population as 
standard. Age adjustment was based on three age 
categories: 45-54, 55-64, 65-74. The entire study period
of thirty-seven years was divided into seven quinquennia 
and one 2 year period to investigate the rate of change 
in the observed trends. A least squares linear regression 
line was fitted for each gender for the entire thirty- 
seven year period and for each quinqennium (349, 350). T-
Tests were performed to ascertain whether the estimated 
slope of the line was significantly different from zero
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(350). Absolute and percentage changes in mortality were 
calculated by expressing the difference between first and 
last quinquennia as a percentage of the first quinquennia. 
The estimation of lives saved was made by multiplying the 
difference between the 1950-5& and 198O-8& age specific 
rates in 10 year intervals by the appropriate 1980-8& 
population and summing the number of deaths in each group.
RESULTS
Time Trends for All Causes of Death
Table 2 presents the age specific and age 
standardised mortality rates per 100,000 population, 
percentage changes, slope, and T in the age specific and 
age standardised rates from all causes, for both males and 
females for the period 1950-198&. In men aged I15-7II the 
age-adjusted mortality rate from all causes in Scotland 
tended to increase slightly until 1965 after which it 
started to decrease. The rate for females decreased 
consistently from 1950 showing a larger fall than males, 
compare to 12.3/0* As a result the male/female 
ratio increased from 1950 to 1975 and after that started 
to decline. The age specific all causes death rate 
increased with advancing age in both males and females 
with males having a higher mortality rate than females of 
the same age. The slope of the best fitting linear 
regression line of death rate over the period 1950-86 was 
statistically significantly different from zero for all 
ages and for men and women except men 65-7& years old.
Time trends for cerebrovascular disease mortality
Figure 1 shows the secular trends, in the age
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standardized and age gender specific mortality rates from 
stroke for men and women aged Z15-7&, on a semi-logarithmic 
scale so that proportionate changes can be compared 
between genders and age groups. Table 1 presents the trend 
in annual crude and age standardized mortality rates per 
100,000 population for the period 1950-86, also, the 
male/female age adjusted rate ratio for each subsequent 
year. Also, cerebrovascular disease deaths have fallen in 
both males and females when expressed as a percentage of 
all deaths for the period 1950-86. These downward trends 
are highly significant in both genders (PC0.0001). Table 3 
illustrates the absolute and percentage changes and slope 
of the age-adjusted mortality rate. In men the age 
adjusted mortality rate from cerebrovascular disease in 
Scotland, estimated by the slope of the linear regression, 
tended to increase slightly from 1950 to 1955, this 
increase was not significant, and after 1956 the slope of 
the linear regression started to decrease. This decreasing 
trend accelerated in 1976. The rate in females shows a 
reduction during 1950-86 and a larger fall than males. 
The average annual decrease was tl.O per 100,000 males and 
5-5 for females. Table ll and Figure 1 show the trend in 
mortality rates for the age-gender specific group and also 
Table li displays the decline in the six age-gender 
categories as indicated by the value of regression slope 
and T. The age and gender specific death rates increase 
with increasing age in both genders. A ten year rise in 
age is accompanied by about a three to fourfold increase 
in mortality. Apart from 1950-52 the rates are higher in 
males than in females. This differences is most pronounced
APPENDIX D
above 55 years of age. Rates are up to 33% higher in men 
than among women over 55 years of age, with the exception 
of 1950-52. Both of these findings are consistent with 
that found in other studies.
Change in trends: Rates for every age gender group
decreased with females experiencing the larger fall and 
the size of the decrease was statistically significant for 
all groups.
From 1975 to 1986 the fall in mortality accelerated 
in males. The percentage changes for the whole period of 
1950-86 was 56.8% in women and 4-2.5% in men.
Avoidance of premature death: The impact of the
falling mortality rates from stroke on premature death 
from 1950-54 to 1980-84, can be estimated by applying the 
1950-54 age specific rates to the appropriate age 
categories in 1980-84-. In the whole population, an 
additional 12,500 persons aged 45-74 would have died from 
cerebrovascular disease in 1980-84. if the 1950-54 rates 
had persisted.
Regional variation
Age-adjusted mortality trends in the four geographic 
regions of Scotland from 1974 to 1986 are presented in 
Table 5. The age-adjusted mortality rate from stroke were 
highest in central and west and lowest in the east region 
for all thirteen years of observation. These findings are 
compatible with other reports on regional variations in 
ischaemic heart disease and stroke in Scotland (20) and 
more widely throughout Britain (25)«
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DISCUSSION
The main finding of this study is a decline in age 
specific and age adjusted mortality rates from stroke in 
Scotland over the years 1950-86. This decline accelerated 
after 1975 for males and has resulted in the substantial 
saving of lives estimated at 12,500 in 1980-84, among the 
middle-aged population.
While being an invaluable data source for 
epidemiology, official mortality statistics may suffer 
some biases which should be taken into account. These 
errors are well documented (290, 353-356). If these errors
are constant in magnitude between years and between the 
subgroups of the population under consideration, then 
mortality data may furnish valuable epidemiological 
information, providing an inexpensive and convenient means 
of obtaining clues to aetiological hypotheses and 
determining consistency between hypothesis. Artifacts due 
to revision of International Classification of Disease and 
change in the diagnostic fashion must be taken into 
consideration in assessing the long term variations in the 
frequency of disease. In Scotland the autopsy rate is 
relatively low (333) and the diagnosis of cerebrovascular 
accidents is based purely on clinical evidence with 
usually no attempt being made to distinguish between 
cerebral haemorrhage and thrombosis. On the other hand, it 
has been concluded that although the sub-diagnosis (type 
of stroke) was unreliable, stroke diagnosis as a whole was 
consistent and reliable (332, 357). Consequently, no
distinction has been made in this paper. Epidemiological 
analyses of vital statistics data must always contend with
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the problem of their validity. The antemortem diagnosis of 
stroke rests primarily on the evaluation of signs and 
symptoms rather than on laboratory measurements (358). 
Furthermore, the observed clinical event localizes the 
site of the lesions rather than their cause. Other forms 
of cardiovascular disease particularly hypertension, often 
accompany stroke (243), and the designation of cause of 
death depends on the Judgement of the certifying 
physician. Diagnostic fashions in death certification 
change over time. The significance of secular trends of 
sub-types of cerebrovascular disease is especially open to 
question, given the difficulties often present in 
distinguishing between atherothrombotic brain infarction, 
embolism, intracerebral and subarachnoid haemorrhage (359, 
360). Even considering deaths, from cerebrovascular 
disease as a single entity, as was done in this report, 
the possibility exists that the burden of stroke deaths 
could have been shifted to other rubrics of cardiovascular 
disease classification (336, 359. 360). However, the
falling mortality trend seen in this study is consistent 
to the pattern of decline in stroke mortality in most 
industrial countries (343). Similarly the strong 
relationship with age in both males and females and the 
higher age specific mortality rates for males found in 
this study reflect the findings in some previous reports 
(335. 352). Since 1979 mortality from stroke has declined
every year for each gender; before that period the pattern 
was less consistent. A broad change in overall mortality, 
rather than an abrupt amelioration of any specific disease
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process leading to death from stroke could be responsible 
for this phenomenon, there has been decline in age- 
specific and age-adjusted all causes death rates from 1965 
in males and 1950 in females. A considerable change also, 
occurred in overall mortality in the same period but, 
change in stroke mortality is more marked. However, 
consideration of the differences between male and female 
trends and its comparison with trends in all causes 
mortality in the two genders suggest that at least part of 
the large declines registered in male and female 
cerebrovascular disease mortality may be due to a decline 
in overall causes of death and particularly respiratory 
infections decline. Change in mortality could result from 
a decline in the .number of high risk individuals in the 
population e.g. persons who suffered a non-fatal stroke, 
could in part , account for the fall in death rate from
respiratory infection. Environmental factors may be 
important determinants of both short and long term 
variations in mortality rates. For example the fact that 
mortality rates for stroke in 1979 are higher than for
neighbouring periods may be attributed to the severe 
winter of 1979. which in Scotland, brought the lowest
temperature and heaviest snowfalls since the winter of
1962/63 (348), and which was associated with high
mortality rates for many conditions. Similarly, the 
unexpectedly low rate in 1977 coincided with a mild 
winter, in which, the total hours of sunshine were above 
average in most areas. The west of Scotland had the 
highest totals for the year and in the Glasgow area the 
period May to August was the driest and sunniest since
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records began around 100 years ago (361).
The greater decrease in stroke mortality observed in 
women may be related to differences in the treatment rates 
between males and females. For example, in New Zealand 
more women than men are currently receiving 
antihypertensive treatment (347). Different risk factors 
may be involved in the pathogenesis of cerebrovascular 
disease (362). The most important risk factors are ageing 
and hypertension. The risk of dying from stroke is most 
clearly related to hypertension with a smaller 
contribution from the other established major 
cardiovascular risk factors (363. 364). The continued
decline in stroke mortality may be the result of more 
efficient treatment and effective control of hypertension, 
to reductions in the risk of stroke among persons with 
hypertension or a decline in hypertensive disease in the 
population secondary to changes in the risk factors for 
elevated blood pressure (336, 365). The possible
influence on secular trends of other potential risk 
factors for stroke such as raised serum lipids and blood 
glucose, oral contraceptives, diet and cigarette smoking 
has not been investigated systematically. Stroke Council 
Report suggest that these risk factors do not have 
consistently strong association with stroke (366), however 
this does not agree with our results based on a cohort 
study in Renfrew and Paisley in West of Scotland. In this 
study based on logistic regression model show that stroke 
mortality is strongly associated with age, blood pressure 
level, impaired glucose metabolism, cigarette smoking and
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negative association with obesity but there are no 
connections with serum cholesterol. Diabetes accelerates 
the atherosclerotic process, but there is a low relative 
risk of stroke in non-hypertensive diabetics (366). 
Furthermore, there is no evidence of a decline in the 
prevalence of diabetes and there is no evidence that major 
improvement in its management has resulted in a major 
decrease in mortality.
There has been an acceleration in the decline of 
tobacco consumption in Scotland since the mid 1970s (368- 
371). and a reduction in the use of cigarette with high 
tar content which, together, may contribute to the 
downward trend in stroke mortality. Changes in dietary 
patterns, including the general decline in the household
use of animal fats and refined sugar and an increase in 
the use of vegetable fats and margarine, have been 
discussed by flory et al. (371) in relation to heart
disease.
The mortality from coronary heart disease and
mortality from all cardiovascular disease are known to 
show considerable regional variation in Scotland (20, 
25). The rates are low in the east part of the country and 
gradually increase westwards and northwestward. Much less 
is known of the regional variation in morbidity and 
mortality from cerebrovascular diseases. According to this 
regional analysis, mortality from stroke is highest in 
central and west part of the country. There are, in 
general, higher rate in the west-central compared to the 
east side of the country for each consecutive year since 
1974.
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Stroke is primarily a disease of the elderly; in 1985 
65% of all stroke deaths occurred in persons age 75 and 
over. Neverthless, more than a third of fatal stroke 
events occurred before age 75, therefore detailed 
examination of the mortality trends for persons under the 
age of 75 is also warranted. With the extension of average 
life expectancy to 70 years for males and 75*8 years for 
female in 1985 in Scotland (350) death among persons under 
75 can be considered to represent premature mortality from 
a public health point of view.
In conclusion, the age-adjusted and age gender
specific death rate from cerebrovascular disease in 
Scotland has been decreasing since 1956. Improved care for 
different primary risk factors associated with stroke such 
as control of hypertension and change in the dietary 
habits and smoking have been proposed as the major reasons 
for the declining mortality. This suggestion is supported 
by several intervention studies showing that effective 
treatment of hypertension reduces cardiovascular
complications, particularly stroke (372, 373)* If the
observed age adjusted time trends for the mortality of 
stroke, show the same pattern in people over 75 as well, 
in the future this will have a great impact on the 
resources for health care. Particularly as in Scotland as 
well as most other industrialised societies, this group of 
patients consumes more resources in terms of hospital days 
than any other diagnostic group in departments of
medicine.
The observed age-adjusted time trends can be used to
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predict future patterns of premature death from stroke and 
to evaluate the additional impact, if any, of community 
based cardiovascular disease prevention programmes.
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TABLE l.Age Adjusted and Crude Death Rate Per 100,000 
Population and Number of Death from 
Cerebrovascular Disease and Stroke Death as a 
Percentage of all Deaths by Gender, Age 45-74, 
Scotland, 1950-1986.
Year No. of Age Adjusted Crude stroke as M/F Age-
Death Death Rate Death Rate a % of Adjusted
All Death Rate Ratio
Male Female Male Female Male Female Male Female
50 1985 2621 347. 4 360. 8 293. 5 318. 1 11. 5 18. 0 0 . 96
51 2107 2723 362. 5 369. 4 307. 4 331. 2 11.9 18. 2 0 . 98
52 2052 2641 357. 1 356. 1 296.9 318. 3 12. 1 18. 7 1. 00
53 2012 2552 357- 4 342. 8 292. 6 307. 2 12. 2 19. 3 1. 04
54 2024 2251 359- 1 365. 4 291. 0 268. 3 11. 8 20. 0 0 . 98
55 2082 2700 371. 1 357. 9 295. 4 318. 8 12. 2 19- 4 1. 04
56 2103 2600 370. 6 341. 0 296. 4 305. 0 12. 1 18. 9 1. 09
57 2039 2517 356. 6 326. 2 384. 4 292. 9 11. 6 18. 6 1. 09
58 2026 2653 352. 1 339. 9 279. 6 306. 7 11. 5 19. 3 1. 03
59 1952 2594 339. 9 329. 3 267. 4 297. 4 10. 8 18. 7 1. 03
60 2109 2405 361. 4 303. 4 286. 4 273. 9 11. 8 17. 7 1. 19
61 1965 2602 337* 2 325. 2 267. 9 296. 5 10. 7 18. 5 1. 04
62 I960 2364 334. 9 294. 7 267. 7 269.9 10. 7 17.3 1. 14
63 1941 2419 331- 1 295. 0 266. 5 275. 8 10. 0 17- 1 1. 12
64 2098 2454 360. 3 297. 2 288. 3 280. 7 11. 4 18. 2 1. 21
65 2038 2540 335. 5 303. 4 277. 9 288. 1 10. 7 18. 6 1. 10
66 2003 2427 322. 5 286. 0 271. 6 274. 1 10. 7 17. 5 1. 13
67 1896 2363 300. 0 275. 5 256. 9 266. 0 10. 6 18. 2 1. 09
68 1976 2333 308. 3 269. 3 266. 5 262. 6 10. 5 17.0 1. 14
69 2002 2358 307. 7 269. 4 269- 5 265. 4 10. 3 16. 8 1. 14
70 1957 2268 296. 6 257. 5 263.7 255.7 10. 0 16. 5 1. 15
71 2071 2257 311. 2 254. 8 279. 6 255- 0 10. 9 16. 9 1. 22
72 2155 2144 320. 4 239- 5 289. 2 240. 8 10. 9 15. 5 1. 34
73 2162 2153 317. 3 238. 0 289. 6 241. 1 10. 8 15- 8 1. 33
74 2083 2160 303. 4 238. 0 278. 9 242. 3 10. 6 15.7 1. 27
75 2134 2083 308. 6 228. 5 286. 6 234. 5 11. 0 15. 8 1.35
76 1991 2016 285- 9 221. 2 268. 0 227. 9 10. 1 14. 8 1. 29
77 1731 1854 248. 6 203. 9 233. 8 210. 7 9. 3 14. 2 1. 22
78 1770 1870 254. 5 205* 7 240. 4 214. 1 9. 2 13. 6 1. 24
- 79 1874 1888 270. 1 207. 7 256. 1 217. 9 9.7 14. 0 1. 30
80 1745 1627 251. 8 180. 6 239. 9 I89. 2 9.6 12. 7 1. 39
81 1688 1722 241. 0 192. 9 229. 0 200. 6 9.4 13. 3 1. 25
82 1563 1608 226. 9 181.1 214. 1 187. 9 8.7 12. 6 1.25
83 1509 1513 216. 9 172. 3 206. 9 177.6 8.7 12. 1 1. 26
84 1431 1416 213. 9 164. 2 197. 0 167. 3 8. 5 11. 8 1. 30
85 1449 1404 214. 9 162. 1 200. 2 166. 9 8.6 11. 5 1. 32
86 1348 1345 199. 6 155. 8 187.3 161. 2 8. 2 11. 4 1. 28
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TABLE 2.Trends in Age-Specific and Age-Adjusted Overall 
Causes Death Rates/100,000 Population , Scotland 
1950-86.
Year Male Female M/F Age- 
Adjusted 
:- Rate 
Ratio
1
/J-5-5^ 55-64 65-74 Adjus­
ted
Rate
45-54 55-64 65—74 Adjus
ted
Rats
50-54 980 2580 5690 2875 620 1480 4000 1880 1. 53
55-59 930 2530 5870 2891 540 1380 3760 1748 1. 65
60-64 930 2580 5950 2931 540 1310 3550 1664 1. 76
65-69 880 2460 5790 2825 540 1240 3300 1568 1. 80
70-74 890 2420 5810 2821 550 1270 3080 1520 1.86
75-79 880 2310 5590 2716 530 1270 2990 1487 1. 83
80-84 780 2150 5230 2521 470 1200 2930 1423 1.77
85-86 706 2079 5055 2420 402 1178 2943 1394 1. 73
Percentage Change Between 50- 54 and 80-84
-20.4 -16. 7 -8. 1 -12. 3 -24.2 -18. 9 -•26. 7 -24. 3 -
Slopef
-5.3 -13. 5 -14.8 -10. 9 -3. 3 -7.8 -■37. 3 -14. 5 -
t$ -5 .1**:—5 . 5**—2 . 0 -3. 5* -3- 1* -ti. 5**--11.8***-io.
SSlope of the regression line where the dependent variable 
is age specific or age adjusted rate and the independent 
variable is year.
*P<0.05, **P<0.01, ***p<o.001
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FIGURE 1.Secular Trends in the Age-Specific and Age-Adjusted M orta lity
Rates from Stroke. Persons U5-7U. Scotland by Sex. Rate Per 
100.000.
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TABLE 3.Absolute Changes$, Percentage Changes and Slope®, 
Age-Adjusted Mortality Rates Cerebrovascular 
Disease, Scotland, 1950-86.
Year Male Female
Change % Change Change % Change
in Rate in Rate Slope& t in Rate in Rate slope t
50-55 + 23.7 + 6.8 + 3. 1 +2.3NS — 2.9 -8 . 0 -1.1 -0.5NS
55-60 -9.7 -2.6 -4. 1 -1.7NS -54.5 -15. 2 -8 . 4 -3- 4*
60-65 -25. 9 -7. 2 -0 . 8 -0.2NS 0 . 0 0 . 0 + 2 . 5 +0.8NS
65-70 -38.9 -11. 6 -6.6 -3. 1* -45.9 -15. 1 -8 . 1 -6 .4***
70-75 + 12. 0 + 4. 0 + 1 . 0 +0.4NS -29. 0 -11.3 -5 . 6 # ysfc*
75-80 -56. 8 -18. 4 -9.3 -2.2NS -47. 9 -21. 0 -7.9 -4. 1*
80-86 -52. 2 -20. 7 -7. 9 -7.8*** -24. 8 -13. 7 -5. 5 -4.9**
50-86 -147.8 -42. 5 -4.4 -15.2***- 205. 0 -56. 8 -6 . 0 -36.l***
©Slope of the regression line where the dependent variable 
is age-adjusted rate and the independent variable is year. 
^Absolute changes in rates are expressed per 100,000 per 
year, see Table 1 for the actual rates.
*P<0.05» **P<0 .01, ***p<0 .001
NS=not significant
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TABLE 4.Trends in Age .Gender Specific Death Rates (Per 
100,000) and Measure of Change Over the Period 
1950-5& to 1980-84 from Cerebrovascular Disease, 
Scotland, 1950-86.
Year Male Female
Age at Death Age at Death
45-54 55-64 65-74 45-54 55-64 65-74
1950-54 67. 8 255.8 868. 5 78. 8 257. 6 845- 1
1955-59 57.1 240.5 890. 6 69. 8 236. 0 812. 2
1960-64 56. 3 228. 4 861. 0 60. 6 200.3 736.2
1965-69 51. 3 213. 7 778. 0 57. 0 184. 0 687. 6
1970-7& 53. 8 209. 0 764. 2 57. 2 163. 9 588. 5
1975-79 51. 2 184. 4 669. 6 48. 5 151. 6 501. 9
1980-84 42. 0 149. 0 576. 4 40. 2 116. 9 431. 4
1985-86 36. 5 134.3 517. 3 31.3 104. 1 390. 8
1950-54 To 1980- 84
% Change -38. 0 -41. 7 -33. 6 -49. 0 -54. 6 -48. 9
Slope§ -0.7 -3. 3 -10. 6 -1.3 -4. 3 -13. 8
t -6. 5* -12.2** -8.8** -11.2** -21.4** -20. 8«
@Slope of regression line where the dependent variable is 
age-specific death rate and the independent variable is 
year.
*P<0.001, **p<o.0001
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TABLE 5.Age-Adjusted and Percentage Change Mortality 
Rate, Cerebrovacular Disease, 1974-1986, four 
Regions of Scotland. Rate Per 100,000.
Region
Year Central West East North
No. of Death 
Death Rate*
No. of Death 
Death Rate
No. of 
Death
' Death 
Rate
No. of 
Death
" Deatl 
Rate
1974 794 302. 7 1670 262. 8 1600 248. 2 179 265.7
1975 747 281. 7 1720 276. 0 1400 215. 5 194 285. 8
1976 684 263.0 1496 258. 8 1464 219. 4 174 256. 7
1977 662 243. 4 1434 232. 1 1358 207* 8 151 219. 7
1978 669 244. 5 1448 235. 9 1373 210. 4 150 219. 6
1979 701 256. 9 1485 242. 2 1417 218.5 ' 159 235. 6
1980 657 239. 5 1270 208. 9 1298 201. 1 147 216. 2
1981 642 229. 9 1337 226. 7 1281 224. 9 150 203. 9
1982 569 203- 5 1266 216. 3 1187 179. 2 163 231. 1
1983 563 191. 6 1204 208. 9 1095 172. 2 128 182. 8
1984 482 174. 5 1135 201. 1 1101 176. 2 129 188. 1
1985 562 200. 7 1106 181. 0 1074 171. 0 111 160. 6
% changes
1974- 80 -20. 9 -20. 5 -19. 0 -18. 6
1980- 85 -16. 2 -13. 3 -15. 0 -25.7
1974- 85 -33. 7 -31. 1 -31. 1 -39. 5
*Age-addusted rate using the 1981 Scottish population.
